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Hematopoietic niches comprise the bone marrow (BM) microenvironment in which 
hematopoietic stem and progenitor cells (HSPC) reside and differentiate. These niches are 
made of several cellular and molecular components and recent studies have suggested that 
extracellular matrices (ECM) of BM stromal cells (BMSC) can support ex-vivo proliferation 
and differentiation of HSPC. Taking inspiration from what is known about the biochemical 
and structural constitution of BM niches, we have used a biomimetic approach to establish 
conditions that mimic the extracellular microenvironment of the niche and use them for ex-
vivo HSPC expansion in a cell free culture system. 
Our cell free culture system comprises an acellular matrix (ACM) substrate derived by 
the decellularization of human bone marrow stromal cell line (HS-5). Using these HS-5 
derived ACMs we analysed the role of atmospheric oxygen (O2) in determining the 
composition of the ACMs and its effect on their ability to support ex-vivo HSPC growth and 
differentiation. ACMs were prepared from HS-5 cells cultured in two atmospheric O2
concentrations- 20%O2 and 5%O2. The biochemical comparison of these ACMs indicated a 
significant loss of specific ECM components, such as collagen, laminin and fibronectin, in 
ACMs prepared at lower O2. Better and enhanced expansion of committed and early HSPC 
was observed on ACMs made at 20% O2 as compared to those made at 5% O2. In ACMs 
prepared at 5% O2, we could also observed the activation of certain regulators and inhibitors 
that could quantitatively or qualitatively alter the properties of the ACM and thus affecting 
their functional efficiency. 
The RNA expression profiles of HS-5 cells, grown under low and high O2 conditions, 
gave us a clearer understanding of the molecular changes that were induced by the change of 
O2 levels in the stromal microenvironment. The comparative RNA profiles showed that the 
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most affected biological process by change in O2 levels in HS-5 cell cultures was “ECM 
remodeling” as reflected by the up regulation of ECM genes in 20% O2 and up regulation of 
the ECM proteolytic enzymes; matrix metalloprotinases (MMPs) in 5% O2 condition.  
We used the above information to improve the efficiency of HS-5 derived ACMs for ex 
vivo expansion of HSPC by inducing biochemical and structural modifications in them. 
Biochemical modifications, leading to increased quantities of ECM components in the ACM, 
were induced by either by adding TGF-ȕ to HS-5 growth medium or by inhibiting the 
proteolytic activity of MMPs through a MMP inhibitor. Specific and significant improvement 
in the ACM’s efficiency for expanding HSPC was observed in MMP inhibited ACM, where 
the expansion of both committed early progenitors and primitive HSC was significantly 
higher. 
Structural modification of HS-5 ACM was done by using the spin coating technique and 
preparation of thin layers of HS-5 derived ACMs on glass or plastic surfaces. These spin 
coated ACMs exhibited unique surface topographical features, and were significantly better 
in supporting ex vivo HSPC expansion as compared to native ACMs. 
In summary, this thesis discusses a novel strategy for ex vivo expansion of human HSPC 
in a cell free culture system and it suggests methods to improve the functional properties of 
stromal cell derived ACMs to support ex-vivo HSPC growth.
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Hematopoiesis is a steady biological process of balanced production of all blood cell 
types and other components. It occurs in specialized tissues such as fetal liver (FL), spleen 
and bone marrow (BM). All the cell types formed during hematopoiesis are derived from 
hematopoietic stem cells (HSC) that have been studied and characterized extensively in the 
last five decades. HSC have the capacity to self renew as well as differentiate into different 
blood cell lineages of, and they can repopulate the hematopoietic tissues that have been 
ablated by high doses of radiation. Detailed understanding of the basic biological and 
functional properties of HSC has led to the development of experimental cell based therapies 
of mainly hematological diseases including leukemia, aplastic anemia, hemoglobinopathies, 
immune and metabolic diseases.  
Some of these basic properties of HSC are described here-  
Self-renewal –HSC have the ability for self-renewal and subsequently can differentiate 
to multipotent lymphoid and myeloid lineages. In order to maintain the stem cell pool, the 
process of asymmetric cell division occurs, where, one of the daughter cells remains 
undifferentiated. However, during the course of differentiation, these HSC loose this property 
of self-renewal and become committed. These lineage committed cells are known as 
progenitor cells [1]. Based on their repopulation capacity, HSC are categorised into short 
term (ST) HSC and long term (LT) HSC. Both these types of progenitor cells can give rise to 
all blood cell lineages but ST-HSC are limited in their renewal capacity, while LT-HSC self-
renew for the life time of the organism[2].  
Multipotency –The primitive HSC differentiate and give rise to multipotent common 
myeloid and lymphoid progenitors. Lymphoid progenitors further differentiate to T-
lymphocytes and B-lymphocytes, whereas myeloid progenitors differentiate into 
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erythrocytes, neutrophils, monocytes, macrophages, dendritic cells, eosinophils, basophils, 
megakaryocytes, and platelets [1].  
Heterogeneity – The HSC are heterogonous cell populations and can be lymphoid or 
myeloid biased, but this heterogeneity of HSC is not contributed by their inherent self-
renewal property. Also, single cell level examination of HSC show that daughter HSC from a 
single clone behave in a similar pattern and have similar repopulation capacity to generate 
myeloid or lymphoid lineage cells [3].
HSC detection – HSC can be detected and enumerated reliably by advanced technologies 
based on cell surface markers from a mixed population of cells. However, they are difficult to 
isolate in the absence of surface markers based identification. The injection of isolated HSC 
into irradiated animal is still considered the most reliable and gold standard method of HSC 
identification. If the animal survives and the newly formed/derived blood cells appear from 
the donor HSC then these cells are considered true HSC having functional stem cell 
properties.
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Hematopoiesis is a developmental process for the generation of all types of blood cells 
and occurs in more than one anatomical site in the mammalian system. Based on its 
occurrence in the anatomical site, hematopoiesis is classified as fetal (primitive) and adult 
(definitive). The fetal hematopoiesis is initiated in the yolk sac, followed by migration to the 
liver and finally to BM, where the initiation of definitive hematopoiesis happens/occurs. 
Hematopoiesis is sustained in the BM for lifetime of the organism. The extra embryonic yolk 
sac has been demonstrated to be the site where first blood cells have been observed. 
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In mouse, the embryonic yolk sac is developed on the 6th day of gastrulation and at 7.5 
days the hematopoiesis occurs in this location[4]. At day 10, first definitive HSC appear in 
AGM region (aorta –gonad mesonephros) located adjacent to the embryonic dorsal aorta and 
at day 11.5 HSC seed the FL and colonize, which is thought to be derived from AGM and the 
placenta. After E12.5, FL serves as the main organ for HSC expansion and differentiation 
until late fetal development and by the time of birth hematopoiseis migrates to the BM and 
establishes for the life time [5]. The BM is the site of adult hematopoiesis and HSC 
maintenance in mammals (Figure 1-1). 
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Hematopoiesis in mammals is initiated during embryonic development and is sustained 
during post-natal development and throughout the adult life. During this course, the 
hematopoietic tissue undergoes significant changes in its spatial and structural organization. 
An important feature of adult hematopoiesis is that it occurs in a hierarchical manner where 
several cell types and sub cell types are generated from common progenitor cells as indicated 
in Figure 1-2.  
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Earlier reviews on this subject [7], have shown that mature blood cells are derived from 
two different progenitor cell populations - Common Lymphoid Progenitors (CLP) and 
Common Myeloid Progenitor (CMP) cells. Lymphoid lineage cells include T, B, and natural 
killer (NK) cells, while myeloid lineages include megakaryocytes and erythrocytes as well as 
granulocytes and macrophages (GM). Under normal physiological conditions, no overlapping 
of progenies of CLP and CMP can be seen [8].  
The current classification of cellular hierarchies in the BM HSC is based upon different 
types of cell-based assays. The immunophenotypic assay uses flow cytometric analysis of 
cell surface markers with monoclonal antibodies and classifies HSC on a non functional basis 
[9], whereas in-vitro and in-vivo colony forming unit (CFU-c and CFU-s respectively) assays 
and the long term repopulation assays (LTRA) determine the self renewal and proliferation 
capacity of HSC [10]. 
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During the course of cell differentiation HSC go through extensive cell surface 
modification, which becomes the basis of their immunophenotypic characterization.  
Human Markers: The cell surface markers for identification and purification of human 
HSC by FACS analysis includes a number of cluster of differentiation markers (CD), for 
instance the most primitive human HSC is identified as CD34+ CD90+ with no expression 
for lineage specific markers[11] Some other groups have identified human primitive HSC in 
the CD34+CD38-/lo fraction[12] [13]. In addition to the markers discussed above, CD45RA 
is also used for identification of primitive HSC as- CD34+CD38-CD90+CD45RA- cells [14]. 
The human multipotent progenitor cells are identified as Lin-CD34+CD38-CD90-c-kit lo 
Flt3L CD133+ CD45RA- in FACS analysis. CMP and CLP cell surface markers are 
CD34+CD38-CD7+CD10 +CD45RA+ and Lin-CD34+CD33+ respectively. Further in the 
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cellular hierarchy of HSC comes the progenies of the CMP 
(erythrocytes,graulocytea,megakaryocytes and macrophages ) and CLP (B cell, T-cell, NK-
cell), these cells are more differentiated in nature, are committed to a particular cell lineage 
and are identified by presence of lineage specific markers in FACS analysis. For example, B 
lymphocytes are CD45+, CD20+, CD24+,T lymphocytes- CD45+, CD3+ and cells of 
myeloid lineages like erythrocytes CD71+ [15], megakaryocytes-CD42b+ , granulocytes-
CD45+, CD15+, CD24+, CD114+, CD182+- and macrophages CD45+,CD68+ (Table 1-1). 
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Colony Forming Units (CFU) Assays - were first described in 1966 by Bradley and 
Metcalf in murine system and in human by Pike and Robinson in 1970, as a short term in- 
vitro quantitative assay for the measurement of differentiation potential of lineage restricted 
progenitor cells [16]. The assay allows the growth of clonal progeny of single progenitor cells 
in semi solid media of agar or methylcellulose. These cells proliferate in response to specific 
cytokines and growth factors, resulting in clusters or colonies with distinct features and 
morphology based on cell type.  
Specific assays are termed CFU-GEMM, CFU-GM, CFU-E, CFU-G and CFU-M [17]. A 
description of these assays is given in Figure 1-3. The CFU-GEMM is the most primitive 
progenitor cell which forms multilineage colonies of granulocytes, erythrocytes, monocyte 
and macrophages on semi solid media in presence of the hematopoietic growth factors 
(HGFs) such as IL-3 [18]. 
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CD34+ CD34+    
CD38- CD38-    
CD90+ CD90-    
CD45RA- CD45RA-    
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Pre-B-
lymphocytes 
Pre-T-
lymphocytes 
Nk cells  
CD34+ CD34+ CD34+ CD56+  
CD38- CD45+ CD45+   
CD90- CD20+ CD3+   
CD45RA- CD24+    
    


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Megakaryocyte 
Progenitor 
Erythroid 
Progenitor 
Granulocyte 
Progenitor 
Granulocyte/ 
Monocyte 
Progenitor 
CD34+ CD34+ CD34+ CD34+ CD34+ 
CD38- CD38+ CD38+ CD38+ CD38+ 
CD133+ CD133+ CD133+ CD133+ CD133+ 
CD45RA- CD45RA+ CD45RA+ CD45RA+ CD45RA+ 
Flt3+ Flt3+ Flt3+ Flt3- Flt3- 
CD42b CD71 CD45+, CD15+, 
CD24+, 
CD114+, 
CD182+ 
CD45+, CD68+. 
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Erythroid-committed progenitors form two distinct types of colonies termed CFU-E and 
BFU-E. In the presence of erythropoietin (EPO) CFU-E divide rapidly and give rise to single 
erythroblast colonies, whereas BFU-Es are generally slow dividing cells and give rise to 
larger colonies of erythroblasts [19]. The immature slow dividing BFU-E differentiates in to 
intermediate mature BFU-E and then to fast dividing CFU-E cells. CFU-GM are the 
progenitor cell for granulocytes and macrophages and give rise to single lineage-committed 
progenitors, CFU-G and CFU-M, under the influence of colony stimulating factors such as 
GM-CSF, G-CSF and M-CSF. The biological process of generation of megakaryocytes and 
platelets is known as megakaryocytopoiesis. Colony forming units of megakaryocytes (CFU-
MK or CFU-Meg) are unipotent in nature and in presence of thrombopoeitin (TPO) give rise 
to mature megakaryocytic cells [20]. 
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In-vivo Colony Forming Unit assay-Spleen (CFU-s) - is an in-vivo functional assay for 
quantification of the proliferative potential of multipotent HSC. Till and McCulloch were the 
first to establish the CFU-s assay to identify primitive progenitor cell populations in mouse 
BM cells that can form colonies of erythroid cells, megakaryocytes, granulocytes and 
macrophages in the spleen of irradiated animals [21]. CFU-s not only exhibit multilineage 
potential but have also shown to have high self renewal capacity, as a single CFU-s cell can 
produce more CFU-s[22]. CFU-s is a heterogeneous cell population with each cell exhibiting 
a different renewal capability. Cells which form colonies in the irradiated spleen at 8th day 
are termed as CFUs-8 and are less proliferative, whereas, cells which form visible colonies at 
12th day are termed as CFUs-12 and considered as more proliferative [22]. 
Long Term Repopulation Assay (LTRA) is an in-vivo measurement of the repopulating 
capacity of HSC and along with its variants is one of the most widely accepted assays. LTRA 
measures the capacity of HSC to provide lifelong reconstitution of all blood-cell lineages 
after transplantation into lethally irradiated recipients. Secondary, and even tertiary, 
transplants can be performed to demonstrate both self-renewal and multi-lineage 
differentiation capacity [23]. 
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The hematopoietic niche concept, first formulated by Schofield in 1978, proposes that 
HSC occupy a specific microenvironment composed of the supporting cells surrounding the 
HSC. The cellular and molecular signals emanating from cells, and the ECM , act in synergy 
to sustain HSC in the niche [24]. The best understood model of hematopoietic niche is in the 
murine marrow where hematopoiesis occurs mainly in the trabecular bone of the epiphyseal 
region (Figure 1-4). In this model, HSC are shown to be located in two types of specialized 
niches called the endosteal/osteoblastic niche and the vascular niche. In humans, 
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hematopoiesis occurs in the shaft (diaphyseal) as well as the epiphysis regions of the long 
appendicular bones and in the ribs. In older people, hematopoiesis is observed mainly in the 
vertebral bones. To understand how the hematopoietic niches might work, it is first important 
to review the architecture of the bone and BM.  
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BM, the soft tissue that fills the cavities of hard bones, is the major site of hematopoiesis 
in adult mammals [25]. With advancements in our knowledge about the spatiotemporal 
organization of the marrow and availability of more information regarding the molecular and 
cellular composition of the hematopoietic microenvironment, many facts about the 
localization of hematopoietic cells and regulation of their linage specific differentiation are 
becoming clearer. For example, the existence of specific cellular and molecular boundaries 
and barriers that define the exclusive location of hematopoietic progenitor cells in the marrow 
cavities is now known. These progenitor cells lie in close proximity with many other cell 
types such as, osteocytes adipocytes and mesenchymal cells [26]. It is also known that 
marrow tissue in the shaft region of long bones harbours progenitors of mainly the adipocytes 
lineage whereas the marrow in the epiphyseal region in the same bone is richer with 
progenitors of hematopoietic and osteogenic lineage. The spatial organization of this region 
and the osteo-hematopoietic niche are shown in Figure 1-4 where we can clearly notice the 
structural distinction between two hematopoietic regions (a) endosteal niche and (b) the 
vascular niche. The former is linked with the endosteum and shows overlapping zones 
between osteogenesis and hematopoiesis whereas the latter is seen in the stromal part of the 
marrow, linked to the blood vessels external lining and it shows exclusively hematopoietic 
progenitors. 
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The BM is a specialized soft and spongy tissue that fills the cavity of the cancellous 
bone. The cellular constituents of BM include hematopoietic islands, adipocytic cells, stromal 
cells and vascular tissue (endothelial cells, smooth muscle cells) [27]. 
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The cellular constituents of the marrow are embedded in an ECM that contains collagen 
fibers, matrix proteins, glycoproteins and proteoglycans. At the endosteal surface, bone 
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forming cells secrete specific matrix (osteoid) that interacts with calcium salts to form 
hydroxyapatite and mineralized bone matrix [28].  
The HSC niche is a complex system where a balanced interaction between a number of 
different cell types and an ECM takes place. The functional constituents of the niches vary 
throughout the marrow space, together with physicochemical factors such as variable calcium 
content and O2 levels. Studies of stem cell niches in non-vertebrates such as Drosophila 
melanogaster, revealed several specific features [29-31]. These reports have shown that the 
hematopoietic niche provides a) signals for stem cell self renewal and cell survival, b) 
supports their asymmetric cell division [26, 32] c) anchors HSC in proximity to the 
extracellular self renewal and cell survival signals [33, 34] and physicochemical factors such 
as nutrient supply and O2 levels d) also helps in stem cell regulation [35]. Thus, components 
of a stem cell niche provide not only the structural and mechanical support, but they also 
deliver specific 3D topographical information and physiological cues to the HSC regarding 
the availability of mobilized and immobilized growth factors that are vital to stem cell 
functions[36].
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HSC are arranged in a spatial manner in the BM, with the slow dividing/quiescent cells 
localized near the endosteum and more differentiated cells towards the central region [37]. 
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The quiescent HSC are maintained in the slow cycling state by the endosteal /osteoblastic 
niche [38], which provide anchorage though cell-cell interactions and inhibit HSC 
differentiation [39]. Growth factors and cytokines produced by the niche cells act on HSC to 
regulate the self-renewal. It has been demonstrated that HSC near to the endosteum are more 
capable of in-vivo and in-vitro hematopoiesis than the cells from the other regions of the BM 
[40]. Various components of the endosteal niches have been shown in Figure 1-5 and their 
functional role has been listed in Table 1-2 Together, this information demonstrates that HSC 
maintenance within the endosteal niche is a complex process mediated by a diverse set of 
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cellular and acellular interactions. Such multiparameter regulation of HSC maintenance and 
growth ensures that a single factor cannot evoke total loss of the HSC pool. 
dĂďůĞϭͲϮZĞŐƵůĂƚŽƌƐĂŶĚĐŽŵƉŽŶĞŶƚƐŽĨĞŶĚŽƐƚĞĂůŶŝĐŚĞ
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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Angiopoietin-Tie2 interactions  [41] 
Thrombopoietin, Mpl receptor  [42] 
stem cell factor (SCF), cKit receptor 
Stromal derived factor (SDF-1/CXCL12), 
CXCR-4 [43] 
[43] 
Transforming growth factor beta (TGF-ȕ), TGF-
ȕ R  
[44] 
Fibroblast growth Factor (FGF), FGFR1-4 [45] [45] 
Parathyroid hormone (PTH) 
Signalling Pathways 
Canonical Wnt-frizzled signalling [46] 
Notch signalling  [47] 
Jak-Stat signalling [48] 
Hedgehog (Hh) signaling pathway [49] 
Bone morphogenic protein (BMP) signalling [50] 
Adhesion molecules 
VLA-4 [51] 
VCAM-1 [52] 
N-cadherin  [39] 
Physio-Chemical gradients 
HIF-1Į/O2 gradient   [53] 
Ca++ ions, calcium-sensing receptor [54] 
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The observation that HSC also reside at a distance from the endosteum[55] and the 
capacity of HSC to self renew and differentiate during fetal development, even before the 
creation of BM cavities, indicates that niches other than osteoblastic niche can also regulate 
HSC fate. Within the BM, HSPC are found adjacent to vascular sinusoids, termed the 
vascular niche. Hematopoietic cells within the vascular niche are in active cell cycle, and 
have a lower repopulation capacity. It is therefore important to understand the differences 
between the two niches. Various cellular and molecular components of vascular niches are 
shown in Figure 1-6 and the functions of the components has been listed in Table 1-3. 
dĂďůĞϭͲϯZĞŐƵůĂƚŽƌƐĂŶĚĐŽŵƉŽŶĞŶƚƐŽĨǀĂƐĐƵůĂƌŶŝĐŚĞ
 

VEGF-VEGF Receptor  [56] 
Ang-1-Tie2 Receptor [57, 58] 
Fibroblast growth Factor (FGF), FGFR1-4 [59] 
SDF-1 –CXCR4 signaling  [60] 

Notch Signaling  

M-CSF, G-CSF, GM-CSF, TGF-ȕ, BMP-2A, ȕ-
FGF IL-6, IL-11, IL-13  

PECAM E and P selactins [61] 
VCAM-1(Vascular cell adhesion molecule)  [62] 
I-CAM (Intercellular cell adhesion molecule)   [62] 
VE-cadherin [59] 
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The vascular niche is more oxygenated and contain HSC which are differentiative in 
nature compared to the less oxygenated quiescent endosteal niche [63]. Vascular niche cells 
are heterogeneous in their cellular nature. Precise cellular components and niche-derived 
factors regulating HSC in the vascular niches remain unclear. The blood vessels that define 
the vascular niche are thin walled sinusoids [63] and the sinusoidal wall consists of a single 
layer of fenestrated endothelial cells. The integrity of these sinusoidal cells is maintained by 
the surrounding niche components including HSC. Sinusoidal cells allow trafficking of HSC 
into and out of the BM and provide cues for self-renewal, survival, and differentiation [58]. 
Recent advances in HSC purification have enabled in situ imaging of HSC and possible 
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endothelial niches [64]. In the BM, 60% of the cells, were observed to be close to sinusoidal 
endothelium [65].  
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One prominent model linking the endosteal and vascular niches proposes that the 
endosteal niche provides a microenvironment suited to quiescence and HSC maintenance, 
while the vascular niche promotes proliferation and differentiation [63]. While the endosteal 
and vascular niches differ in many fundamental aspects, there are also common components 
in both, such as reticular and stromal cell populations. CXCL12-abundant reticular cells 
(CAR cells) which have been demonstrated to maintain the stem cell pool and regulate HSC 
trafficking by CXCL12/CXCR4 have been shown to be present in both the endosteal and the 
vascular niches, indicating that both share some common features [43]. Similarly, endothelial 
cells, the major cellular component of vascular niche, are also scattered throughout the BM 
and can be identified in the endosteal region where they could be important for osteogenesis 
as well as vasculogenesis [66, 67]. The role of Notch signaling and angiopoietin-1 (Ang-1) 
mediated regulation of HSC has been demonstrated in both niches. Studies done by Jung 
group show that Annexin II (Anx II) is expressed by both OBs and endothelial cells. While 
Anx II mediated adhesion between HSC and OBs has been studied, Anx II mediated, 
endothelial cell-HSC interaction is yet to be investigated [68]. 
These components of endosteal and vascular niches in BM are the intrinsic factors that 
regulate the in-vivo maintenance and expansion of the HSC population throughout life, and 
also regulate the balance of cell proliferation and differentiation. Therefore, ex-vivo
expansion requires the presence/addition/incorporation of many extrinsic factors including 
recombinant growth factors, co-culturing with feeder cells, growing on different substrates 
etc. section 1.3 contains the detailed discussion of ex-vivo HSPC expansion. 
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Until now, the technologies and methodologies applied for the ex-vivo expansion of HSC 
remain limited in number, and largely dependent on the use of known growth factors. The use 
of HSC in treating haematological abnormalities and cancers by transplantation and stem cell 
based therapies has increased remarkably in last three decades [69]. Therefore, ex-vivo HSC 
expansion is required not only to meet the ever-increasing demand of allogenic or autologous 
stem cell transplantation but also to understand the basic biology behind the stem cell 
regulation. 
Ex-vivo expansion of HSPC is achieved in many different ways, for example, co-
culturing with supporting stromal cell population, using a well-defined culture medium, 
transfecting with transcription factors, adding cytokines, and culturing in a bioreactor etc. 
The resulting stem cell expansion utilizing different methods is yet to be fully optimized, 
because it still does not mimic the exact nature of the BM niche or microenvironment. The 
limited number of sources to isolate HSC like BM, umbilical cord blood (UCB) and 
mobilized peripheral blood (MPB), technical difficulties associated with the tissue source and 
small number of stem cells present in these tissues can make it a difficult to get enough stem 
cells for transplantation and stem cell therapy. Regardless of the limitations, the role of new 
factors and regulators in specific lineage expansion can be understood only by expanding it in 
ex-vivo conditions. There is constant pressure on clinicians and researchers to invent new 
improved and advanced methods to improve number of HSC or HSPC mainly to be used in 
transplantation therapies, which is possible by ex-vivo expansion.  
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PB, UCB, and BM are the major sources of HSC. The harvested cells from all these 
sources are routinely used in transplantation process, gene and stem cell based therapies. 
BM – BM is considered as first and classical source of HSC [70], it is believed that less 
than 1 in 100,000 cells in BM have repopulating capacity. The HSC reside in BM 
predominantly in a quiescent state. HSC are harvested under general anaesthetic from the 
donor by aspiration mainly from the iliac crest in some cases, from the sternum and are either 
infused back into the same patient (autologous) or into a different person (allogenic) or from 
a twin donor to a twin patient (syngenic). The infused cells proliferate and initiate new blood 
cell formation. BM transplantation process restores hematopoiesis or stem cells in the 
patients whose stem cells were damaged because of chemotherapy. 
UCB– In late 80’s the importance of the UCB and placenta, as a rich source of HSC was 
understood by researchers and clinicians. It serves as an alternative source for HSC other than 
BM [70]. The cord tissue is delivered with the new born, and discarded as a biological waste. 
In recent times, the UCB units are cryopreserved extensively, which serves as a source to 
isolate stem cell later when it is required. The preserved cells can be used in autologous 
transplantation and therapies related to hematological disorders. Stem cells from UCB are 
more primitive when compared to BM stem cells and the immune cells in UCB cause less 
graft versus host disease (GVHD). Available data suggest that 30% of non –related 
transplantations are done with UCB derived HSC. In one study, it was reported that UCB 
from unrelated donors could restore hematopoiesis in patients although they do not have 
identical HLA match [71]. More than 70 malignant and non-malignant diseases have been 
treated using UCB derived HSC/HSPC for example sickle cell, leukemia, and non-Hodgkin's 
lymphoma.  
ŚĂƉƚĞƌϭͲ/ŶƚƌŽĚƵĐƚŝŽŶ
Ϯϭ

MPB- A small number of proliferating HSC are always present in blood circulation, 
which is becoming the choice of source for transplantation procedure in recent times. In order 
to increase the number of HSC in SHULSKHUDO circulation, the resident HSC of the BM are 
mobilized by the administration of cytokine-G-CSF. The cells isolated from MPB are twice 
the number isolated from the BM, and are easy to harvest and transplant and the survival rate 
is high as compared to HSC isolated from BM. 
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To improve the clinical outcome of autologous and allogeneic HSC transplantation many 
groups are focusing on ex- vivo expansion of HSC particularly in cases with a limited graft 
size. Unfortunately, the expansion of HSC in-vitro is difficult to achieve because their 
proliferation is accompanied by differentiation and the cells lose their stemness over the 
increased culture time. One of the reasons for this could be the absence of inductive 
microenviromental signals that are provided by the niche in-vivo conditions. New approaches 
are being investigated using feeder cells, novel growth factors, transcription factors, special 
culture media etc to improve ex-vivo HSC/HSPC expansion. The methods mentioned in this 
part of the section can be categorized as 2D culture condition, as they do not incorporate use 
of 3D scaffolds. 
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The microenvironment of BM –HSC niche comprises of stromal cells along with the 
other cellular components. The interaction of HSC with the stromal cells in BM regulates its 
behavior and directs stem cells to take a cell fate decision. BM stromal cells (BMSC) are 
known for their stem cell growth supporting properties and are routinely used as feeder 
layers. These stromal cells help in creating a niche like environment and supports stem cell 
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growth, proliferation, and survival in in-vitro conditions. Long back in late 70s Dexter’s 
experiments revealed that stromal cell mediated cell to cell contact is crucial for HSC 
expansion [72]. In the late 90s, one group demonstrated that, two permanent BMSC lines 
possess feeder capacity and maintain clonogenic cell proliferation of B cells, and produce a 
variety of HGFs including IL-6, IL-7, IL-8, IL-10, IL-11, kit ligand, LIF, GM-CSF, G-CSF 
and M-CSF and cell lines were capable of supporting long-term culture of normal primary 
hematopoietic progenitor cells [73]. Mikkola el al showed that OP9 a BMSC line preserves 
the stemness of HSPC if co-cultured, and prevents differentiation [74]. Till now the plastic 
adherent BMSC were considered supportive for HSC expansion, but very recently a group 
has proved that non adherent BMSC human mesenspheres promoted enhanced expansion of 
cord blood CD34+ cells through secreted soluble factors [75]. 
MSCs, have unique multi differentiation property, and support HSC maintenance and in 
a co-culture system. MSCs facilitate HSC growth through the secretion of soluble factors and 
cell-cell contact. MSCs have been used as feeder cell layer to co- culture HSPC, and mainly 
to understand the changes in the surface markers and functional properties occurring in cell 
during the course of expansion. Stro-1(+) MSCs cell line is used as an universal and 
reproducible stromal feeder layer for efficient HSC expansion. The stromal cells established 
from the embryonic cells (UG26-1B6) expands HSC and preserves the stem cell property by 
secreting wnt5a [76].  
Stromal cells feeder layers from human embryo liver cell lines (BAEP2W and 
BAEP2SV40), and conditioned media from the BM and cord tissues enhanced expansion of 
middle term clonogenic cell growth of HSC [77]. In one approach, Lemnischka and co-
workers used a cell line derived from clonal cell population of a stromal cell line (AFT024) 
and were successful in maintaining the HSC up to 4-7 weeks [78]. During the developmental 
hematopoiesis, HSC are found in different anatomical sites and tissues, other than the BM, 
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first in AGM, then in yolk sac and FL. Each anatomical site differs from other in their 
microenvironment components, which influences their stromal cells ability to support HSC 
growth and function. The BMSC fail to support FL derived HSC in ex-vivo condition and 
induce apoptosis [79]. AGM on the other hand regardless on developmental stage and 
anatomical location is known to increase the number of HSC when co-cultured with it [76]. 
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Ex-vivo expansion of HSC, requires a use of culture media that have great potential value 
for the reconstitution of normal and altered hematopoiesis , and can be scaled up to a large 
scale expansion after careful investigation [80]. As discussed earlier the HSC niche in BM 
comprises of many cellular and molecular components. The soluble, secretory cytokines, 
growth stimulators or the inhibitors secreted by BM cells influences the expansion of HSC in-
vivo. The understanding of molecular mechanism by which the soluble factors regulate the 
stem cell behavior led to the formation of specialized cell culture medium for ex vivo HSC 
expansion. Large numbers of multilineage progenitor cells can be obtained if cultured with 
specialized condition media supplemented with specific growth stimulating factors or 
cytokines. HSC expanded with culture media loses its pluripotent nature with the longer 
culture time and differentiates to terminally differentiated cells, in order to maintain the 
pluripotency of the cultured cells for a longer period, the role of novel cytokines and growth 
factors are being investigated. Recent advancement has been made to prepare a cytokine 
containing media that maintains the HSC in more proliferative state and prevent its extensive 
differentiation. The goal of using specialized media supplemented with specific growth factor 
depends of the type of lineage expansion. Most extensively used HGFs along with serum or 
serum free media are- SCF, TPO, IL-6, Flt3-L. 
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Stem cell factor (SCF), also known as steel factor, binds to c-Kit, a tyrosine kinase 
receptor. C-kit receptor is expressed by HSC. SCF prevents apoptosis; almost all the HSC 
expansion media contain SCF [81].  
Thrombopoeitin (TPO) is the primary cytokine involved in megakaryocytic and platelet 
development, they promote survival of HSC in in-vitro culture and contributes to both 
generation and expansion of HSC during definitive hematopoiesis[82]. 
Interleukin 6 and 3 (IL-6, IL-3) - are the growth factors secreted by a number of cells 
and are involved in evoking a number of biological activities. They stimulate the clonal 
growth of granulocyte and macrophage progenitor cells, IL-6 was shown to synergize with 
IL-3 in stimulating the growth of multipotential hematopoietic progenitor cells in BM. IL-6 
interacts with IL-4 and specifically enhances the growth of megakaryocytic, erythroid, 
myeloid and multipotential progenitor cells [83].  
FMS-like tyrosine kinase 3 ligand (Flt3-L) - The Flt3-L is a member of a small family 
of growth factors that stimulate the proliferation of HSC/HSPC [84]. 
Palsson’s group used a combination of HGFs, IL-3, GM-CSF, and EPO for ex-vivo
expansion. Rapid and regular exchange of culture media with these HGFs resulted in the 
extensive expansion and proliferation of long term BM myelopoiesis [85]. Suzuki group used 
the combination of HGFs and a chimeric protein (SCF, TPO, Flt3-L, IL-3, IL-6/sIL-6R, and 
Delta 1,) in a serum free culture media to expand cord blood cells which resulted in 6 fold 
increase in SCID-repopulating cell (SRC) number [86]. In recent times, there have been 
remarkable increases in the use of novel and functional bio molecules, which have HSC 
growth supporting potential. Bone morphogenic protein (BMP) is member of TGF-ȕ family, 
and supports ex-vivo HSPC expansion mostly by modulation of sonic hedgehog pathways 
[87]. HSC express receptor for Fibroblast growth factor (FGF) on their cell surfaces, both 
FGF1 and FGF2 are known to induce expansion of HSPC in serum free culture conditions 
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[88]. The novel growth factors of angiopoietin family bind to the Tie-2 tyrosine kinase 
receptor. Angiopoietin growth factors are important in angiogenesis. Tie-2/Ang-1 signaling 
pathway plays a critical role in the maintenance of HSC in a quiescent state in the BM niche 
[41]. Lodish group used DNA arrays to identify novel HGFs, by employing this method they 
investigated the role of regulators like Insulin growth factor-(IGF2)[89], angiopoietin like 
proteins (ANGPTL7, ANGPTL5) [90] and microfibrillar associated proteins (MFAP4).
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The ECM of the stem cell niche provides structural integrity, anchorage for the cell, 
initiates many signal transduction events and acts as a store for cytokines and growth factor 
present in the niche, making them readily available to the cells [91], thereby influencing the 
HSC expansion also both in-vivo and ex-vivo. The cellular adhesion of HSC to the ECM 
inhibits cell differentiation and prevents apoptosis [92]. In particular, the relative elasticity or 
stiffness of the microenvironment can directly modify stem cell differentiation decisions [93]. 
The extracellular domain of many ECM-interacting cell surface proteins is involved in cell-
cell and cell-matrix interactions and the cytoplasmic domains are involved in mediating 
signal transmission to the cells. Polarized attachment to support cells or to the ECM through 
junction complexes, or asymmetrically localized factors within the niche, can provide cues 
that orient stem cell division and/or specify different cell fates for stem cell progeny [94]. 
ECM proteins there are three main classes of ECM proteins - structural proteins such as 
collagen and elastin, specialized proteins such as fibronectin and laminin, and proteoglycans. 
Histochemical analyses have revealed that the ECM components fibronectin, collagen I, III, 
and IV, laminin, and various proteoglycans are major components of BM, and can directly 
affect HSC [95]. Gene knockout studies in mice have been useful in understanding the roles 
of ECM molecules in HSC regulation [96]. 
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Laminins (LMN) - These heterotrimeric extracellular proteins regulate cellular adhesion 
through integrin- receptors, and deletion of the gamma chain results in defective basement 
membranes in mice. HSC show similar binding affinity to laminin and fibronectin. The 
adhesive properties of laminin isoforms can affect the migration of HSC in-vivo [97]. The 
laminin and fibronectin coated plates in the presence of growth factors, show approximately 
800 fold expansion in CFU colonies, CFU-GEMM [98]. 
Fibronectin (FN) is a high molecular weight adhesive glycoprotein containing many 
binding domains that can bind to structural regions of other cells, and shows binding affinity 
for integrins, collagens, and proteoglycans. FN has been shown to play a dual role where it 
supports the adhesion as well growth of HSC. CD34+ cells pre- treated with FN show 
enhanced cell adhesion, specifically with FN fragments containing the CBD (cell binding 
domain) and HBD (heparan binding domain). FN pre-treatment also resulted in better 
expansion of CFU-GM and BFU-E [99]. The adhesion and growth supporting activity can be 
inhibited by cellular interaction inhibitors [100].
Collagen (COL) is required for the structural integrity of the stromal microenvironment 
of BM in-vivo, and type I or type IV COL are key components of basal lamina. A culture 
system made of HSC, MSC and collagen fibrils constructed by Schneider et al resembled the 
endosteal niche of BM to a certain extent and supported expansion of lineage committed cells 
and immature CD34+ CD38− cells [101]. The selective inhibition of BMSC derived collagen 
with specific inhibitors results in the reduced proliferation of stromal cells and hematopoietic 
progenitor cells [102]. 
Proteoglycans are specialized glycoproteins that usually carry glycosamino-glycans 
(GAGs). GAGs are important in cell signaling due to their unique location on the cell 
membrane and in the ECM [103]. Agrin proteoglycans expressed by mesenchymal cells and 
OBs have been shown to regulate cell survival and proliferation of HSC. HSC express a cell 
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surface receptor for agrin. The growth-supporting role of agrin is supported by studies in 
agrin deficient mice, which show phenotypic defects in cell survival and defective 
hematopoiesis [104]. Proteoglycans like heparan sulphate (highly sulphated 
glycosaminoglycan) expressed by BMSC support hematopoiesis by localizing the cytokines 
on the stromal surface. Proteoglycans can function both in soluble and insoluble forms. 
Heparan sulphate glycoprotein along with growth factors like IL-3 and SCF enhances the 
cellular adhesion of progenitor cells in BM and interaction with thrombospondin specifically 
enhances the adhesion in CFU-GM and CFU-GEMM [105].  
Matrix metalloproteinases (MMPs) are zinc dependent proteolytic endopeptidase 
involved in the degradation of number of ECM proteins. Different types of MMP participate 
in the BM ECM remodeling and regulate release of bound cytokines and HSC from BM into 
the circulation. For instance, MMP9 releases membrane bound kit ligand factor and enhances 
kit ligand mediated HSC mobilization [106]. 
Tissue inhibitors of metalloproteinases (TIMPs) are natural inhibitors of MMPs and 
active regulators of ECM remodeling. TIMP1 and TIMP2 do not affect or alter in-vivo
hematopoiesis however, quantitative PCR studies demonstrate 10 fold up regulation of 
TIMP3 expression in stromal cells of the endosteum in comparison to other regions and has 
been shown to regulate HSC proliferation and trafficking [107].  
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The ultimate goal of HSC expansion systems is to replicate key aspects of the HSC niche 
that promote self-renewal over differentiation. Although there have been extensive studies 
devoted in achieving a better understanding of the soluble factors, transcription factors, the 
niche or microenvironment and the mechanism(s) by which they regulate the stem cell 
behavior, it is only recently that a understanding has been developed about physical and 
mechanical factors involved in regulation of HSC self-renewal, lineage specification and 
expansion. In Table 1-4 some of the artificial culture system for ex-vivo HSC/HSPC 
expansion are listed. 
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3D,tantalum-coated porous biomaterial 
(TCPB)[108] 
1.5-fold expansion of HSPC numbers 6.7-fold 
increase in colony-forming ability  
3D,tantalum-coated porous biomaterial 
(Cytomatrix)[109] 
CD45+,CD34+ cells increased 3-fold. 
increase in the frequency of CD34+,CD38-
cells, CD34(+)CD133(+) cells and CD34+ 
CD61+ cells
carboxylic acid functionalized single 
walled carbon nanotubes (f-SWCNT-
COOH)[110]
expansion of HSPC, CD45+CD34+CD38-
 population, and GM colonies 
3D culture system polymer particles 
with grafted epoxy-polymer-chains 
[111]
Long term expansion and maintenance of 
HSPC  
3D culture system Hydrogel cultures of 
placental MSCs [112] 
growth of CD34+ cells in 3D-cultures
3D fibrin scaffolds [113] Higher cell proliferation rates, adhesion, cell 
migration and engraftment efficiencies of 
HSPC
3D scaffold conjugated with FN[114] 100-fold CD34+ expansion 
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Three factors are important in the artificial 3D microenvironment, 1) the stem cells itself 
2) scaffold or the substrate surrounding the stem cells and, 3) the media used for expansion 
[115]. Many biomaterials have been investigated for their potential for HSPC expansion, such 
as TCPS, polyethylene (PE), high-density PE (HDPE), polycarbonate (PC), PET, cellulose 
acetate, Teflon fluorinated ethylene propylene (FEP), glass, polysulfone (PS), Teflon 
perfluoralkoxy (PFA), polymethylpentene (PMP), barex (polyacetonitrile-methylacrylate), 
polypropylene (PP), acetal (polyformaldehyde), cellulose acetate, titanium, aluminium, and 
stainless-steel 316 and 304 [116]. None of the above-mentioned material has been considered 
as a superior substrate for expansion. Surface topography, surface stiffness, shape and 
structure of this culture system may influence the cellular behaviour. There are several 
biological products available that can be used to make bio-scaffolds, often coated with one or 
more multiple functional proteins.  
These functional proteins belong to the BM microenvironment are known for their 
growth inductive properties. Matrigel has been used to culture MSCs, BM cells, neuronal 
cells etc since long time because it mimics the more or less exact nature of the basement 
membrane niche [117, 118]. Cytomatrix has developed a 3D culture system made up of 
biomaterials coated on tantalum. This 3D culture system expands human BM derived HSPC 
in culture media without added growth factors [109]. In another study one group has used 
hydroxylated, carboxylated and animated nano-fibres and films for UCB CD34+ expansion 
and show approximately 50 fold increase in the total expansion as compared to the TCP 
[109]. 
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The concept of stem cell niches has been used in the tissue-engineering field to prepare 
bioengineered 3D scaffolds for the purpose of ex vivo HSPC expansion[119]. Although many 
inorganic biomaterials have been used for this application [120, 121] the use of cell-free 
acellular matrix ECM (ACM) as biological scaffolds for tissue engineering has been less 
common[122]. The use of ACM as 3D scaffolds or 2D substrates has increased in recent 
times. Structural support, and the biological signals provided by the ECM components of 
ACM have proved particularly helpful in co-culturing and organ recellularization 
experiments. ACM are prepared by decellularizing whole tissues or in-vitro cultured cells 
(Figure 1-7). Most of the ACM scaffolds are used in tissue engineering approaches in order to 
repair the damage to the tissue, such as cartilage, skin, bone, bladder, blood vessels, heart, 
liver, lung and etc [122]. 

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Cultured in-vitro cells secret ECM that can be harvested by treating the monolayer cells 
with decellularizing agents such as detergents or alkali solutions. Cell monolayers are easy to 
decellularize, and once decellularized can be stored for a longer time, whereas decellularized 
organ or whole tissue have storage limitations. The ACM prepared by the cultured cells 
contain a range of ECM molecule, GAGs, proteoglycans etc (Figure 1-8). 
 Use of tissue/Cells decellularization provides numerous benefits, including:  
•  Allows researchers to investigate the ECM products and its effectiveness when using 
a new decellularization technology  
• Comparison of different ECM products;  
•  Minimising the variations in the ECM products so that they do not cause any adverse 
reaction to the host  
•  Developing new and advanced clinical applications utilizing ECM products within 
the field of regenerative medicine and tissue engineering [123] 

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Decellularization is the process of the removal of nuclear and cellular content leaving 
behind the ECM, in tissue or cells. There are many different types of decellularization agents 
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available, but their usage depends on the type of tissue, cellularity, density, thickness and 
lipid content [123]. ACMs are prepared in such a way that after decellularization the 
functional proteins of ECM, GAGs and proteoglycans remain 90-95% intact. There are many 
different methodologies available for whole tissue or cell culture decellularization which may 
be categorized as mechanical, physical, chemical and enzymatic (Table 1-5). All these 
methodologies have their own advantages and disadvantages, and in many instances, one or 
two different approaches are combined to get efficient decellularization. Most of the 
decellularization procedure can remove the nuclear content but can also have adverse effect 
by modifying the biological activity of the matrix and can alter its ultra structure.  
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Published reports suggest the important role of physical properties of substrate in stem 
cell lineage specification and fate determination [124]. Substrate stiffness, surface roughness, 
surface energy, elasticity, thickness are critical factors of any tissue engineer substrates. 
Matrix stiffness or elasticity - Matrix stiffness is the measurement of its elasticity, which 
can be soft or rigid. In artificial matrix culture system the stiffness depends on the percentage 
of cross linking agent used. Softer matrices mimic brain tissue elasticity (0.1-kpa) and the co-
cultured cells can be diverted to acquire neuronal lineage differentiation, intermediate 
 
Physical treatment  Agitation , sonication  
Mechanical treatment Mechanical pressure , freeze thaw 
Chemical treatment Alkali, acid, detergents, organic solvents, chelating 
agents, hypotonic solutions 
Enzymatic methods Proteases , nuclease enzymes 
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matrices (8-17kpa) support myogenic lineage while rigid matrices (25-40 kpa) mimic the 
collagenous bone microenvironment[125]. In a report, it was shown that hematopoietic cell 
line KG-1a seeded on fibronectin coated hydrogels of varying stiffness adhered better and 
migrated faster on harder substrates [126].
Structural topography- ACM derived from the cultured cells may have variations in 
their fibrillar structure and surface topography and substrate thickness- With use of AFM the 
thickness of the ACM can be measured, the thinner the measured sample, harder substrate. It 
is considered that the thinner matrix substrate reaches the higher elasticity modules and 
mimics the rigid bone microenvironment. 35 kPa is the greatest degree of stiffness that the 
HSC experience in the endosteal niche [126]. 
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ACM can provide biological cues that alter the behavior (proliferation, differentiation 
and survival) of cells co-cultured on it. Examples of cells that have been expanded on cell-
free matrices include MSCs, neuronal cells [127], osteogenic cells and hepatic cells derived 
from murine embryonic stem cells. In one of the studies, researchers used porcine brain 
derived ACM as a coated surface to culture neurons derived from human iPS cells, which 
resulted in the expression of neuronal makers. They also studied the ECM profile of the brain 
derived matrix and concluded that it is rich in glycosamino-glycans and contains COL I, COL 
III, COL IV, COL V, COL VI, perlecan (PLC), and LMN [128]. One study showed that 
MSC-derived ACM contains major ECM protein like COL types I, III, and V, syndecan-1, 
PLC, FN LMN, biglycan (BGN), and decorin (DCN), similar to native BM ECM. This ACM 
supported MCFU (mesenchymal colony forming units), which failed to grow on untreated 
tissue culture plates as colonies, suggesting that ACM provides an inductive environment, 
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which supports the growth of MCFS [129]. MSCs derived ECM has shown to support 
neuronal cell adherence and growth [127].
Decellularized human amniotic membrane has also been investigated, both for use as a 
surgical patch and for in-vitro cell culture [130]. The decellularized amniotic matrix 
contained all major structural components of the matrix, including COL type IV and I, LMN, 
and FN and was found to be biocompatible with no decrease in cell viability after incubation 
with soluble tissue extracts. The ACM of amniotic membrane had great tensile strength, 
extensibility, or elasticity even after decellularization. Listed below are ACM derived from 
various types of cells and its tissue culture application (Table 1-6). 
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There are very few reports on the use of ACM as a substrate for ex-vivo HSPC 
expansion, and none of these deal with the use of whole ECM as a substrate, focussing 
 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Chick embryo Fibroblast [131] Cell culture substrate  
Alveolar epithelial cells [132] Basement membrane model, primary 
hepatocyte culture, tracheal cell culture 
HEK293 cells [133] Pancreatic lineage differentiation of ES 
cells 
Osteoblast-like SAOS-2 [134] Ti coating for bone implantation 
Mesenchymal stem cell [135] culture system for expanding large-
scale highly functional human 
mesenchymal stem cells 
Chondrocyte [136],[137] Chondrocyte monolayer culture, 
Scaffold for implantation 
Adipogenic mesenchymal stem cell 
[138] 
Adipogenesis of mesenchymal stem cell
Mouse stromal cells –MS-5 [80] Ex-vivo expansion of human HSPC 
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instead on the use of one or two ECM proteins which are coated on tissue culture plastic 
(TCP)`. One group has used micro wells coated with COL type I to expand UCB derived 
CD133+ cells. In another study, coatings of FN, heparin sulphate and tropocollagen I, 
hyaluronic acid, and co-fibrils of COL type I with heparin or hyaluronic acid was used to the 
analyse the adherence of human CD133+ HSPC in-vitro and suggest the design of advanced 
culture carriers supporting site-specific proliferation or differentiation of HSPC [139]. 
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Ex-vivo expanded HSC and HSPC are being used as a source of transplants to treat the 
patients suffering from hematologic disorders and malignancies. It is very important to 
understand the molecular mechanism to improve the methodology for the ex-vivo expansion 
of HSC to procure sufficient number of stem cells to meet the ever-increasing demand of 
HSC. Ex vivo expansion of HSC/HSPC are now routinely used in clinical practices and a 
variety of therapeutic applications. These possible applications include: a) development of 
effective stem cell therapy for hematological disorders, b) supplementing expanded HSPC to 
shorten the time to hematopoietic recovery after chemotherapy or transplantation, c) 
expanding HSPC from a single marrow aspirate or aphaeresis to reduce the need for large-
scale marrow harvest or multiple leukapheresis, d) generating sufficient HSPC to improve the 
engraftment kinetics of UCB. 
Non Malignant Diseases- Sickle cell anaemia and ȕ-thalassaemia in which the red blood 
cells (RBCs) get damaged because of genetic abnormalities, have been cured by transplanting 
ex-vivo expanded HSC combined with gene therapy[140]. Successful clinical trials have been 
reported in case of ȕ-thalassemia, where ex-vivo expanded cells have been transduced with 
globin gene [141]. Nine patients suffering from alcoholic liver cirrhosis were recruited in a 
clinical trial, where ex-vivo expanded autologous CD34+ cells were injected in hepatic artery. 
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There were no treatment related side effects observed in the follow up [142]. The use of ex 
vivo expanded Treg cells has also proven to improve clinical outcomes in Type 1 diabetes 
[143], the destructed B cell have been successfully treated by cord blood derived expanded 
cells [144].  
Malignant Diseases- Ex-vivo expanded HSC and HSPC were also proved efficient as 
therapeutic options for malignant diseases also. A cytokine and tetraethylenepentamine 
(TEPA)-based ex-vivo expansion trial is currently being investigated. The transplantation 
methodology involves infusion of either two unmanipulated UCB units or one unmanipulated 
unit and one ex-vivo expanded unit in to the patients having high-risk hematologic 
malignancies. The expanded cells were preclinically selected for CD133 using CliniMACS 
and were cultured with media supplemented with cytokines (SCF, G-CSF and TPO) for 14 
days. The median time taken for engraftment in patients was much lesser in the patients who 
received unmanipulated unit combined with expanded cells as compared to the two 
unmanipulated units. The overall percentage survival at two years observed with expanded 
cells was also much higher than the unexpanded and unmanipulated cells [145]. In another 
UCB expansion approach similar to ex-vivo expanded peripheral blood progenitor cells 
(PBPC), a rapid and engraftment of neutrophil engraftment was reported following infusion 
in adult recipients [146]. 
A clinical trial at phase I is also being investigated to assess the efficiency of progenitor 
cells of UCB expanded in the presence of the Notch ligand, Delta1, and their role in the rapid 
engraftment in the patients suffering from leukemia. In this case the progenitor cells were 
selected preclinicaly for CD34 before culturing with defined culture media containing Notch 
ligand Delta1 and serum-free media supplemented with SCF, TPO, Flt3-L, IL-3 and IL-6. 
Cultured cell were harvested for infusion after 16 days. The cell dose derived from expanded 
cells grafts was significantly higher in average number as compared to the non expanded cells 
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graft. There was no toxicity observed after infusion and transplantation with expanded cells. 
The follow up study show that out of ten, seven patients survived with no post transplantation 
diseases [147]. The ex-vivo expanded T cells derived from the UCB grafts have been 
successfully used in transplantations as infusions in cases of malignant relapse [148]. MSCs 
have been routinely used as feeder cells to expand HSPC as they closely mimic the BM 
microenvironment. In a report Shpall et al have used co-cultured MSC and CB progenitor 
cells and show expansion of the progenitor cell population, this experimental results are now 
being translated in a successful clinical trials, by combining a unmanipulated CB unit with a 
unit that has been expanded for 14 days in the presence of cytokines (SCF, Flt3-L, G-CSF, 
and TPO), on either family member donor derived MSCs. The results show a net 40-fold 
expansion of CD34+ cells and a median time to neutrophil and platelet engraftment of 15 
(range 9-42) and 40 (range 13-62) days respectively. No toxicities were observed after 
transplantation with the expanded cells [149]. 
Use of ex-vivo expanded HSPC in clinical trials and transplantation has experienced both 
success and failure. Although there are a number of clinical trials going on to test the efficacy 
of ex-vivo expanded cells to be used as infusion in transplantation, still many unanswered 
queries persists which requires a careful attention. The main difficulties in HSC expansion
are engraftment ability of the expanded progenitor cells and the exact replication of the in -
vitro observations into efficient and successful in-vivo transplantation outcome. Further 
development and improvement is required in preclinical engraftment models that use 
expanded, manipulative or non-manipulative cells as infusion. Improvement in cell culture 
methodology protocols are required which do not alter the long-term engraftment potential of 
the cells during culturing and the development of methodologies to expand HSPC aiming to 
improve cell-based therapies for diseases and disorders is important.  
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 Excessive differentiation- Excessive differentiation is the major setback in ex-vivo
HSC and HSPC expansion. Many experimental procedures find it difficult to control cell 
differentiation under in-vitro conditions [150]. The lack of the best combination of regulatory 
factors for ex vivo expansion that do not alter self-renewal capacity results in the high 
percentage of unsuccessful transplantation in patients and bigger animal models. The 
methodology used in ex-vivo expansion requires the addition of certain growth factors in the 
culture media, which may induce defects in case of long-term culture and ultimately may 
cause transplantation failure if used as infusion [151]. In some of the cases its reported that 
the expanded cells induce and promote apoptosis [152], disturb stem cell homing in BM 
[153] and initiate cell cycling [154].
Problems with source and timing of the transplantation- Since long, UCB has been 
used as an alternative source to procure stem cell for transplantation. In clinical practices, the 
UCB is kept preserved as a single unit and only a fraction of cells are expanded, rest of the 
cells are often kept unmanipulated. For ex-vivo expansion, the cells are cultured at least for 2 
weeks, resulting in infusion later than the unmanipulated cells. Discontinuity in the infusion 
or unavoidable expansion phase may significantly affect the efficiency of the engraftment, to 
overcome this difficulty, use of multiple UCB products is suggested, where one unit can be 
used for expansion and can be combined with a second, unmanipulated product such that 
both products can then be infused on the same day of the transplant. In high volume UCB 
transplant programs, timing of expansions can be an obstacle logistically. In order to 
overcome such challenges, the stem cell laboratory has to be adequately equipped with work 
force and supporting technology. 
Graft contamination- The manipulated cells products like expanded cells may carry 
infections. Progenitor cells may contain pathogens or microorganisms, if in low level they are 
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not of clinical relevance in the transplantation but if these cells are cultured for the expansion, 
the microorganism can reach to significant level and may cause graft contamination and 
ultimately graft failure [155]. In Table 1-7 various types of culture systems, their modality 
and limitations of their use has been listed.  
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In our lab, previously we have used ACM from MS-5 (mouse stromal cells) cells that 
mimic the BM niche-like conditions and support the ex vivo expansion of human HSPC. 
HSPC expansion of MS-5 ACM showed optimal expansion of HSPC. These results provide a 
new methodology for the ex vivo expansion of human CD34+ cells on heterologous cell-free 
biological scaffolds. Thus, the findings are helpful in understanding the biochemical 
organization of HSC niches, and also suggest the possible design of bioactive and biomimetic 
surfaces for ex-vivo HSPC expansion[80]. By utilizing the informations obtained through 
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Extrinsic supplementation of 
growth factors to 
simulate in-vivo conditions 
Cost, extensive differentiation, loss 
of primitive phenotype  
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provide a biological scaffold 
that effectively mimics bone 
Can be labour-intensive 
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conserved signaling pathway 
controlling cell fate 
determination 
Coating of tissue culture plates with 
immobilized Delta 
ligand adds time and cost 
ͶȏͳͷͺȐ role in stem cell self-renewal Short half-life of protein 
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persuades cells to self-renew 
rather than differentiate 
Cost, frequent addition of 
Supplement 
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mouse system, we improved the efficiency and clinical applicapability of this cell free culture 
system by deriving ACM from human stromal cell line. The overview of the work has been 
described in the following section as outline of the thesis. 
ͳǤͶ 
This study describes a novel methodology to expand UCB derived HSPC on human 
stromal cell derived ACM. The study aims at efficient replication of the extracellular 
component of the BM niche, also to establish and achieve optimum expansion of HSPC on a 
cell free culture system. It has been suggested that loss of ECM components in the niches can 
alter HSPC behavior in-vivo; these alterations have been also observed in the in- vitro culture 
system of TCP surfaces. The presence of ECM molecules such as fibronectin and collagen 
which normally bind the soluble factors and present them to the cell in the correct 
conformation have been reported to enhance the HSPC expansion in- vitro [160].  
In this thesis, I have established a cell free culture system by decellularization of 
human stromal cell line (HS-5) for enhanced expansion of human HSPC. These ACM were 
also used as culture substrate to understand the role of important niche regulators such as 
molecular (TGF-ȕ, MMPs) and physicochemical factors (O2) on HSPC growth and 
expansion.  
Chapter-2, lists all the materials and the general overview of the methods used to 
carry out the work. 
Chapter-3, focuses on preparation and characterization of HS-5 ACM and its use as 
substrate to expand UCB CD34+ cells. HS-5 cells were cultured under different O2
conditions and were treated with NH4OH to prepare ACM. ACM thus prepared were 
morphologically and qualitatively by phase contrast microscopy, SEM, biochemical staining 
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and immunofluorescence stainings. The functional properties of HS-5 ACM prepared from 
two different O2 conditions, to support HSPC expansion were assessed. The MACS sorted 
UCB CD34+ cells were cultured on HS-5 ACMs and functionality of the expanded cells were 
analysed by colony forming unit assays and purity was checked by flow cytometry. 
Functional and biomarker characterization of both pre and post-expanded HSPC was done by 
flow cytometry and colony forming assays to calculate the fold change of the expanded cells. 
This chapter mainly focuses on understanding the role of O2 in the regulation of niche ECM 
components, that in turn influences the HSPC growth and expansion.  
Chapter-4, mainly focuses on molecular profiling by gene expression analysis of HS-
5 cells grown under different O2 conditions of matrix preparation, to find the candidate genes 
that are responsible for differential HSPC expansion response. The microarray results were 
validated using qRT-PCR. The data thus acquired, was analysed using various tools such as 
MetaCore, DAVID, GOEAST, EGAN to identify the specific regulators and biological 
pathways that were maximally affected in HS-5 cells due to change in O2 tension. 
Chapter-5, focuses on the induction of modifications in biochemical and structural 
properties of HS-5 ACM to get even better and efficient ACM substrate for ex-vivo HSPC 
expansion. The modifications in the HS-5 ACM properties were induced to understand the 
mechanism of regulatory actions of important BM niche components. 
For the biochemical, modification of ACM experiments, two important niche 
regulators (TGF-ȕ and MMPs) were chosen from the data obtained thorough molecular 
profiling by gene expression analysis of HS-5 cells of different O2 conditions. The 
modifications were induced by the addition or inhibition of these regulators in HS-5 cultures 
and ACM were prepared through decellularization. 
For structural modification experiments, the surface topology of the HS-5 ACMs were 
modified from thick ACM to thin film ACM by using spin coating technology. Physical, 
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biochemical and topographical characterization of these modified ACM was done and ability 
to support HSPC expansion was also analysed. 
Chapter-6 concludes the findings of the work and gives some future directions to this 
project.
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This thesis describes the use of ACM derived from human BMSC in different cell culture 
conditions, for the ex-vivo expansion of human UCB CD34+ cells. The research focuses on 
the characterization of a Human stromal cells line (HS-5), its decellularization to prepare 
ACM, isolation of UCB CD34+ cells, and ex-vivo expansion of UCB CD34+ cells on the HS-
5 ACM. Using the ACM role of O2 in regulation of stromal matrix properties and its effect on 
HSPC expansion was understood. The gene expression profile of HS-5 cells in different 
culture conditions was analysed by m-RNA profiling microarray studies. Finally, an attempt 
to induce compositional and structural changes in ACM of the HS-5 was done to improve 
functional properties of HS-5 ACM. In this chapter, we describe the general methodology 
along with the materials used in carrying out these studies.  
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Ethylenediamine tetra acetic acid (EDTA), Trypan 
Blue, Alcian blue, protease inhibitor cocktail, 
Trichloro aceticacid (TCA), proteomics grade trypsin, 
agarose, β-mercaptoethanol, BSA, ethidium bromide, 
Tris base, tricine, Proteinase K, Triton X-100, SDS, 
Acrylamide, Bis-acrylamide and Actinomycin D, 
Stemline II serum free media and cell culture grade 
Dimethyl sulfoxide (DMSO) 
Sigma-Aldrich, St. Louis, 
http://www.sigmaaldrich.com 
DTT, dNTPs, Reverse Transcriptase, RNAse OUT 
and PCR components. Alpha-minimum essential 
media (Į-MEM), fetal bovine serum (FBS), 
Penicillin/streptomycin (Pen/Strep), Glutamax, TGF –
ȕ 1, Dulbecco’s Phosphate buffered saline without 
magnesium and calcium, pH 7.2 (DPBS), 0.25% 
trypsin/EDTA 
Invitrogen, Carlsbad, CA, 
http://www.invitrogen.com.  
Thrombopoietin (TPO), stem cell factor (SCF,), 
interleukin-6 (IL-6), Flt3 Ligand (Flt3L) growth 
factors were from Millipore, Bedford, MA, USA. 
MMP III inhibitor  
Calbiochem,  
EMD Biosciences, San Diego, 
CA 
Methocult media-H4434  Stem Cell Technologies, 
Vancouver, BC, Canada 
Ficoll–Paque plus GE Healthcare Bio-sciences 
AB, Uppsala, Sweden 
NH4OH Solution  SRL, Mumbai, India. 
SYBR Green ABI- Applied biosystem. 
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AutoMACS and MidiMACS Miltenyi Biotec Inc, Germany 
FACS Calibur Flow Cytometer Becton-Dickinson Biosciences, USA 
Forma Series II And Hepa Class 100 
Incubators 
Thermo Fisher Scientific Inc., 
Rockford, IL 
Hemocytometer Hausser Scientific, PA, USA 
Automatic Cell Counter Sceptor Milipore, USA 
Biological safety Cabinets ESCO, Germany 
Centrifuges 5810 R And 5417 R Eppendorf, Germany 
Fourier Transform Infrared Spectroscopy-FTIR FTIR- Alpha T BRUKER, USA 
WS-400 6NPP-Lite Spin Coater Laurell technologies Corporation, USA 
Coolsafe 110-4 Pro, SCANVAC FREEZER 
DRYER 
Scientific Laboratory Supplies, UK 
Axioplan-2 And Live Cell 200M Carl Zeiss, Germany 
Scanning Electron Microscope (SEM)- 3400N Hitachi, Japan 
Confocal Laser-Scanning Microscope-AOBS Carl Zeiss, Germany 
Atomic Force Microscope Nanonics Micro Imaging, Israel 
Nanodrop® ND-1000 Nanodrop Tech., Delaware, USA 
ABI 7900 HT Sequence Detection System ABI PRISM, California, USA 
Protein Gel Apparatus Hoefer, Inc., MA,USA 
Multiskan Spectrum ELISA Plate Reader Thermo Fisher Scientific Inc. , 
Rockford, IL 
Thermanox cover slips , 24 well plates, 6 well 
plates, round 30mm, 60mm, 90 mm culture 
dishes, T25, T75 culture dishes, freezing vials 
Thermo Fisher Scientific, Rochester, 
NY 
CPDA blood bags SPAN diagnostics, Mumbai  
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MACS CD34 Microbead Kit Miltenyi Biotec Inc. Germany 
RNeasy mini kit Qiagen 
Blyscan sulfated glycosamino glycan kit Bicolor life science assay 
Masson’s trichrome kit Sigma 
Bradford protein estimation kit BioRad. 
Superscript-III First stand synthesis kit Invitrogen  
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HS-5 cells ATCC (CRL1482) Human Bone marrow stromal cell line 
UCB CD34+ Primary cells Fresh Human Umbilical cord blood 
ʹǤʹǤͷ 
dĂďůĞϮͲϱ^ŽĨƚǁĂƌĞĂŶĚƉƌŽŐƌĂŵƐƵƐĞĚ
 Ȁ
FACS analysis CellQuest- Becton Dickinson and Company, 
1997
Axiovert 200M (Carl Zeiss, Inverted 
fluorescent microscope
AxioVision, Version release 4.4.0.0-Carl 
Zeiss
Axioplan 2 Imaging (Carl Zeiss, Upright 
fluorescent microscopy)
AxioVision, Version release 4.4.0.0-Carl 
Zeiss
Leica confocal imager LAS-AF Leica application suite –Advanced 
Fluorescence- Leica Microsystems 
Primer designing Primer Blast, NCBI
Oligonucleotide Properties Oligo Calc: Oligonucleotide Properties 
Calculator, Nortwestern University
RT-PCR data acquisition and analysis SDS v 2.3 software-SABiosciences
Histograms, graphs, statistical analysis Graph Pad Prism
www.graphpad.com/scientific-
software/prism/
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Antibodies for Immunofluorescence Study
Antibody (Catalogue number) Manufacturer Dilution
Alexa fluor -488 Phalloidin Actin (A12379) Molecular Probes 1:500
Mouse Anti human collagen Sigma 1:500
Rabbit Anti human laminin (073K4312) Sigma 1:200
Mouse Anti human Fibronectin Clone FN-15 Sigma 1:500
Mouse monoclonal Anti human integrin –ȕ1
(610468) 
BD 1:100
Rabbit Anti human integrin Į5 Clone P1D6 
(13547) 
Santacruz 1:100
Mouse Anti human HIF-1 Į Abcam 1:200
Alexa Fluor® 594 Goat Anti-Mouse IgG Antibody 
(A11032) 
Molecular Probes 1:500
Alexa Fluor® 594 Goat Anti-Rabbit IgG 
Antibody(A11012) 
Molecular Probes 1:500
Antibodies for Flow Cytometry
CD34 PE( 348057) Becton Dickinson Biosciences
CD133 PE (130-098-826) Miltenyi Biotec Inc
CD45 FITC ( 347463) Becton Dickinson Biosciences
CD34 FITC ( 348053) Becton Dickinson Biosciences
CD38 FITC ( 555459) Becton Dickinson Biosciences
7AAD ( 559925) Becton Dickinson Biosciences
Anti –mouse IgG-FITC (349041) Becton Dickinson Biosciences
Anti- mouse IgG-PE (349043) Becton Dickinson Biosciences
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Primer designing was done by using reference human m-RNA sequence on online 
program of Primer Blast from NCBI. Oligonucleotides primers were ordered from Bioserve 
pvt ltd. and are listed in the Table 2-5 below. 
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Gene Forward Primer Reverse Primer 
B2M CTGGAGGCTATCCAGCGTACTCC GGTTCACACGGCAGGCATACTCATC 
ITPR1 CAGTTCAAAAGCCCTGTGGGAGG GATCAGGGTCCACTGAGGGCTGAAA 
INSG1 CCAGATTGCACGACCACTTCTGG GAAAAGCTATGGTGATCCCCAGCCC 
EFEMP GCTGTGCAAGGAACTCTGCTAGC GCATTGCTGTCTCACAGGATCCCAC 
CALB2 CTCCTGCCTGTCCAGGAAAACTT CAGAGCACAATCTCCAGGTCCTTGC 
EGFR  GGCAGGGAATGCGTGGACAAGT TTCGCATGAAGAGGCCGATCCC
PLAT TGCAACAGTGGCAGGGCACA TGTTCCAGTTGGTGCACTCGGC 
NID 1 CCAATCGGGCGGAATGCCTGAA TGGGTGCAGCCGCCATTGTT 
FN ACTGGTAACCCTTCCACACCCCA TGTTGCCCAACACTGGGTTGCT 
LAM3 TCACAGCAGCAAAGGGTGCCA TGGCAGCGTTCACAGTGCTCTC 
LAMC GCTGTGCAAGGAACTCTGCTAGC GCATTGCTGTCTCACAGGATCCCAC 
COL1 CTCCTGCCTGTCCAGGAAAACTT CAGAGCACAATCTCCAGGTCCTTGC 
COL3 AAGGCCCTGAAGCTGATGGGGT AGCAAACAGGGCCAACGTCCA 
COL4 GCCTGCGCAAGTTCAGCACAA TGGGGCACGGTGGGATCTGAAT 
LAM4 TGAACGTTGCGCTCCTGGCTAC CAGTCCATGCCTGTAGGGGGTTCA 
ANGPT AACGCCGAGTTGCTGCAGTTCT AATGGCTGCAGGTGCCAAACCA 
SPARC TCCACTGCGTGCTCCCCTCA GAAGCAGCCGGCCCACTCAT 
PTX3 GGTCTGCAGTGTTGGCCGAGAA TGCAGCAGCATGCGCTCTCT 
SFRP1 TGTGCCAGCGAGTTTGCACTGA TTGTGGATGGCCGTCAGCAAGT 
IGFBP4 AGAAGCCCCTGCACACACTGAT TGAAGCTGTTGTTGGGGTGGTCA 
THBS2 TCCCAGAGGCAGTTCGAGATCGT TAGAAGGGCTCGTCCAGAGCGAAG 
DCN TGGGTGTCAGCCGGATTGTGTTC TTTGCCACAGGAGCCCTCAAAGC
GAPDH ACATCGCTCAGACACCATGGGGA TGACGGTGCCATGGAATTTGCCA 
MMP1 CCCTTCTACCCGGAAGTTGAG GAGCTGTAGATGTCCTTGGGG 
MMP2 CCAGCTGGCCTAGTGATGAT CCGCATGGTCTCGATGGTAT 
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MMP3 TACAAGGAGGCAGGCAAGAC GGTTCATGCTGGTGTCCTCA 
MMP7 CTACAGTGGGAACAGGCTCA CACTCCACATCTGGGCTTCT 
MMP8 TGCTATCACCACACTCCGTG GCCACTCAGAGCCCAGTATT 
MMP9 CGACGTCTTCCAGTACCGAG GTTGGTCCCAGTGGGGATTT 
MMP10 GGAGCAAGGCTTCCCTAGAC CGCCTAGCAATGTAACCAGC 
MMP11 AAGACTCACCGAGAAGGGGA TGAGACTCAGTGGGTAGCGA 
MMP13 AGGAGCATGGCGACTTCTAC CTAAGGAGTGGCCGAACTCA 
TIMP1 CTTCTGCACTGATGGTGGGT TAAATGTCCACGCTAGGGGC 
TIMP2 AAGCGGTCAGTGAGAAGGAAGT GTGCCCGTTGATGTTCTTCTCT
TIMP3 GTGGTGGGGAAGAAGCTGGTAA CAAAGCAAGGCAGGGTAGTAGCA 
TIMP4 GCCTTTTGACTCTTCCCTCTGT CTTTCGTTCCAACAGCCAGTCT
ITGA1 CAGACGCTCAGTGGAGAACA TGTACATAGGGGCTCCGACT 
ITGA2 GTGGCTTTCCTGAGAACCGA GATCAAGCCGAGGCTCATGT 
ITGA3 TGGACATTGACTCGGAGCTG TAGCGGGTCCGCTTAAAGAA 
ITGA4 GGCTCGGGAGCAGTAATGAA GTGGAGCTCCGATAGCAACA 
ITGA5 GAGTTTGGCCGATTTGGCAG GGGCCCCCAGGAAATACAAA 
ITGA6 TTCGGGAGTACCTTGGTGGA AGCGTTTAAAGAATCCACACTTCC
ITGB1 AAGCGAAGGCATCCCTGAAA GTCTACCAACACGCCCTTCA 
ITGB2 CATCTTCGCGGTGACCAGTA TGGACCACATTGCTGGAGTC 
ITGB3 GAAGCAGAGTGTGTCACGGA TGCATCATTCCTCCAGCCAA 
ITGB4 TCCCCATCTTTGCTGTCACC TGGAGCGGATCCGATTGAAG 
ŚĂƉƚĞƌϮͲDĂƚĞƌŝĂůƐĂŶĚ'ĞŶĞƌĂůDĞƚŚŽĚƐ
ϱϭ

ʹǤ͵ 
The general methodologies that were followed throughout the work are described here in 
this section and the specific methods are covered in detail in individual chapters of 3,4 and 5. 
ʹǤ͵Ǥͳ 
ʹǤ͵ǤͳǤͳ Ǧͷ
HS-5 cells were maintained in CM-1 (media compositions Table 2-6). Cultured cells 
were maintained in 5% CO2, 20% O2 and 90% humidity in standard cell culture incubators 
The cells were cultured until they were 80-90% confluent, before splitting to next passage. 
For matrix modifications experiments, HS-5 cells were maintained in CM-1 for initial two 
days and later in either CM-2 or CM-3 until confluence. 
dĂďůĞϮͲϴĞůůĐƵůƚƵƌĞŵĞĚŝĂĐŽŵƉŽƐŝƚŝŽŶƐ
  
,^ͲϱŵĞĚŝĂ;DͲϭͿ ǹ-Minimum Essential Media (ĮMEM), 10% FCS, 
Penicillin (100U/ml) Streptomycin (100μg/ml) 1X 
glutamax 
Serum containing media 
DDWŝŶŚŝďŝƚŽƌ
ŵĞĚŝĂ;DͲϮͿ
ǹ-Minimum Essential Media (ĮMEM),10% FCS, 
Penicillin (100U/ml) Streptomycin (100μg/ml) 1X 
glutamax, MMP inhibitor 10nm 
Serum containing media 
d'&ŵĞĚŝĂ;DͲϯͿ ǹ-Minimum Essential Media MEM),10% FCS, 
Penicillin (100U/ml) Streptomycin (100μg/ml)1X 
glutamax, TGF-ȕ 10ng/ml 
Serum containing media 
,^ĞǆƉĂŶƐŝŽŶ
ŵĞĚŝĂ
Stemline II with Pen/Strep and thrombopoietin 
(TPO)-25ng/ml, stem cell factor (SCF)-25ng/ml, 
interleukin-6 (IL-6)-50ng/ml and Flt3 Ligand 
(Flt3L)-40ng/ml
Serum free media 
&ƌĞĞǌŝŶŐŵĞĚŝĂ 60% CM1, 30% serum, 10% DMSO Serum containing media
ŚĂƉƚĞƌϮͲDĂƚĞƌŝĂůƐĂŶĚ'ĞŶĞƌĂůDĞƚŚŽĚƐ
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ʹǤͶǤͳǤʹǦͷ
In order to understand the changes induced in the ECM of the stromal cells under low and 
high O2 tensions and its overall effect on ex-vivo expansion of CD34+ cells, HS-5 cells were 
cultured and maintained in two O2 conditions a) 20% O2 and b) 5% O2 condition. 
20% O2 condition- standard tissue culture incubator- 37϶C, 5% O2, 20% O2  
5% O2 condition- Hypoxia incubator -37϶C, 5% O2, 5% O2
Splitting of cells- Media was completely removed from the culture dish/ flask and the cells 
were washed with PBS. 0.25% trypsin was added to detach the cells from the surface and was 
observed under microscope for complete detachment after which, complete media (double the 
volume of trypsin) was added to neutralize trypsin. The entire volume was collected in a 
falcon tube and centrifuged at 1000 rcf for ~5 min at RT. The supernatant was discarded and 
the pellet was gently resuspended in a small volume of CM-1. Cell enumeration was 
performed before freezing or distribution to fresh vessels such that uniform cell numbers 
were maintained for all the staining and matrix preparation experiments. 
Cell Count- For enumeration of the cells, the pellet obtained after trypsinization was 
resuspended in CM-1. Viable cell counting was performed by using trypan blue. 10 μl of 
resuspended cells were mixed with 10 ul of 0.1% trypan blue (Gibco), and loaded on 
Neubaur’s chamber. The number of live and dead cells were counted on the 4x16 squares. 
Total number of cells and viability percentage was calculated with formulas given below. 
ƋƵĂƚŝŽŶϮͲϭĞůůŶƵŵďĞƌ
Total cells counted X dilution factor X 104  = Number of cells/ml 
No of squares 
ŚĂƉƚĞƌϮͲDĂƚĞƌŝĂůƐĂŶĚ'ĞŶĞƌĂůDĞƚŚŽĚƐ
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ƋƵĂƚŝŽŶϮͲϮĞůůǀŝĂďŝůŝƚǇ
No of live cells X 100 = % viability  
No of live + dead cells
Freezing of cells- After trypsinization, supernatant was discarded and pellet was 
resuspended in a minimum volume of media (usually ~ 10 ml). After determination of cell 
number, freezing medium was added and distributed to freezing vials (~1ml per vial/ 
2x106cells per vial) and kept at -80 ºC for a day and then shifted to liquid nitrogen.
ʹǤ͵Ǥʹ 
Immunofluorescence staining of HS-5 cells, and ACM was done to detect the expression 
of major ECM proteins. Samples were fixed on cover slips with 4% formaldehyde for 20 min 
at RT, followed by washing with 1X PBS. Cells were permeablized with 0.1% triton X-100 
for 10 min at RT and washed 3 times with 1X PBS. Non specific antibody binding was 
blocked by antibody blocking solution (3% BSA) for 40 min at RT later washed 3 times with 
1X PBS. The cells were stained with phalloidin -actin for 1hr in dark at RT followed by 
washing and sequential staining with specific antibodies for ECM proteins in appropriate 
dilutions. Excess antibody staining was removed by PBS wash and secondary antibody 
conjugated with Alexa fluor 594 for ECM molecules was added and incubated for 1 hr in 
dark at RT. Excess antibody was removed by washing with PBS and the stained cells and 
ACM samples were mounted on glass slides with DAPI in Vectashield mounting medium. 
Fluorescent images of various ECM proteins were acquired using Leica Confocal microscope 
and images post processing were done using - LAS-AF Leica application suite, multiview 
4000 software.  
ŚĂƉƚĞƌϮͲDĂƚĞƌŝĂůƐĂŶĚ'ĞŶĞƌĂůDĞƚŚŽĚƐ
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ʹǤ͵Ǥ͵ 
Ǧͷ
Gene expression analysis was done to understand the change in molecular profiles in HS-
5 cells due to varying culture conditions.  
ʹǤ͵Ǥ͵Ǥͳ 
Total RNA was extracted and purified from HS-5 cells grown in two different O2 
tensions by using the RNeasy Plus Mini Kit as per the manufacturer’s protocol. The confluent 
culture dishes with HS-5 cells were washed with PBS with subsequent addition of 600 μl of 
Buffer RLT Plus. Cells were lysed by the addition of RLT buffer and scraped thoroughly; 
lysate was passed 5 times through a 20-gauge needle. The lysate was then passed through a 
gDNA eliminator spin column to remove DNA contamination. 70% ethanol was added to the 
flow-through to provide appropriate binding conditions for RNA, and the sample was then 
applied to an RNeasy spin column, where total RNA binds to the membrane and 
contaminants were efficiently washed away with Buffer RW1 and RPE. RNA was then eluted 
in 30-50 μl of diethyl pyrocarbonate (DEPC) treated ddH2O. 
ʹǤ͵Ǥ͵Ǥʹ 
The nucleic acid concentration and the purity of RNA preparation was determined by 
measuring the absorbance at 260 nm using a Nanodrop spectrophotometer ND1000. 50 ȝg of 
double stranded DNA, 33 ȝg of single stranded DNA (primers for PCR) and 40 ȝg of single 
stranded RNA was taken to be equal to 1.0 OD260. Purity was checked by taking the ratio of 
the absorbance at 260 nm to 280 nm. The A260/A280 ratio should be close to 2.0 for pure 
RNA. Purified RNA of HS-5 cells of two different O2 were to prepare c-DNA for whole 
ŚĂƉƚĞƌϮͲDĂƚĞƌŝĂůƐĂŶĚ'ĞŶĞƌĂůDĞƚŚŽĚƐ
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genome microarray analysis (described in chapter-4), and quantitative PCR for various genes 
for ECM and other niche regulators. 
ʹǤ͵Ǥ͵Ǥ͵ 
Reverse transcription (RT) was performed by using superscript c-DNA first strand 
synthesis kit as per the manufacturers’ instructions. Reaction was carried out in a final 
concentration of 5 mM magnesium chloride; 1 mM each of dNTPs; 1X PCR buffer; 1 unit 
RNAse inhibitor; 2.5 units superscript IIITM and 1-2 μg total RNA. A master mix was 
prepared (20 μl per reaction) and final volume was made up with DEPC-treated water. 1 μg 
of purified RNA and Oligo dT were incubated at 65°C for 5 min. Reverse transcription was 
carried out in a step cycle comprising extension at 55°C for 1 hr. Inactivation of RT enzyme 
was done at 75°C for 15 min. cDNA was quantified in NanoDrop and was stored at -20°C for 
further use. 
ʹǤ͵Ǥ͵ǤͶ ǦȋǦȌ
qRT-PCR assays were performed on the ABI prism 7900 HT sequence detection system 
(ABI). PCR reaction was setup using SYBR green power master mix (ABI), following the 
manufacturer’s instructions. A typical 10 μl reaction mixture contained 5 μl of 2X SYBR 
green dye, 1 pm of each primer, 1 μl of template DNA and 2 μl of distilled water. All 
reactions were set up in triplicates, in a 384-well optical reaction plate. The PCR conditions 
were as follows: 95 ºC for 10 min, 95 ºC for 15 sec, 60ºC for 30 sec and 72 ºC for 30 sec for 
40 cycles. All the reactions were analysed using the software (SDS 2.3) provided with the 
instrument. The relative expression of the genes was calculated by using 2-¨¨Ct formula using 
GAPDH or 18s RNA normaliser. The values reported are the mean of three biological 
ŚĂƉƚĞƌϮͲDĂƚĞƌŝĂůƐĂŶĚ'ĞŶĞƌĂůDĞƚŚŽĚƐ
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replicates. The standard deviation from the mean is shown as error bars in each group. The 
generation of amplification plots, standard curves and dissociation stage analysis was as per 
the manufacturer’s protocol. The calculation of the melting temperature of each amplicon 
(TM) was done directly by software provided. 
ʹǤ͵ǤͶ Ǧͷ
The HS-5 cells decellularization process to prepare acellular matrices is described in this 
section. Acellular matrices derived from HS-5 stromal cells were used as substrate for ex-vivo
CD34+ expansion.  
ʹǤ͵ǤͶǤͳ Ǧͷ
Decellularization was carried out by a standardized protocol, described in detail by 
Tiwari et al[80]. Decellularization solution was prepared by adding of NH4OH in sterile MQ 
to make the final concentration of 0.02M. 
ŚĂƉƚĞƌϮͲDĂƚĞƌŝĂůƐĂŶĚ'ĞŶĞƌĂůDĞƚŚŽĚƐ
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&ŝŐƵƌĞϮͲϭĞĐĞůůƵůĂƌŝǌĂƚŝŽŶŵĞƚŚŽĚŽůŽŐǇ
For decellularization process media was discarded from the confluent culture dishes and 
washed with 1X PBS. MQ water was added and the cells were observed under the 
microscope until the cells swell and turn round. MQ water was removed carefully and slowly 
0.02 M NH4OH was added to cover the cell surface. Bursting of cells forming the matrix was 
observed under the microscope. The decellularized matrix dishes were left for drying 
overnight in sterile condition. Next day decellularized matrices were washed thoroughly with 
PBS to remove traces of NH4OH. Matrices thus prepared were termed as “acellular matrix 
(ACM)” and were used as substrates for ex-vivo HSPC expansions. 
ʹǤ͵Ǥͷ 
ʹǤ͵ǤͷǤͳ 
Fresh UCB was collected in accordance with approved institutional guidelines, and with 
appropriate ethics approval. UCB samples were obtained from full-term delivering mother 
ŚĂƉƚĞƌϮͲDĂƚĞƌŝĂůƐĂŶĚ'ĞŶĞƌĂůDĞƚŚŽĚƐ
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donors at Sridevi Nursing Home, Warasiguda, Hyderabad with signed consent (Appendix II). 
Each UCB unit was collected by midwives directly into blood collection bags containing 30 
ml of citrate phosphate dextrose anticoagulant (CPDA), and stored at RT. Collected UCB 
bags were transferred to lab in aseptic conditions for isolation of HSPC (CD34+cells) 
(Appendix I). 
ʹǤ͵ǤͷǤʹ ȀȋȌ
CD34+ cell isolation was begun within 24 hours of collection. Blood samples were 
diluted 1:4 with phosphate buffered saline lacking magnesium chloride and calcium chloride, 
and containing 2mM ethylenediamine tetra acetic acid (EDTA). Ficoll-Paque Plus™ density 
gradient was used to isolate MNC by overlaying 20 ml of diluted UCB onto 16ml of Ficoll-
Paque Plus aqueous media, and centrifugation at 19ºC 400 rcf, for 30 min. The MNC buffy 
coat layer was collected, diluted 1:2.5 with PBS 2mM EDTA and centrifuged (19ºC, 400 rcf, 
and 10 min). This wash step was repeated and the cells were then diluted 1:1 with PBS 2mM 
EDTA, centrifuged (19ºC, 400 rcf, 10 min) and resuspended in PBS 2mM EDTA for cell 
count and viability determination with 0.4% trypan blue solution.  
ʹǤ͵ǤͷǤ͵ Ǧ͵ͶΪ
Separation and enrichment of the CD34+ cells from the MNC fraction of the UCB was 
performed using a “Direct CD34 Progenitor Cell Isolation Kit” as per manufacturer’s 
protocols. Briefly, the pellet of MNC was suspended in 300ȝl of cold degassed PBS 2mM 
EDTA containing 0.5% bovine serum albumin (BSA) per 1 x 108 total cells. 100ȝl Fc 
antibody receptor blocking reagent was added per 1 x 108 total cells and incubated for 5 min 
at 6-12 ºC, followed by addition of 100ȝl CD34-microbeads per 1 x 108 total cells and 
incubated for 30 min (6-12 ºC). 
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&ŝŐƵƌĞϮͲϮϯϰнĐĞůůƐŝƐŽůĂƚŝŽŶďǇŵĂŐŶĞƚŝĐƐĞƉĂƌĂƚŝŽŶŝŶƵƚŽD^
Excess antibodies were removed by the addition of 5ml cold degassed PBS 2mM EDTA 
0.5% bovine serum albumin and centrifugation (6ºC, 200 rcf, 10 min). Labelled cells were 
isolated from MNCs by magnetic sorting on AutoMACS cell sorter (Miltenyi Biotec Inc., 
Bergisch-Gladbach, Germany) using the “double positive selection program” provided by the 
manufacturers, according to the manufacturer’s instructions. CD34+ enriched cells were 
centrifuged (6ºC, 200 rcf, 10 min) and resuspended in PBS for cell counts and viability 
determination. The MACS separated CD34+ cells were used as target cell population for 
expansion on ACM, various modified ACM surfaces along with appropriate controls 
described in chapters 3 and 5. 
ʹǤ͵Ǥ͸ 
All the experiments of HSPC expansion done on various ACM such as native, biochemically 
modified and spin coated were repeated three or more than three times with separate samples. 
Elution  Binding of CD34+ cells
ŚĂƉƚĞƌϮͲDĂƚĞƌŝĂůƐĂŶĚ'ĞŶĞƌĂůDĞƚŚŽĚƐ
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Experimental data was expressed as means ± standard error (SE). Statistical analysis was 
done by Graph Prism using Student’s unpaired t-test and ANOVA for comparison between 
various conditions of expansion, and statistical significance was accepted-as*p0.05.
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϲϬ
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͵Ǥͳ 
HSPC transplantation (HSCT) has become an established mode of treatment for a variety 
of haematological disorders, malignant and non-malignant diseases. One of the major 
problems often encountered in HSCT is insufficient stem cell number, particularly when 
UCB is used as the source of HSPC expansion. An efficient and practical ex-vivo HSPC 
expansion methodology is critical to realize the full therapeutic potential of HSCT. The aim 
of ex- vivo HSPC expansion is not only to increase the number of cells but also to expand the 
primitive HSPC population that can sustain hematopoiesis for a longer time without losing its 
self-renewal properties. HSC self-renewal is driven in-vivo by the stem cell niche [161], and 
attempts are therefore being made to recreate similar inductive growth conditions for 
enhanced ex-vivo HSPC expansion. In the BM, HSPC behaviour is a regulated balance of cell 
proliferation, self-renewal and differentiation, but in- vitro the capacity for self-renewal is 
lost due to uncontrolled differentiation. Reports suggest that the signals emanating from BM 
niches are important for HSPC regulation, and one of the major reasons behind the failure of 
ex-vivo HSC expansion in long term culture is the lack of these crucial signalling clues [35]. 
The BM niche is a complex architecture of different cellular and molecular components 
and is comprised of two distinct niche compartments, endosteal and vascular (Reviewed in 
chapter 1). The endosteal niche is considered as quiescent niche where HSC that are more 
primitive reside, and the vascular niche is more proliferative in nature. The difference in the 
functionality of two niches is a result of their cellular and molecular compositions. The cells 
of the endosteal niche are osteoblastic in nature whereas the sinusoidal and endothelial cells 
are the major cellular components of vascular niches. A rich composition of ECM molecules, 
and various soluble and secreted growth factors and cytokines are distributed among two 
niches in BM [35]. 
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
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Apart from the cellular components, a major difference between the two niches is their 
O2 content. O2 is a critical physicochemical factor of HSC niches in BM. Endosteal niches 
are low in O2 whereas vascular niche contains high O2 tension [162]. 
Although much progress has been made in the identification of cellular components of 
the HSC niches in BM, the role of ECM is still poorly understood. The BM ECM is mainly 
comprised of fibrous structural proteins such as collagens, specialized proteins including 
fibronectin and laminin, and proteoglycans [163]. These ECM components provide critical 
environmental cues that are amongst the most important factors in the maintenance of stem 
cell properties. ECM secreted by the stromal cells in the BM creates a growth inductive 
microenvironment and regulate HSC behaviour in a number of ways: 
• The cyto-adhesive nature of ECM protect cells from apoptosis and inhibit its 
extensive differentiation [92]. 
• ECM also binds to circulating growth factors secreted by the BM cells and 
immobilize them within the local niche [164]. 
• The most important function of ECM is cell-ECM interaction, as functionality of 
ECM in HSC regulation is mainly dependent on the crosstalk between HSC and 
ECM. 
ACM that are prepared by cell and tissue decellularization mimic the scaffolding like 
complex architecture of native niches retaining their molecular and biochemical nature and 
functionality in some respects. Thus, ACM mimic both the structural and functional 
properties of 3D culture systems. Although the use of ACM has been investigated over a 
number of years in the culture of different cell types, very few reports are available for its use 
in ex-vivo HSPC expansion. In our laboratory, we were successful in establishing a novel 
method for ex-vivo HSPC expansion by using ACM derived from mouse and human BMSC. 
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
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Reports published from our lab show that mouse stromal cells derived ACM (MS-5) can 
expand human UCB CD34+ to a significant level[80]. However, a xenogeneic system such as 
this, using mouse ACM to expand human UCB CD34+ cells, has limited clinical 
applications. To overcome the problem we have prepared human ACM from cultured human 
BMSC (HS-5) for human UCB CD34+ expansion. 
HS-5 is a BM derived stromal cell line. The cells have fibroblastoid morphology and 
secrete significant levels of granulocyte colony-stimulating factor (G-CSF), granulocyte-
macrophage-CSF (GM-CSF), macrophage-CSF (M-CSF), Kit ligand (KL), macrophage-
inhibitory protein-1 alpha, IL-6, IL-8, and IL-11. HS-5 conditioned media supports 
proliferation of HSPC in the absence of serum [165].We have exploited these properties of 
HS-5 cells to generate ACM for lineage specific ex-vivo expansion of human UCB derived 
CD34+ cells.  
In an attempt to understand the intricate role of stromal extracellular micro 
environmental components on HSPC expansion, ACM were prepared by decellularizing 
confluent HS-stromal cells to mimic the BM extracellular micro environmental conditions. 
As discussed in detail earlier in chapter 1, BM is a rich source of multipotent HSC that 
reside in two different niches. A gradient of O2 tension exists between the two niches, which 
has different regulatory effects on the resident HSC/HSPC. O2 can regulate stem cell 
properties and direct its lineage specific expansion by modulating the niche conditions and 
components[121]. We have investigated the role of O2-mediated ECM changes on HSPC 
expansion. HS-5 cells were cultured in two different O2 tensions a) 20% O2 b) 5% O2. 
Confluent. HS-5 cells were subjected to decellularization to prepare ACM, which was used as 
cell free substrate for UCB CD34+ expansion. We hypothesize that the ability of ACM to 
support expansion of HSPC reduces at lower O2 (5% O2) tensions. These alterations in the 
ŚĂƉƚĞƌϯͲ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stromal matrix properties may be due to O2 mediated ECM remodeling as evident from 
matrix characterization study. 
In this chapter, we describe the morphological properties and molecular characterization 
of HS-5 derived ACM generated under low and high O2 conditions. We have analysed the 
growth and differentiation of human UCB derived CD34+ cells over a period of 8 days on the 
decellularized HS-5 ACM using a serum free expansion media (see media composition Table 
2-6). HSPC expansion on different ACM was assessed phenotypically by flow cytometry and 
functionally by CFU assays, which assess the presence of multi-potent and committed 
progenitors (CFU-GEMM, BFU-E and CFU-GM) and the level of expansion. Fold expansion 
of HSPC was calculated to determine which matrix supported the maximum expansion 
(equation-1 section 3.5.1.1). The specific lineages supported by each ACM were also 
calculated based on the flow cytometry and CFU assays (equation-2 section 3.5.1.1). 
The main objectives of the chapter 3 are- 
• Decellularization of HS-5 human BMSC to prepare ACMs 
• Morphological, cytochemical, and biochemical characterization decellularized ACMs 
• Assessment of HS-5 derived decellularized ACM as substrate to expand human UCB 
CD34+ cells 
• Investigate the role of physicochemical factor O2 in stromal matrix properties 
regulation and its effect on HSPC expansion 
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HS-5 cells were cultured in Į-MEM containing 10% FBS (CM1) until confluent before 
preparation of ACM by decellularization as described in section 2.4.1.  
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To understand the role of O2 mediated ECM changes on ACM properties and to 
investigate its effects on HSPC expansion, cells were cultured and maintained in two 
different O2 tensions in hypoxic (5% O2, 5% CO2, 37˚ C) and standard cell culture (20% O2, 
5% CO2, 37º C). 
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For validation of the lower O2 tension present in the culture conditions, HS-5 cells of 5% 
and 20% O2 tension were stained with appropriate antibody dilution of HIF-1Į (Hypoxia 
inducible factor) and STC-1 (staniocalcin-1) a regulator in hypoxia pathway in 1% BSA in 
PBS for 45 min in dark. The protocol for fixing and blocking was followed as described in 
chapter 2 section 2.3.2 Primary antibodies against HIF- 1Į (1:200), STC-1 (1:200) were 
added to the samples. After an hour of incubation, samples were washed and incubated with 
appropriate anti mouse isotype IgG-Alexa flour-594 (1:500) secondary antibodies. After an 
hour of incubation, samples were washed with 1X PBS and mounted with Vectashield 
containing DAPI mounting medium and images were taken under Apotome microscope. 
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Protein for the western blot analysis was isolated using cell lysis buffer (20 mM Tris pH 
7.5, 150 mM Nacl, 1mM Na2 EDTA, and 1% Triton X100). The protein was diluted with 2X 
loading buffer (100 mM Tris-Cl (pH 6.8), 4% (w/v) SDS, 0.2% (w/v) bromophenol blue 20% 
(v/v) glycerol, 200 mM DTT ) so that 30 μg of protein was loaded per well into a 10% SDS-
PAGE gel. The gel was subjected to electrophoresis at 120 V for 90 min at RT. The gel was 
then electro transferred using wet transfer apparatus (BioRad, Hercules, CA) on 
nitrocellulose membrane. The membrane was blocked with 5% BSA in TBST (25 mM Tris, 
192 mM glycine, 10% methanol, 1% tween 20) and subsequently washed with TBST. Anti-
HIF-1Į mAb, was added for overnight incubation at 4ºC with shaking. The membrane was 
washed again with TBST and then incubated with anti mouse HRP conjugate 2˚ antibody for 
1 hr at RT on a shaker. The membrane had a final wash with TBST followed by detection by 
chemiluminescence method. 
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Cell proliferation assay was performed using a 3-(4,5-dimethylthiazol-2-yl)-2, 5-
diphenyl tetrazolium bromide (MTT) assay to understand the kinetics of proliferation 
differences in HS-5 cells due to change in O2 tension. For this assay, HS-5 cells were 
trypsinized and plated in 24 -well flat bottom tissue culture plate at a concentration of 
1 × 104 cells/well containing 200 μl CM-1 media. Cells were incubated in hypoxic and 
standard cell culture incubators separately over 8 days. At the end of each time point (i.e. 1 
day, 2 day, 4 day, 6 day and finally 8 day) culture media was carefully removed, cells were 
washed with warm PBS, and serum free media was added along with 25 μl of MTT solution 
(2mg/ml). After 4hr of incubation, colored crystals of formazan were dissolved with 100 μl 
of acidified alcohol. Plates were gently swirled to mix the cells with MTT solutions and 
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optical density (O.D.) was read on a multiwell scanning spectrophotometer ELISA plate 
reader at 570nm (Thermo Scientific Multiskan Spectrum UV/Vis micro plate and cuvette 
spectrophotometer). 
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Decellularization of HS-5 stromal cells was performed following the standard protocol 
described in general methodology in chapter 2 section 2.5.1. Confluent HS-5 cells of 20% 
and 5% O2 conditions were incubated in MQ water followed by treating with 0.02M NH4OH 
for complete decellularization and ACM preparation (Figure 3-1). 
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The efficiency of decellularization of the HS-5 stromal cells with 0.02 M NH4OH was 
analysed by phase microscope and SEM, matrices were also stained to confirm the complete 
removal of nuclear material using DAPI and H&E. DNA isolation and quantification was 
also performed before and after the HS-5 cells decellularization.  
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HS-5 stromal cells and decellularized ACM were incubated with 4% formaldehyde for 
20 min at RT followed by washing with 1X PBS. Fixed cells and ACM were observed under 
light microscope (Axioplan 2 Carl Zeiss, Germany). Image acquisition and processing was 
done using Axiovision software (Version release 4.4. from Carl Zeiss Germany). 
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DAPI staining for the detection of intact nuclei was performed by fixing the HS-5 
stromal cells and the decellularized ACM on cover slips with chilled 70% methanol for 20 
min, followed by incubation in solution of DAPI (1 mg/ml) for 10 min in the absence of light. 
Samples were washed and examined in fluorescence microscope (Axioplan-2, Carl Zeiss, 
Germany) with 20X magnification. The digital images were analysed and processed with 
Axiovision software. 
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Fixed HS-5 cells and decellularized ACM were washed with PBS, followed by washing 
with MQ water and stained with Mayer’s haematoxylin for 10 min at RT, then rinsed in 
running tap water for 8 min. Samples were then dehydrated with 95% alcohol followed by 
absolute alcohol, 1 min each, and finally mounted with DPX mounting medium. Mounted 
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Samples were observed for the presence of pink colour staining for nuclear material under the 
light microscope.  
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To estimate total DNA content in HS-5 stromal cells and decellularized ACM, both samples 
were scrapped and collected carefully in sterile tubes, centrifuged at 2500 rpm for 5 min to 
obtain a pellet. The pellet was thoroughly disturbed in buffer containing 1M Tris-HCL, 0.5M 
Na-EDTA, 1M Nacl and 20% SDS followed by addition of 5M Na –per chlorate. The lysed 
solution of DNA samples were purified with Phenol-Chloroform-Isoamyl alcohol (25:24:1) 
followed by centrifugation at 10000 rpm for 5 min. Aqueous layers were collected and 
ethanol precipitated at -20ºC for at least 1 hr. Samples were dried and rehydrated in 1X TE 
buffer. Purity and concentrations of DNA isolated from HS-5 stromal cells and decellularized 
ACM were determined in NanoDrop® ND-1000- (NanoDrop Technologies, Wilmington, 
Delaware USA). 
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FT-IR analysis was done for confirming the presence of matrix specific functional groups in 
decellularized HS-5 ACM. Matrix sample was extracted in a minimum volume of MQ water, 
suspended well, sonicated and lyophilised overnight. The lyophilized matrix sample was 
further kept in vacuum for another six hr and was submitted for FT-IR analysis. FT-IR 
analysis was performed using a Thermo Nicolet Nexus 670. 
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The ACM containing culture dishes of each O2 condition were incubated with extraction 
buffer (125 mM Tris-HCL, pH 6.8, 0.1% SDS, 10% glycerol, 1% DTT, 0.05 mM PMSF ) 
containing protease inhibitor cocktail at 37°C for 1 hour followed by scrapping with a sterile 
scrapper. The protein extracts were pooled and sonicated three times, 60 sec each with 30 sec 
gap and centrifuged at 14000 rpm for 30 min at 4°C. Supernatant was kept for overnight 
Trichloro acetic acid (TCA) precipitation. The precipitates were recovered by centrifugation 
at 15,000 rpm at 4°C, for 30 min. Protein pellets were washed with cold 100% acetone to 
remove excess of SDS and TCA and vacuum-dried. The protein was dissolved in rehydration 
buffer (6M Urea, 2M Thiourea, 2% (w/v) CHAPS and 50mM DTT) and estimated by 
Bradford method and stored at -70°C for further analysis. 
͹Ǥ͸ǤͺǤͷǤͷ Ǧ
The concentration of the extracted protein was estimated using Bradford assay. A 
standard curve was plotted using BSA as standard and the concentration of the sample was 
calculated. BSA standards of concentrations 1μg/μl, 2μg/μl, 4μg/μl, 6μg/μl and 8μg/μl were 
prepared through dilution of the 1mg/ml stock. This was used to obtain a standard OD curve 
from an ELISA reader. The measurements were made at 595nm. A curve was plotted using 
the known BSA concentration samples, and the protein concentration of the unknown sample 
was estimated. 
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Denaturing SDS-PAGE was performed on a 4% stacking gel and a 10% separating 
acrylamide gel under reducing conditions (2 mM dithiothreitol added to the sample buffer) 
according to the method of Laemmli [166]. Gels were stained with 0.2% Coomassie blue R-
250 (Sigma), 50% methanol, 10% acetic acid and destained overnight in 50% methanol and 
10% acetic acid. The wells were loaded with 30 μg of protein obtained from extracted HS-5 
matrix proteins of both O2 culture conditions.
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Collagen content in HS-5 ACM of each O2 tension was estimated using standard Sirius 
red method. Working concentration of Sirius red solution was prepared by adding 60ug/ml of 
Sirius red in 0.5 M acetic acid. A curve was plotted using collagen type 1 (1μg/μl) as a 
standard. The standards of concentrations 1 μg/μl, 5 μg/μl, 10 μg/μl, 15 μg/μl, 20 μg/μl, 25 
μg/μl, and 30μg/μl were prepared through dilution of the rat collagen type I stock. ACM 
samples for the collagen estimation were scrapped thoroughly and collected in tubes. The 
collection tubes were centrifuged to obtain pellet that was further dissolved in 0.5M acetic 
acid. 1000 μl of Sirius red working solution was added to the tubes containing ACM samples 
and standards. After mixing the content thoroughly the samples were incubated at RT for 1hr, 
followed by centrifugation at 10,000 rpm for 30 min at RT. The pellet was dissolved properly 
in 100 μl of 0.1N KOH and the measurements were made at 540 nm. A curve was plotted 
using the known concentration samples, and the collagen concentration of the ACM sample 
was estimated using this standard curve. 
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Estimation of total matrix GAGs and proteoglycans content in HS-5 ACM was done by 
standard method using Blyscan GAG assay kit. The Blyscan Assay is a quantitative dye-
binding method for the analysis of sulfated proteoglycans and glycosaminoglycans, (sGAG). 
The proteoglycans and GAGs were extracted from each ACM sample by standard protocol 
using papain extraction buffer containing. Chondroitin 4 sulfate proteoglycans supplied with 
kit was taken as standard. The ACM samples were washed with 1X PBS. Papain extraction 
reagent was added (∼500 μl for 35 mm dish). ACM samples were incubated for 3 hr at 60ºC. 
ACM extract were scrapped thoroughly and collected in fresh 1.5 ml tubes followed by 
centrifugation at 10000 g for 10 min. 50 μl of supernatant was retained for assay. To each 
tube 500 μl of Blyscan dye was added and mixed followed by incubation for 1 hr at RT. The 
contents were transferred to micro centrifuge and centrifuged at 12000 rpm for 15 min. The 
supernatant was drained carefully. 0.25ml of dissociation reagent (supplied with kit) was 
added to each tube. Vortexed for 10 min to 1 hr and 200 μl was transferred to each well of the 
96 well plate. Optical density measurement was done at 656 nm.  
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For SEM analysis, HS-5 stromal cells were seeded at 1X104 cells/cm2 on 18 mm thermo 
cover slips and grown as described in section 2.2.1. Cells were rinsed in PBS, fixed in 2.5% 
glutaraldehyde, washed and dehydrated in a gradient of ethyl alcohol (50%, 60%, 70%,80% 
90%,100%) and finally stored in acetone. Fixed cells were then subjected to critical point 
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drying (CPD) and mounted on aluminium stubs before being sputter coated with a thin layer 
of gold and examined at constant kV. For SEM analysis of ACM confluent HS-5, cells were 
decellularized with 0.02M NH4OH, and resulted ACM sample was subjected for sample 
preparation, and analysed in SEM. 
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Cytochemical staining was performed on HS-5 stromal cells of 20% and 5% O2
condition to detect presence of major ECM proteins, and also to understand the qualitative 
changes in ECM due to change in O2 tension.  
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HS-5 stromal cells and decellularized ACM were stained with Alcian blue for detection 
of ECM-bound GAGs. Samples were fixed in 4% formaldehyde, washed twice with PBS and 
rinsed in 3% acetic acid (pH 2.5) for 5 min to equilibrate the pH, then incubated with 1% 
alcian blue 2 hr, followed by washes in 3% acetic acid, 3% acetic acid/50% ethanol and 
finally in water. Presence of GAGs were verified by the accumulation of sea blue stain as 
observed under phase contrast microscope with 20X magnification. 
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HS-5 stromal cells and decellularized ACM were stained using Masson’s trichrome kit 
(Sigma) for the detection of a collagenous matrix. Briefly, samples were washed three times 
in PBS and fixed in ice-cold 75% ethanol for 10 min, incubated with light green stain at 25°C 
for 30 min on an orbital shaker before being washed with ddH2O until no leaching was 
detected. Samples were then washed in 75% ethanol to remove non-specific dye, dried at 
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20ºC and examined for the presence of greenish-blue stain under phase microscope with 20X 
magnification. 
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HS-5 stromal cells and decellularized ACM were washed with PBS and MQ water. 
Nuclei were stained with Weigert’s iron haematoxylin working solution for 5 min and then 
stained with picro Sirius red for 1hr followed by washing twice in acidified water. 
Nonspecific staining was cleared by ethanol wash and samples were dried at 25°C, examined 
for the presence of red stain under phase microscope with 20X magnification. 
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HS-5 stromal cells and decellularized ACM were washed with PBS and MQ water, 
stained with Weigert’s iron haematoxylin working solution for 5 min, and washed in running 
tap water for 5 min. They were then stained with fast green solution for 2 min, rinsed quickly 
with 1% acetic acid solution for no more than 10 –15 sec and then stained in 0.1% saffranin -
O solution for 20 min. Finally, samples were dehydrated and cleared with 95% ethyl alcohol, 
then absolute ethyl alcohol, and then cleared with xylene, 1 min each before being mounted 
using resinous medium DPX. Samples were examined for the presence of orange- red stain 
under phase contrast microscope with 20X magnification. 
͵ǤʹǤ͸ 
Immunofluorescence staining of the HS-5 stromal cells and decellularized ACM was 
done using the standard protocol described in detail in chapter 2 section 2.3.3. 
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Fixed HS-5 stromal cells, and decellularized ACM, were incubated with the appropriate 
dilution of Phalloidin actin Alexa flour -488 in 1% BSA in PBS for 45 min in dark. Primary 
antibodies against fibronectin (1:500), laminin (1:200) and collagen (1:500) were added to 
the samples. After an hour of incubation, samples were washed and incubated with 
appropriate anti mouse isotype IgG-Alexa flour-594 (1:500) or anti rabbit IgG-Alexa flour-
594 (1:500) 2º antibodies. After an hour of incubation, samples were washed with 1X PBS, 
mounted with Vectashield containing DAPI mounting medium. Images were taken using 
Leica AOBS confocal microscope with 63X magnification. 
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O2 may direct influence changes in ECM or otherwise could be involved in down 
regulating signalling cascades involved in ECM synthesis, ECM remodeling or cell-ECM 
interaction. Expression of various ECM genes, MMP genes and genes for various Integrin 
subunits were quantified in HS-5 stromal cells under different O2 conditions. The detail 
protocol of qRT-PCR and primer used in the quantitative analysis is described in chapter 2 
Section 2.3.3.4.  
͵ǤʹǤͺ Ǧ͵ͶΪǦͷ
ACM generated by decellularizing HS-5 cells under two different O2 tensions were used 
as culture substrates for expansion of human UCB CD34+ cells. The detailed procedures for 
UCB sample collection, sample processing to obtain MNC, further processing and isolation 
of CD34+ cells from total mononuclear cells by AutoMACS using CD34+ antibody 
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conjugated with magnetic beads has been discussed in detail in chapter 2 Section 2.3.5.2 and 
2.3.5.3.  
͵ǤʹǤͺǤͳ ͵ͶΪʹ
All the decellularized ACM were prepared in 24 well tissue culture plates. The 
conditions used for the preparation of HS-5 ACM are listed in Table 3-1. The HSPC 
expansion on HS-5 ACMs were carried out in hypoxia incubator (37϶ C, 5% CO2, 5% O2) for 
a period of 8 days in HSPC expansion media. 
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5% O2 HS-5 ACM 20%O2 HS-5 ACM 
5% O2 control (TCP) 20% O2 control (TCP) 
The control surfaces were prepared by incubating the empty 24 well plates with media 
(CM1) without cells, and incubated at 20% and 5% O2 tensions and further treating with 
decellularizing solutions. Magnetically sorted UCB CD34+ cells were resuspended in HSPC 
expansion media containing Stemline II serum free media supplemented with 1X Pen/Strep 
and GFs -TPO-25ng/ml, SCF-25ng/ml, IL-6-50ng/ml and Flt3L-40ng/ml and seeded at 1X 
104 viable cells/ml in control (TCP) and ACM wells. All expansion cultures were placed in 
the hypoxic incubator (5% O2, 5% CO2, 37ºC, humidified) for 8 days (Figure 3-2). 
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,^WĞǆƉĂŶƐŝŽŶĐƵůƚƵƌĞŽŶǀĂƌŝŽƵƐ,^ͲϱDŝŶĂ,^WĞǆƉĂŶƐŝŽŶŵĞĚŝĂƵƐŝŶŐŚǇƉŽǆŝĂŝŶĐƵďĂƚŽƌͲϯϳ϶͕ϱйKϮ͕
ϱйKϮ
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϳϴ

͵ǤʹǤͺǤʹ 
After 8 days of expansion in HSPC expansion media, cells were pipetted carefully to 
resuspend the contents of each well and were collected into separate sterile 15ml collection 
tubes. 1ml PBS was added to each well and transferred into the same collection tubes. 
Collection tubes were centrifuged (20ºC, 480g, 10 min) followed by resuspension of the cell 
pellet in 200ȝl of PBS. Manual cell counts and viability determination with 1% trypan blue 
were preformed for each tube and aliquot for post-culture flow cytometry and CFU assays. 
͵ǤʹǤͺǤ͵ 	
Flow cytometric characterization and surface marker analysis of the HSPC was 
performed prior to culture. 2x104 MACS separated CD34+ cells were added to FACS tubes 
containing 100ȝl of PBS/2% FACS solution and appropriate antibodies and viability dye 
were added as shown in Table 3-2. Stained cells were incubated at RT in the dark for 20 min. 
After incubation, cells were washed with 1X PBS containing 2% FCS to remove excess 
antibody. Finally the cell pellets were resuspended in 300ȝl fixative solution (PBS 2% FCS 
1% formaldehyde 2ȝg/ml actinomycin D), and stored at 4ºC in dark. Data acquisition and 
analysis was performed within three days. 
dĂďůĞϯͲϮŶƚŝďŽĚŝĞƐĐŽŵďŝŶĂƚŝŽŶĨŽƌ&^ĂŶĂůǇƐŝƐ

For FACS analysis of expanded cells, harvested cells were stained in similar manner as 
described for pre –culture cells. Flow data was acquired using a FACS Calibur flow 
 

FACS Stain -1  CD45-FITC,CD34-PE, 7AAD 
FACS Stain- 2 CD38-FITC,CD34-PE, 7AAD 
FACS Stain- 3 CD34-FITC, CD133-PE, 7AAD 
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϳϵ

cytometer where 5,000 – 10,000 total events per sample were collected. The events acquired 
were analysed with CellQuest Pro software for both pre-culture and post-culture samples in 
order to calculate the fold expansion of target cell population numbers. Events were first 
gated for small side scatter and medium forward scatter, and then analysed based on 
fluorescence in the FITC, PE and 7-AAD channels. For determining the mean and standard 
error values, data from three experiments, with triplicate samples in every experiment, was 
used. Fold increase in total cell number and lineage specific cells was calculated using 
following formulas. 
ƋƵĂƚŝŽŶϯͲϭ&ŽůĚĞǆƉĂŶƐŝŽŶƚŽƚĂůĐĞůůƐ
For total cells 
Count of total viable cells after expansion 
Count of total viable cells before expansion 
ƋƵĂƚŝŽŶϯͲϮ&ŽůĚĞǆƉĂŶƐŝŽŶůŝŶĞĂŐĞƐƉĞĐŝĨŝĐĐĞůůƐ
For lineage specific cells  
(Lineage specific cell percentage × Count of total viable cells) after expansion  
(Lineage specific cell percentage × Count of total viable cells) before expansion 
͹Ǥ͸Ǥ;Ǥ͹Ǥͷ 
Pre culture colony forming assay was performed by culturing 2X103 MACS separated 
CD34+ cells in semi-solid Methocult media. The cells were incubated for 14 days in standard 
tissue culture incubator (5% CO2, 20% O2, 37ºC).  
dĂďůĞϯͲϯŽůŽŶǇĨŽƌŵŝŶŐƵŶŝƚĂƐƐĂǇƐ
 
CFU-GM Committed progenitors of Granulocyte & Macrophages.
BFU-E Burst forming units –Erythroid  
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϴϬ

CFU-GEMM Progenitor cells for Granulocyte Erythroctye, 
Megakaryocytic & Macrophages  
Detection and enumeration of visible and distinct colonies for granulocyte, macrophages 
(CFU-GM), Burst Forming Unit–Erythroid (BFU-E) and Colony Forming Unit–Granulocyte, 
Erythrocyte, Macrophage, Megakaryocyte (CFU-GEMM) was done. CFU assay was 
performed with pre-culture and post-culture samples to allow calculation of fold change in 
total colony forming units. After 8 days of expansion on ACM, cells were harvested as 
described in section 3.2.8.2 and resuspended into appropriate concentrations in Stemline II, 
pen/strep and 2% FCS. Cells were diluted 1:10 in Methocult® media and plated in triplicate 
in 12 well plates. Cells were plated at 2x 103 viable cells per ml. All cultures were incubated 
for 14 days in standard tissue culture incubators (5% CO2, 20% O2, 37ºC). Different colonies 
(Table 3-3) with distinct morphologies (Appendix-XVI), were manually counted following 
the 14-day incubation, as per manufacturer’s instructions. 
͵Ǥ͵ 
͵Ǥ͵Ǥͳ ʹǦͷ
As discussed before, to mimic the BM microenviromental conditions and to understand 
the regulatory role of O2 in niche mediated HSPC expansion, the ACMs were prepared by 
HS-5 cells cultured at 5% and 20% O2 condition. The physicochemical condition provided by 
vitro culture system may not necessarily mimic the exact O2 conditions (specifically lower 
O2) that cells sense in the in-vivo artificial niche. Validation of the presence of lower O2
tension in HS-5 cells was done by two methods and the results are described below. 
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϴϭ

͵Ǥ͵ǤͳǤͳ Ȃ	ǦͳȽ
HIF-1Į protein expression in HS-5 cells of two different O2 tension was determined by 
western blot. The marked increase in the HIF-1Į protein expression was observed that 
indicate, induction of hypoxia pathway in HS-5 cells of 5% O2 (Figure 3-3). 
&ŝŐƵƌĞϯͲϯtĞƐƚĞƌŶďůŽƚƚŽĚĞƚĞĐƚ,/&ϭͲɲĞǆƉƌĞƐƐŝŽŶŝŶ,^ͲϱĐĞůůƐŽĨϱйĂŶĚϮϬйKϮĐŽŶĚŝƚŝŽŶ
͵Ǥ͵ǤͳǤʹ Ȃ	ǦͳȽǦͳ
The immunostaining performed on HS-5 cells of 5% and 20% O2 condition cells with 
HIF-1Į and STC -1, show differences in the expression profile (Figure 3-4).  
&ŝŐƵƌĞϯͲϰ/ŵŵƵŶŽƐƚĂŝŶŝŶŐǁŝƚŚ,/&ϭɲĂŶĚ^dͲϭŝŶ,^ͲϱĐĞůůƐ
(Scale bar - 25 μm) 
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϴϮ

The cells of 5% O2 condition showed enhanced expression of both markers as compared 
to 20% O2. The results of both western blotting and immunofluoroscence staining indicate 
activation of HIF-1Į driven hypoxia pathway in HS-5 cells at lower O2 tension. 
͵Ǥ͵Ǥʹ ǦͷȂ
Assessment of proliferation by MTT assay over 8 days suggested no significant growth 
difference in the HS-5 cells cultured at different O2 tensions Figure 3-5. 

&ŝŐƵƌĞϯͲϱDddĐĞůůƉƌŽůŝĨĞƌĂƚŝŽŶĂƐƐĂǇĨŽƌ,^ͲϱĐĞůůƐ;ŶсϯͿ
As there was, no significant differences observed in HS-5 cell growth, differences in ECM 
expression are likely to be due to the molecular changes occurring in HS-5 stromal cells at 
lower O2 tension.  
͵Ǥ͵Ǥ͵ 
Decellularization is the process of removal of nuclear and cellular component from cultured 
cell monolayer or intact tissue with the treatment of a decellularizing agent to leave behind 
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϴϯ

the intact ECM components. Chemical methods using NH4OH employed for HS-5 cells 
decellularization was efficient in total cell lysis preserving the complex 3D architecture. 
Although preparation of 100% nuclear material free matrix is not possible but the 
methodology employed by us using NH4OH gave maximum matrix yield with negligible 
amount of nuclear material retention as observed by DNA quantification results (Figure 3-6). 

&ŝŐƵƌĞϯͲϲƐƚŝŵĂƚŝŽŶŽĨEĐŽŶƚĞŶƚŝŶ,^ͲϱD
&ŝŐƵƌĞϯͲϳƐƐĞƐƐŵĞŶƚŽĨĚĞĐĞůůƵůĂƌŝǌĂƚŝŽŶĞĨĨŝĐŝĞŶĐǇ
>ĞĨƚ ƉĂŶĞů /ŶƚĂĐƚ ,^Ͳϱ ĐĞůůƐ ďĞĨŽƌĞ ĚĞĐĞůůƵůĂƌŝǌĂƚŝŽŶ͕ ƌŝŐŚƚ ƉĂŶĞů ĚĞĐĞůůƵůĂƌŝǌĞĚ D͘ ͕  ƉŚĂƐĞ ĐŽŶƚƌĂƐƚ
ŵŝĐƌŽƐĐŽƉǇ͕͕ŶƵĐůĞĂƌƐƚĂŝŶŝŶŐďǇW/͕ĂŶĚ͕&ŶƵĐůĞĂƌƐƚĂŝŶŝŶŐďǇ,ΘƐƚĂŝŶŝŶŐ͘;ƐĐĂůĞďĂƌͲϭϬϬђŵͿ
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϴϰ

The phase contrast images (Figure 3-7 A-B) show morphological differences in HS-5 
cells and decellularized ACM. The ACM were also observed and analysed by detection of 
nuclear material by DAPI (Figure 3-7 C-D) and H&E staining (Figure 3-6 E-F) also showed 
efficiency of decellularization by exhibiting lesser staining for nuclear material in ACM as 
compared to stromal cells.  
͵Ǥ͵Ǥ͵Ǥͳ 	ǦǦ
The FTIR results showed the presence of functional groups like H2O, alkenes, amide groups, 
sugar molecules, and phosphate groups in ACM of both O2 tensions (Figure 3-8).  
dĂďůĞϯͲϰ/ZƐƉĞĐƚƌĂůƌĂŶŐĞŽĨƐƉĞĐŝĨŝĐĨƵŶĐƚŝŽŶĂůŐƌŽƵƉƐ
	
 ȋǦͳȌ
Phosphate groups 875-880 
Sugar Molecules 990-1225 
Amide groups 1550-1690 
Alkane groups 2850-3000 
H2O 2600-3600 
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϴϱ

&ŝŐƵƌĞϯͲϴ&dͲ/ZƐƉĞĐƚƌĂůŝŵĂŐĞƐŽĨDŽĨͿϮϬйĂŶĚͿϱйKϮĐŽŶĚŝƚŝŽŶƐ,^ͲϱD
Table 3-4 shows the range of IR spectral bands for particular functional groups. The results of 
FT-IR analysis confirms the presence of matrix proteins functional groups in decellularized 
ACM after decellularization of stromal cells. The presence of amide groups in the FT-IR 
spectra indicate proteinaceous matrix, and sugar groups indicate proteoglycans, and GAG-
rich matrices. The Presence of a single peak for phosphate groups in the FT-IR spectra 
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϴϲ

indicates that the ACM are poorly mineralized (Figure 3-8). The FT-IR analysis was 
performed more than three times, with three different samples. 
͵Ǥ͵ǤͶ Ǧͷ
͵Ǥ͵ǤͶǤͳ 
The total matrix of decellularized HS-5 ACM of both O2 tension, were quantified to 
estimate the difference in the content. The loss of matrix protein was observed in the ACM of 
5% O2 condition as compared to the ACM of 20% O2 condition (Table 3-5). 
&ŝŐƵƌĞϯͲϵ^ƐƚĂŶĚĂƌĚŐƌĂƉŚĨŽƌĞƐƚŝŵĂƚŝŽŶŽĨƚŽƚĂůŵĂƚƌŝǆƉƌŽƚĞŝŶŝŶ,^ͲϱĐĞůůƐ


dĂďůĞϯͲϱdŽƚĂůŵĂƚƌŝǆƉƌŽƚĞŝŶĞƐƚŝŵĂƚŝŽŶ;ŶсϯͿ
 ρȀρȋάȌ
ͷΨʹǦͷ          11.5±0.011 
ʹͲΨʹǦͷ 16.0±0.008 

ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϴϳ



&ŝŐƵƌĞϯͲϭϬdŽƚĂůĞǆƚƌĂĐƚĞĚŵĂƚƌŝǆƉƌŽƚĞŝŶŽĨ,^ͲϱĐĞůůƐŽĨƚǁŽĚŝĨĨĞƌĞŶƚKϮĐŽŶĚŝƚŝŽŶ
The 1D SDS-PAGE run for matrix protein extracted from decellularized ACM of 5% and 
20% O2 condition show difference in profile. A significant amount of small molecular weight 
protein loss was observed in 5% O2 ACM as compared to the 20% O2 ACM (Figure 3-10). 
͵Ǥ͵ǤͶǤʹ Ǧͷ
&ŝŐƵƌĞϯͲϭϭZĂƚĐŽůůĂŐĞŶƐƚĂŶĚĂƌĚŐƌĂƉŚ
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϴϴ

The estimation of total collagen present in HS-5 ACM of 5% and 20% O2 was done by Sirius 
red method. The results suggest higher collagen enrichment in 20% O2 ACM as compared to 
the 5% O2 ACM (Table 3-6). 
dĂďůĞϯͲϲŽůůĂŐĞŶĞƐƚŝŵĂƚŝŽŶďǇ^ŝƌŝƵƐƌĞĚ
͵Ǥ͵ǤͶǤ͵ 

Ǧͷ
The total GAGs and proteoglycans content in HS-5 ACM of 5% and 20% O2 condition 
were estimated by standard method using Blyscan GAG assay kit. Similar to other matrix 
protein estimation, the total GAGs and proteoglycans were also observed to be present in 
higher concentration in 20% O2 ACM as compared to the 5% O2 ACM (Table 3-7). 
&ŝŐƵƌĞϯͲϭϮŚŽŶĚƌŽŝƚŝŶϰƐƵůĨĂƚĞƐƚĂŶĚĂƌĚ
 ρȀρ
ͷΨʹǦͷ 6.95 
20% O2 HS-5 ACM 10.7
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϵϬ

dĂďůĞϯͲϳdŽƚĂů''ƐĂŶĚƉƌŽƚĞŽŐůǇĐĂŶƐĞƐƚŝŵĂƚŝŽŶŝŶ,^ͲϱD
 

ȀρȀρ
ȋάȌ
ͷΨʹǦͷ 3.9±0.4 
ʹͲΨʹǦͷ 6.6±0.4 
͵Ǥ͵Ǥͷ Ǧͷ
The microscopic morphological characterization, of HS-5 stromal cells and 
decellularized ACM of two different O2 conditions provides information about the structural 
and topographical differences present in these two substrates.  
͵Ǥ͵ǤͷǤͳ 
Phase contrast microscopy confirmed the presence of an intact layer of matrix after 
decellularization of the cells grown at both 20% and 5% O2 conditions. Figure 3-13, panels 
A-D, show representative images of intact HS-5 cells grown at 20% and 5% O2 respectively, 
whereas B-E show images of decellularized ACM from HS-5 cells grown at 20% and 5% O2
condition respectively. Absence of the intact stromal cells and nuclei, and thick layering of 
the matrix components can be observed in the decellularized ACM. 
͵Ǥ͵ǤͷǤʹ Ǧ
Scanning electron microscopy (SEM) of the HS-5 stromal cells, decellularized ACM was 
performed to analyse the micro detailing, architecture, uniformity and irregularities present in 
matrices (Figure 3-14). 
ŚĂƉƚĞƌϯͲǆͲǀŝǀŽ,^WĞǆƉĂŶƐŝŽŶŽŶ,^ͲϱD
ϵϭ

&ŝŐƵƌĞϯͲϭϯWŚĂƐĞĐŽŶƚƌĂƐƚŵŝĐƌŽƐĐŽƉǇŽĨ,^ͲϱƐƚƌŽŵĂůĐĞůůƐĂŶĚĚĞĐĞůůƵůĂƌŝǌĞĚD
Ϳ,^ͲϱƐƚƌŽŵĂůĐĞůůƐ͕ĂŶĚͿĚĞĐĞůůƵůĂƌŝǌĞĚDϮϬйKϮĐŽŶĚŝƚŝŽŶƌĞƐƉĞĐƚŝǀĞůǇͿ,^ͲϱƐƚƌŽŵĂů ĐĞůůƐ͕ĂŶĚͿ
ĚĞĐĞůůƵůĂƌŝǌĞĚϱйKϮĐŽŶĚŝƚŝŽŶ;ƐĐĂůĞďĂƌͲϭϬϬђŵͿ
&ŝŐƵƌĞϯͲϭϰ^ĐĂŶŶŝŶŐĞůĞĐƚƌŽŶŵŝĐƌŽƐĐŽƉǇŽĨ,^ͲϱƐƚƌŽŵĂůĐĞůůƐĂŶĚĚĞĐĞůůƵůĂƌŝǌĞĚD
Ϳ ,^Ͳϱ ƐƚƌŽŵĂů ĐĞůůƐ Ϳ ĚĞĐĞůůƵůĂƌŝǌĞĚ D ŽĨ ϮϬй KϮ ĐŽŶĚŝƚŝŽŶƐ ƌĞƐƉĞĐƚŝǀĞůǇ͘ Ϳ ,^Ͳϱ ƐƚƌŽŵĂů ĐĞůůƐ Ϳ
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HS-5 stromal cells, and decellularized ACM prepared at two different O2 conditions 
were stained with cytochemical stains. Presence of collagen in different cells and matrices 
were assessed by staining with Sirius red and masson trichrome. GAGs and proteoglycans in 
the cells and ACM were assessed by staining with alcian blue, and saffranin-O. 
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Cells and decellularized ACM grown at 20% O2 show better retention of all the 
cytochemical stains, indicating the presence of collagen, proteoglycans and glycosamino-
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glycans rich matrix. In contrast, ACM of HS-5 cells grown at 5% O2 showed lower 
expression of matrix proteins or loss of matrix components(Figure 3-15).
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Specific immunostaining showed greater expression of all three major ECM proteins 
(fibronectin, collagen and laminin) in ACM derived from cells culture at 20% O2 as 
compared to 5% O2 (Figure 3-16). The ECM proteins were tagged with Alexa flour 594 and 
thus can be identified with red fluorescence in the confocal images shown below. 
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(Scale bar -25μm) 
The absence of green fluorescence of phalloidin actin-actin-488 indicates the removal of 
cytoskeleton and cellular part by decellularization procedure (Figure 3-17). Absence of DAPI 
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stained nuclear materials after decellularization can be seen in the ACM. Similar to 
cytochemical analysis, immunofluoroscence characterization also shows better expression of 
major ECM molecule in HS-5 cells under 20% O2 culture conditions (Figure 3-16). 
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Expression of all the major ECM molecules was found to be higher in HS-5 cells 
cultured at 20% O2, whereas MMP 10, which degrades fibronectin and proteoglycans in 
COL-20%O2 COL-5%O2
LMN-5%O2LMN-20%O2
FN-5%O2-FN-20%O2
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ECM, showed higher expression in HS-5 cells cultured at 5 % O2. Integrin Į1, Į5, and ȕ1, ȕ5 
expression was found to be higher in HS-5 cells cultured at 20% O2 (Figure 3-18). 
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Every expansion experiment was performed using single CB sample for each 
experiment. The volume of the CB samples collected (n = 5) was 60.3 ± 14.8 ml. The average 
cell viability of isolated cells after MACS separation was 68% as assessed by trypan blue. 
The percentage purity for CD34+ CD45lo cells after MACS separation as assayed by flow 
cytometry was 65.03 % and for CD34+ CD38- , CD34+CD133+ cells was found to be 2.99 
%, and 62.46% respectively. 
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The average of five expansion experiments is depicted, in which demonstrates that total 
and lineage specific cell expansion was observed to be significantly higher in ACM derived 
from HS-5 grown at 20% O2 compared to both 5% ACM and no-ACM controls (TCP). 
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(* p  0.05; ** p  0.01; # N/S) 
The most significant difference (p<0.01)was observed in the viable cell expansion of 
CD34+CD133+ cell populations , whereas expansion of the CD34+CD38- subset was not 
significantly different between conditions (Figure 3-19). 
Representative dot plot of flow analysis from one experiment to assess the level of 
expansion of HSPC on HS-5 ACM of two different O2 condition using lineage specific 
markers is shown in Appendix-VI. 
Similarly, the expansion of all colony forming cell units was observed to be higher in 
20% ACM conditions, in comparison to other conditions and controls (Figure 3-20). Notably, 
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a 90-fold increase in BFU-Es cell populations was observed in 20% O2 ACM. The 5% O2
ACM was observed to be less supportive matrix substrate for BFU-E expansion.  

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Development of precise and efficient methodologies for ex-vivo expansion of human 
HSPC is essential in realizing its potential in treatment of hematologic disorders and 
malignant diseases. Although BMSC have had been shown to preserve the stemness of HSPC 
during short-term expansion, they do not provide all the signals required for self-renewal in 
long-term expansion. Similarly, in suspension culture system the signalling clues are 
provided in the form of growth factors and ligands added in to the expansion media that is 
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diluted over a period a time. The lack of cell-to-matrix interaction is another factors may be 
responsible for inefficient maintenance of HSPC during in -vitro culture. 
Here we present an efficient and novel strategy to expand HSPC using a homologous 
biological cell free substrate made of decellularized ACM from HS-5 cells, BMSC line that 
partially mimics the growth inductive extracellular microenvironment of HSC niche in BM. 
The functionality of HS-5 derived ACM depends on the quality of matrix prepared. 
Decellularization using a solution of NH4OH removes the intact cellular and nuclear content,
leaving behind the scaffold like structure of ECM that remains functionally active and 
provides critical biological cues required in ex-vivo HSPC expansion. Many studies have 
attempted to examine the cell-matrix interactions using matrix components extracted and 
reconstituted as single-component ECM preparations in 2D culture systems. These reports are 
valuable in defining interactions between cells and individual ECM components, but cannot 
provide information about tissue and specific cell ECM composition, and also in 
recapitulating the intricate arrangements of multiple ECM molecules. To our knowledge, this 
is the first description of the preparation and characterization of human, tissue-specific ACM 
substrate that in its native configuration can significantly expand human HSPC under ex-vivo
conditions. Our approach for the preparation of ACM and HSPC expansion has significant 
advantages over the other conventional methods, as it captures the true complexity and 
functionality of native ECM of BM[167]. 
The HS-5 ACM exhibits well spread porous and fibrous mesh like structural features 
similar and resemble in appearance to the natural ECM composites present in stromal cells 
and native tissue. It is rich in collagen, fibronectin, laminin , GAGs and proteoglycans which 
provide structural guidance and present growth factors to HSPC [168]. The potential role of 
these ECM molecules as critical components of BM niche in regulating HSC behaviour is 
known and has been reviewed in chapter 1. For example, HSPC show binding affinity to 
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laminin and fibronectin. The adhesive properties of laminin isoforms also affect the migration 
of HSC in-vivo [97]. Laminin and fibronectin coated plates in the presence of growth factors, 
show approximately 800 fold expansion in CFU colonies, specifically CFU-GEMM. FN has 
been shown to play a dual role where it supports the adhesion as well as growth of HSC. FN 
pre-treatment has been shown to support better expansion of CFU-GM and BFU-E in culture 
conditions [99]. In the BM niche a complex and intricate composition of ECM molecule is 
involved in HSC regulation, and defects in any of the factor can affect the balance between 
cell proliferation and differentiation. HS-5 ACM represents the intrinsic 3D ECM network 
mimicking the complexity of the native BM niche. Structural and biochemical properties of 
exhibited by ACM scaffold indicate that it can provide a suitably complex microenvironment 
and may guide HSC differentiation towards specific lineages. 
To recreate the BM niche complexity that is attributed by its two different niches, the 
ACM were prepared by culturing HS-5 cells in two different O2 tensions i.e. 20% and 5% O2. 
Differential expression of major ECM molecules in HS-5 stromal cells and matrices grown at 
20% and 5% O2 tension was evident from our results. HS-5 cells are able to adapt to the 
lower O2 environment but their ECM properties and functionalities are affected. The 
properties of the two niches were different not only in terms of ECM composition but also in 
the other important molecular regulators such as MMPs, TIMPS and integrin sub units. 
MMP-TIMP balanced activity is important for bone remodeling and ECM turnover. ECM-
integrin cross talk is essential for maintaining the cell physiology and ECM stability. 
Reduced expression of integrin sub units ȕ1, ȕ5, Į1 and Į5 at lower O2 could possibly 
explain the reduced ECM expression in HS-5 cells at lower O2 tension, as these sub units are 
known to bind their ECM ligands such as collagen, and fibronectin.  
The overall ECM differences in HS-5 cells at different O2 tension are reflected in the abilities 
of the ACM to support expansion of HSPC. The ex-vivo expansion outcomes demonstrate 
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that the lineage specific expansion of HSPC is improved and preserved when ACM are 
prepared from cell grown at 20% O2 conditions. It was reported by Mantalaris et al, that 
marrow cells co-cultured on porous surfaces produces more erythroid cells than Dexter 
culture system[169]. 
There could be multiple reasons behind differential response of two types of ACM prepared 
from same stromal cells first, HS-5 represent a distinct functional stromal population of BM 
that only at specific O2 tension remain functional, when the culture conditions are altered to 
lower O2 tension these stromal cells lose their stromal matrix properties. Along with the loss 
of important ECM components, there could be activation of other regulatory pathways and 
networks that evoke actions of inhibitors and all together makes ACM of lower O2 condition 
inefficient to be used as culture substrates. There is also a possible indication that the HS-5 
stromal cells belong to the vascular region of BM as the ACM generated from these cells 
selectively expand BFU-Es. Expansion media used by us in our culture system did not 
contain exogenous EPO. One possibility of higher expansion of BFU-Es on the HS-5 ACM is 
that EPO and other HGFs secreted by HS-5 cells remains bound to the ECM components 
even after decellularization that contribute in the lineage specific cell expansion.  
In conclusion, for the first time, to our knowledge, we have successfully cultured HSPC 
on human BMSC line derived HS-5 ACM. We demonstrated that HS-5 ACM could function 
as an ex- vivo niche for HSPC expansion and could generate larger HSPC quantities than 
suspension cultures on TCP. The presence of soluble and insoluble niche regulatory factors 
present in the HS-5 ACM could be the reason behind the close proximity of cells to the 
matrix substrate in the in-vivo niche [170]. The HSPC sense the signalling cues and react 
appropriately to the signals emanating from the ACM and regulate cell behaviour [170]. The 
biological signal of HS-5 ACM are affected and altered at lower O2 tension, which could 
possibly explain the lesser expansion of HSPC. 
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From our HS-5 ACM preparation, characterization and using it as substrates for ex-vivo 
HSPC expansion we conclude that- 
• We were successful in preparing efficient homologous ACM substrates by 
decellularization of HS-5 cells lines that partially mimic BM niche properties in terms 
of ECM composition.  
• The morphological and biochemical characterization, shows better qualitative as well 
as quantitative ECM properties exhibited by HS-5 ACM of 20% O2 condition as 
compared to ACM of 5% O2 condition.  
• The HS-5 ACM of 20% O2 condition support significant expansion of committed 
progenitor cells, specifically BFU-Es expansion.  
As reviewed in chapter 1 none of the artificial tissue engineering surfaces allows 
simultaneous understanding of exact recreation niche properties or extracellular features like 
ECM composition, ECM assembly, and capacity to expand HSPC. The properties of HS-5 
ACM to support specific and distinct population of BFU-Es lineage, suggests that this in-
vitro system could serve as a surrogate model of a vascular niche of BM. Furthermore, our 
method of ECM surface preparation by cells decellularization is easily applicable to other cell 
types and allows researchers to modulate the composition and structure of the secreted ECM 
to create variations of tissue-specific matrices. 
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The most important function of the HSC niche is to regulate the balance between cell 
self-renewal and differentiation thorough various cellular and molecular components present 
in the microenvironment [171]. The HSC microenvironment in human BM consists of 
various cellular, molecular and ECM components where individual component have been 
shown to play a role in cell regulation. It is very important to understand the intricate 
relationship between HSC and their niche, to assist in replicating these relationships in-vitro
to ensure the formation of functional growth inductive conditions for ex-vivo expansion 
purposes. As discussed previously, stromal cells are a heterogeneous population of cells of 
mesenchymal origin that includes reticular endothelial cells, fibroblasts, chondrocytes, 
adipocytes, and osteogenic precursor cells [37, 172]. Stromal cells secrete or provide HSC 
with growth factors known for their hematopoietic activity such as interleukins, GM-CSF, G-
CSF, TGF –ȕ, ANGPTLs etc. The cell–cell contacts and signaling through stromal cells 
adhesion molecules keep HSC in close proximity to self-renewal and survival signals of the 
niche[33, 34], and many other positive and negative stimuli for their survival, migration and 
differentiation [173]. ECM secreted by the BMSC influences the stem cell behaviour in a 
number ways. It facilitates the cell-ECM interaction and directs cell fate determination, 
growth factors are immobilized locally though ECM molecules, provides structural and 
mechanical support as well as specific 3D topographical information and physiological cues 
vital to stem cell functions [36].  
To understand the specific molecular signature of a number cells such as ESCs, neural 
stem cells (NSCs), MSCs and HSC, microarray-based analyses have been performed by 
many groups [174-178]. In similar attempts, complete molecular profiling of HSC 
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microenvironment responsible for niche mediated HSC regulation was understood by 
analysing the differential genes expression in FL and BMSC [179]. 
In chapter 3, we discussed the role of human BM stromal cell line derived ACM on ex-
vivo HSPC expansion. The HS-5 ACM was observed to be rich in ECM components and was 
functionally similar to BM niche ECM in supporting ex-vivo expansion. We demonstrated 
that oxygen plays a role in modulating the HS-5 stromal matrix properties. It is therefore 
important to characterize the molecular nature of HS-5 cells to understand the regulatory 
action of O2 in HSPC expansion. We have therefore performed microarray analysis of the 
HS-5 cells grown under two different O2 tensions, in order to understand the impact of 
oxygen tension on the expression of critical molecules involved in the control of HSPC 
growth and differentiation. These include cytokines, growth factors, cell adhesion molecules, 
ECM proteins, ligands - receptors, matrix proteases, stimulators and inhibitors secreted or 
expressed by HS-5 cells.
Based on these results, we reason that molecules responsible for expanding different 
lineages would be differentially expressed in HS-5 cells grown under two different O2
tensions. Since we were interested in the genes involved in the regulation of HSPC through 
the ECM, we have focused on genes that encode ECM and secreted proteins. We hypothesize 
that there are regulators yet to be discovered, which affect or modulate the stem cell 
supportive ability of the matrices prepared from HS-5 cells comes from many interacting 
molecules.  
In this chapter, we have attempted to identify some of these genes and regulators by 
keeping the following specific aims- 
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• Isolation, qualitative and quantitative analysis of the m-RNA of HS-5 cells of two 
different O2 conditions. 
• Whole genome microarray analysis of HS-5 cell grown in two different O2 
conditions. 
• Identification of the molecular function, cellular composition, biological process, 
networks and pathways of the differentially regulated genes in HS-5 cells due to 
change in O2 tension. 
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Strategy employed in the particular study involves A) Cell culture of HS-5 cells in two 
different O2 condition, isolation of total RNA from cultured HS-5 cells, c-DNA synthesis and 
hybridization, B) Filtration of raw data, normalization and data analysis by various 
bioinformatics tools C) Microarray data validation by qRT-PCR. 
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As described earlier, acellular matrices were prepared from HS-5 stromal cells cultured 
in CM-1 and maintained at 37ºC under two different oxygen condition – normal oxygen 
tension (20% O2) and low O2 tension (5% O2) (described in detail in chapter 2 section 
2.4.1.2). 
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High-quality total RNA was extracted and purified from HS-5 cells grown in different 
culture conditions of varying O2 tension (20% and 5% O2) using the RNeasy Plus Mini Kit as 
per the manufacturer’s protocol. The detail process of total RNA isolation, purification and 
quantification is described in chapter -2 section 2.4.2. The results of both quantitative and 
qualitative assessment of HS-5 RNA of two different O2 conditions is shown in Appendix-IV.  
ͶǤʹǤͶ Ǧ
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The Australian Genome Research Facility (AGRF) Melbourne, Australia performed gene 
expression profiling of HS-5 cells. Total RNA from HS-5 cell preparations, corresponding to 
two conditions of matrix preparation each in triplicate, was labelled and hybridized to 
Illumina's Human microarray chip-HumanWG6v3 (48804 probes), Expression BeadChips 
according to manufacturer's protocol (http://www.illumina.com/support/literature.ilmn). Total 
ŚĂƉƚĞƌϰͲDŽůĞĐƵůĂƌƉƌŽĨŝůŝŶŐŽĨ,^ͲϱĐĞůůƐ
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RNA and labelled cDNA was quantified using Bio analyser prior to hybridization. The arrays 
were scanned using Illumina Bead Array Reader and the image data was processed by 
BeadStudio. The raw data output (not normalized) of BeadStudio was used for the data 
processing.
ͶǤʹǤͷ 
dĂďůĞϰͲϭĂƚĂďĂƐĞĂŶĚ^ŽĨƚǁĂƌĞƵƐĞĚĨŽƌDŝĐƌŽĂƌƌĂǇŶĂůǇƐŝƐ
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Data normalization and filtration
1 MAMSAP database Deakin University
For functional and molecular clustering:
2 Database for Annotation, Visualization 
and Integrated Discovery (DAVID) 
http://david.abcc.ncifcrf.gov
3 Gene Ontology Enrichment Analysis 
Software Toolkit (GOEAST) 
http://omicslab.genetics.ac.cn/GOEAST/
4 For localizations, pathways and network analysis:
5 GeneGo-MetaCore software http://www.genego.com/metacore.php
6 For associations with ‘Hematopoiesis’ related networks:
8 Exploratory Gene Association 
Networks (EGAN)  
http://akt.ucsf.edu/EGAN/
Basic information about the genes and regulators 
9 Kyoto Encyclopaedia of Genes and 
Genomes (KEGG) and BIOCARTA 
http://www.genome.jp/kegg/
http://www.biocarta.com/genes/allPathwa
ys.asp 
10 National Centre for Biotechnology 
Information (NCBI) 
http://www.ncbi.nlm.nih.gov/
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The results of microarray analysis of the list of genes involved in one of the most 
affected pathway in HS-5 cells due to change in O2 tension i.e. ECM remodeling were further 
validated through q RT-PCR and Zymography. 
ͶǤʹǤ͸Ǥͳ Ǧ
 qRT-PCR for validation of microarray data was performed for 13 different genes, 7 of 
which were up regulated in 20% O2 condition while 5 were up regulated in 5% O2 condition. 
Oligonucleotides used in this study and its sequences are listed in Table 2-4 in chapter 2, and 
protocol of qRT-PCR is described in section 2.4.2. 
ͶǤʹǤ͸Ǥʹ Ȃ
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As the microarray data analysis indicates up regulation of genes for MMPs at lower O2
tension, their proteolytic activity was measured and confirmed by gelatine zymography. 
Zymography was performed as described by Lorenzl et al [180]. Protein concentration of 
secreted MMP in conditioned media of HS-5 cells of 5% and 20% O2 condition samples were 
quantified using Bradford Protein Assay. Aliquots containing 20 μg of protein were mixed 
with sample buffer then subjected to SDS-PAGE in non reducing conditions. Gels contained 
7.5% (w/v) polyacrylamide copolymerized with 1% (w/v) gelatin. After electrophoresis, gels 
were washed twice for 30 min in 2% (v/v) Triton X-100 then incubated at 37ºC for 20 hr in 
incubation buffer [50 mM Tris, 5 mM CaCl2, 1 M ZnCl2, and 0.01% (w/v) sodium azide (pH 
-7.5)]. After incubation, gels were fixed in 20% TCA for 30 min then stained in 0.5% (w/v) 
Coomassie Brilliant Blue R-250 for 90 min. Gels were then washed for 60 min in distaining 
ŚĂƉƚĞƌϰͲDŽůĞĐƵůĂƌƉƌŽĨŝůŝŶŐŽĨ,^ͲϱĐĞůůƐ
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solution (35% (v/v) ethanol and 10% (v/v) acetic acid). Proteolytic activity generated clear 
bands against the dark background of the gel. 
ͶǤ͵ 
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The quantitative estimation of total RNA concentration of HS-5 cells of different O2
condition (in triplicates) done by Nanodrop is represented in Appendix IV. The qualitative 
analysis of the isolated and purified RNA by bioanalyzer is also shown in Appendix IV. 
ͶǤ͵Ǥʹ 
The raw data was filtered with strict parameters to get statistically significant expression 
values of differentially regulated genes in HS-5 cells with cut off value of 1.2 fold up 
regulation and more.  
dĂďůĞϰͲϮŝĨĨĞƌĞŶƚŝĂůůǇƌĞŐƵůĂƚĞĚŐĞŶĞƐŝŶ,^ͲϱĐĞůůƐ
Total/ 
differentially 
regulated 
In HS-5 cells 
Up regulated at 
 20% O2 condition 
Up regulated at 
 5% O2 condition 
48804/1941(3.9%) 
Genes  
961-
1.9% 
Genes  
891 -98% Genes 
1.2 fold 
980-2% 
Genes  
904 -92.4% Genes 1.2 
fold  
85-8.8% Genes 5 
fold 43- 4.3% Genes 5 fold 
43- 4.4 % Genes 
10 fold 13-1.3% Genes 10 fold  
Total number and percentage of differentially regulated genes is listed in the Table 4-2. 
Bioinformatic data analysis tools, were used, for the normalization of raw data to a fixed 
ŚĂƉƚĞƌϰͲDŽůĞĐƵůĂƌƉƌŽĨŝůŝŶŐŽĨ,^ͲϱĐĞůůƐ
ϭϬϴ
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threshold value, data lower than this value (1.2) was considered as non-significant and was 
not included in the analysis. On microarray chip-Human WG6v3_ilm of total 48804 genes, 
1941 genes (3.9%) were differentially expressed in HS-5 cells grown in varying O2 tension.  

dĂďůĞϰͲϯ'ĞŶĞƐƵƉƌĞŐƵůĂƚĞĚŝŶ,^ͲϱƐƚƌŽŵĂůĐĞůůƐŽĨϮϬйKϮĐŽŶĚŝƚŝŽŶ
MAMSAP database 
Probe 
ID 
Gene 
Symbol 
Gene Name Fold Change Function 
5960762 PCDH18 protocadherin 18 18.8998 Cell Adhesion 
5960762 PCDH18 protocadherin 18 18.8998 Cell Adhesion 
4610364 CCL7 chemokine C C motif ligand 7 CCL7 252.7847 Chemokine 
6620121 CCL8 chemokine C C motif ligand 8 CCL8 55.6986 Chemokine 
620717 CCL5 chemokine C C motif ligand 5 CCL5 33.3892 Chemokine 
3180068 IL19 interleukin 19 IL19 23.7498 Chemokine 
6270553 CXCL10 chemokine C X C motif ligand 10 19.6294 Chemokine 
2760148 IL11RA interleukin 11 receptor, alpha 5.9145 Chemokine 
4610364 CCL7 chemokine C C motif ligand 7 CCL7 252.7847 Chemokine 
6620121 CCL8 chemokine C C motif ligand 8 CCL8 55.6986 Chemokine 
620717 CCL5 chemokine C C motif ligand 5 CCL5 33.3892 Chemokine 
3180068 IL19 interleukin 19 IL19 23.7498 Chemokine 
6270553 CXCL10 chemokine C X C motif ligand 10 19.6294 Chemokine 
2760148 IL11RA interleukin 11 receptor, alpha 5.9145 Chemokine 
2120021 COL3A1 collagen, type III, alpha 1 41.2412 Extra Cellular Matrix 
50368 DCN decorin DCN , transcript variant C 29.7972 Extra Cellular Matrix 
6980612 HAS3 hyaluronan synthase 3 18.6864 Extra Cellular Matrix 
2370132 TNFRSF11B tumor necrosis factor receptor 
superfamily, member 11b 
16.1251 Extra Cellular Matrix 
ŚĂƉƚĞƌϰͲDŽůĞĐƵůĂƌƉƌŽĨŝůŝŶŐŽĨ,^ͲϱĐĞůůƐ
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5130435 LAMA4 laminin, alpha 4 LAMA4 14.6819 Extra Cellular Matrix 
7160253 LAMA4 laminin, alpha 4 9.9147 Extra Cellular Matrix 
4040592 FN1 fibronectin 1 8.594 Extra Cellular Matrix 
2510091 COL8A1 collagen, type VIII, alpha 1 7.8763 Extra Cellular Matrix 
6560465 CCBE1 collagen and calcium binding EGF 
domains 1 
7.1809 Extra Cellular Matrix 
6180528 FN1 fibronectin 1 FN1 5.8105 Extra Cellular Matrix 
6550762 FBLN2 fibulin 2 5.4289 Extra Cellular Matrix 
4730324 COL10A1 collagen, type X, alpha 1 5.1253 Extra Cellular Matrix 
2120021 COL3A1 collagen, type III, alpha 1 41.2412 Extra Cellular Matrix 
50368 DCN decorin DCN , transcript variant C 29.7972 Extra Cellular Matrix 
6980612 HAS3 hyaluronan synthase 3 18.6864 Extra Cellular Matrix 
2370132 TNFRSF11B tumor necrosis factor receptor 
superfamily, member 11b 
16.1251 Extra Cellular Matrix 
5130435 LAMA4 laminin, alpha 4 LAMA4 14.6819 Extra Cellular Matrix 
7160253 LAMA4 laminin, alpha 4 9.9147 Extra Cellular Matrix 
4040592 FN1 fibronectin 1 8.594 Extra Cellular Matrix 
2510091 COL8A1 collagen, type VIII, alpha 1 7.8763 Extra Cellular Matrix 
6560465 CCBE1 collagen and calcium binding EGF 
domains 1 
7.1809 Extra Cellular Matrix 
6180528 FN1 fibronectin 1 FN1 5.8105 Extra Cellular Matrix 
6550762 FBLN2 fibulin 2 5.4289 Extra Cellular Matrix 
4730324 COL10A1 collagen, type X, alpha 1 5.1253 Extra Cellular Matrix 
6180554 SVEP1 sushi, von Willebrand factor type A 17.6825 Extra Cellular Region 
4480035 LRRC17 leucine rich repeat containing 17 17.099 Extra Cellular Region 
6180554 SVEP1 sushi, von Willebrand factor type A 17.6825 Extra Cellular Region 
4480035 LRRC17 leucine rich repeat containing 17 17.099 Extra Cellular Region 
4150477 LOXL4 lysyl oxidase like 4 9.6874 Extracellular Region 
7200706 LOXL3 lysyl oxidase like 3 8.1773 Extracellular Region 
ŚĂƉƚĞƌϰͲDŽůĞĐƵůĂƌƉƌŽĨŝůŝŶŐŽĨ,^ͲϱĐĞůůƐ
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The normalized and filtered data set of genes transcriptionally active, showed more than 
5 fold up regulation in HS-5 cells of 20% O2 condition as compared to 5% O2 condition is 
listed in the Table 4-3. A significant enrichment of gene related to ECM molecules and 
cytokines was observed. These up regulated molecules and factors are important in niche 
mediated HSC regulation. 
4120386 PCOLCE procollagen C endopeptidase 
enhancer 
6.8982 Extracellular Region 
3460682 PTX3 pentraxin related gene 6.4126 Extracellular Region 
5700458 LOXL1 PREDICTED lysyl oxidase like 1 6.1422 Extracellular Region 
3060377 MFAP4 microfibrillar associated protein 4 
MFAP4 
5.8971 Extracellular Region 
4150477 LOXL4 lysyl oxidase like 4 9.6874 Extracellular Region 
7200706 LOXL3 lysyl oxidase like 3 8.1773 Extracellular Region 
4120386 PCOLCE procollagen C endopeptidase 
enhancer 
6.8982 Extracellular Region 
3460682 PTX3 pentraxin related gene 6.4126 Extracellular Region 
5700458 LOXL1 PREDICTED lysyl oxidase like 1 6.1422 Extracellular Region 
3060377 MFAP4 microfibrillar associated protein 4 
MFAP4 
5.8971 Extracellular Region 
5810685 THBS1 thrombospondin 1 5.5816 Metricellular Protein 
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MAMSAP database 
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ͷͺ͸ͲͲ͵ͻ CALB2 calbindin 2, 29kDa 
calretinin CALB2 , 
transcript variant 
CALB2c, mRNA
13.3145 Calcium-binding 
Protein
͵ͺͲͲͳͻ DDIT4L DNA damage inducible 
transcript 4 like 
DDIT4L , mRNA
14.2989 Cell growth 
inhibitor
͸ͷͻͲ͸ͺʹ CCL3 chemokine C C motif 
ligand 3 CCL3 , mRNA
5.1129 Chemokine
͵ͻͶͲͶʹ͹ ESM1 endothelial cell specific 
molecule 1 ESM1 ,
9.1312 Growth factor
ͳ͹ͶͲͳͳʹ PNLIPRP3 pancreatic lipase related 
protein 3 PNLIPRP3 , 
mRNA
9.2849 Lipase activity
͹͸ͳͲͲʹ͸ PNPLA8 patatin like 
phospholipase domain 
containing 8 PNPLA8 , 
mRNA
5.0893 Lipase activity
ͶͺͳͲ͸͹ͳ SPTLC1 serine 
palmitoyltransferase, 
long chain base subunit 
1 SPTLC1 , transcript 
variant 2, mRNA
5.3301 Lipid biosynthesis
͹ʹͳͲ͸ͺͳ LIPG lipase, endothelial LIPG 
, mRNA
9.8072 Lipoprotein 
metabolism
ͳͺʹͲ͵͵ʹ INSIG1 insulin induced gene 1 
INSIG1 , transcript 
variant 2, mRNA
10.6469 Membrane protein
͸ͳͲͲͶ͸ͺ NPTX1 PREDICTED  neuronal 
pentraxin I NPTX1 , 
mRNA
9.9561 Metal ion binding
ͶͶͻͲͲ͹ʹ GFRA2 GDNF family receptor 
alpha 2 GFRA2 , mRNA
9.781 Neurotrophic 
factors
͸ͳͺͲ͵͵ʹ ADAMTS5 ADAM metallopeptidase 
with thrombospondin 
type 1 motif, 5 
aggrecanase 2  
ADAMTS5 , mRNA
22.3106 Proteolytic 
enzyme
ͳͷͲͳͺͲ MMP10 matrix metallopeptidase 
10 stromelysin 2  
MMP10 , mRNA
17.6554 Proteolytic 
enzyme
Ͷ͵ͲͲͷͲ BAMBI BMP and activin 
membrane bound 
inhibitor homolog 
Xenopus laevis  BAMBI 
, mRNA
9.3075 Signal 
transduction
͵Ͳ͸Ͳ͸͵ͻ SFRP2 secreted frizzled related 
protein 2 SFRP2 , 
5.2649 Soluble 
modulators
͵͵͹Ͳ͹͵͸ SOX4 SRY sex determining 
region Y box 4
5.2375 Transcription 
factors
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Genes that were transcriptionally active in HS-5 cells and showed up regulation more than 5 
fold in cells grown at 5% O2 condition as compared to 20% O2 are listed in Table 4-4. This 
data set shows gene enrichment for regulators of enzymatic activity such as lipase and 
proteolytic enzymes. There was no significant expression of genes that were important in 
niche mediated HSC regulation was observed in HS-5 cells of lower O2 condition. 
ͶǤ͵Ǥ͵ 	
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DAVID data analysis tool was used to obtain information about gene ontology of 
differentially regulated genes in HS-5 cells of two different O2 conditions. This online tool 
categorises the input data sets into various functional clusters based on statistical significance 
and gene enrichment scores. We observed that HS-5 cells of 20% O2 conditions were 
significantly enriched with the genes of major functional clusters related to cytokines, ECM, 
binding proteins, secreted protein, glycoprotein, that play important cellular functions like 
growth, survival, proliferation and differentiation.  
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The red bars indicate the number of genes that are transcriptionally active in HS-5 
cells when the cells were grown at 5% O2 condition, where as the blue bar represents the 
number of genes active at 20% O2 condition (Figure 4-2). As clearly represented in the bar 
graph the functional clusters consisted of genes that are important in tissue homeostasis, and 
normal cellular functions were significantly up regulated in cells of 20% O2 tension.  
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Functional  
biological clusters 
Up-regulated 
20% O2
Up-regulated 
5% O2
Glycoprotein 226 105 
Signal 199 79 
Secreted 111 41 
ECM 49 14 
Growth factor binding 17 
Regulation of cell 
growth 
14 16 
Chemotaxis 10 3 
Cytokine binding 12  
Negative regulation of 
cell death 
27 24 
Cytoskeleton part 32 47 
regulation of cell 
communication 
15 20 
Carbohydrate binding 25 16 
GAG's binding 14 7 
Polysaccharide binding 18 7 
Collagen 13 4 
Genes involved in the biological process such as cell death were upregulated in 5% O2
condition indicating that the change in O2 tension affects the expression of many functional 
bio molecules and regulators that are vital in normal cell growth, and survival. These above 
mentioned (Table 4-5) biological processes and cell components comprised of genes also 
play important role in construction of functional BM HSC microenvironment. ECM 
represents the insoluble part of the niche and provides structural support to the cells and help 
in cell –cell, cell-ECM interaction, whereas the cytokines represent the soluble part of the 
ŚĂƉƚĞƌϰͲDŽůĞĐƵůĂƌƉƌŽĨŝůŝŶŐŽĨ,^ͲϱĐĞůůƐ
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BM niche and regulate cell growth. Different binding proteins help in cell growth and 
survival by binding to growth factors. The most significant GO terms for cellular pathway, 
cellular component (CC), biological process (BP), and molecular function (MF) were 
identified in HS-5 cells of 20% and 5% O2 conditions. Total numbers of regulators, 
enrichment score, and p-value of individual GO terms are listed in the Table 4-6. 
dĂďůĞϰͲϲ>ŝƐƚŽĨŵĂũŽƌ'KƚĞƌŵŝŶ,^ͲϱĐĞůůƐͲs/
Go TERM HS-5 cells-20% O2 Enrichment 
score 
Count p-value 
KEGG_PATHWAY ECM-receptor 
interaction 
2.6 16 6.32E-05 
GOTERM_BP_FAT Biological adhesion 4.4 55 5.68E-05 
GOTERM_CC_FAT Extracellular matrix 7.5 41 2.65E-14 
GOTERM_MF_FAT ECM structural 
constituent 
2.6 90 3.90E-03 
GoTERM HS-5 cells-5% O2 Enrichment 
score 
Count p-value 
KEGG_PATHWAY Steroid biosynthesis 4.01 10 1.10E-08 
GOTERM_BP_FAT Negative regulation of 
gene expression 
2.89 42 1.30E-04 
GOTERM_CC_FAT Endoplasmic reticulum 
part 
2 15 5.50E-01 
GOTERM_MF_FAT Transcription regulator 
activity 
2.6 90 3.90E-03 
As evident from the table shown above most significant MF, CC, and BP in HS-5 cells of 
20% O2 were related to ECM. However, the MF, CC and BP in HS-5 cells of 5% O2 were 
mainly involved in the biosynthesis of lipid, sterols as well as in negative regulation of gene 
expression and transcription. 
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MetaCore tool was used for elucidating the significant biological pathways affected in 
HS-5 cells due to change in O2 tension. The normalized data set as separate list for each 
oxygen condition, when subjected to the MetaCore tool gave list of top 10 significant 
biological pathways up regulated in two different O2 conditions.  
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As illustrated in the MetaCore bar graphs (Figure 4-3) the biological pathways, which 
were up regulated in HS-5 stromal cell at 20% O2 condition mainly represent regulators and 
genes involved in ECM synthesis and remodeling. Approximately 60% of the up regulated 
biological pathways are known to be involved in ECM remodeling, cell adhesion, 
cytoskeletal remodeling, TGF and Wnt signalling, chemokine, epithelial to mesenchymal 
transition, and Integrin mediated cell adhesion pathways (Table 4-7). 
ͳ Immune response_IFN alpha/beta 
signaling pathway 
2.898E-09 10 24
ʹ Cell adhesion_Chemokines and adhesion 3.022E-07 16 100
͵ Cell adhesion_ECM remodeling 1.294E-06 11 52
Ͷ Immune response_Antiviral actions of 
Interferons 
1.294E-06 11 52
ͷ Cytoskeleton remodeling_TGF, WNT and 
cytoskeletal remodeling 
6.339E-06 15 111
͸ Development_Regulation of epithelial-to-
mesenchymal transition (EMT) 
1.097E-05 11 64
͹ Cytoskeleton remodeling_Cytoskeleton 
remodeling 
4.965E-05 13 102
ͺ Development_PDGF signaling via STATs 
and NF-Kb 
9.262E-05 7 32
ͻ Immune response_Antigen presentation 
by MHC class I 
3.361E-04 6 28
ͳͲ IFN gamma signaling pathway 5.108E-0 8 54
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(MetaCore) 
No significant biological pathways with important regulatory roles in the BM HSC niche 
were observed in 5% O2 tension (Figure 4-4. and Table 4-8). The most significant pathway at 
low O2 tension was, not unexpectedly, regulation of hypoxia. Inhibition of the ERK pathway 
was also observed at 5% O2 condition. There are few published reports on the role of ERK 
signaling in the HSC microenvironment, but one study has reported that ERK1 deficient 
ŚĂƉƚĞƌϰͲDŽůĞĐƵůĂƌƉƌŽĨŝůŝŶŐŽĨ,^ͲϱĐĞůůƐ
ϭϭϵ

mouse exhibit defective bone function and osteoporotic phenotype with defective homing and 
lodging of HSC in BM [181].  
dĂďůĞϰͲϴ>ŝƐƚŽĨƚŽƉϭϬďŝŽůŽŐŝĐĂůƉĂƚŚǁĂǇƐŝŶ,^ͲϱĐĞůůƐŽĨϱйKϮĐŽŶĚŝƚŝŽŶ
List of genes involved in regulation of top 10 most significant biological pathways in HS-5 
cells of both 20% and 5% O2 condition has been represented in Appendix XI and Appendix 
XIII. 
 Ǧͷ
ͷΨʹ
Ǧ 








1 Transcription_Role of Akt in hypoxia 
induced HIF1 activation 
9.096E-07 8 27
2 Development_Glucocorticoid receptor 
signaling 
5.060E-06 7 24
3 Erk Interactions: Inhibition of Erk 6.178E-06 8 34
4 Regulation of CFTR activity (norm and 
CF) 
8.476E-06 10 58
5 Cholesterol Biosynthesis 1.491E-05 12 89
6 PGE2 pathways in cancer 3.730E-05 9 55
7 Role of (HP1) family in transcriptional 
silencing 
3.780E-05 6 22
8 Signal transduction_Activin A signaling 
regulation 
4.935E-05 7 33
9 Apoptosis and survival_HTR1A signaling 1.197E-04 8 50
10 Immune response_Function of MEF2 1.197E-04 8 50
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The relative importance of different biological pathways was established by combining 
the data obtained from MAMSAP database, DAVID ontology tool and MetaCore tool for the 
two conditions of ACM prepared, and the following significant features could be identified. 
ͶǤ͵ǤͷǤͳ 	
Micro dissection of the ECM related functional cluster was done using DAVID ontology tool 
to get the exact number of ECM related genes differentially regulated in HS-5 stromal cells 
due to change in O2 tension.  
&ŝŐƵƌĞϰͲϱEƵŵďĞƌŐĞŶĞƐƉƌĞƐĞŶƚŝŶDĨƵŶĐƚŝŽŶĂůĐůƵƐƚĞƌƐŝŶ,^ͲϱĐĞůůƐͲs/
Analysed data is represented in the bar graph (Figure 4-5) of the number of the ECM related 
genes up regulated in 20% and 5% O2 condition. 
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ͶǤ͵ǤͷǤʹ 
Insoluble ECM components of the BM niche can be involved in various molecular functions 
apart from providing structural and mechanical strength to the tissues. We identified ECM 
mediated molecular functions to understand its importance in the maintaining tissue 
homeostasis. Gene Ontology Enrichment Analysis Software Toolkit (GOEAST) is a web 
based software toolkit which was used to identify significantly enriched GO terms for 
molecular functions among given lists of ECM genes transcriptionally active in HS-5 cells of 
20% O2.
&ŝŐƵƌĞϰͲϲDŽůĞĐƵůĂƌĨƵŶĐƚŝŽŶŽĨDƌĞůĂƚĞĚŐĞŶĞƐŝŶ,^ͲϱƐƚƌŽŵĂůĐĞůůƐ
ECM and its components were segregated into molecular functions, and the significance of 
expression data was based on the enrichment of genes involved in a particular molecular 
function. The GO terms for molecular functions with higher enrichment are shown in darker 
shade blocks, whereas lesser enriched molecular functions with lighter shade blocks. The 
molecular functions that are interdependent are connected with red lines (Figure 4-6).  
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&ŝŐƵƌĞϰͲϳEĞƚǁŽƌŬŽĨŐĞŶĞƐŝŶǀŽůǀĞĚŝŶƉƌŽĐĞƐƐŽĨ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ƚŚĞƌŵŽŵĞƚĞƌͲůŝŬĞ ĨŝŐƵƌĞƐ͘hƉͲǁĂƌĚƚŚĞƌŵŽŵĞƚĞƌƐŚĂǀĞƌĞĚĐŽůŽƌĐŝƌĐůĞĂŶĚ ŝŶĚŝĐĂƚĞƵƉͲƌĞŐƵůĂƚĞĚĞǆƉƌĞƐƐŝŽŶ
ŽĨŐĞŶĞƐĂŶĚĚŽǁŶͲǁĂƌĚǁŝƚŚďůƵĞĐŝƌĐůĞŝŶĚŝĐĂƚĞĚŽǁŶͲƌĞŐƵůĂƚĞĚĞǆƉƌĞƐƐŝŽŶůĞǀĞůƐŽĨƚŚĞŐĞŶĞƐŝŶ,^ͲϱĐĞůůƐ
ŽĨϮϬйKϮĐŽŶĚŝƚŝŽŶ͘
ECM remodeling is a balanced biological process of ECM synthesis and degradation 
that maintains the homeostasis in BM niche, and also involved in cellular processes, such as 
cell development, proliferation, motility, adhesion, wound healing, and angiogenesis. The 
ŚĂƉƚĞƌϰͲDŽůĞĐƵůĂƌƉƌŽĨŝůŝŶŐŽĨ,^ͲϱĐĞůůƐ
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
network diagram of gene and regulators of ECM remodeling gives a clearer picture of the 
biological process (Figure 4-7) and genes involved in the regulation of ECM remodeling are 
listed in Table 4-9.
dĂďůĞϰͲϵ'ĞŶĞƐŝŶǀŽůǀĞĚŝŶƉƌŽĐĞƐƐŽĨ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MMP10 Metalloprotease 17.6 Up HS-5 5% O2
HK2 Protease 2.92 Up HS-5 5% O2
EGFR Receptor 1.39 Up HS-5 5% O2
SPARC ECM 1.52 Up HS-5 20% O2
PLAT Protease 1.74 Up HS-5 20% O2
LAMC1 ECM 1.82 Up HS-5 20% O2
COL4A1 ECM 3.14 Up HS-5 20% O2
COL4A5 ECM 3.27 Up HS-5 20% O2
TIMP2 Proteases 3.43 Up HS-5 20% O2
MMP2 Metalloprotease 2.15 Up HS-5 20% O2
COL1A1 ECM 2.16 Up HS-5 20% O2
LAMA3 ECM 2.20 Up HS-5 20% O2
NID1 ECM 2.92 Up HS-5 20% O2
IGFBP4 Binding protein 4.47 Up HS-5 20% O2
LAMA3 ECM 2.20 Up HS-5 20% O2
NID1 ECM 2.92 Up HS-5 20% O2
IGFBP4 Binding protein 4.47 Up HS-5 20% O2
FN1 ECM 8.59 Up HS-5 20% O2
LAMA4;L
AMA3 
ECM 14.6 Up HS-5 20% O2
COL3A1 ECM 41.2 Up HS-5 20% O2
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As discussed earlier being one of the most important components of the BM 
microenvironment, ECM plays a critical role in HSC maintenance in-vivo. We identified the 
regulators of ECM remodeling that were transcriptionally active in HS-5 cells of 20% O2 by 
comparing with GeneGO MetaCore database. 
The biological process of ECM remodeling consist of a number genes for ECM proteins, 
proteases such as MMPs, tissue inhibitor of metalloprotinases (TIMPs)-, PLAT etc. 
Collagens-COL1A, COL4A1, COL3A1, COL4A5, laminins-LAMC1, LAMA3, LAMB3, 
LAMA4, LAMA3, fibronectins-FN1, and SPARC that are important in maintaining the 
functionality of HSC niche in BM were up regulated in HS-5 stromal cells whereas MMPs 
(proteolytic enzymes that degrade various components of the ECM) were down regulated. 
MMP-2 (up regulated) in HS-5 stromal cells are known as gelatinases and degrade collagen 
IV but are important in homing of HSC to the BM niche, whereas MMP-10 (also known as 
stremeolysin 2) is involved in the degradation of proteoglycans and fibronectin is down 
regulated. The differential expression of MMPs signifies the presence of less proteoglycans 
and fibronectin in HS-5 stromal cells grown at lower oxygen condition. Endogenous, 
TIMP2 (Up regulated) reduces excessive proteolysis ECM degradation by MMPs. Down 
regulation of TIMP under lower oxygen tension indicates the imbalance MMP-TIMP activity, 
responsible for excessive ECM degradation in HS-5 cells at the lower oxygen condition.  
ͶǤ͵ǤͷǤͶ 
The complexity of the ECM remodeling process is illustrated in the Figure 4.8. Genes up 
regulated in HS-5 cells of 20% O2 are circled in red and are mainly related to ECM, Up 
regulated genes in HS-5 cells of 5% O2 are circled in blue. The proteolytic enzymes MMPs 
were up regulated in HS-5 cells grown at 5% O2 compared to cells grown at 20% O2. The 
ŚĂƉƚĞƌϰͲDŽůĞĐƵůĂƌƉƌŽĨŝůŝŶŐŽĨ,^ͲϱĐĞůůƐ
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endogenous inhibitor of MMPs i.e. TIMP2 was observed to be upregulated at 20% O2 that 
controls the excess proteolytic activity of MMPs in HS-5 cells, making it rich in functional 
ECM.  
&ŝŐƵƌĞϰͲϴEĞƚǁŽƌŬŽĨŐĞŶĞƚŚĂƚƌĞŐƵůĂƚĞƉƌŽƚĞŽůǇƐŝƐĂŶĚ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ŽŶ ƚŚĞ ŵĂƉ ĂƐ ƌĞĚ ĐŽůŽƌ ĐŝƌĐůĞ ŝŶĚŝĐĂƚĞ ƵƉͲƌĞŐƵůĂƚĞĚ ĞǆƉƌĞƐƐŝŽŶ ŽĨ ŐĞŶĞƐ ĂŶĚ ďůƵĞ ĐŝƌĐůĞ ŝŶĚŝĐĂƚĞ
ĚŽǁŶͲƌĞŐƵůĂƚĞĚĞǆƉƌĞƐƐŝŽŶůĞǀĞůƐŽĨƚŚĞŐĞŶĞƐŝŶ,^ͲϱĐĞůůƐŽĨϮϬйKϮĐŽŶĚŝƚŝŽŶ͘
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Another significant biological process that was upregulated in HS-5 cells grown at 20% 
O2 was “integrin mediated cell adhesion” (Figure 4-9). The active data of upregulated genes 
ŚĂƉƚĞƌϰͲDŽůĞĐƵůĂƌƉƌŽĨŝůŝŶŐŽĨ,^ͲϱĐĞůůƐ
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was used to create a network pathway to better understand the process and its role in HSC 
niche in BM.  
&ŝŐƵƌĞϰͲϵEĞƚǁŽƌŬŽĨŐĞŶĞƐŝŶǀŽůǀĞĚŝŶŝŶƚĞŐƌŝŶŵĞĚŝĂƚĞĚĐĞůůĂĚŚĞƐŝŽŶ
Integrins regulate cell-cell, cell-ECM interaction and also link ECM to the cell 
cytoskeleton. As illustrated in Figure 4-9 the data set of transcriptionally active genes belong 
to ECM molecules and few belong to cytoskeletal part. The cellular interaction of HSC to the 
ECM components of BM niche is important to sustain hematopoiesis and largely mediated by 
integrin subunits. It has been shown that CD34+ HSC express Integrin Į4ȕ1 and Į5ȕ1 that 
binds to the VCAM and fibronectin on BMSC, and this interaction is important for HSC 
homing to the BM niche [182].  
Other important MetaCore Maps of biological pathways active in HS-5 cells of 20% O2 
and 5% O2 condition are represented in Appendix XII and Appendix XIV. 
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Exploratory Gene Association Network (EGAN) online tool was used to constructing 
networks of genes belonging to the ECM, cytokines and secreted molecules groups. These 
clusters are important functional components of the BM HSC niche. Figure 4-10 shows a 
network of all the genes related to ECM, ECM parts, and extracellular region genes that are 
transcriptionally active in HS-5 cells at 20% O2 condition. All the upregulated genes are 
denoted here in the Figure as nodules, which are interconnected with blue, red and green 
lines. The green lines represent the cellular location of the genes, red lines show gene –gene 
interaction, where as the blue line shows the organ location of the particular genes. 
&ŝŐƵƌĞϰͲϭϬǆƉůŽƌĂƚŽƌǇŐĞŶĞĂƐƐŽĐŝĂƚŝŽŶŶĞƚǁŽƌŬŽĨDĂŶĚŶŝĐŚĞƌĞŐƵůĂƚŽƌƐŝŶ,^ͲϱĐĞůůƐ
A number of cytokines secreted by HS-5 cells at 20% O2 that show their direct or indirect 
effect on regulation of hematopoeisis is described in Figure 4-11. 
ŚĂƉƚĞƌϰͲDŽůĞĐƵůĂƌƉƌŽĨŝůŝŶŐŽĨ,^ͲϱĐĞůůƐ
ϭϮϴ

&ŝŐƵƌĞϰͲϭϭ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The data suggest significant enrichment of ECM and cytokine molecules that are secreted by 
BM cell. ECM is involved in the hematopoietic regulation through cell-matrix adhesion 
process whereas secreted cytokines navigate hematopoietic cell trafficking and localization in 
tissue compartments.  
ͶǤ͵Ǥ͸ 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Several signalling pathways that are directly involved in regulation of HSC behaviour 
were noted to be up regulated in HS-5 cells of 20% O2 condition, though these did not reach 
statistical significance (Table 4-10). Such pathways and their role in the HSC function 
regulation is described below- 
EPO pathway-Erythropoietin (EPO) is a major hormone involved in expansion of 
erythroid progenitor cells, and regulates erythrocyte proliferation and differentiation. EPO 
ŚĂƉƚĞƌϰͲDŽůĞĐƵůĂƌƉƌŽĨŝůŝŶŐŽĨ,^ͲϱĐĞůůƐ
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along with Flt3L, TPO, SCF and EPO has been used to expand UCB MNC to erythroid 
progenitors [183] . 
ERK 1, Akt1, MAPK3, and SHC1 the key factors of ERK1/ERK2 pathways were 
upregulated in HS-5 stromal cells. These extra cellular signal regulated kinases are key 
regulators of the MAP kinase cascades. These key factors are considered to be very important 
in the fate determination of erythroid and megakaryocytic lineages [184]. 
Downstream regulators of Ras signaling- such as MAPK13, MAPK14, MAPK3, 
ARHGAP1, COL1A2, SHC1 genes are upregulated in HS-5 stromal cells. Ras signaling is 
and its critical role in differentiation of erythroid cells was studied in erythroid and non 
erythroid cell lines [185]. 
CAV1, SOCS1, IL12A, IFNAR2, STAT4, SOCS1, STAT1, STAT2 are the key factors 
of the JAK-STAT pathway and are up regulated in the HS-5 stromal cells JAK-STAT 
pathway coupled with Akt pathway has been shown to play an important role in erythroid cell 
regulation and differentiation through EPO induction [186]. 
IRF9, IRF7, IRF2, IL27RA, CD276, IL12A are the key factors of IFN-y signaling 
cascade and are up regulated in HS-5 stromal cells at physiological O2 condition. IFN-ڜ is 
critical for the survival of mature erythroid progenitor cells and prevents apoptosis [187]. 
Our previous results show that HS-5 ACM support lineage specific expansion of 
committed progenitor cell population and more specifically expansion of BFU-Es. The 
activation of the pathways mentioned above could possibly explain the role of HS-5 ACM 
mediated lineage specific erythroid cell expansion.
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These pathways are listed inTable 4-10. 

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In order to validate the microarray results, qRT-PCR was performed for genes that 
were up regulated at 20% O2 condition such as COL1, COL3, COL4, SPARC, MMP2, 
TIMP2, FN (all involved in ECM remodeling) and also for the gene that were up regulated at 
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Panther_Pathway P04393:Ras Pathway 0.884956
Biocarta epoPathway: EPO Signaling 0.331567
Biocarta il6Pathway:IL 6 s 0.356127
Biocarta insulinPathway:Insulin Signaling 0.356127
Biocarta il2Pathway:IL 2 signaling 0.404232
Panther_Pathway P00056:VEGF signaling 1.011378
Panther_Pathway P00035:Interferon-gamma signaling 0.632111
Biocarta erkPathway:Erk1/Erk2 MAPK Signaling 
0.576539
Panther_Pathway P00038:JAK/STAT signaling 0.005777
Panther_Pathway P00035:Interferon-gamma signaling 0.104181
Panther_Pathway TGF-ȕ signaling pathway 0.1741276
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5% O2 condition such as, MMP10, ANGPTL4, EGFR, ITPR1 and CALB2 (Figure 4-12 and 
Table 4-11). 
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COL -I  ޓ2 fold ޓ2 fold 20% O2
COL- III  ޓ3.5 fold ޓ3.5 fold 20% O2
COL IV  ޓ1.2 fold ޓ1.2 fold 20% O2
SPARC  ޓ3 fold ޓ3 fold 20% O2
MMP2  ޓ1.2 fold ޓ1.2 fold 20% O2
TIMP2  ޓ1.2 fold ޓ1.2 fold 20% O2
FN  ޓ4 fold ޓ4 fold 20% O2
MMP10 ޓ1.2 fold ޓ1.2 fold 5% O2
ANGPTL4  ޓ4 fold ޓ4 fold 5% O2
EGFR  ޓ 1.3 fold ޓ1.3 fold 5% O2
ITPR1  ޓ 3 fold ޓ3 fold 5% O2
CALB2  ޓ 2 fold ޓ 2 fold 5% O2
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The results of up regulation of MMP genes in HS-5 cells of 5% O2 condition was further 
confirmed by gelatin Zymography. Gelatin Zymography can detect the proteolytic activities 
of gelatinases such as MMP2, MMP9. The results obtained indicate comparatively more 
proteolytic activity in HS-5 cells of 5% O2 condition as compared to 20% O2 condition 
(Figure 4-13).  
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With this study, we have demonstrated the expression of several biological molecules 
in HS-5 cells that are already known to be involved in HSPC maintenance in-vivo. Our main 
aim was to identify molecular nature of HS-5 cells and identify genes that could provide 
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clues about regulatory role of BM microenvironment. One possible interpretation of these 
molecular findings is that HS-5 matrices are biological substrates whose ECM, secreted 
cytokines, and signaling pathways specifically support committed progenitor cell expansion. 
The expression pattern of HS-5 cells suggests its possible HSC growth supporting properties 
in BM niche. These cells express both stimulatory and inhibitory factors for HSC 
proliferation and differentiation, in this manner, mimic the molecular nature of the HSC niche 
in BM [188]. The ACM of HS-5 stromal cells prepared in two different O2 conditions show 
significant differences in their capacity to expand cells due to difference in functional 
property. 20% O2 tension proved optimum in ACM mediated HSPC expansion when 
compared to 5% O2 tension.  
We were able to identify a significant number of interesting gene products and multi-
component molecular networks active in HS-5 cells grown at 20% O2. Data suggest that at 
this O2 condition in approximately 60% of genes belonging to the key components of the 
HSC niche of top 10 biological pathways were upregulated. Under these culture conditions, 
HS-5 cells secrete a significant amount hematopoietic cytokines, functional ECM molecules 
and also show activation of major signaling pathways. An array of all these regulatory factors 
along with insoluble ECM molecules is critically important in fate determination of HSC. 
These multi-component interactions suggest that the balance of self-renewal and 
differentiation is governed by many interacting molecular cues emanating from the niche. 
This molecular nature of HS-5 cells hence explains the observed ability to support ex vivo
HSPC expansion and growth.  
When we looked for transcripts of ECM molecules, we found many typical basement 
membrane and structural components, such as collagen, laminin and fibronectin to be highly 
expressed in the HS-5 cells. A details observation of enriched GO term for ECM molecules 
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mediated molecular functions were identified such as-binding activity, structural activity; 
receptor binding, pattern binding, extracellular matrix structural constituents, cytokine 
activity, heparin activity and polysaccharide binding. We have discussed in detail about the 
important role of ECM molecules in the construction of growth inductive niche for HSC in 
chapter-1.  
The transcripts of specific cytokines that were upregulated in HS-5 cells of 20% O2 condition 
such as interleukins have been shown to regulate HSPC and HSC activity in AGM [189]. IL-
12 is an effective cytokine which regulates in-vivo HSPC mobilization [190]. IL3 and IL6 are 
added along with EPO in culture for erythroid cell expansion [191]. CCL5 has been shown to 
regulate MAPK pathway, FAK phosphorylation and also activates STAT signalling in 
BMSC, and may also be involved in regulating HSC thorough these signalling pathways 
[192]. From the differentially expressed HS-5 gene expression data, a possible switch on or 
activation of certain signalling pathways was observed due to the up regulation of important 
genes of these pathways (Table 4-10). For instance, up regulation of the EPO pathway that is 
a critically important pathway for erythropoiesis and regulates erythrocyte proliferation and 
differentiation [183] . ERK 1 pathway is very important in the fate determination of erythroid 
and megakaryocytic lineages [184]. Ras signaling plays critical role in differentiation of 
erythroid cells [185]. JAK-STAT pathway coupled with Akt pathway has been shown to play 
an important role in erythroid cell regulation and differentiation through EPO induction 
[186]. IFN-ڜ signaling cascade critical for the survival of mature erythroid progenitor cells 
and prevents apoptosis [187]. As discussed earlier the up regulation or activation of the 
pathways mentioned can be linked to the HS-5 ACM mediated lineage specific selective 
expansion of BFU-Es.  
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Apart from the major structural, secreted components, and signaling pathways, mentioned 
above several other molecular factors were also identified in HS-5 cells that have been shown 
to regulate HSC behaviour and are described here- 
• ANGPTLS- Angiopoietins- like 5, angiopoietins-like 7 and microfibril-associated 
glycoprotein 4 (MFAP4) support expansion of HSC in culture [90]. 
• VCAM - binds to ȕ1 integrins expressed on HSC and plays an important role in 
adhesion of progenitor cells in the niche [193]. 
• Bone morphogenic protein (BMP) - HSC do not produce BMP but express cell 
surface receptors for it. Long term cultures of BMSC secret BMP and SMAD 
signaling molecules and their HSC growth supportive activity was confirmed by 
clonogenic assays like colony forming unit assays [194]. 
• Decorin (DCN) - DCN is class I type SLRP that is expressed in various tissues, and 
regulate osteogenesis by regulation of TGF signaling and control proliferation and 
growth of osteogenic stem cells [195].  
• Agrin (AGN) - Primitive HSC express receptors for Agrin, which is secreted by BM 
cells. Agrin plays important role in HSC regulation in-vivo, mice deficient in agrin 
show defects in hematopoiesis[104].  
• Thrombospondin (TSP) TSP is a glycoprotein that is involved in a number of cellular 
bindings like calcium binding, GAGs, fibronectin and collagen binding. TSP is 
synthesized and secreted by endothelial cells, smooth muscle cells and carcinoma 
cells, secreted TSP binds to ECM, and participate in cell adhesion and other functions. 
TSP acts as a cyto adhesion molecules and binds to HSC and regulates cell behavior 
[196]. 
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• Secreted protein, acidic and rich in cysteine (SPARC) - SPARC is expressed 
abundantly in the BM niche. SPARC regulates the expansion of UCB CD 34+ cells 
in-vitro by regulating the expression of number of genes related to critical cellular 
functions like proliferation, differentiation and anti-apoptosis. SPARC was shown to 
be involved in CD34+ cell proliferation and differentiation [196] [197]. 
• Vinculin (VCL) - vinculin is an actin binding protein and important factor in Integrin 
mediated focal adhesion of cells. With the loss of VCL, HSC fail to differentiate in to 
granulocyte and monocytic lineage, and their homing and migration to BM becomes 
defective [198].  
• Insulin growth factor binding protein (IGFB2) - IGFBP2 along with SCF, TPO, FGF-
1, ANGPTL5 have been shown to enhance UCB HSC expansion in serum free culture 
condition[156]. IGFBP4 have been reported to regulate migration of HSC in the BM 
[199]. 
• Hematopoietically expressed homeobox protein (Hhex) - Hhex is the homeobox gene 
family and plays an important role in the hematopoietic progenitor development. 
Hhex deficient phenotype show defects in the maturation of CD45- HSC [200]. 
• Interferon alpha (IFNα) - Activation of IFN α pathways alters HSC function, and 
promotes proliferation of quiescent HSC in-vivo [201].  
• Interferon regulatory factor-2(IRF2) - IRF2 which is a suppressor of the IFN signaling 
preserves the self-renewal and multilineage differentiation capacity of HSC [202]. 
• RNA binding protein ZFP36L2 has been shown to play important role in self-renewal 
of burst-forming unit erythroid progenitors [203]. 
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• CCBE1 collagen and calcium binding EGF domains 1 are lymphoangiogenic factors 
but have been shown to be an essential factor in fetal liver hematopoiesis [204].  
• Slits (slit2/slit3) are BM ECM proteins that regulate and enhance HSC/HSPC homing 
in the niche [205].  
• ISG15 are ubiquitin like protein, loss ISG15 in mice results in reduction in erythroid 
cells in BM.  
• Regulatory network of KLF1, KLF4, and MYC is essential in embryonic 
erythropoiesis [206]. 
The above discussed molecular profile exhibited by HS-5 cells, signifies that HSC 
regulation mediated by stromal microenvironment is indeed a complex and balanced 
biological process. In simple words the HS-5 specific functional ECM molecules anchorage 
HSC to BM, bind to a number of hematopoietic cytokines secreted by HS-5 cells, activate 
important signalling pathways.  
The TGF-ȕ pathways is one such pathway observed to be affected due to change in O2 
tension and was up regulated in HS-5 cells of 20% O2 condition and down regulated at lower 
O2 condition. TGF-ȕ is a cytokine and act as with critical signaling molecule in BM niche. It 
has multifunctional activity in a wide range of biological processes such as immune response, 
angiogenesis, tumor development, wound healing and also in hematopoiesis. Multifunctional 
activity of TGF- ȕ is known to induce ECM synthesis. Its paradigmatic action has been 
shown to regulate synthesis of collagen I, II, III, IV, and V collagen, thrombospondin, 
osteopontin, tenascin, elastin, hyaluronic acid, osteonectin/SPARC fibronectin, as well as 
chondroitin [207]. The possibility of differential expression of ECM molecules can be 
indirectly linked to the active TGF- ȕ signaling in the HS-5 cells of 20% O2 condition. The 
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multifunctional TGF –ȕ is also known to be involved in controlling HSC regulation by 
inhibiting cell proliferation [17]. The TGF-ȕ1 knock-out mice exhibit increase in 
extramedullary hematopoiesis [208]. The regulatory effect of TGF-ȕ signifies its role in 
controlling the multi-dimensional activity of niche by stimulating ECM synthesis and also 
controlling excessive HSPC proliferation. The BM microenvironment naturally supports the 
regeneration of HSPC in spite of presence of TGF-ȕ in the microenvironment, therefore a 
better understanding of how TGF-ȕ and other factors regulate HSPC in this context, along 
with possible mechanisms of cross talk or redundancy, is certainly required to develop novel 
and better strategies for HSPC expansion. 
Apart from the role of TGF-ȕ signaling in ECM synthesis, its proteolytic cleavage by 
MMPs was another important biological process found to be affected in HS-5 cells due to 
change in O2 conditions. At lower O2 conditions proteolytic pathways mediated by MMPs 
were more active as compared to 20% O2 condition. 
The enhanced expression of proteolytic enzymes MMP10, MMP 25, ADAMTS5-5, serine 
proteases etc (Appendix XV), indicate an active proteolytic biological signalling/ pathways in 
these cells. Few earlier reports have demonstrated the role of acute hypoxia in down 
regulation of TIMP mRNA and simultaneous up-regulation of MMP mRNA in-vitro [209]. In 
retinal cells chemically induced hypoxic conditions have been reported to up regulate of the 
gene expression of MMP2 and MMP 9 [210], where as in breast cancer cells stimulation of 
MMP 9 by HIF-1Į has been reported [211]. The reason for reduced expression of ECM 
molecules can also be possibly linked to the elevated expressions of MMPs at hypoxic or 
lower O2 tension. 
The loss of functional properties in HS-5 cells at 5% O2 strongly suggests that a critical 
feature for the maintenance of stromal functional properties were missing or lost when these 
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cells were cultured at low O2 tension. The major phenotypic effect observed in HS-5 cell 
grown at lower O2 tension was qualitative and quantitative loss of functional ECM molecules. 
As discussed above, stromal microenvironment-mediated HSPC maintenance is a complex 
and multi- component regulation. Any alteration in balanced environment can affect the 
whole biological process and ultimately may show defects in niche mediated HSPC 
regulation. A better understanding of how critically important niche regulators regulate 
HSCs, and cross talk among these regulators with niche components is definitely required to 
develop better strategies for HSC expansion. Future protocols for ex vivo expansion of HSCs 
can be modified by modulating the activity of niche signaling factors and regulators. 
Understanding the reasons behind such differential ECM properties exhibited by HS-5 cell of 
two different oxygen tension would also highlight the designing of possible mechanism to 
overcome the observed defects. 
This study and obtained findings may assist in identifying the molecular profile of a 
stem cell supportive microenvironment, which may be of value for both tissue engineering 
and regenerative medicine. However, it has yet to be determined, which of the identified 
regulators are critical for HSPC expansion, and at what specific concentrations. In future, the 
functional role of these regulators along with their concentration needs to be systematically 
analysed. . 
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ECM is one of the most important component of HSC niche in BM, and its qualitative 
or quantitative alteration could significantly influence HSC/HSPC growth and expansion. It 
is evident that balanced turnover of ECM is a prerequisite for the structural and functional 
homeostasis of HSC niches in BM. Any alteration either qualitative or quantitative could 
impose severe defects in hematopoeisis. As ECM has been proved to be is a complex 
composition of various molecules, a refined analysis of the ECM production by HS-5 cells 
was understood by microarray analysis and has been discussed in chapter 4. Since stromal 
cell lines produce different ECM components, it’s interactions seen with HSC are still 
difficult to interpret as the effects may either be mediated by stromal cells and/or by their 
multiple ECM components. In such cases cell free ECM riche matrices like ACM would 
help to elucidate these interactions. In a standard culture system of ACM, modulation of the 
activity of individual niche regulators can be induced to understand the regulatory role. In 
attempt of achieving the better understanding of the important role of the key factors of 
niche, we utilized the data obtained in microarray analysis of HS-5 cells of two different O2
tension. The main objective of the study was to modify the stromal matrix functional and 
structural properties and use the resultant ACM for HSPC expansion purposes. 
As it was clear from the data of molecular profiling, one of the most affected pathway 
in HS-5 cells “ECM remodeling”. The turnover or balance process of synthesis and 
degradation of ECM components is termed as ECM remodeling. We selected molecular 
factors that are directly or indirectly involved in ECM remodeling such as MMPs (ECM 
proteolytic enzymes) and TGF-ȕ (inducer of ECM synthesis). ECM remodeling is an 
important biological process involved in multiple cellular functions such as tissue 
homeostasis, development, reproduction, proliferation, cell motility, adhesion, wound 
ŚĂƉƚĞƌϱͲŝŽĐŚĞŵŝĐĂůĂŶĚƐƚƌƵĐƚƵƌĂůŵŽĚŝĨŝĐĂƚŝŽŶƐŝŶ,^ͲϱD
ϭϰϮ

healing, angiogenesis, etc [212]. In the chapter 4, along with the molecular properties of 
HS-5 cells we have also discussed about the ECM remodeling, and genes involved in this 
biological process in detail. We observed that major and critical regulators of ECM 
remodeling i.e. proteolytic enzymes collectively named as MMPs and their proteolytic 
activity was significantly higher in 5% O2 condition. Few published reports also showed 
that induced or acute hypoxia increases m-RNA expression of many MMPs [211]. These 
proteolytic enzymes degrade various components of the ECM also participate in signaling 
pathways that initiate releases of HSC from quiescent niche to more proliferative niche 
[213]. In normal physiological conditions, the ECM bound HGFs and cytokines are released 
by proteolytic activity of MMPs [214]. MMPs also participate in activation of inactive 
MMPs or pro-MMPs by their proteolytic activity [215] (Figure 5-1). 
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There are total 25 different types of MMPs, that have been categorised in to six groups, 
depending on their structure and substrate specificity: 1) Collagenase, 2) Gelatinases, 3) 
Stromelysin, 4) Matrilysin, 5) Membrane-type MMPs (MT-MMPs) 6) and other MMPs 
(Table 5-1). 
In normal tissues MMPs are expressed or secreted at low levels and activity is tightly 
controlled at the transcription level [216]. Various niche components and regulators including 
biological stimulators, inhibitors, growth factors and ECM ligands can modulate the activity 
of MMPs [217]. The proteolytic activity of MMPs is also controlled by endogenous 
inhibitors, including specific tissue inhibitors of the metalloproteinases (TIMPs) and TIMP-
like molecules such as thrombospondin-2 (TSP-2), alpha 2- macroglobulin and endostatin 
[218]. 
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MMP-1 Collagens (I, II, III, VII, VIII and X), L-selectin, proteoglycans,  
MMP-2 (gelatinase A) Activates MMP-1 and MMP-9 by cleaving off the prodomain 
MMP-3 (stromelysin-1) Collagens (III, IV, V and IX), perlecan, decorin, laminin, elastin, 
cytostatin, plasminogen 
MMP-7 (matrilysin-1) Cleaves ECM components E-cadherin and pro-Į-defensin 
MMP-8 (neutrophil 
collagenase) 
Collagens (I, II, III, V, VII, VIII and X), aggrecan and fibronectin 
MMP-9 (gelatinase B) Bone matrix 
MMP-10 (stromelysin-2) Collagens (III-V), aggrecan, elastin 
MMP-12 (macrophage 
metalloelastase) 
Collagen IV, elastin, fibronectin, vitronectin, laminin, entactin and 
fibrin 
MMP-13 Collagens (I, II, III, IV, IX, X and XIV), , aggregan, fibrinogen  
MMP-15 (MT1-MMP) ProMMP-2i, laminin, fibronectin, tenascin, entactin, aggrecan, p 
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The balance between MMPs and TIMPs is critical for controlling ECM remodeling 
specifically in tissues [219]. Many studies have investigated the role of MMPs in tumor 
progression, angiogenesis etc but their specific roles in the BM niche ECM remodeling and 
its effect on HSPC expansion are largely untouched. In this chapter, we have shown that by 
regulating the endogenous MMP activity in HS-5 culture, the proteolytic cleavage of ECM 
molecules can be controlled, that in turn may influence the potential of MMP inhibited ACM 
(MMPi-ACM) to expand HSPC expansion ex-vivo. 
As discussed earlier ECM remodeling is a balanced process of ECM synthesis and 
degradation. “ECM degradation” in tissues and cells is largely driven by the proteolytic 
activity of MMPs, while “ECM synthesis” is regulated by many factors, including the TGF 
group of proteins.  
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TGF-ȕ is a cytokine that is involved in many cell physiological activities including 
proliferation, differentiation, migration, apoptosis and ECM production in various types of 
cells. Secreted TGF- ȕ exists in 3 isomeric forms - TGF-ȕ1, TGF-ȕ2 and TGF-ȕ3. Apart from 
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collagen and fibronectin synthesis regulation, many other ECM protein have also been shown 
to be affected by TGF- ȕ activity such as, thrombospondin, osteopontin, tenascin, elastin, 
hyaluronic acid osteonectin/SPARC, as well as chondroitin dermatan sulfate proteoglycans 
such as biglycan and decorin. TGF -ȕ have also been found to inhibit the m-RNA expression 
of different proteolytic enzymes such as collagenase and plasminogen activator known to 
degrade ECM [207] (Figure 5-2). 
Apart from the molecular composition, structural topographical features of the HSC 
niche in BM play a critical role and exhibit regulatory effects on cell fate determination, cell 
growth and survival. It is only recently, that an understanding has developed about physical 
mechanical and topographical factors in regulation of HSC self-renewal and cell expansion. 
These physical and mechanical factors may be employed alongside soluble factors in an 
artificial culture system to promote HSC expansion. The native decellularized matrices do not 
allow manipulation or modification of substrate physical properties, but the desired 
topographical features such as thickness and stiffness can be achieved if matrix components 
are collected as solution and coated on tissue culture surfaces.  
To understand the role of ACM surface topography in our model, thin coatings of HS-5 
ACMs were prepared by extracting matrix in solution and spin coating them onto tissue 
culture surfaces (plastics or glass). The coated surfaces were then tested for their ability to 
support HSPC expansion. Spin coating is a process by which a uniform layer of biological 
solutions can be made on any surface by applying a uniform rotation/min (rpm) under 
vacuum and sterile conditions. From these structural modification in stromal matrix 
properties, we showed that both native and spin coated ACM could expand HSPC however,  
spin coated ACM showed better expansion results.
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In this chapter, we describe the biochemical and structural modifications induced in the 
HS-5 stromal cells to get better understanding of the regulatory role of BM niche factors in 
HSPC expansion. Biochemical modifications were induced by inhibiting the MMP activity 
using MMP inhibitor and by inducing ECM synthesis with exogenous TGF-ȕ. The ACMs 
prepared from the biochemically modified cells were used as substrate for HSPC expansion. 
The structural modifications were done by using spin coating technique to prepare thin films 
of HS-5 ACM. HSPC expansion on biochemically and structurally modified ACM were 
assessed phenotypically by flow cytometry and functionally by CFU assays. Fold expansion 
of the HSPC were calculated to determine which matrix supported the maximum expansion. 
The specific HSPC lineages supported by each matrix were also calculated based on flow 
cytometry and CFU assays. The main objectives of this chapter -5 are  
• To induce biochemical modifications in HS-5 ACM derived from HS-5 cells of 
20% and 5% O2 condition 
• To induce structural and topographical modifications in HS-5 ACM 
• Morphological, biochemical and topographical characterization of modified 
ACMs 
• Ex-vivo HSPC expansion on biochemically and structurally modified ACMs 
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To inhibit the endogenous activity of MMPs, a commercial pan-inhibitor MMP-III 
inhibitor (Merck Milipore) [220] was used. MMP inhibitor used in this protocol is a 
homophenylalanine-hydroxamic acid based broad-spectrum cell-permeable, reversible 
inhibitor of matrix metalloproteinases that inhibits MMP-1, MMP-2, MMP-3, MMP-7 and 
MMP-13. HS-5 cells were maintained in CM-1 for initial two days followed by growing in 
CM-2 containing 10 nm of MMP inhibitor until confluence (Table 2-6). The MMP inhibited 
cells were than decellularized to prepare modified ACM as described in chapter 2 section 
2.3.4. 
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 To induce ECM synthesis in HS-5 cells, TGF- ȕ1 was exogenously added in to HS-5 
culture media. HS-5 cells were maintained in CM-1 for initial two days followed by growing 
in CM-3 containing 10 ng/ml of TGF-ȕ until confluence [221] Media composition is given in 
Table 2.6. The TGF- ȕ induced cells were than decellularized following the protocol as 
described in chapter 2 section-2.3.4 
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qRT-PCR was performed to quantify gene expressions of various ECM molecules, 
MMP, TIMP and TGF-β-dependent genes. Methodology for qRT-PCR was followed as 
described in detail in chapter 2 section 2.4.3. 
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Specific immunostaining for fibronectin, collagen type-1 and laminin was performed as 
described in chapter -3 section-3.4.3.
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   The detailed procedure of UCB sample collection, sample processing, isolation of total 
MNC, further processing and isolation of CD34+ cells from total MNC by MACS in 
AutoMACS, using CD34+ antibody conjugated with magnetic beads is discussed in detail 
in chapter 2 section 2.3.5. Biochemically modified and control ACMs were prepared in 24 
well tissue culture plates. The total number of conditions for ex-vivo HSPC expansion on 
biochemically modified ACMs are listed in the Table 5-2.  
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For structural modification experiments, HS-5 cells were cultured in CM-1 with regular 
media change until confluence. Once the cells reach confluence they were allowed to grow 
for additional 4-6 days for better ECM preparation. The main thrust of this study was to 
understand the effect of structural, topographical features of ACM on the ex-vivo HSPC 
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5% O2 ACM (Control) 20% O2 ACM (Control) 
5% O2 TGF- ȕ ACM 20% O2 TGF- ȕ ACM 
5% O2 MMPi ACM 20% O2 MMPi ACM 
ŚĂƉƚĞƌϱͲŝŽĐŚĞŵŝĐĂůĂŶĚƐƚƌƵĐƚƵƌĂůŵŽĚŝĨŝĐĂƚŝŽŶƐŝŶ,^ͲϱD
ϭϱϬ

expansion therefore the experiments were performed in only single O2 condition i.e. ACM 
prepared or derived from HS-5 cells of 20% O2. The culture conditions for HSPC expansion 
were 37ºC, 5% O2, 20% CO2 (Hypoxia incubator). 
All procedures for decellularization were done under sterile conditions as mentioned in 
detail in chapter 2 section. The decellularized ACMs were allowed to dried and washed with 
PBS to remove traces of NH4OH. ACMs obtained on 24 well plates were used as native 
ACM substrates. For spin coating, ACMs suspensions obtained from three 60mm dishes were 
pooled, briefly sonicated and its total protein content was estimated; the suspension was 
immediately processed. 
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Decellularized ACM of HS-5 cells were prepared as described above. Dried matrices 
were washed thoroughly with PBS, and MiliQ water was added and kept for incubation for 1 
hr at RT. (Figure 5-4). 
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The matrix was then scraped thoroughly, and collected in sterile 1.5 ml tubes. The collected 
and extracted matrix was sonicated to get uniform matrix suspension. Based on the estimation 
for total protein present in a well of 24 well plates, 50μg protein equivalent matrix sample 
were placed on each well of a 24 well tissue culture plate or borosilicate glass cover slips (18 
× 18mm) and spin coated for 60 sec at 1000 rpm under vacuum, using a WS-400 6NPP-Lite 
Spin Coater under sterile conditions. The coated plates and cover slips were dried overnight 
in the laminar flow cabinet, followed by washing in PBS with Pen/Strep and thus used as 
substrate for ex-vivo HSPC expansion and also for ACM characterization. 
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Morphological characterization of native and spin coated ACMs was performed by SEM. 
Both substrates were rinsed with PBS, fixed in 2.5% glutaraldehyde, washed and dehydrated 
by washing in a increasing concentrations of ethyl alcohol (50%, 60%, 70%,80% 90%,100%) 
and finally kept in acetone. The fixed and dehydrated samples were then subjected to CPD 
and sputter coating with a thin layer of gold. The samples were examined at a range of 5-10 
kV in the microscope. 
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Freshly prepared native and spin coated ACMs were dried in a de-humidified desiccator 
for 16 hr and subjected for AFM measurements. AFM analysis was carried out in 200-300 
kHz tapping modes using a multi probe imaging microscope Multiview 4000 TM (Nanonics 
Imaging Ltd, Israel) equipped with a hybrid-scanner. Images were collected at scanning 
frequencies of 5 kHz using glass tip cantilevers at 512×512 pixels resolution. Scan regions of 
5×5 or 2×2μm2 were used for data collection and data of multiple scan regions were gathered 
and averaged (as indicated in the results section). Root-mean-square (rms) values were used 
to calculate average surface roughness. For calculation of the coating thickness, a scratch on 
the native or spin coated surface was made to expose the underlying plastic or glass surface 
and differences in the data values of the scratched and exposed surfaces were used to 
calculate the thickness of the matrix. For final image reconstruction and calculation of height 
variations, thickness and surface roughness, software provided by the manufacturers (WSxM 
v4.3) was used. 
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Various cytochemical stains were used to characterise the spin coated ACMs for 
detection of major ECM components. Presence of collagenous matrix in thespin coated 
ACMs was demonstrated by staining with Masson’s trichrome kit as instructed by the 
manufacturer. Similarly, fibrillar collagen was detected by staining the spin coated ACM with 
picro Sirius red. Proteoglycans and ECM-bound GAGs were detected by staining with 
safranin-O and alcian blue respectively. Details of each of these staining protocols have been 
described in chapter 3 section 3.4.2. 
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Immunofluorescence staining was performed to examine the expression of major ECM 
proteins, fibronectin, collagen and laminin in the spin coated ACM as described in chapter 3 
section 3.4.3. 
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Spin coated thin film ACM prepared in structural modification experiments were used as 
substrate to expand human UCB CD34+ cells. The detailed procedure of UCB sample 
collection, sample processing, isolation of total MNC, further processing and isolation of 
CD34+ cells from total MNC by MACS in AutoMACS, using CD34+ antibody conjugated 
with magnetic beads is discussed in detail in chapter 2 section 2.3.5. The protocol for HSPC 
expansion on modified ACMs was performed as described in chapter 3 section 3.2.8. All the 
structurally modified spin coated and control ACMs conditions were prepared in 24 well 
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tissue culture plates. The total number of conditions for ex-vivo HSPC expansion is listed in 
the table below- Table 5.3. 
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The endogenous level (without any treatment) MMP gene expression as quantified by 
qRT-PCR showed that, the HS-5 cells at 5% O2 condition exhibit elevated expression MMPs 
as compared to 20% O2 condition. The analysis was done for MMP1, 2, 3, 7, 8, 9, 10, 11 and 
13. At 5% O2 condition expression of MMP1, MMP2, MMP8, MMP9 and MMP10 were 
observed to be higher, while only MMP13 expression was more in 20% O2 condition (Figure 
5-5). 
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Control TCP 
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Spin coated ACM 
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The expression analysis of TIMPs (1,2,3,4) genes by qRT-PCR was done to quantify 
endogenous level gene expression in HS- 5 cells of 20% and 5% O2 condition. Expression of 
TIMP1, TIMP2, and TIMP 4 were higher in HS-5 cells of 20% O2 condition as compared to 
the cells of 5% O2 condition (Figure 5-6). 
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The expression analysis of MMP genes in HS-5 cells was done before and after MMP 
inhibition by MMP inhibitor III. After culturing the cells with MMP inhibitor, decrease in the 
level of gene expression of MMP1, MMP3, MMP9, and MMP13 was observed in cells of 5% 
O2, while expression of MMP1, MMP3, MMP9 and MMP10 was observed to reduced in 
cells cultured at 20%O2 (Figure 5-7). 
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The expression analysis of major MMP substrates (ECM) was done to quantify basal 
level gene expression in HS- 5 cells of 20% and 5% O2 condition by qRT-PCR. After 
inhibition of MMP activity, level of gene expression for COL1, COL3, COL4, LAM4, 
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LAMC and FN was found to be increased in MMP inhibited cells of 20% O2 condition as 
compared to respective control. Level of gene expression for COL1, COL4, LAM4, LAMC, 
and FN was found to be increased in the MMP inhibited HS-5 cells of 5% O2 condition as 
compared to respective control after inhibition of MMP activity (Figure 5-8). 
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qRT-PCR analysis for major ECM molecules was done to quantify their gene 
expression in HS- 5 cells, cultured at 20% and 5% O2 after with and without by exogenously 
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added TGF-ȕ. After induction with TGF ȕ, level of gene expression for COL1, COL3, COL4, 
LAM4, LAMC and FN was found to be increased in cells of +TGF-ȕ-20% O2 condition as 
compared to respective control. The expression of COL4, LAM4, and FN was found to be 
increased in the HS-5 cells of +TGF- ȕ -5% O2 condition as compared to respective control 
(Figure 5-9).  
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Modified ACM prepared by inhibiting endogenous MMP activity by MMP inhibitor 
show enhanced expression for the major ECM molecules such as collagen, fibronectin, and 
laminin as compared to the unmodified ACMs. Based on the qualitative observation it was 
clear that modified ACMs (MMPi) prepared from both O2 tension showed improvement in 
the ECM components as compared to their respective controls (Figure 5-10). Inhibition of 
MMP resulted in better expression for ECM molecules specifically fibronectin and laminin, 
compared to the control ACM at both O2 conditions.  
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Addition of TGF- ȕ to the HS-5 culture resulted in increased expression of major ECM 
molecules such as collagen, fibronectin, and laminin at both 5% and 20% O2 (Figure 5-11). 
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The functional properties and HSPC expansion capacity of the MMP inhibited and TGF- 
ȕ induced ACMs of both 20% and 5% O2 condition were investigated by seeding equal 
number of MACS separated CD34+ cells on each ACM and controls and incubated in 5% O2 
for 8 days in expansion media. Cells were stained with FACS antibodies before (pre) and 
after (post) expansion and CFU- assays were set up as described in chapter-3 section 3.2.8.  
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The average purity for CD34+ CD45lo, CD34+CD38- and CD34+CD133+ markers in 
cell isolated from UCB by magnetic separation before expansion were found to be 56% ±0.5, 
8% ±1.7 and 50% ± 2.5 respectively. 
The average of three experiments expansion data is presented in the bar graphs. The 
analysis and calculation were done to get total fold viability, and fold expansion of 
CD34+CD45lo, CD34+CD38- and CD34+CD133+ as this subsets of markers represents 
different lineages of HSPC. Post expansion results show that total and lineage specific HSPC 
expansion was significantly higher in MMP inhibited ACM of 20% O2 condition. Total viable 
cells were expanded in all MMP inhibited ACM above 50 fold however it was significantly 
higher on MMPi ACM 20% O2 up to 100 fold. Viable cells expansion of CD34+ CD45lo was 
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observed to be higher on MMPi ACM -20% O2 conditions (70 fold) as compared to the other 
modified ACMs and control ACMs. Improvement in the functional properties of MMPi 
ACM of 5% O2 was also observed that supported significant expansion of CD34+CD45lo for 
up to 16 fold as compared to its respective control ACM of 5% O2 condition. The expansion 
of CD34+CD133+ cell population was significantly higher on MMPi ACM 20% O2 (30 fold), 
as compared to its respective control ACM (13 fold). The expansion for CD34+CD38- cell 
population was significantly lower on all the ACM substrates when compared to expansion 
outcomes of CD34+CD45lo and CD34+CD133+ cell populations.  
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Conditions Fold viable 
cells 
Mean ±SE 
Fold 
CD34+CD45lo 
Mean ±SE 
Fold 
CD34+CD38- 
Mean ±SE 
Fold 
CD34+CD133+ 
Mean ±SE 
20%O2 ACM CNT 70±0.3 21±0.3 9±0.9 13±2.1 
MMPi-ACM -20% O2 104±11 73±17 16±6.6 30±7 
TGF-ȕ-ACM-20% O2 42±1 4±1.8 8±2.5 11±1.1 
5%O2 ACM CNT 45± 1.6 9±0.3 6±1 8±2.4 
MMPi-ACM -5% O2 66±9.4 16±0 12±4.8 11±2.6 
TGF-ȕ-ACM-5% O2 41±2.1 8±0.3 10±0.4 9±0.4 
Contrary to expansion outcomes on MMP inhibited ACMs the results show total and 
lineage specific cell expansion were decreased on TGF- ȕ induces ACM at both oxygen 
condition. The results indicate that total viable cell expansion was significantly decreased in 
all the TGF- ȕ induced ACMs of both 20% and 5% O2 conditions as compared. Fold 
expansion for viable cells for CD34+CD45lo and CD34+CD133+ were also seen to decrease 
on the modified ACMs of TGF- ȕ as compared to MMP inhibited and control ACM. 
Interestingly the fold expansion for CD34+CD38- was seen to be significantly improved for 
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up to 10 fold on TGF- ȕ –ACM -5% O2 condition, as compared to other modified ACMs and 
control ACM (Table 5-4 and Figure 5-12). 
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Representative dot plot of flow analysis to assess the level of expansion of HSPC on 
biochemically modified HS-5 ACM of two different O2 condition using lineage specific 
markers is  shown in Appendix-VII and VIII. 
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Functional properties and clonogenic potential of the cells expanded on modified and 
unmodified ACMs were assessed by CFU- assays in semi-solid media. The expansion of all 
CFU-c including total CFUs was observed to be higher on MMP inhibited ACMs of both 
oxygen condition, in comparison to their respective controls ACM and TGF-ȕ ACM. The 
greatest expansion of CFU-GM (144 fold) was obtained on MMPi-ACM 20% O2 Functional 
properties of ACM of 5% O2 were also seen to be improved after inhibition of MMP activity 
where significantly higher expansion of CFU-GM (68 fold) was obtained as compared to 
control ACM at 5% O2. The greatest effect of MMP inhibition was observed on the 
expansion of BFU-Es where 170 fold expansion was obtained on MMPi ACM-20% O2. On 
MMPi –ACM 5% O2 BFU-Es expansion was found to be higher as compared to its respective 
control ACMs (Table 5-5 and Figure 5-13). Highest fold expansion for CFU-GEMM of up to 
60 fold was observed on MMPi-ACM-20% O2.  
In contrast to results obtained on MMP inhibited ACMs, no significant differences were 
observed for the expansion of CFU-GM, CFU-GEMM, BFU-Es and total CFUs, on TGF-ȕ
ACM. Although the TGF–ȕ of ACM -20% O2, and TGF- ȕ ACM 5% O2 condition showed 
increased expansion for BFU-Es, the differences were not statistically significant as 
compared to their respective control ACM (Figure 5-13). 
.  
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Conditions Fold  
BFU-E 
Mean ±SE 
Fold 
CFU-GM 
Mean ±SE 
Fold 
CFU-GEMM 
Mean ±SE 
Total Fold  
CFU 
Mean ±SE 
20%O2 ACM-CNT 80±6.6 62±4.7 30±0.1 67±0.5 
MMPi -ACM 20% O2 173±5.2 144±9.3 66±3.5 152±4.1 
TGF-ȕ-ACM -20% O2 106±21.0 33±1.2 25±0.6 36±2.6 
5%O2 ACM-CNT 42±0.5 41±3.0 31±3.4 41±1.5 
MMPi -ACM 5% O2 83±5.5 68±9.6 43±13.2 73±7.5 
TGF-ȕ-ACM -5% O2 50±1.3 28±1.6 24±6.4 30±1.2 

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After HS-5 cells were decellularized by treatment with NH4OH the intracellular 
components of cells were removed leaving behind the ACM Phase contrast micrographs of 
HS-5 cells, before (Figure 5-14 A) and after (Figure 5-14 B). The treatment with NH4OH 
clearly demonstrates the absence of cell nuclei in the decellularized native ACM.  
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SEM analysis of the native and spin coated ACM show the micro detailing and 
architecture of the matrix surfaces. Native ACM (Figure 5-15 A) exhibit the presence of thick 
bulky structures made by deposited matrix component after decellularization, where the 
porous surface structure is visible as irregular shape measuring few μm in sizes. On the other 
hand, spin coated ACM (Figure 5-15 B) exhibited a uniform layering of the ACM and 
presence of nano-sized globular structures on the entire surface. 
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AFM analysis of native and spin coated ACM was performed to understand the 
topographical differences (thickness, roughness, uniformity) on the surface of the matrices. 
To analyse the 2D and 3D asymmetry of the coated surfaces, line scan AFM imaging was 
done on both substrates.  
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Based on 2D analysis, large variations in surface height and other structural irregularities 
could be seen on the native ACM (Figure 5-16 A) as compared to the spin coated ACM, 
which was more uniform and symmetrical (Figure 5-16 B). The 3D data analysis (Figure 5-
16 C and D) showed these differences more clearly as dark and light shades. The units and 
dimensions of representative line scans of native and spin coated ACMs are shown in Figure 
5-16 E and F. The highest and lowest peaks on native ACM were at +60nm and -40nm 
respectively and that for spin coated ACM at +12nm and -4nm respectively. The large range 
of differences in the values of surface height suggests that native ACM surface was more 
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irregular that spin coated ACM. The spin coated ACM show repetition of similar surface 
height profile in a line scan. 
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The deposited matrix thickness in native and spin coated ACM was measured in AFM. 
The average thickness of the matrix was calculated, equal to the difference between the 
scratched and exposed glass surface and the average matrix deposit level. In native ACM, 
different levels of thickness were observed, consistent with the mixed symmetries present on 
the surface. The average thickness was calculated by scanning random segments in different 
frames and total 6 scans were used for the final calculation in both substrates. The 
representative AFM image of thickness profile of native ACM is shown and spin coated 
ACM in. Native ACM thickness was calculated to be 550±50nm, and in spin, coated ACM 
was calculated to be 166±17nm. The thickness profile generated by AFM indicated that spin 
coated ACM are indeed thin film matrices layered uniformly over an area where as the native 
ACMs are thicker matrices. For measurement of surface roughness, a total of 4 scans from 
random segments of each substrate were used and the average root mean square roughness of 
native and spin coated ACM was calculated, by the WSxM v4.3 software. The results are 
shown in respectively, as can been seen the values were 26 ± 16 Ra for native ACM and 
51.25 ±3.4 Ra for spin coated ACMs (Figure 5-17). 
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 Matrix Thickness 
ACM (nm) 
Matrix Thickness 
SPIN COAT ACM 
(nm) 
1 600 140 
2 600 160 
3 450 200 
Avg (Mean ±SE) 550± 50 166± 17 
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Cytochemical staining of substrates showed that both native and spin coated ACM show 
similar retention of matrix constituents such as collagen, proteoglycans and GAGs In contrast 
to the native ACM, where the stains are retained by deposited matrix leaving spaces in 
between, the spin coated ACM exhibit stain retention in more uniformed manner (Figure 5-
18). These results indicate that differences in the physicochemical properties of the substrates 
did not affect the qualitative distribution of matrix proteins on the two substrates. 
&ŝŐƵƌĞϱͲϭϴǇƚŽĐŚĞŵŝĐĂůĐŚĂƌĂĐƚĞƌŝǌĂƚŝŽŶŽĨ,^ͲϱƐƉŝŶĐŽĂƚĞĚD
ͷǤͶǤͶǤ͸ 
Antibody staining of spin coated ACM confirmed the presence of all three major ECM 
molecules i.e. fibronectin, collagen type I, and laminin in the substrates (Figure 5-19). No 
nuclear staining (as shown by DAPI staining) or presence of cytoplasmic actin (as shown by 
Alexa Fluor-488 phalloidin actin staining) could be seen. The spin coated ACM exhibited 
uniformly distributed non fibrous particulate matrix on the surface (A,B,C) 
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HSPC expansion on spin-coated substrates was evaluated by flow cytometry and colony 
forming assays. The percentage purity of pre expansion culture UCB cells for 
CD34+CD45lo, CD34+CD38- and CD34+CD133+ was found to be 73%, 4%, and 60% 
respectively as characterized in cytometer assay. After expansion on spin coated ACMs 
increase in the total fold viable cell was seen as compared to control and native ACM.  
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Spin coated ACM showed improved expansion for CD34+CD45lo and CD34+CD133+ 
as compared to other substrates suggesting that symmetrical but rougher structural features of 
Substrates  Fold expansion 
total viable cells 
Mean ±SE 
Fold expansion 
CD34+CD45lo 
Mean± SE 
Fold expansion 
CD34+CD38-
Mean ±SE 
Fold expansion 
CD34+CD133+ 
Mean± SE 
TCP 47.0 ± 1.9 17.±5.8 2.3±1.8 24.2 ± 0.8 
Native ACM 74.4. ± 3.7 25.0±10.8 4.2±2.8 34.7 ± 0.6
Spin coated ACM 94.2 ±1.6 38.0±4.2 10.60±5.4 44.0 ± 0.8 
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the substrates can impose stimulatory effects on HSPC. Expansion of CD34+CD38- cells was 
not statistically significantly (P 0.05), but was higher on spin coated surfaces than on native 
ACM. (Table 5-7 and Figure 5-20)  
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Representative dot plot from one experiment of flow analysis to assess the level of 
expansion of HSPC on structurally modified spin coated and native ACM, using lineage 
specific markers is shown in Appendix-IX. The CFU assay results Table 5-8 showed slightly 
higher expansion of CFU-GM and BFU-E on spin coated ACM compared to native ACM, 
but the difference of BFU-E expansion only could reach statistical significance. 
ŚĂƉƚĞƌϱͲŝŽĐŚĞŵŝĐĂůĂŶĚƐƚƌƵĐƚƵƌĂůŵŽĚŝĨŝĐĂƚŝŽŶƐŝŶ,^ͲϱD
ϭϳϰ

dĂďůĞϱͲϴǀĞƌĂŐĞĨŽůĚ,^WĞǆƉĂŶƐŝŽŶŽŶƐƚƌƵĐƚƵƌĂůůǇŵŽĚŝĨŝĞĚDͲ&hͲĂƐƐĂǇ
Substrates  Fold 
TOTAL CFU- 
Mean± SE 
Fold 
CFU-GM 
Mean± SE 
Fold 
CFU-GEMM 
Mean ±SE 
Fold 
BFU-E 
Mean± SE 
TCP 93 ± 55 32±5.2 21±11.7 43 ± 14
Native D 142 ± 84 67±22 48.6±13 103 ± 25
Spin coated 
ACM 
266 ±50 115±62 48±11.6 139 ± 22
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We have previously reported that ACM derived from mouse stromal cells significantly 
expands HSPC cell populations [80, 222]. With our current results on human BMSC derived 
ACMs we show that these matrices and its components represent suitably complex 
environment to HSPC and support their ex-vivo expansion. Several studies have reported the 
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expansion of HSPC on scaffolds or substrates with varying affinities; up to 3 fold on 
Cytomatrix system [109], 4.8 fold on bio mimetic scaffolds [223], 6.8 fold on fibrous 
matrices [224] and ׽100 fold on FN-conjugated scaffold [114] for CD34+ cells. Although, 
all the mentioned examples are valuable and add more information to the already available 
protocols of achieving enhanced expansion, they largely depend on the use of monomeric 
matrix proteins as coatings or 3D scaffolds. These results provide limited information about 
cellular, molecular and extracellular complexity of the niches in BM [225, 226]. In our study, 
we have not only demonstrated that HS-5 ACMs are suitable for HSPC expansion and mimic 
the micro environmental condition of human BM, but have also shown that stromal matrix 
properties can be modified by modulating the actions of the important BM niche regulators 
.Our results show that it is possible to expand human HSPC on decellularized biological 
scaffolds obtained from a BM-derived stromal cell line and even better expansion can be 
achieved by modulation of stromal matrix properties.  
Microarray profiling of HS-5 cells grown in 20% and 5% O2 condition and the detail 
analysis of the data obtained gave us valuable information regarding the total cellular, 
extracellular and secretory profile of HS-5 cells. The most important pathway that was 
significantly affected in HS-5 cells when they were grown in 5% O2 condition was “ECM 
remodeling”. Taking notes from the microarray data, we chose two very important regulators 
that are involved in active ECM remodeling in cells and tissues i.e. MMPs and TGF-ȕ. In this 
chapter, we have described in detail about the procedures of inducing modifications in the 
stromal matrix properties, preparation of modified ACMs, quantitative, qualitative 
characterization of these ACMs and finally functional characterization for its effects on the 
HSPC expansion. 
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HSPC expansion on HS-5 native ACMs (without any modifications) cultured at two 
different oxygen conditions gave consistently better expansion on ACM prepared at 20% O2
as compared to 5%O2 condition. The matrices were prepared at both 20% and 5% O2 but the 
expansion of HSPC is done at 5% O2 condition. The differential response of 20% O2 ACM 
and 5% O2 ACM for HSPC expansion was due to altered stromal matrix quality. At lower O2
tension the normal ECM synthesis by HS-5 cells was drastically reduced, and the proteolytic 
activity of matrix degrading enzymes; MMPs were increased as observed by qRT-PCR. As a 
result, ACM that were prepared from HS-5 cell grown at 5%O2 were less efficient in 
supporting ex-vivo HSPC expansion due to the lower quantity and altered quality of ECM 
secreted by the cells. 
The modifications that were induced in the HS-5 stromal matrices by inhibiting the 
endogenous MMPs activity were found to enhance the ECM quality and quantity in the 
modified ACMs. As discussed previously, endogenous MMPs degrade many important 
components of the HSC niche in BM through their proteolytic activity, including collagen, 
laminins, fibronectin and proteoglycans [106]. MMP1, which exists in two forms (secreted 
and membrane bound), are known as collagenase and degrade collagen type I, II, III. MMP1 
also degrade IGFBP. IGFBP is an important environmental factor, and essential for survival 
and cycling of HSC [227]. Reports suggest that at lower O2 tension the stromal cells secret 
more MMP1[228]. Balanced activity of MMP2 is required for the homing of transplanted 
HSPC to BM. SDF-1, a critical regulator of HSC mobilization, regulates the production of 
MMPs, specifically gelatinases, to enhance the migration of HSC [229]. [106]. MMP2 and 
MMP9 are expressed by myeloid cells in BM tissue, MMP2 is also expressed by 
erythroblasts [109]. Long term BM cultures constitutively express inactive form of MMP9 
and MMP2. Different types of MMPs in their inactive or membrane forms have been 
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detected in erythroid, megakaryocyte and myeloid progenitor cell populations. Balanced 
activity of different MMPs in BM signifies its importance in normal hematopoeisis where it 
takes part in the hematopoietic recovery after BM failure [106]. 
The TIMP family of proteins inhibit and regulate endogenous MMP activity. HS-5 
stromal cells show enhanced expression for TIMP1, TIMP2, and TIMP4 at the 20% O2 
condition, whereas at the lower oxygen condition the expression for these inhibitors were 
reduced. One of the possible explanations for the reduced ECM synthesis in HS-5 cells 
cultured at 5% O2 is therefore an imbalance of TIMP-MMP activity, resulting in enhanced 
proteolytic activity of MMPs. Recent findings suggest that TIMPS are also involved in 
diverse cellular functions. TIMP1 has a role in controlling the cell cycle dynamics of LT-
HSC. TIMP-1 and TIMP-2 exhibit erythroid potentiating activity in-vitro. Over expression of 
TIMP 3 has been linked to HSPC proliferation, and myelopoiesis in-vivo[107]. 
We have demonstrated that inhibition of MMP activity results in enhanced expression of 
major ECM molecules, both by qualitative (immunofluorescence) assessment and by 
quantitative assessment of FN, LMN and COL. When these MMP inhibited ACMs are used 
as substrates they show improvement in the expansion of HSPC. The functional assays also 
show that MMP inhibited ACMs particularly support erythroid cell expansion. These 
selective expansion results further supports our hypothesis that the HS-5 cells are from the 
distinct region of the BM whose matrix supports HSPC expansion and directs cells towards 
erythroid lineage differentiation. The 5% O2 ACM whose efficiency was found to be affected 
due to higher proteolytic activity of MMPs was also observed to be improved and respond in 
better HSPC expansion after inhibition of endogenous MMPs activity. 
In another approach of ECM remodeling, we used TGF- ȕ to induce more ECM synthesis in 
HS-5 cells. TGF- ȕ is a known key regulator of ECM assembly, bone remodeling, bone 
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formation and resorption[230]. TGF -ȕ takes part in two pathways one that reduces excessive 
matrix degradation and in another that stimulates matrix deposition (Figure 5-2). TGF-ȕ
inhibits excessive action of protienases by suppressing their synthesis, and up regulates the 
synthesis of inhibitors of protienases[231]. It also increases the expression of the major ECM 
molecules such as fibronectin and collagen, and plays a critical role in the interaction of cells 
with ECM mediated through integrin receptors[207]. 
Our results show that ACMs induced by TGF- ȕ were not efficient for HSPC expansion. 
None of the TGF- ȕ induced ACMs showed differences in the expansion capacities as 
compared to the controls. A possible explanation of the inefficiency of TGF-ȕ induced ACMs 
could be because of the diverse roles of TGF-ȕ. It is a growth factor that is involved in 
multiple pathways, and also evokes many diverse cellular responses. While it is known as 
inducer of ECM synthesis, it is also known as negative regulator of HSC proliferation. We 
postulate that the inefficiency of TGF -ȕ modified ACMs could be because of the traces of 
residual growth factor still bound to matrix that negatively affects HSPC expansion. 
Therefore, although HS-5 ACM quality and quantity both were improved after induction with 
TGF-ȕ, this negative direct effect on hematopoiesis may have masked any benefit. 
A growing body of evidence suggest that the surface chemistry and topography of 
culture materials influence the rate of HSPC proliferation. The structural features of the 
ECM, which regulate cell shape, ranges from macro to nano scale. ECM surface properties 
which can structure can influence the alteration in the regulation of stem cell behaviour 
include surface topography, surface roughness, fiber diameter etc. To understand the role of 
substrate topography we used spin coating technique to prepare and thin films of extracted 
ACM, and used these coated material as a substrate for HSPC expansion.  
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The results obtained on structurally modified ACMs signify the important role of 
substrate topography in expansion of HSPC. It is interesting to note that though the 
biochemical composition of native and spin coated ACMs is same, but their ability to 
promote HSPC expansion is significantly different. The topographical differences in surface 
roughness and nano-globular surface architecture of the substrates could be responsible for 
this functional difference. It has been shown by others that thinner matrices that have higher 
elastic modulus and stiffness can better mimic the rigid bone microenvironment [21]. We 
propose that spin coated ACMs which are thinner (3.5 fold) and more rough (2 fold) than 
native ACMs could reflect the bone matrix microenvironment better than native ACMs. The 
nano-globular surface features of tissue engineered substrates are also known to support 
better osteogenic functions. Surface micro-topography and roughness have also been shown 
to play an important role in the differentiation of MSCs [22] and ESCs [23] and in the 
adhesion, spreading, proliferation and differentiation of osteogenic cells. Our data also 
corroborate that an optimum topography and roughness of substrates are necessary for 
achieving enhanced availability of the nutritive medium and growth factors to the cells and 
therefore such surfaces are better than others are for supporting all cell functions.  
Here, we have shown that ACMs derived from human BMSC after compositional and 
structural modification can be used even more efficiently for the multi-lineage HSPC 
expansion ex vivo. These ACMs are highly enriched in ECM components such as fibronectin 
and laminin that are known to enhance CFU-GM and BFU-E progenitor cell growth ex vivo
through Į4 and Į5 integrins [18].  
The findings from the induced modifications in stromal matrix and structural properties 
clearly signify the importance of a balanced ECM turnover in the construction, maintenance 
and regulation of HSC niche in BM. Any alteration in the balanced ECM turnover show 
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profound effects on the multiple components of the niche and ultimately on HSPC regulation. 
The main function of the niche to maintain balance between cell self renewal and 
differentiation largely depends on its multifunctional component where ECM plays a central 
role. Similarly, the topography of the in-vivo bone matrix, known to be optimum of HSC 
regulation, can be replicated in a controlled manner by using advanced technology to prepare 
substrates that are more efficient.  
The findings suggest that the biochemical environment provided by the HS-5 ACMs is 
suitable for supporting HSPC growth. The consistent results of more significant expansion of 
BFU-Es obtained on HS-5 ACM, MMPi ACM, and spin coated ACM is suggestive that they 
could serve as a surrogate model of a vascular niche of BM. The matrix modification 
experiments were performed to determine whether modified matrices retain their 
functionality. Changes in the composition of the extracellular matrix have profound effects 
on cell proliferation and differentiation. The development of many cell types in-vitro can be 
manipulated by altering the levels of fibronectin, collagens, and other major components of 
the matrix. As the ECM in the niche is known to regulate important interdependent cellular 
responses, any alteration in it either qualitative or quantitative can exert alteration in normal 
cell maintenance. HSC fate decisions largely depend on the intricate balance of adhesive 
interactions with ECM components and stimulation by soluble factors. Tightly controlled 
ECM homeostasis is crucial for regulating many essential cellular processes, and also in 
hematopoiesis. When this balance is disturbed, an aberrant ECM can contribute to altered 
conditions, including defects in HSPC differentiation and regulations. 
With our results of biochemical modification and HSPC expansion on modified ACM, 
we conclude that – 
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• Stromal matrix properties can be modified by modulating the actions of the important 
BM niche regulators, even better and enhanced expansion can be achieved on these 
modified ACMs. 
• By inhibition of endogenous MMP activity, we were able to control the loss of ECM 
by proteolytic action of MMPs and ACM properties was improved that in turn made 
them more efficient substrate to be uses for expansion purposes. 
• Better expansion outcomes were observed in MMPi ACM as compared to TGF- ȕ
ACM. TGF-ȕ is multifunctional regulatory factor- it is a known inducer of ECM 
synthesis but also known as negative regulator of HSC growth. 
These experimental results of expansion on MMP inhibited matrices is a significant 
contribution to the active field of HSC expansion and may prove to be of great clinical 
importance in the near future. 
With the findings of structural modifications in HS-5 ACM, and HSPC expansion on 
spin coated ACMs we conclude that- 
•  When the HS-5 ACM topology was changed from thick to thin, asymmetric to 
uniformly rougher, the functionality of the substrate increased that supported enhanced 
expansion of HSPC. 
•  Changes in substrate topography imposed growth stimulatory activity  and was 
comparatively more efficient in maintain higher percentage of cells in viable condition. 
•  Although the structural topology was changed however, due to same biochemical 
properties the HS-5 ACM still selectively expand BFU-Es more significantly but in 
higher number. 
Our protocol by which we have prepared spin coated HS-5, and obtained significant 
level of HSPC expansion, may have numerous benefits and applications in the field of HSPC 
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transplantation other regenerative therapies. It also provides a general protocol to prepare 
ACMs from other cell sources (e.g. embryonic fibroblasts, foreskin fibroblasts etc.) and 
replace their use as feeder layers to minimise variations in lineage specific cell expansion ex 
vivo. Both native and modified ACMs prepared by our method can provide better 
understanding of HSC niche properties and reveal novel regulatory roles of soluble and ECM 
bound signalling molecules. Even the physicochemical requirements of biomimetic surfaces 
for ex-vivo multi-lineage or lineage specific expansions can be analysed by our methodology. 
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Establishing in-vitro culture conditions under which large numbers of fully functional 
HSPC can be generated has been a central goal in transplantation and regenerative medicine 
field. In this thesis, we describe a novel and efficient method of ex-vivo HSPC expansion, 
using human BMSC line derived acellular matrices (ACM). Through our findings, we 
highlight the basic understanding of the much-investigated HSC biology, the two-way 
communication between the niches and cells. The main objective was to understand, 
incorporate and reconstruct the regulatory properties of HSC BM niche in a cell free culture 
system for enhanced HSC maintenance and/or expansion. Relevant to this work have been 
the evaluation of ACM compatibility and functional properties and its capability in HSPC 
expansion assessed through conventional CFU and flow cytometry assays. The study 
highlights the concept of multi component HSC niche in BM, comprised of physiochemical 
factors (O2 tension) cellular (stromal cells), soluble (cytokines) and insoluble factors (ECM) 
and their importance in construction of a growth inductive functional microenvironment. Our 
finding gives the clear understanding of the molecular profile of HS-5 cell line. Identification 
of candidate genes, specifically regulators of “BM ECM remodeling” that play a central role 
in maintenance of HSC in a multi component microenvironment were also done. Our results 
clearly indicate that modification of the properties and /or activity of stromal matrix and 
important niche regulators opens up a new possible strategy for enhanced HSPC expansion.  
Why the concept of HSC niche is important in reconstruction and 
development of advance culture systems? 
Hematopoiesis is a process of continuous and balanced generation of blood cells 
throughout the life of an organism [232]. The key features such as self- renewal, proliferation 
and differentiation of HSC are controlled by a specialized microenvironment referred to as 
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the stem cell niche. The components of the niche help in, maintaining HSC stemness, inhibit 
excessive proliferation, apoptosis, and determine the cell fate. [233]. A two-way cellular 
communication occurs between niche components and HSC. In the endosteal niches, 
osteoblastic cells participate in the maintenances of HSC quiescence by binding through cell 
adhesion molecules. Manipulation or ablation of osteoblastic cells in quiescent endosteal 
niches shows depletion of HSC number under in-vivo conditions [234]. The sinusoidal 
endothelial cells provide alternative niche to HSC as vascular or proliferative niche. These 
two niches control the balance between cell self-renewal and differentiation by their 
components such as supportive cells and ECM, arranged in a specific orientation and in the 
presence of physicochemical and growth factors. 
In our published report in manuscript III, we have explained in detail about the 
biochemical nature, various components of the niches and their effect on the regulation of 
HSC behaviour.  
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HSC hold great importance in the field of regenerative medicine, where a number of 
malignant and non-malignant haematological disorders can be treated by transplantation of 
these self-renewing cells. Although stem cell therapies are moving steadily toward the regular 
clinical practices, the lower cell yield is still a major challenge in transplantation. Over the 
last decade the concept of HSC niches and their role in regulation of HSC is well accepted, 
and has led to the hypothesis that mimicking the stem cell niche would facilitate enhanced 
HSPC growth ex vivo. The successful designing of an efficient culture system for HSC 
expansion is possible only with the complete understanding of the niche mediated cell 
regulation.  
Taking a step ahead of conventional culture system and with an aim to establish a cell 
free system for ex-vivo HSPC expansion we have used human BM derived stromal cell line to 
prepare decellularized ACM that provide HSCs a “niche in culture dish” that mimics BM 
extra cellular microenvironment.  
Why acellular matrices (ACM)? 
ACMs are biological substrates obtained by decellularization of tissue, organ or 
cultured cells. ACMs preserve the native ECM properties in its ultra structure and serves as 
excellent system in conditions where complex composition of ECM is required. ACMs are 
complex milieu of secretary products bound to the insoluble ECM, and has been shown to 
regulate many important cellular functions [123]. In recent times extensive studies have been 
dedicated to optimize the use of whole organ, tissue, and in-vitro culture derived ACM in the 
fields of tissue regeneration and bioengineering, and has also been used as effective, natural, 
nano scale scaffolds with programmable cell responsiveness [235]. ACMs have mostly been 
used in reconstruction surgeries and organ regeneration and in the expansion of MSCs, 
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osteogenic cells, neurogenic, hepatic cells etc however very few reports describe use of ACM 
in expansion, differentiation and maintenance of the HSPC.  
In our previous studies we showed that, the ACM based culture system derived from 
cultured mouse BMSC (MS-5) support significant growth and expansion of human UCB 
CD34+ cells. Application of this system to human UCB cells yielded a rapid up to 80-fold 
increase of HSPC with multilineage ability [80]. The findings of this study are already 
reported in manuscript II. After studying the role of ACM from a heterologous source in 
expansion of human HSPC, we took a step forward to create a homologous culture system, 
for which we have used human BM stromal cells derived ACMs for expansion of human 
HSPC. Our results have provided an enormous scope for designing cell free culture systems 
where a more homogenous human specific microenvironment can be provided for the growth 
of human cells. By the use of this system it would also be possible to overcome the 
limitations associated with the conventional culture systems such as loss of growth 
supporting properties in stromal cells as feeder layers in long term culture conditions. The 
ACM can be used as a standard culture system not only to get enhanced HSPC expansion but 
also in understanding the roles of niche regulatory factors whose action has not been fully 
understood.  
Role of O2 in niche mediated HSC regulation 
With the use of HS-5 cells derived ACMs we tried to answer the questions by 
understanding the role of niche physicochemical factors such as oxygen on stromal 
microenvironment.  
Major difference in endosteal and vascular niches apart from their cellular composition is 
the concentration of O2. The endosteal niches contain lower O2 concentrations as compared to 
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the more perfused vascular niches. By using high throughput imaging Levesque’s group have 
demonstrated that endosteum in the BM constantly expresses HIF-1Į and are indeed hypoxic 
in nature. The more primitive HSC remain attached to the hypoxic endosteal niche, 
maintaining their quiescence and stemness [236]. In Contrast to the quiescent niche, 
sinusoidal endothelial cells in vascular niches are abundant in nutrients and O2 concentration 
through optimum blood supply. At the comparatively higher O2 concentration and ample 
availability of growth factors HSC proliferate and exhibit multilineage potential. The 
undifferentiated HSC mature and differentiate to progenitor cells while remaining close or 
attached to sinusoids of vascular niche. This process completely defines HSC differentiation 
along with “oxygen paradigm” where quiescent cells reside in low oxygen endosteal niche 
and then migrate towards higher O2 vascular niches for multilineage differentiation. Many 
studies describe that ex-vivo expansion and maintenance of HSC significantly increase at 
lower oxygen tension (1%-5%). In contrast to the semi-solid and co-culture, the liquid or 
suspension culture show optimum expansion of BM MNC cells at 20% O2 concentration 
[237]. Undifferentiated cells of megakaryocyte (Mks) differentiate into mature form at more 
perfused regions. At higher O2 tension CD34+ generated Mks show increased differentiation 
and expansion [238].  
In our study, effect of O2 on stromal matrix microenvironment was investigated to get a 
better understanding of its regulatory role in the niche function. The HSPC expansion was 
performed at 5% O2 condition but ACM used as substrate were prepared in two different O2
concentrations i.e. 5% and 20%. Our results show, that ACMs derived from HS-5 cells 
cultured at 20% O2 were better in maintaining UCB CD34+ cell viability, also supported, and 
directed lineage specific cell expansion of CFU-GM and BFU-Es. We observed that the 
ACM prepared at lower O2 tension were not capable of efficient HSPC expansion. The 
differential response of HSPC expansion was mediated through the changes in stromal 
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microenvironment from which the ACM were prepared; therefore, we initiated a study to 
understand the underlying regulation of molecular changes in HS-5 cells. 
Differential response of HS-5 ACMs prepared at normal and lower O2
conditions in supporting HSPC expansion.
As discussed in chapter 1, the two different ACMs generated by culturing same cells 
in two different culture conditions respond in a differential manner in supporting UCB 
CD34+ expansion. We observed that the ACMs of lower O2 tension were not as e efficient in 
supporting HSPC expansion compared to the ACMs of higher O2 tension. The stromal cells 
of BM are common cellular component of both niches whereas O2 persists as a gradient. 
Differential O2 tension may induce alteration in stromal cells response that may reflect in the 
form of less growth factors secretion, less ECM production and more secretion of inhibitory 
factors. Another possibility is that the different stromal cells populations represent 
functionally distinct components of the marrow microenvironment and any alteration in the 
physicochemical conditions such as O2 may reflect in altered cell physiology. 
Although much is known about the effect of O2 gradient on HSPC expansion, its effect 
on the niche components such as stromal cells, ECM and growth factors is still not fully 
understood. Our findings point out that stromal cell can significantly change the constitution 
of their matrix in response to O2 levels. In quantitative and qualitative analysis, we observed 
loss of certain matrix components in HS-5 cells in 5% O2 condition. The BM stroma that 
consists of a heterogeneous cell population provides the structural and physiological support 
to HSC. ECM is secreted and deposited by heterogeneous BMSC into the local niche 
microenvironment, and regulate the cell survival by inhibiting apoptosis. With the 
information obtained by quantitative and qualitative assessment of ACMs of 20% and 5% O2 
condition, we observed that HS-5 cells alter their functional properties at lower O2
ŚĂƉƚĞƌϲͲ'ĞŶĞƌĂůĚŝƐĐƵƐƐŝŽŶ
ϭϵϬ

concentration. A significant loss of matrix proteins was observed by SDS-PAGE. The ACMs 
of HS-5 cells of 5% O2 show reduced expression for collagen, laminin, proteoglycans, GAGs 
and more specifically fibronectin both in quantitative and qualitative assessments.  
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Using ACM, we demonstrated a defect in the regenerative capacity of stromal 
microenvironment due to change in O2 tension. The defective hematopoiesis may have 
resulted from either the failure of the stromal microenvironment to secrete growth factors 
essential for hematopoiesis or the significant loss of stromal matrix proteins. In culture, HS-5 
cells of both O2 condition show healthy cellular generation pattern but the subsequent 
production and secretion of functional stromal matrix was only observed in 20% O2 that 
could efficiently support HSPC expansion. HS-5 ACMs of 20% O2 condition supports 
optimum expansion, as they are highly enriched in the ECM molecules where as ACM of 5% 
O2 show inefficiency in expansion, due to altered and poor ECM quality. The consistency 
was maintained in the outcomes of HSPC expansions on HS-5-ACMs that show enhanced 
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growth of committed progenitors CFU-GM and BFU-Es, but failure in supporting primitive 
cells population CFU-GEMM. These selective expansion results made us assume that the 
HS-5 cells are distinct cell population of probably the vascular niche of BM and its complex 
and riche matrix supports expansion of committed progenitors. 
What types of molecular changes occur in HS-5 stromal matrices due to 
change in O2 tension? 
Analysis of the genes and pathways active in HS-5 cells cultured at two O2
concentrations revealed a significant difference in the molecular compositions. HS-5 cells in 
their default culture condition i.e. 20% O2 show up regulation of genes involved in 
proliferation, active metabolism and cell-to-cell signaling, cell-ECM interactions, whereas at 
5% O2, HS-5 cells show up regulation of the genes involved in negative regulation of cell 
proliferation, glycosylation, oxidative stress etc.  
Pathway analysis of the genes expressed by HS-5 cells at 20% O2 condition 
demonstrated that several pathways involved with cell adhesion and ECM remodeling were 
up-regulated including integrin signaling, Wnt signaling, actin cytoskeletal signaling, 
interleukin signaling, TPO signaling, PDGF signaling, TGF-ȕ signaling, IL-6 signaling and 
JAK-STAT pathways, PDGF signaling etc. stimulates cell proliferation, differentiation, and 
events critical to hematopoiesis [239]. 
The “ECM-cell interaction” biological pathway was an important observation that 
was found to be up regulated in HS-5 cells at 20% O2 condition due to enrichment of 
associated genes. This cytoadhesion may also be important in modulation of the cellular 
response to other extracellular factors, such as soluble growth factors and other growth 
stimulatory and inhibitory factors [240]. The cell- ECM interactions also play an important 
role in cell division, and may affect stem cell self-renewal and/ or differentiation and the 
ŚĂƉƚĞƌϲͲ'ĞŶĞƌĂůĚŝƐĐƵƐƐŝŽŶ
ϭϵϮ

action of cytokines upon it. In BM HSC niche, HSC express VLA-4 and integrin Į5ȕ1 to 
bind fibronectin and osteopontin in the BM ECM [241]. HSC binding to fibronectin helps 
stem cell maintenance. These observations signify that the cell needs to interact with a matrix 
component to activate intracellular signal transduction cascades.  
 The molecular profiling of HS-5 cells of 20% O2 condition exhibited a higher percentage of 
the upregulated genes of functional ECM cluster, glycoproteins, cell, matrix, and biological 
adhesions. Twenty three % of genes were part of glycoproteins, 11% genes were from 
various secretary products, and 20% genes were involved in signalling. Glycoproteins that 
show functional importance in regulating stem cells behaviour for example IGFBPs [227]. 
Fibulins (FBLN) [242] secreted frizzled-related protein 1 (SFRP1) [243],  THBS1, THBS2 2, 
SPARC, DCN [244] SPOCK1, NRP1 [245] have been reported to regulate HSPC function by 
cyto adhesion, controlling cell cycling, and by inhibiting apoptosis. 
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Compared to the cells of 20% O2 condition, cells of 5% O2 showed poor enrichment of genes 
related to ECM. In 20% O2 of HS-5 cells total 4 pathways among the most significant top 10 
pathways were from the functional clusters of ECM, ECM remodeling, cytokine adhesion 
and cytoskeleton remodeling. ACM generated from such cells that mimic BM molecular 
profiles support better HSPC expansion as compared to ACMs of 5% O2 conditions. 
With the current study and in detail analysis of O2 mediated stromal matrix properties 
regulation and its effect on HSPC expansion, we understood that HS-5 cells are a distinct 
functional sub population of BM, and secrete a number of important growth factors, 
cytokines, and synthesize highly complex ECM that exhibit multi functional activity in HSC 
regulation. However the stromal matrix quality and functionality gets severely hampered 
when the O2 tension of HS-5 cell culture is modified. 
Modification of stromal matrix properties and the effect of modified matrices 
on HSPC expansion 
By using molecular profiling data obtained from HS-5 cells we understood the 
underlying mechanism of ACM mediated HSPC expansion. The major functional property of 
ACM is dependent on the ECM composition that mimic BM niche like matrix composition. 
A balanced synthesis and degradation of ECM in the BM is important for tissue homoeostasis 
and proper functioning. The synthesis and degradation of ECM is collectively called as ECM 
remodeling. Choosing two important regulators that participate in the process of ECM 
remodeling, we tried to manipulate the molecular composition and functional properties of 
stromal matrix as ECM is one of the key regulator of the microenvironment. The most 
important regulatory action in ECM remodeling is mediated by the proteolytic enzymes, i.e. 
MMPs. In hematopoietic microenvironment MMPs degrade different ECM molecules to 
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maintain BM tissue homeostasis and also regulate HSC mobilization, homing and migration 
in BM. MMP activity is tightly controlled at the level of transcription by its inhibitors, and 
imbalanced MMP activity leads to pathological conditions which may also affect and alter 
normal niche mediated HSC regulation [246].  
A balanced ECM activity was exhibited by cells at 20% O2 condition that show 
transcriptional activation of both MMP2, and its inhibitor TIMP2. Whereas higher proteolytic 
activity with higher expression of MMP10, MMP25, ADAMTS, and other proteases was 
observed in cells at 5% O2 condition along with down regulation of TIMPs. Apart from the 
microarray profiling data, results obtained in quantitative assessment of MMPs gene profile 
show up regulation of MMP1, MMP3 in HS-5 cells of 5% O2 conditions. These differential 
MMP expression in stromal cells due to change in O2 tension indicate a stress induced 
proteolytic activity where the stromal matrix properties are dependent on the balanced MMP 
proteolytic activity. The more proteolytically active HS-5 cells at 5% O2 generate poor 
quality ECM, and altered structural and functional properties.  
          Our experimental results suggest that through inhibition of endogenous MMP 
activities, we could control the proteolytic degradation and excess ECM loss. We used a 
chemical MMP III inhibitor that acts as a pan inhibitor and inhibits multiple MMPs. 
Inhibition of MMP activity in HS-5 cells has shown an improvement in the quality of ECM, 
with enhanced expression of collagen, fibronectin and laminin. This modified ACM 
generated by MMP inhibited cells supported enhanced HSPC expansion as compared to 
native ACM. The main functional changes observed on MMP inhibited ACM was increase in 
the capability to maintain HSPC in viable condition along with increase in the total cell 
number that reflected in fold expansion of committed progenitor cell population. 
Contrasting HSPC expansion outcomes were observed when the HS-5 stromal matrix 
modifications were induced by TGF-ȕ. Although we observed improvement in the ECM 
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quality in HS-5 cells, however the ACM prepared from these cells did not support significant 
cell expansion. Since TGF-ȕ specifically induces the synthesis of fibronectin and collagen in 
many cells there is high possibility that an improved ECM quality would contribute to the 
generation of efficient ACM that would in turn enhance the expansion outcomes. In contrast, 
the TGF- ȕ induced ACM failed to support expansion. As TGF-ȕ is a known negative 
regulator of HSC proliferation.  
The matrix modification experiments were performed to understand that how the 
important molecular factors exhibit a well-balanced activity in a complex multi-component 
system. By choosing two important niche regulators, we observed that each regulator could 
evoke a differential response in case of HSPC expansion, although both regulators participate 
in ECM remodeling. We also understood that under in-vitro system, the modification induced 
by inhibition of negative regulators of ECM could be considered as strategy that is more 
effective rather that induction of new ECM molecules. The complex architecture of the HSC 
niche in BM is hard to recreate in-vitro. Instead of exact recreation, modification of 
microenvironment by targeting individual niche factor can become an alternative strategy in 
designing efficient culture system. The study of the MMP inhibited ACM and its effects on 
ex-vivo HSPC expansion have been concluded in manuscript IV (under preparation). 
Role of substrate topographical features on ACM mediated HSPC expansion 
After characterizing the biochemical and molecular signature of HSPC growth 
supporting HS-5 ACM, we wanted to understand the role of ACM topographical features and 
its contribution in expansion. For this, we modified the ACM structural features, by 
extracting them in solution that was used in preparation of uniformly coated thin films of 
ACM substrates. The substrate feature changes from bulky, non-symmetrical, with variable 
thickness to more symmetrical, thinner and uniform in coated ACMs. 
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Recreation of the exact niche like condition in-vitro is difficult due to multi-component 
complex architecture of niche. All the molecular factors need to be in correct arrangements 
within a physicochemical (O2) microenvironment whose optimum topology is mostly 
attributed by structural ECM molecules that altogether are responsible for niche functionality. 
In addition to the ECM biochemical properties, mechanical properties of ECM such as 
substrate elasticity, rigidity, roughness and thickness show profound effects on proliferation 
and differentiations of many cell types [124, 247]. The specific physiological signals of sub 
nano meter or lesser size in the form of substrate topology is known to elicit specific cells 
responses. The in-vivo tissue stiffness is supposedly many folds lower than tissue culture 
substrates such as glass and plastic. The in-vivo tissue stiffness mostly attributed by its ECM 
components, changes with aging that can elicit different responses in stem cell populations.  
The role of substrate stiffness has been demonstrated on various biological culture 
systems such as collagen and hyaluronic acid gels, polymers, etc and mainly contributes to 
the cytoadhesion of cells. Surface micro-topography and roughness have also been shown to 
play an important role in the differentiation of mesenchymal [248], embryonic stem cells 
[249] and in the adhesion, spreading, proliferation and differentiation of osteogenic cells 
[250]. 
 In our ACM based HSPC culture system, we observed that spin coated ACM were 
almost three times less thick than the native HS-5 ACMs. As discussed before stiffer and 
harder biological substrate mimic the collagenous bone matrix topology and helps in bone 
formation and development, this may also contribute in construction of functional BM niche. 
Substrate roughness is another topological feature, that if present in optimum percentage 
enhances grater cell expansion and differentiation. In-vivo niche roughness is contributed by 
fibrous matrix molecules and mineralized content, and it is suggested that roughness show 
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direct effect on osteoblast attachment, proliferation, and differentiation and thus contribute in 
niche formation [251]. The generated HS-5 ACM that were prepared by spin coating, 
exhibited uniform topological characteristics due to presence of nano size globular structures 
present all over surface. The roughness of the HS-5 spin coated ACM provide in-vivo niche 
like topology and support growth and better cell expansion of HSPC. 

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The substrate topological feature like thickness, roughness, stiffness all together 
contribute to the tissue elasticity, that provides mechanical signals for the expansion of 
HSPC. The findings of the study of topographical properties of HS-5 spin coated ACM and 
its effect on HSPC expansion has been described in Manuscript I, (under review). In this 
paper we have reported the results of these studies which suggests that, the topographical 
differences between the native and spin coated ACM were responsible for the functional 
differences exhibited and also indicates that an optimum topography and roughness of 
substrates are necessary for achieving uniform/enhanced availability of the nutritive medium 
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and growth factors to the cells and therefore such surfaces are better than others are for 
supporting all cell functions. 
Advantage of using ACM based culture system in HSPC expansion 
Apart from HS-5 ACM, other cell free culture system such as covalent immobilization of 
fibronectin and adhesion peptides (CS-1 and RGD) have been reported to support enhanced 
cytoadhesion of HSPC [114]. A 3D scaffold conjugated with FN show expansion of CD34+
cells (׽100 fold) and long-term culture initiating cells (׽47-fold) in serum free culture 
system [114]. In FN based ACM culture system HSPC cytoadhesion have been shown to 
increase the regenerative capacity of the cells in culture conditions [252].  
In case of HSPC expansion, we observed that the ACMs of xenogeneic tissues such as 
mouse stromal cells (MS-5) were more nature stimulating substrates as compared to 
homologous ACM of human stromal cells (HS-5). Many reports show, successful utilization 
of xenogeneic ACM system in tissue engineering of many tissues. In xenogeneic system, 
ACM system minimizes the possibility graft rejection and immune reaction by removal of 
cell surface antigens at same time retains the conserved ECM structure and function. In 
human stromal derived ACM, the chances of immunogenic reaction are close to the minimum 
that makes it more reliable source specifically for cell therapy in humans. The major 
advantage of using ACM as culture system is it’s resemblance to the ECM composition of 
native tissues. ACMs are competitively more biocompatible than the stromal culture systems. 
The endogenously secreted or exogenously added factors are preserved and retained on the 
ECM of the ACM culture system that minimizes the extra use of expensive growth factors. 
The uniformity in structural and biochemical features of ACM minimizes the batch-to-batch 
variation in experimental process that is usually observed in stromal culture systems. This 
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uniformity also helps in equivalent distribution of important culture factors required for cell 
growth.  
The use of ACM based culture system demonstrates the synergistic regulation of HSPC 
expansion by exhibiting 3D architecture of ECM along with its biochemical nature. With 
recent advancement in technological aspects like live imaging, tracking, extraction and 
manipulation of target niche molecules and regulators makes the understanding much clearer 
regarding the effect of such factors on HSC maintenance and differentiation. With the 
extensive research that is being carried out in the field of HSC biology identification of novel 
niche regulators is becoming a routine process, and adds on to the increasing list of factors, 
representing the complete picture of the niche. As mentioned earlier, HSC niche is a multi 
dimensional system, and ECM components are one the most important regulator of the 
multicomponent niche. The variable nature of niche depends on the variable activities of 
important niche regulators. The work presented in this thesis supports this concept, and points 
to O2, as an important variable factor that regulate the modification of ECM, MMPs and other 
important ECM components. Along with the biochemical properties, the niche architecture 
also directs the cell fate and directs the lineage specific differentiation in HSPC. 
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In summary, the main findings of this thesis are- 
• Human bone marrow stromal cells (HS-5) can be used to prepare a decellularized 
matrix, termed as ACM that is rich in a number of functional ECM molecules and 
hematopoietic growth factors and cytokines. This ACM serves as an excellent cell 
free culture system for ex vivo lineage specific expansion of HSPC. 
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• The ACM mimics the in vivo microenvironment of the HSC niche in the BM and its 
properties are significantly altered when O2 concentration in growth medium of HS-5 
cultures is reduced from 20 to 5%. The ACM prepared from cells in lower O2 show 
significantly lesser HSPC expansion. These results highlight the role of O2 in HSC 
growth and differentiation.
• We have also demonstrated the role of MMPs and other proteolytic enzymes active in 
ACM in controlling the matrix constitution and its potency to support HSPC 
expansion. 
• We have demonstrated that topographical features of ACM such as surface roughness, 
thickness, uniformity, stiffness can play an important role in HSC differentiation and 
growth. And hence HSC expansion was more efficient on spin coated ACM that were 
thinner, stiffer and rougher as compared to native ACM. 
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• In our study describing the role of human BM stromal HS-5 cell line derived ACM on 
HSPC expansion, a comparative analysis with other tissue specific stromal cell 
derived ACM could have given us more information regarding the regulatory actions 
of HS-5 ACM. 
• Although the HS-5 cell line is derived from the BM stroma, the exact location in BM 
was not clear. Because of the functional property of HS-5 ACM to support committed 
progenitor cell expansion we assume that these cells belong to vascular niche. The 
confirmation of the HS-5 cell origin could have given us more information. 
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• The condition media of HS-5 cell line has been reported to expand HSC in serum free 
condition. In contrast to the mouse stromal cells, not many studies show use of HS-5 
cells as feeder layer in expansion experiments. Although we have performed the 
expansion experiments on mitotic inactive HS-5 cells the results obtained were 
insufficient to compare with ACM and were not included as major findings. 
• Although the consistent lineage specific expansion of committed progenitor of 
erythroid cell population by HS-5 ACM was observed in CFU assays, validation 
through erythroid specific cell markers in FACS could have given us a confirmation 
of the expansion. 
•  Although whole genome array analysis gave us a broader image of the molecular 
changes in HS-5 cells due to change in O2, based on the results obtained an additional 
and more specific gene specific array focusing on the most affected biological process 
would have given us a broader understanding of underlying mechanism of differential 
regulation.  
• Purifications of the individual ECM proteins of HS-5 stromal cells, and their addition 
in ACM based HSPC expansion culture system could have added additional 
informative value to the study. 
• In functional modification of ACM experiment, we used a chemical inhibitor that acts 
as pan inhibitor and inhibits activity of multiple MMPs. Although the quantitative 
assessment of gene expressions show difference in the expression level of MMPs in 
HS-5 cells at two O2 tensions, which MMPs proteolytic activity was most responsible 
for the ECM degradation and alteration in ECM functionality was not exactly clear. 
In structural modification of ACM experiment coating of a fixed concentration of matrix 
protein was done based on the estimation of protein content in native ACM. A comparative 
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study with a range from lower to higher concentration of protein coated on tissue culture 
substrate could have given us a concentration based HSPC expansion response.  
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The technical limitations and challenges experienced during the current study can be 
addressed in the future.  
In matrix compositional modification experiments, ACM prepared by TGF-ȕ induction 
in HS-5 cells, although the ECM content and quality was improved, it did not show 
significant level of HSPC expansion. We are not sure whether the negative regulatory action 
was imposed directly by exogenously added TGF- ȕ or by the components of the ECM that 
was synthesized by induction with TGF- ȕ. In future a more detail study for understanding 
the mechanism underlying the TGF- ȕ mediated HSPC expansion can be performed. 
The data obtained from the molecular profiling suggest a defect in the integrin signaling 
and focal adhesion process in HS-5 cells at lower oxygen condition. Our preliminary results 
obtained through immunostaining for various integrin subunits and regulators of focal 
adhesion also support similar outcome. For a broader understanding of the effects of O2 on 
the important components of cell-cell, cell-ECM interaction can be obtained by additional 
qualitative and quantitative assays such as western blotting. 
We would like to study molecular profile of HS-5 stromal cell specific proteoglycans 
that is one of the most important ECM components. The growth and differentiation of HSC is 
supported by proteoglycans such as heparan sulfate (HS) which has been reported to be 
involved in the interaction of HSC to stromal cells[253]. It has been observed that HS 
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secreted into solution by the stromal cells has the capacity to support hematopoietic cytokines 
in the maintenance and HSC expansion. We initiated the study on the characterization of 
different proteoglycans from HS-5 cells. 
The preliminary results show that we were successful in extracting the HS-5 stromal cell 
specific proteoglycans using two different extraction protocols 1) Guanidin HCL based 
extraction 2) Papain based extraction. We have also quantified the total amount and 
concentrations of proteoglycans in HS-5 stromal cells and also in decellularized matrices, to 
see how the amount of proteoglycans retained in decellularized material affects the HSPC 
expansion. Molecular characterizations of proteoglycans content of HS-5 cells were 
performed by immunostaining for heparan sulfate, perlecan and CD44 antibody. An 
expression profiling by PCR was done for a set of proteoglycans gene such as biglycan, 
glyipcan-3, versican, decorin, syndecan-1, syndecan-4, agrin, CD44, aggrecan. Mass 
spectrometry analysis was also performed to identify key proteoglycans molecules involved 
of HS-5 stromal microenvironment. 
In mass spectrometry the sugars attached to the protein core of the proteoglycans were 
detected. Based on the molecular weight of the peaks obtained, it was found that the sugars 
were expressed as moieties in the increasing order starting from 1 sugar to 5 sugars. In future, 
we would like improve the extraction and characterization protocols for complete 
characterization of proteoglycans specifically present in HS-5 stromal microenvironment.
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Appendix III-Umbilical cord blood processing data sheet 
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Appendix IV-HS-5 RNA quantitative and qualitative assessment 
YƵĂŶƚŝƚĂƚŝǀĞĂƐƐĞƐƐŵĞŶƚŽĨ,^ͲϱZE
Ǧ 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
HS-5 5% O2
ng/μl 
260/280 
ratio 
HS-5 5% O2 2183.0 2.1 
HS-5 5% O2 1979.8 2.11 
HS-5 5% O2 2081.4 2.1 
HS-20% O2
ng /μl 
260/280 
ratio 
HS-20% O2 1285.6 2.1 
HS-20% O2 1483.6 2.11 
HS-20% O2 1384.6 2.1 
YƵĂůŝƚĂƚŝǀĞĂƐƐĞƐƐŵĞŶƚŽĨ,^ͲϱZEŝŶŝŽĂŶĂůǇǌĞƌ
MX3- 5% O2 HS-5 cells, MX4- 20% O2 HS-5 cells, 
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Appendix V-Representative dot plots  
  
A) FACS compensation controls B) Representative dot plot of cells pre-expansion UCB 
derived CD34+ cells stained with set of markers such as CD34+PE CD45+FITC , CD34+PE 
CD38-FITC, CD133+PE CD 34+ FITC. 
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Appendix VI-Representative FACS dot plot  
Post expansion analysis-Representative dot-plot of three different lineage markers to 
assess the level of expansion of HSPC on HS-5 ACM of two different O2 conditions and 
controls. Dot-plot shows the percentage of cells, expanded on ACM expressing specific 
markers CD34+PE CD45+FITC, CD34+PE CD38-FITC, and CD133+PE CD34+FITC. 
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Appendix VII-Representative FACS dot plot  
Post expansion analysis-Representative dot-plot for three different lineage markers to 
assess the level of HSPC expansion on biochemically modified HS-5 ACM of 20% O2
condition, native ACM Dot-plot shows the percentage of cells, expanded on various modified 
ACMs expressing specific markers CD34+PE CD45+FITC, CD34+PE CD38-FITC, and 
CD133+PE CD34+FITC. 
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Appendix VIII-Representative FACS dot plot  
Post expansion analysis-Representative dot-plot for three different lineage markers to 
assess the level of HSPC expansion on biochemically modified HS-5 ACM of 5% O2
condition, native ACM Dot-plot shows the percentage of cell expanded on various ACMs 
expressing specific markers CD34+PE CD45+FITC, CD34+PE CD38-FITC, and CD133+PE 
CD34+FITC. 
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Appendix IX-Representative FACS dot plot  
Post expansion analysis-Representative dot-plot for three different lineage markers to 
assess the expansion of HSPC on Spin coated HS-5 ACM, native ACM and control. Dot-plot 
shows the percentage of cells expanded on native and spin coated ACMs expressing specific 
markers CD34+PE CD45+FITC, CD34+PE CD38-FITC, and CD133+PE CD34+FITC. 
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Appendix –X- Representative images of HSPC expansion  
UCB CD34+ cells expanded on A) TCP, B) native ACM, C) Spin coated ACM 
Appendix –XV1 
Colony forming unit -cells 
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Appendix XI List of gene transcriptionally active in the top 10 most significant up 
regulated pathways in HS-5 cells of 20% O2 condition 
Enrichment analysis report
Enrichment by GeneGo 
Pathway Maps 
 (1) meta core final 
input data file  
HS-5 CELL 
20% O2 
# Maps Total PValue FDR In Data Genes from Active Data 
1 
Immune response_IFN 
alpha/beta signaling 
pathway
24 2.898E-
09 
5.833E+00 10 IRF2, STAT2, IRF9, ISG15, 
ISGF3, ISG54, STAT1, IFNAR2, 
STAT1/STAT2, SOCS1 
2 
Cell 
adhesion_Chemokines 
and adhesion
100 3.022E-
07 
4.116E+00 16 Shc, GRO-1, Caveolin-1, 
Collagen IV, GCP2, Vinculin, 
Thrombospondin 1, PLAT (TPA), 
Fibronectin, Tcf(Lef), c-Myc, 
Actin, Flotillin-2, LAMA4, 
Collagen I, MMP-2 
3 
Cell adhesion_ECM 
remodeling
52 1.294E-
06 
3.785E+00 11 Collagen IV, IBP4, TIMP2, PLAT 
(TPA), Fibronectin, Nidogen, 
Osteonectin, LAMA4, Collagen I, 
MMP-2, Collagen III 
4 
Immune 
response_Antiviral 
actions of Interferons
52 1.294E-
06 
3.785E+00 11 OAS1, MxA, STAT2, OAS3, 
IRF9, WARS, OAS2, PKR, 
ISGF3, 2'-5'-oligoadenylate 
synthetase, STAT1 
5 
Cytoskeleton 
remodeling_TGF, WNT 
and cytoskeletal 
remodeling
111 6.339E-
06 
3.192E+00 15 Shc, Caveolin-1, Collagen IV, 
Vinculin, PLAT (TPA), 
Fibronectin, MYLK1, Tcf(Lef), c-
Myc, Actin, p38 MAPK, MLCK, 
MRLC, TCF7L2 (TCF4), Frizzled 
6 
Development_Regulation 
of epithelial-to-
mesenchymal transition 
(EMT)
64 1.097E-
05 
3.033E+00 11 IL-1RI, Tropomyosin-1, PDGF-R-
alpha, TNF-R1, TGF-beta 3, 
Fibronectin, Frizzled, EDNRA, 
SIP1 (ZFHX1B), PDGF-R-beta, 
MMP-2 
7 
Cytoskeleton 
remodeling_Cytoskeleton 
remodeling
102 4.965E-
05 
2.444E+00 13 Shc, Caveolin-1, Collagen IV, 
Vinculin, PLAT (TPA), 
Fibronectin, MYLK1, Tcf(Lef), c-
Myc, p38 MAPK, MLCK, 
MRLC, Collagen I 
8 
Development_PDGF 
signaling via STATs and 
NF-kB
32 9.262E-
05 
2.231E+00 7 Shc, PDGF-R-alpha, PDGF 
receptor, PKR, c-Myc, STAT1, 
PDGF-R-beta 
9 
Immune 
response_Antigen 
presentation by MHC 
class I
28 3.361E-
04 
1.723E+00 6 PSMD1, PSMB8(LMP7), HSP90, 
PSME2, PSME1, TAP2 (PSF2) 
10 
Immune response _IFN 
gamma signaling 
pathway
54 5.108E-
04 
1.587E+00 8 IRF9, PKR, c-Myc, ISGF3, p38 
MAPK, AFAP, STAT1, SOCS1 
ƉƉĞŶĚŝǆ
Ϯϭϳ

Appendix XII Important network pathways in HS-5 cells of 20% O2 condition 
Cell adhesion and chemokine adhesion 

Cell adhesion and chemokine adhesion is the second scored map (map with the second 
lowest p-value) based on the enrichment distribution sorted by “Statistically significant 
Maps” in HS-5 cells of 20% O2 condition. The network pathway represented above show 
thermometer-like figures. Up-ward thermometers have red color and indicate up-regulated 
signals and down-ward (blue) ones indicate down-regulated expression levels of the genes in 
the cell adhesion and chemokine adhesion network or pathway in HS-5 cells of 20% O2
condition. 
ƉƉĞŶĚŝǆ
Ϯϭϴ

Cytoskeleton remodeling_TGF, WNT and cytoskeletal remodeling 
Cytoskeleton remodeling_TGF, WNT and cytoskeletal remodeling was the fifth scored 
map (map with the fifth lowest p-value) based on the enrichment distribution sorted by 
'Statistically significant Maps' set in HS-5 cells of 20% O2 condition. Up-ward thermometers 
have red color and indicate up-regulated signals and down-ward (blue) ones indicate 
down-regulated expression levels of the genes involved in Cytoskeleton remodeling_TGF, 
WNT and cytoskeletal remodeling network or pathway in HS-5 cells of 20% O2
ƉƉĞŶĚŝǆ
Ϯϭϵ

Appendix XIII List of gene transcriptionally active in the top 10 most significant up 
regulated pathways in HS-5 cells of 5% O2 condition 
Enrichment analysis report
Enrichment by GeneGo Pathway Maps HS-5 cells 5% O2 condition 
# Maps Total pValue In 
Data 
Genes from Active Data 
1 Transcription_Role of Akt in 
hypoxia induced HIF1 
activation
27 9.096E-
07 
8 VEGF-A, GLUT1, NCOA1 (SRC1), ALDOA, 
p300, HSP70, PGK1, NIP3 
2 Development_Glucocorticoid 
receptor signaling
24 5.060E-
06 
7 NCOA1 (SRC1), HSP90, GCR-alpha, p300, 
SUMO-1, HSP70, GCR-beta 
3 Signal transduction_Erk 
Interactions: Inhibition of Erk
34 6.178E-
06 
8 PKA-reg (cAMP-dependent), PP2A catalytic, 
ERK2 (MAPK1), PTPRR, PEA15, VHR, 
ERK1/2, MKP-1 
4 Regulation of CFTR activity 
(norm and CF)
58 8.476E-
06 
10 PRKAR2A, PP2A regulatory, PKA-reg type II 
(cAMP-dependent), PKA-reg (cAMP-
dependent), PP2C, PP2A catalytic, S100A10, 
Filamin B (TABP), PP2A structural, Adenylate 
cyclise 
5 Cholesterol Biosynthesis 89 1.491E-
05 
12 CYP51A1, SC5D, SC4MOL, FDFT1, 
HMGCS1, MVD, LSS, ERG1, DHCR7, 
HMDH, NSDHL, DHC24 
6 PGE2 pathways in cancer 55 3.730E-
05 
9 ABCC4, VEGF-A, PKA-reg (cAMP-
dependent), TGF-alpha, ERK2 (MAPK1), 
EGFR, ERK1 (MAPK3), Axin, Adenylate 
cyclise 
7 Transcription_Role of 
heterochromatin protein 1 (HP1) 
family in transcriptional 
silencing
22 3.780E-
05 
6 Axin2, HDAC9, MEF2, Histone H3, Histone 
deacetylase class II, 14-3-3 
8 Signal transduction_Activin A 
signaling regulation
33 4.935E-
05 
7 ALK-4, Ubiquitin, Histone H3, p300, 
SMAD7, Histone H2, BAMBI 
9 Apoptosis and survival_HTR1A 
signaling
50 1.197E-
04 
8 PP2A regulatory, PKA-reg (cAMP-
dependent), PP2A catalytic, ERK2 (MAPK1), 
PP2A structural, ERK1 (MAPK3), Adenylate 
cyclase, Bcl-2 
10 Immune response_Function of 
MEF2 in T lymphocytes
50 1.197E-
04 
8 HDAC9, MEF2D, ERK5 (MAPK7), 
MEF2, p300, MAP2K5 (MEK5), IP3 receptor, 
14-3-3 
ƉƉĞŶĚŝǆ
ϮϮϬ

Appendix XIV- Important network pathways in HS-5 cells of 20% O2 condition 
Transcription role of Akt in hypoxia induced HIF1 
Transcription role of Akt in hypoxia induced HIF1 activation was the top scored map 
(map with the the lowest p-value) based on the enrichment distribution sorted by 'Statistically 
significant Maps' set in HS-5 cells of 5% O2 condition. Up-ward thermometers have red color 
and indicate up-regulated signals and down-ward (blue) ones indicate down-regulated 
expression levels of the genes involved in transcription role of Akt in hypoxia induced HIF1 
activation network or pathway in HS-5 cells of 5% O2 condition. 
ƉƉĞŶĚŝǆ
ϮϮϭ

Signal transduction_Erk Interactions: Inhibition of Erk 
Signal transduction_Erk Interactions: Inhibition of Erk was the third scored map (map 
with the third lowest p-value) based on the enrichment distribution sorted by 'Statistically 
significant Maps' set in HS-5 cells of 5% O2 condition. Up-ward thermometers have red color 
and indicate up-regulated signals and down-ward (blue) ones indicate down-regulated 
expression levels of the genes involved in Signal transduction Erk Interactions and inhibition 
of Erk signaling in HS-5 cells of 5% O2 condition.
ƉƉĞŶĚŝǆ
ϮϮϴ

Appendix –XV-list of proteolytic enzymes, molecules, proteases and peptidases up 
regulated in HS-5 cell of 5% O2 condition 
Annotation 
Cluster 190
Enrichment Score: 
0.19219087079573918
Category Term Count PValue Genes Fold 
Enrichment
UP_SEQ_
FEATURE 
short sequence 
motif:Cysteine 
switch
4 0.2606963 MMP10, 
ADAMTS1, 
ADAMTS5, MMP25
2.253426
GOTERM_
MF_FAT 
GO:0008234~cystein
e-type peptidase 
activity 
8 0.44469207 SENP2, BRCC3, 
ATG4D, MALT1, 
USP36, CTSS, 
TNFAIP3, VCPIP1
1.265677
SP_PIR_
KEYWORD
S
thiol protease 6 0.59333215 SENP2, ATG4D, 
USP36, CTSS, 
TNFAIP3, VCPIP1
1.159433
SP_PIR_
KEYWORD
S 
extracellular matrix 10 0.66007399
3 
MMP10, COL13A1, 
COL6A3, CRTAP, 
SFTPD, ADAMTS1, 
EMILIN2, 
ADAMTS5, 
MMP25, ANGPTL4
1.010295
SP_PIR_
KEYWORD
S 
metalloprotease 6 0.74687736
9 
MMP10, BRCC3, 
C21ORF57, 
ADAMTS1, 
ADAMTS5, MMP25
0.967474
INTERPRO IPR006025:Peptidase 
M, neutral zinc 
metallopeptidases, 
zinc-binding site 
4 0.78541145
9 
MMP10, 
ADAMTS1, 
ADAMTS5, MMP25 
0.970804
GOTERM_
MF_FAT 
GO:0008237~metall
opeptidase activity 
7 0.83359293
9 
MMP10, BRCC3, 
C21ORF57, 
ADAMTS1, RCE1, 
ADAMTS5, MMP25
0.853295
SP_PIR_
KEYWORD
S 
cleavage on pair of 
basic residues 
7 0.96848752
8 
PAM, UCN, 
CARTPT, SCG5, 
ADAMTS1, 
ADAMTS5, MMP25
0.628918
SP_PIR_
KEYWORD
S 
Protease 13 0.98021135
4 
BRCC3, MALT1, 
CTSS, MMP25, 
SENP2, MMP10, 
ATG4D, C21ORF57, 
ADAMTS1, USP36, 
TNFAIP3, 
ADAMTS5, VCPIP1
0.653978
GOTERM_
MF_FAT 
GO:0070011~peptid
ase activity, acting 
on L-amino acid 
peptides 
16 0.98788847
3 
NRIP3, BRCC3, 
RCE1, MALT1, 
CTSS, MMP25, 
SENP2, MMP10, 
ATG4D, CRBN, 
C21ORF57, 
ADAMTS1, USP36, 
0.650129
ƉƉĞŶĚŝǆ
ϮϮϵ

TNFAIP3, 
ADAMTS5, VCPIP1 
GOTERM_
MF_FAT 
GO:0008233~peptid
ase activity 
16 0.99321434
6 
NRIP3, BRCC3, 
RCE1, MALT1, 
CTSS, MMP25, 
SENP2, MMP10, 
ATG4D, CRBN, 
C21ORF57, 
ADAMTS1, USP36, 
TNFAIP3, 
ADAMTS5, VCPIP1
0.621814
ZĞĨĞƌĞŶĐĞƐ
ϮϯϬ

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ƉŚǇƐŝŽůŽŐǇ͘ϭϵϳϬ͖ϳϲ͗ϳϳͲϴϰ͘
΀ϭϳ΁ŽƵůŽŵďĞů>͘/ĚĞŶƚŝĨŝĐĂƚŝŽŶŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵͬƉƌŽŐĞŶŝƚŽƌĐĞůůƐ͗ƐƚƌĞŶŐƚŚĂŶĚĚƌĂǁďĂĐŬƐŽĨ
ĨƵŶĐƚŝŽŶĂůĂƐƐĂǇƐ͘KŶĐŽŐĞŶĞ͘ϮϬϬϰ͖Ϯϯ͗ϳϮϭϬͲϮϮ͘
΀ϭϴ΁ DŽŶĞƚƚĞ &͕ ^ŝŐŽƵŶĂƐ '͘ ^ĞŶƐŝƚŝǀŝƚǇ ŽĨ ŵƵƌŝŶĞ ŵƵůƚŝƉŽƚĞŶƚŝĂů ƐƚĞŵ ĐĞůů ĐŽůŽŶǇ ;&hͲ'DDͿ
ŐƌŽǁƚŚƚŽŝŶƚĞƌůĞƵŬŝŶͲϯ͕ĞƌǇƚŚƌŽƉŽŝĞƚŝŶ͕ĂŶĚŚĞŵŝŶ͘ǆƉĞƌŝŵĞŶƚĂůŚĞŵĂƚŽůŽŐǇ͘ϭϵϴϳ͖ϭϱ͗ϳϮϵͲϯϰ͘
΀ϭϵ΁ <ŝŵƵƌĂ ,͕ ƵƌƐƚĞŝŶ ^͕ dŚŽƌŶŝŶŐ ͕ WŽǁĞůů :^͕ ,ĂƌŬĞƌ >͕ &ŝĂůŬŽǁ W:͕ Ğƚ Ăů͘ ,ƵŵĂŶ
ŵĞŐĂŬĂƌǇŽĐǇƚŝĐ ƉƌŽŐĞŶŝƚŽƌƐ ;&hͲDͿ ĂƐƐĂǇĞĚ ŝŶ ŵĞƚŚǇůĐĞůůƵůŽƐĞ͗ ƉŚǇƐŝĐĂů ĐŚĂƌĂĐƚĞƌŝƐƚŝĐƐ ĂŶĚ
ƌĞƋƵŝƌĞŵĞŶƚƐĨŽƌŐƌŽǁƚŚ͘:ŽƵƌŶĂůŽĨĐĞůůƵůĂƌƉŚǇƐŝŽůŽŐǇ͘ϭϵϴϰ͖ϭϭϴ͗ϴϳͲϵϲ͘
΀ϮϬ΁ƌŽƵĚǇs͕ >ŝŶE>͕ &ŽǆE͕ dĂŐĂd͕ ^ĂŝƚŽD͕<ĂƵƐŚĂŶƐŬǇ<͘dŚƌŽŵďŽƉŽŝĞƚŝŶ ƐƚŝŵƵůĂƚĞƐ ĐŽůŽŶǇͲ
ĨŽƌŵŝŶŐ ƵŶŝƚͲŵĞŐĂŬĂƌǇŽĐǇƚĞ ƉƌŽůŝĨĞƌĂƚŝŽŶ ĂŶĚ ŵĞŐĂŬĂƌǇŽĐǇƚĞ ŵĂƚƵƌĂƚŝŽŶ ŝŶĚĞƉĞŶĚĞŶƚůǇ ŽĨ
ĐǇƚŽŬŝŶĞƐƚŚĂƚƐŝŐŶĂůƚŚƌŽƵŐŚƚŚĞŐƉϭϯϬƌĞĐĞƉƚŽƌƐƵďƵŶŝƚ͘ůŽŽĚ͘ϭϵϵϲ͖ϴϴ͗ϮϬϮϲͲϯϮ͘
΀Ϯϭ΁dŝůů:͕DĐ͘ĚŝƌĞĐƚŵĞĂƐƵƌĞŵĞŶƚŽĨƚŚĞƌĂĚŝĂƚŝŽŶƐĞŶƐŝƚŝǀŝƚǇŽĨŶŽƌŵĂůŵŽƵƐĞďŽŶĞŵĂƌƌŽǁ
ĐĞůůƐ͘ZĂĚŝĂƚŝŽŶƌĞƐĞĂƌĐŚ͘ϭϵϲϭ͖ϭϰ͗ϮϭϯͲϮϮ͘
΀ϮϮ΁ ^ŝŵŝŶŽǀŝƚĐŚ >͕DĐƵůůŽĐŚ ͕ dŝůů :͘ dŚĞ ŝƐƚƌŝďƵƚŝŽŶ ŽĨ ŽůŽŶǇͲ&ŽƌŵŝŶŐ ĞůůƐ ĂŵŽŶŐ ^ƉůĞĞŶ
ŽůŽŶŝĞƐ͘:ŽƵƌŶĂůŽĨĐĞůůƵůĂƌƉŚǇƐŝŽůŽŐǇ͘ϭϵϲϯ͖ϲϮ͗ϯϮϳͲϯϲ͘
ZĞĨĞƌĞŶĐĞƐ
ϮϯϮ

΀Ϯϯ΁^ǌŝůǀĂƐƐǇ^:͕,ƵŵƉŚƌŝĞƐZ<͕>ĂŶƐĚŽƌƉWD͕ĂǀĞƐ͕ĂǀĞƐ:͘YƵĂŶƚŝƚĂƚŝǀĞĂƐƐĂǇĨŽƌƚŽƚŝƉŽƚĞŶƚ
ƌĞĐŽŶƐƚŝƚƵƚŝŶŐŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐďǇĂĐŽŵƉĞƚŝƚŝǀĞƌĞƉŽƉƵůĂƚŝŽŶƐƚƌĂƚĞŐǇ͘WƌŽĐĞĞĚŝŶŐƐŽĨƚŚĞ
EĂƚŝŽŶĂůĐĂĚĞŵǇŽĨ^ĐŝĞŶĐĞƐŽĨƚŚĞhŶŝƚĞĚ^ƚĂƚĞƐŽĨŵĞƌŝĐĂ͘ϭϵϵϬ͖ϴϳ͗ϴϳϯϲͲϰϬ͘
΀Ϯϰ΁ ^ĐŚŽĨŝĞůĚ Z͘ dŚĞ ƌĞůĂƚŝŽŶƐŚŝƉ ďĞƚǁĞĞŶ ƚŚĞ ƐƉůĞĞŶ ĐŽůŽŶǇͲĨŽƌŵŝŶŐ ĐĞůů ĂŶĚ ƚŚĞ ŚĂĞŵŽƉŽŝĞƚŝĐ
ƐƚĞŵĐĞůů͘ůŽŽĚĞůůƐ͘ϭϵϳϴ͖ϰ͗ϳͲϮϱ͘
΀Ϯϱ΁ƐŬŵǇƌD͕YƵĂĐŚ:͕WƵƌƚŽŶ>͘ĨĨĞĐƚƐŽĨƚŚĞďŽŶĞŵĂƌƌŽǁŵŝĐƌŽĞŶǀŝƌŽŶŵĞŶƚŽŶŚĞŵĂƚŽƉŽŝĞƚŝĐ
ŵĂůŝŐŶĂŶĐǇ͘ŽŶĞ͘ϮϬϭϭ͖ϰϴ͗ϭϭϱͲϮϬ͘
΀Ϯϲ΁ŝĂŶĐŽW͕ZŝŵŝŶƵĐĐŝD͕'ƌŽŶƚŚŽƐ^͕ZŽďĞǇW'͘ŽŶĞŵĂƌƌŽǁƐƚƌŽŵĂůƐƚĞŵĐĞůůƐ͗ŶĂƚƵƌĞ͕ďŝŽůŽŐǇ͕
ĂŶĚƉŽƚĞŶƚŝĂůĂƉƉůŝĐĂƚŝŽŶƐ͘^ƚĞŵĐĞůůƐ͘ϮϬϬϭ͖ϭϵ͗ϭϴϬͲϵϮ͘
΀Ϯϳ΁ dƌĂǀůŽƐ '^͘ EŽƌŵĂů ƐƚƌƵĐƚƵƌĞ͕ ĨƵŶĐƚŝŽŶ͕ ĂŶĚ ŚŝƐƚŽůŽŐǇ ŽĨ ƚŚĞ ďŽŶĞ ŵĂƌƌŽǁ͘ dŽǆŝĐŽůŽŐŝĐ
ƉĂƚŚŽůŽŐǇ͘ϮϬϬϲ͖ϯϰ͗ϱϰϴͲϲϱ͘
΀Ϯϴ΁ dĂŬĂŐŝ D͕ WĂƌŵůĞǇ Zd͕ dŽĚĂ z͕ ĞŶǇƐ &Z͘ hůƚƌĂƐƚƌƵĐƚƵƌĂů ĐǇƚŽĐŚĞŵŝƐƚƌǇ ŽĨ ĐŽŵƉůĞǆ
ĐĂƌďŽŚǇĚƌĂƚĞƐŝŶŽƐƚĞŽďůĂƐƚƐ͕ŽƐƚĞŽŝĚ͕ĂŶĚďŽŶĞŵĂƚƌŝǆ͘ĂůĐŝĨŝĞĚƚŝƐƐƵĞŝŶƚĞƌŶĂƚŝŽŶĂů͘ϭϵϴϯ͖ϯϱ͗ϯϬϵͲ
ϭϵ͘
΀Ϯϵ΁ dƌĂŶ :͕ ƌĞŶŶĞƌ d:͕ ŝEĂƌĚŽ ^͘ ^ŽŵĂƚŝĐ ĐŽŶƚƌŽů ŽǀĞƌ ƚŚĞ ŐĞƌŵůŝŶĞ ƐƚĞŵ ĐĞůů ůŝŶĞĂŐĞ ĚƵƌŝŶŐ
ƌŽƐŽƉŚŝůĂƐƉĞƌŵĂƚŽŐĞŶĞƐŝƐ͘EĂƚƵƌĞ͘ϮϬϬϬ͖ϰϬϳ͗ϳϱϰͲϳ͘
΀ϯϬ΁yŝĞd͕^ƉƌĂĚůŝŶŐ͘ŶŝĐŚĞŵĂŝŶƚĂŝŶŝŶŐŐĞƌŵůŝŶĞƐƚĞŵĐĞůůƐ ŝŶƚŚĞƌŽƐŽƉŚŝůĂŽǀĂƌǇ͘^ĐŝĞŶĐĞ͘
ϮϬϬϬ͖ϮϵϬ͗ϯϮϴͲϯϬ͘
΀ϯϭ΁ <ŝŐĞƌ ͕ :ŽŶĞƐ >͕ ^ĐŚƵůǌ ͕ ZŽŐĞƌƐ D͕ &ƵůůĞƌ Dd͘ ^ƚĞŵ ĐĞůů ƐĞůĨͲƌĞŶĞǁĂů ƐƉĞĐŝĨŝĞĚ ďǇ
:<ąΦ͞^ddĂĐƚŝǀĂƚŝŽŶŝŶƌĞƐƉŽŶƐĞƚŽĂƐƵƉƉŽƌƚĐĞůůĐƵĞ͘^ĐŝĞŶĐĞ͘ϮϬϬϭ͖Ϯϵϰ͗ϮϱϰϮͲϱ͘
΀ϯϮ΁ zĂŵĂƐŚŝƚĂ zD͕ :ŽŶĞƐ>͕ &ƵůůĞƌDd͘KƌŝĞŶƚĂƚŝŽŶ ŽĨ ĂƐǇŵŵĞƚƌŝĐ ƐƚĞŵ ĐĞůů ĚŝǀŝƐŝŽŶ ďǇ ƚŚĞW
ƚƵŵŽƌƐƵƉƉƌĞƐƐŽƌĂŶĚĐĞŶƚƌŽƐŽŵĞ͘^ĐŝĞŶĐĞ͘ϮϬϬϯ͖ϯϬϭ͗ϭϱϰϳͲϱϬ͘
΀ϯϯ΁^ŽŶŐy͕yŝĞd͘ͲĐĂĚŚĞƌŝŶͲŵĞĚŝĂƚĞĚĐĞůůĂĚŚĞƐŝŽŶŝƐĞƐƐĞŶƚŝĂůĨŽƌŵĂŝŶƚĂŝŶŝŶŐƐŽŵĂƚŝĐƐƚĞŵĐĞůůƐ
ŝŶƚŚĞƌŽƐŽƉŚŝůĂŽǀĂƌǇ͘WƌŽĐEĂƚůĐĂĚ^Đŝh^͘ϮϬϬϮ͖ϵϵ͗ϭϰϴϭϯͲϴ͘
΀ϯϰ΁ ^ŽŶŐ y͕ ŚƵ ,͕ ŽĂŶ ͕ yŝĞ d͘ 'ĞƌŵůŝŶĞ ƐƚĞŵ ĐĞůůƐ ĂŶĐŚŽƌĞĚ ďǇ ĂĚŚĞƌĞŶƐ ũƵŶĐƚŝŽŶƐ ŝŶ ƚŚĞ
ƌŽƐŽƉŚŝůĂŽǀĂƌǇŶŝĐŚĞƐ͘^ĐŝĞŶĐĞ͘ϮϬϬϮ͖Ϯϵϲ͗ϭϴϱϱͲϳ͘
΀ϯϱ΁ tŝůƐŽŶ ͕ dƌƵŵƉƉ ͘ ŽŶĞͲŵĂƌƌŽǁ ŚĂĞŵĂƚŽƉŽŝĞƚŝĐͲƐƚĞŵͲĐĞůů ŶŝĐŚĞƐ͘ EĂƚƵƌĞ ƌĞǀŝĞǁƐ
/ŵŵƵŶŽůŽŐǇ͘ϮϬϬϲ͖ϲ͗ϵϯͲϭϬϲ͘
΀ϯϲ΁ DŽƌƌŝƐŽŶ ^:͕ ^ƉƌĂĚůŝŶŐ ͘ ^ƚĞŵ ĐĞůůƐ ĂŶĚ ŶŝĐŚĞƐ͗ ŵĞĐŚĂŶŝƐŵƐ ƚŚĂƚ ƉƌŽŵŽƚĞ ƐƚĞŵ ĐĞůů
ŵĂŝŶƚĞŶĂŶĐĞƚŚƌŽƵŐŚŽƵƚůŝĨĞ͘Ğůů͘ϮϬϬϴ͖ϭϯϮ͗ϱϵϴͲϲϭϭ͘
΀ϯϳ΁Ăůǀŝ>D͕ĚĂŵƐ'͕tĞŝďƌĞĐŚƚ<t͕tĞďĞƌ:D͕KůƐŽŶW͕<ŶŝŐŚƚD͕ĞƚĂů͘KƐƚĞŽďůĂƐƚŝĐĐĞůůƐ
ƌĞŐƵůĂƚĞƚŚĞŚĂĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůŶŝĐŚĞ͘EĂƚƵƌĞ͘ϮϬϬϯ͖ϰϮϱ͗ϴϰϭͲϲ͘
΀ϯϴ΁ƌĂŝ &͕ zŽƐŚŝŚĂƌĂ,͕,ŽƐŽŬĂǁĂ<͕EĂŬĂŵƵƌĂz͕'ŽŵĞŝ z͕ /ǁĂƐĂŬŝ,͕ Ğƚ Ăů͘EŝĐŚĞ ƌĞŐƵůĂƚŝŽŶŽĨ
ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůůƐ ŝŶ ƚŚĞ ĞŶĚŽƐƚĞƵŵ͘ ŶŶĂůƐ ŽĨ ƚŚĞ EĞǁ zŽƌŬ ĐĂĚĞŵǇ ŽĨ ^ĐŝĞŶĐĞƐ͘
ϮϬϬϵ͖ϭϭϳϲ͗ϯϲͲϰϲ͘
΀ϯϵ΁ ,ŽƐŽŬĂǁĂ <͕ ƌĂŝ &͕ zŽƐŚŝŚĂƌĂ ,͕ /ǁĂƐĂŬŝ ,͕ EĂŬĂŵƵƌĂ z͕ 'ŽŵĞŝ z͕ Ğƚ Ăů͘ <ŶŽĐŬĚŽǁŶ ŽĨ EͲ
ĐĂĚŚĞƌŝŶƐƵƉƉƌĞƐƐĞƐƚŚĞ ůŽŶŐͲƚĞƌŵĞŶŐƌĂĨƚŵĞŶƚŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͘ůŽŽĚ͘ϮϬϭϬ͖ϭϭϲ͗ϱϱϰͲ
ϲϯ͘
΀ϰϬ΁ ƚĞƌ ,ƵƵƌŶĞ D͕ &ŝŐĚŽƌ '͕ dŽƌĞŶƐŵĂ Z͘ ,ĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůůƐ ĂƌĞ ĐŽŽƌĚŝŶĂƚĞĚ ďǇ ƚŚĞ
ŵŽůĞĐƵůĂƌĐƵĞƐŽĨƚŚĞĞŶĚŽƐƚĞĂůŶŝĐŚĞ͘^ƚĞŵĐĞůůƐĂŶĚĚĞǀĞůŽƉŵĞŶƚ͘ϮϬϭϬ͖ϭϵ͗ϭϭϯϭͲϰϭ͘
΀ϰϭ΁ƌĂŝ&͕,ŝƌĂŽ͕KŚŵƵƌĂD͕^ĂƚŽ,͕DĂƚƐƵŽŬĂ^͕dĂŬƵďŽ<͕ĞƚĂů͘dŝĞϮͬĂŶŐŝŽƉŽŝĞƚŝŶͲϭƐŝŐŶĂůŝŶŐ
ƌĞŐƵůĂƚĞƐŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƋƵŝĞƐĐĞŶĐĞŝŶƚŚĞďŽŶĞŵĂƌƌŽǁŶŝĐŚĞ͘Ğůů͘ϮϬϬϰ͖ϭϭϴ͗ϭϰϵͲϲϭ͘
΀ϰϮ΁ zŽƐŚŝŚĂƌĂ ,͕ ƌĂŝ &͕ ,ŽƐŽŬĂǁĂ <͕ ,ĂŐŝǁĂƌĂ d͕ dĂŬƵďŽ <͕ EĂŬĂŵƵƌĂ z͕ Ğƚ Ăů͘
dŚƌŽŵďŽƉŽŝĞƚŝŶͬDW> ƐŝŐŶĂůŝŶŐ ƌĞŐƵůĂƚĞƐ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůů ƋƵŝĞƐĐĞŶĐĞĂŶĚ ŝŶƚĞƌĂĐƚŝŽŶǁŝƚŚ
ƚŚĞŽƐƚĞŽďůĂƐƚŝĐŶŝĐŚĞ͘ĞůůƐƚĞŵĐĞůů͘ϮϬϬϳ͖ϭ͗ϲϴϱͲϵϳ͘
΀ϰϯ΁^ƵŐŝǇĂŵĂd͕<ŽŚĂƌĂ,͕EŽĚĂD͕EĂŐĂƐĂǁĂd͘DĂŝŶƚĞŶĂŶĐĞŽĨƚŚĞŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƉŽŽů
ďǇy>ϭϮͲyZϰĐŚĞŵŽŬŝŶĞƐŝŐŶĂůŝŶŐŝŶďŽŶĞŵĂƌƌŽǁƐƚƌŽŵĂůĐĞůůŶŝĐŚĞƐ͘/ŵŵƵŶŝƚǇ͘ϮϬϬϲ͖Ϯϱ͗ϵϳϳͲ
ϴϴ͘
΀ϰϰ΁zĂŵĂǌĂŬŝ^͕ /ǁĂŵĂ͕dĂŬĂǇĂŶĂŐŝ^͕ƚŽ<͕ŵĂ,͕EĂŬĂƵĐŚŝ,͘d'&ͲďĞƚĂĂƐĂĐĂŶĚŝĚĂƚĞďŽŶĞ
ŵĂƌƌŽǁŶŝĐŚĞƐŝŐŶĂůƚŽŝŶĚƵĐĞŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůŚŝďĞƌŶĂƚŝŽŶ͘ůŽŽĚ͘ϮϬϬϵ͖ϭϭϯ͗ϭϮϱϬͲϲ͘
ZĞĨĞƌĞŶĐĞƐ
Ϯϯϯ

΀ϰϱ΁ZŝǌŽ͕sĞůůĞŶŐĂ͕ĚĞ,ĂĂŶ'͕^ĐŚƵƌŝŶŐĂ::͘^ŝŐŶĂůŝŶŐƉĂƚŚǁĂǇƐŝŶƐĞůĨͲƌĞŶĞǁŝŶŐŚĞŵĂƚŽƉŽŝĞƚŝĐ
ĂŶĚůĞƵŬĞŵŝĐƐƚĞŵĐĞůůƐ͗ĚŽĂůůƐƚĞŵĐĞůůƐŶĞĞĚĂŶŝĐŚĞ͍,ƵŵĂŶŵŽůĞĐƵůĂƌŐĞŶĞƚŝĐƐ͘ϮϬϬϲ͖ϭϱ^ƉĞĐEŽ
Ϯ͗ZϮϭϬͲϵ͘
΀ϰϲ΁DĂůŚŽƚƌĂ^͕<ŝŶĐĂĚĞWt͘ĂŶŽŶŝĐĂůtŶƚƉĂƚŚǁĂǇ ƐŝŐŶĂůŝŶŐ ƐƵƉƉƌĞƐƐĞƐsDͲϭĞǆƉƌĞƐƐŝŽŶďǇ
ŵĂƌƌŽǁƐƚƌŽŵĂůĂŶĚŚĞŵĂƚŽƉŽŝĞƚŝĐĐĞůůƐ͘ǆƉĞƌŝŵĞŶƚĂůŚĞŵĂƚŽůŽŐǇ͘ϮϬϬϵ͖ϯϳ͗ϭϵͲϯϬ͘
΀ϰϳ΁ ŚŽƵ <͕ ,ƵĂŶŐ >͕ ŚŽƵ ͕ ,Ƶ ͕ >ŝƵ t͕ ŚŽƵ :͕ Ğƚ Ăů͘ tŶƚ ĂŶĚ EŽƚĐŚ ƐŝŐŶĂůŝŶŐ ƉĂƚŚǁĂǇƐ
ƐĞůĞĐƚŝǀĞůǇƌĞŐƵůĂƚŝŶŐŚĞŵĂƚŽƉŽŝĞƐŝƐ͘ŶŶĂůƐŽĨŚĞŵĂƚŽůŽŐǇ͘ϮϬϭϬ͖ϴϵ͗ϳϰϵͲϱϳ͘
΀ϰϴ΁tĂƌĚ͕dŽƵǁ/͕zŽƐŚŝŵƵƌĂ͘dŚĞ:ĂŬͲ^ƚĂƚƉĂƚŚǁĂǇŝŶŶŽƌŵĂůĂŶĚƉĞƌƚƵƌďĞĚŚĞŵĂƚŽƉŽŝĞƐŝƐ͘
ůŽŽĚ͘ϮϬϬϬ͖ϵϱ͗ϭϵͲϮϵ͘
΀ϰϵ΁ ,ŽĨŵĂŶŶ /͕ ^ƚŽǀĞƌ ,͕ ƵůůĞŶ ͕ DĂŽ :͕ DŽƌŐĂŶ <:͕ >ĞĞ ,͕ Ğƚ Ăů͘ ,ĞĚŐĞŚŽŐ ƐŝŐŶĂůŝŶŐ ŝƐ
ĚŝƐƉĞŶƐĂďůĞ ĨŽƌ ĂĚƵůƚŵƵƌŝŶĞ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůů ĨƵŶĐƚŝŽŶ ĂŶĚ ŚĞŵĂƚŽƉŽŝĞƐŝƐ͘ Ğůů ƐƚĞŵ ĐĞůů͘
ϮϬϬϵ͖ϰ͗ϱϱϵͲϲϳ͘
΀ϱϬ΁DĂƌƚŝŶĞǌͲŐŽƐƚŽ:͕DŝŬŬŽůĂ,<͕,ĂƌƚĞŶƐƚĞŝŶs͕ĂŶĞƌũĞĞh͘dŚĞŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůĂŶĚŝƚƐ
ŶŝĐŚĞ͗ĂĐŽŵƉĂƌĂƚŝǀĞǀŝĞǁ͘'ĞŶĞƐΘĚĞǀĞůŽƉŵĞŶƚ͘ϮϬϬϳ͖Ϯϭ͗ϯϬϰϰͲϲϬ͘
΀ϱϭ΁ dĂŝĐŚŵĂŶ Z^͕ ŵĞƌƐŽŶ ^'͘ dŚĞ ƌŽůĞ ŽĨ ŽƐƚĞŽďůĂƐƚƐ ŝŶ ƚŚĞ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ŵŝĐƌŽĞŶǀŝƌŽŶŵĞŶƚ͘
^ƚĞŵĐĞůůƐ͘ϭϵϵϴ͖ϭϲ͗ϳͲϭϱ͘
΀ϱϮ΁dĂŶĂŬĂz͕DŽƌŝŵŽƚŽ/͕EĂŬĂŶŽz͕KŬĂĚĂz͕,ŝƌŽƚĂ^͕EŽŵƵƌĂ^͕ĞƚĂů͘KƐƚĞŽďůĂƐƚƐĂƌĞƌĞŐƵůĂƚĞĚ
ďǇƚŚĞĐĞůůƵůĂƌĂĚŚĞƐŝŽŶƚŚƌŽƵŐŚ /DͲϭĂŶĚsDͲϭ͘ :ŽƵƌŶĂůŽĨďŽŶĞĂŶĚŵŝŶĞƌĂů ƌĞƐĞĂƌĐŚ ͗ ƚŚĞ
ŽĨĨŝĐŝĂůũŽƵƌŶĂůŽĨƚŚĞŵĞƌŝĐĂŶ^ŽĐŝĞƚǇĨŽƌŽŶĞĂŶĚDŝŶĞƌĂůZĞƐĞĂƌĐŚ͘ϭϵϵϱ͖ϭϬ͗ϭϰϲϮͲϵ͘
΀ϱϯ΁dĂŬƵďŽ<͕'ŽĚĂE͕zĂŵĂĚĂt͕ /ƌŝƵĐŚŝƐŚŝŵĂ,͕ /ŬĞĚĂ͕<ƵďŽƚĂz͕ĞƚĂů͘ZĞŐƵůĂƚŝŽŶŽĨƚŚĞ,/&Ͳ
ϭĂůƉŚĂůĞǀĞůŝƐĞƐƐĞŶƚŝĂůĨŽƌŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͘ĞůůƐƚĞŵĐĞůů͘ϮϬϭϬ͖ϳ͗ϯϵϭͲϰϬϮ͘
΀ϱϰ΁ĚĂŵƐ'͕ŚĂďŶĞƌ<d͕ůůĞǇ/Z͕KůƐŽŶW͕^ǌĐǌĞƉŝŽƌŬŽǁƐŬŝD͕WŽǌŶĂŶƐŬǇD͕ĞƚĂů͘^ƚĞŵĐĞůů
ĞŶŐƌĂĨƚŵĞŶƚ Ăƚ ƚŚĞ ĞŶĚŽƐƚĞĂů ŶŝĐŚĞ ŝƐ ƐƉĞĐŝĨŝĞĚ ďǇ ƚŚĞ ĐĂůĐŝƵŵͲƐĞŶƐŝŶŐ ƌĞĐĞƉƚŽƌ͘ EĂƚƵƌĞ͘
ϮϬϬϲ͖ϰϯϵ͗ϱϵϵͲϲϬϯ͘
΀ϱϱ΁KŚ/,͕<ǁŽŶ<Z͘ŽŶĐŝƐĞƌĞǀŝĞǁ͗ŵƵůƚŝƉůĞŶŝĐŚĞƐĨŽƌŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƌĞŐƵůĂƚŝŽŶƐ͘^ƚĞŵ
ĐĞůůƐ͘ϮϬϭϬ͖Ϯϴ͗ϭϮϰϯͲϵ͘
΀ϱϲ΁ ŽĂŶ W>͕ ŚƵƚĞ :W͘ dŚĞ ǀĂƐĐƵůĂƌ ŶŝĐŚĞ͗ ŚŽŵĞ ĨŽƌ ŶŽƌŵĂů ĂŶĚŵĂůŝŐŶĂŶƚ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ
ĐĞůůƐ͘>ĞƵŬĞŵŝĂ͗ŽĨĨŝĐŝĂů ũŽƵƌŶĂůŽĨƚŚĞ>ĞƵŬĞŵŝĂ^ŽĐŝĞƚǇŽĨŵĞƌŝĐĂ͕>ĞƵŬĞŵŝĂZĞƐĞĂƌĐŚ&ƵŶĚ͕h<͘
ϮϬϭϮ͖Ϯϲ͗ϱϰͲϲϮ͘
΀ϱϳ΁ <ŽƉƉ ,'͕ ǀĞĐŝůůĂ ^d͕ ,ŽŽƉĞƌ d͕ ^ŚŵĞůŬŽǀ ^s͕ ZĂŵŽƐ ͕ ŚĂŶŐ &͕ Ğƚ Ăů͘ dŝĞϮ ĂĐƚŝǀĂƚŝŽŶ
ĐŽŶƚƌŝďƵƚĞƐƚŽŚĞŵĂŶŐŝŽŐĞŶŝĐƌĞŐĞŶĞƌĂƚŝŽŶĂĨƚĞƌŵǇĞůŽƐƵƉƉƌĞƐƐŝŽŶ͘ůŽŽĚ͘ϮϬϬϱ͖ϭϬϲ͗ϱϬϱͲϭϯ͘
΀ϱϴ΁<ŽƉƉ,'͕,ŽŽƉĞƌd͕ǀĞĐŝůůĂ^d͕ZĂĨŝŝ^͘&ƵŶĐƚŝŽŶĂůŚĞƚĞƌŽŐĞŶĞŝƚǇŽĨƚŚĞďŽŶĞŵĂƌƌŽǁǀĂƐĐƵůĂƌ
ŶŝĐŚĞ͘ŶŶĂůƐŽĨƚŚĞEĞǁzŽƌŬĐĂĚĞŵǇŽĨ^ĐŝĞŶĐĞƐ͘ϮϬϬϵ͖ϭϭϳϲ͗ϰϳͲϱϰ͘
΀ϱϵ΁ǀĞĐŝůůĂ^d͕,ĂƚƚŽƌŝ<͕,ĞŝƐƐŝŐ͕dĞũĂĚĂZ͕>ŝĂŽ&͕^ŚŝĚŽ<͕ĞƚĂů͘ŚĞŵŽŬŝŶĞͲŵĞĚŝĂƚĞĚŝŶƚĞƌĂĐƚŝŽŶ
ŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐƉƌŽŐĞŶŝƚŽƌƐǁŝƚŚƚŚĞďŽŶĞŵĂƌƌŽǁǀĂƐĐƵůĂƌŶŝĐŚĞŝƐƌĞƋƵŝƌĞĚĨŽƌƚŚƌŽŵďŽƉŽŝĞƐŝƐ͘
EĂƚƵƌĞŵĞĚŝĐŝŶĞ͘ϮϬϬϰ͖ϭϬ͗ϲϰͲϳϭ͘
΀ϲϬ΁ zƵŶ,:͕ :Žz͘ WƌŽĚƵĐƚŝŽŶŽĨ ƐƚƌŽŵĂů ĐĞůůͲĚĞƌŝǀĞĚ ĨĂĐƚŽƌͲϭ ;^&ͲϭͿĂŶĚĞǆƉƌĞƐƐŝŽŶŽĨyZϰ ŝŶ
ŚƵŵĂŶďŽŶĞŵĂƌƌŽǁĞŶĚŽƚŚĞůŝĂůĐĞůůƐ͘:ŽƵƌŶĂůŽĨ<ŽƌĞĂŶŵĞĚŝĐĂůƐĐŝĞŶĐĞ͘ϮϬϬϯ͖ϭϴ͗ϲϳϵͲϴϱ͘
΀ϲϭ΁ZŽƐƐ͕&ƌĞĞŵĂŶ^͕ŚĂŽz͕ŚĂŶũĂůd^͕ZŽƐƐ:͕>Ăǆ^͕ĞƚĂů͘ŶŽǀĞůƌŽůĞĨŽƌWDͲϭ;ϯϭͿŝŶ
ƌĞŐƵůĂƚŝŶŐŚĂĞŵĂƚŽƉŽŝĞƚŝĐƉƌŽŐĞŶŝƚŽƌĐĞůůĐŽŵƉĂƌƚŵĞŶƚĂůŝǌĂƚŝŽŶďĞƚǁĞĞŶƚŚĞƉĞƌŝƉŚĞƌĂůďůŽŽĚĂŶĚ
ďŽŶĞŵĂƌƌŽǁ͘WůŽ^ŽŶĞ͘ϮϬϬϴ͖ϯ͗ĞϮϯϯϴ͘
΀ϲϮ΁ǀĂŶƵƵů:͕sŽĞƌŵĂŶƐ͕ǀĂŶĚĞŶĞƌŐs͕ŶƚŚŽŶǇ͕DƵů&W͕ǀĂŶtĞƚĞƌŝŶŐ^͕ĞƚĂů͘DŝŐƌĂƚŝŽŶ
ŽĨŚƵŵĂŶŚĞŵĂƚŽƉŽŝĞƚŝĐƉƌŽŐĞŶŝƚŽƌĐĞůůƐĂĐƌŽƐƐďŽŶĞŵĂƌƌŽǁĞŶĚŽƚŚĞůŝƵŵŝƐƌĞŐƵůĂƚĞĚďǇǀĂƐĐƵůĂƌ
ĞŶĚŽƚŚĞůŝĂůĐĂĚŚĞƌŝŶ͘:ŽƵƌŶĂůŽĨŝŵŵƵŶŽůŽŐǇ͘ϮϬϬϮ͖ϭϲϴ͗ϱϴϴͲϵϲ͘
΀ϲϯ΁ <ŽƉƉ ,'͕ ǀĞĐŝůůĂ ^d͕ ,ŽŽƉĞƌ d͕ ZĂĨŝŝ ^͘ dŚĞ ďŽŶĞ ŵĂƌƌŽǁ ǀĂƐĐƵůĂƌ ŶŝĐŚĞ͗ ŚŽŵĞ ŽĨ ,^
ĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶĂŶĚŵŽďŝůŝǌĂƚŝŽŶ͘WŚǇƐŝŽůŽŐǇ͘ϮϬϬϱ͖ϮϬ͗ϯϰϵͲϱϲ͘
΀ϲϰ΁ <ŝĞů D:͕ zŝůŵĂǌ K,͕ /ǁĂƐŚŝƚĂ d͕ dĞƌŚŽƌƐƚ ͕ DŽƌƌŝƐŽŶ ^:͘ ^>D ĨĂŵŝůǇ ƌĞĐĞƉƚŽƌƐ ĚŝƐƚŝŶŐƵŝƐŚ
ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĂŶĚ ƉƌŽŐĞŶŝƚŽƌ ĐĞůůƐ ĂŶĚ ƌĞǀĞĂů ĞŶĚŽƚŚĞůŝĂů ŶŝĐŚĞƐ ĨŽƌ ƐƚĞŵ ĐĞůůƐ͘ Ğůů͘
ϮϬϬϱ͖ϭϮϭ͗ϭϭϬϵͲϮϭ͘
΀ϲϱ΁>ŝt͕:ŽŚŶƐŽŶ^͕^ŚĞůůĞǇt͕zŽĚĞƌD͘,ĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƌĞƉŽƉƵůĂƚŝŶŐĂďŝůŝƚǇĐĂŶďĞ
ŵĂŝŶƚĂŝŶĞĚŝŶǀŝƚƌŽďǇƐŽŵĞƉƌŝŵĂƌǇĞŶĚŽƚŚĞůŝĂůĐĞůůƐ͘ǆƉĞƌŝŵĞŶƚĂů,ĞŵĂƚŽůŽŐǇ͘ϮϬϬϰ͖ϯϮ͗ϭϮϮϲͲϯϳ͘
ZĞĨĞƌĞŶĐĞƐ
Ϯϯϰ

΀ϲϲ΁ EĂŬĂŵƵƌĂ z͕ ƌĂŝ &͕ /ǁĂƐĂŬŝ ,͕ ,ŽƐŽŬĂǁĂ <͕ <ŽďĂǇĂƐŚŝ /͕ 'ŽŵĞŝ z͕ Ğƚ Ăů͘ /ƐŽůĂƚŝŽŶ ĂŶĚ
ĐŚĂƌĂĐƚĞƌŝǌĂƚŝŽŶŽĨĞŶĚŽƐƚĞĂůŶŝĐŚĞĐĞůůƉŽƉƵůĂƚŝŽŶƐƚŚĂƚ ƌĞŐƵůĂƚĞŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͘ůŽŽĚ͘
ϮϬϭϬ͖ϭϭϲ͗ϭϰϮϮͲϯϮ͘
΀ϲϳ΁'ƵĞƌƌŽƵĂŚĞŶ^͕ůͲ,ŝũũŝ/͕dĂďƌŝǌŝZ͘KƐƚĞŽďůĂƐƚŝĐĂŶĚǀĂƐĐƵůĂƌĞŶĚŽƚŚĞůŝĂůŶŝĐŚĞƐ͕ƚŚĞŝƌĐŽŶƚƌŽů
ŽŶŶŽƌŵĂůŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͕ĂŶĚƚŚĞŝƌĐŽŶƐĞƋƵĞŶĐĞƐŽŶƚŚĞĚĞǀĞůŽƉŵĞŶƚŽĨůĞƵŬĞŵŝĂ͘^ƚĞŵ
ĐĞůůƐŝŶƚĞƌŶĂƚŝŽŶĂů͘ϮϬϭϭ͖ϮϬϭϭ͗ϯϳϱϴϱϳ͘
΀ϲϴ΁:ƵŶŐz͕tĂŶŐ:͕^ŽŶŐ:͕^ŚŝŽǌĂǁĂz͕,ĂǀĞŶƐ͕tĂŶŐ͕ĞƚĂů͘ŶŶĞǆŝŶ//ĞǆƉƌĞƐƐĞĚďǇŽƐƚĞŽďůĂƐƚƐ
ĂŶĚ ĞŶĚŽƚŚĞůŝĂů ĐĞůůƐ ƌĞŐƵůĂƚĞƐ ƐƚĞŵ ĐĞůů ĂĚŚĞƐŝŽŶ͕ ŚŽŵŝŶŐ͕ ĂŶĚ ĞŶŐƌĂĨƚŵĞŶƚ ĨŽůůŽǁŝŶŐ
ƚƌĂŶƐƉůĂŶƚĂƚŝŽŶ͘ůŽŽĚ͘ϮϬϬϳ͖ϭϭϬ͗ϴϮͲϵϬ͘
΀ϲϵ΁ ĂŚůďĞƌŐ ͕ ĞůĂŶĞǇ ͕ ĞƌŶƐƚĞŝŶ /͘ ǆ ǀŝǀŽ ĞǆƉĂŶƐŝŽŶ ŽĨ ŚƵŵĂŶ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĂŶĚ
ƉƌŽŐĞŶŝƚŽƌĐĞůůƐ͘ůŽŽĚ͘ϮϬϭϭ͖ϭϭϳ͗ϲϬϴϯͲϵϬ͘
΀ϳϬ΁ <ŝƚĂ <͕ >ĞĞ :K͕ &ŝŶŶĞƌƚǇ ͕,ĞƌŶĚŽŶE͘ ŽƌĚďůŽŽĚͲĚĞƌŝǀĞĚ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵͬƉƌŽŐĞŶŝƚŽƌ
ĐĞůůƐ͗ĐƵƌƌĞŶƚĐŚĂůůĞŶŐĞƐ ŝŶĞŶŐƌĂĨƚŵĞŶƚ͕ ŝŶĨĞĐƚŝŽŶ͕ĂŶĚĞǆǀŝǀŽĞǆƉĂŶƐŝŽŶ͘^ƚĞŵĐĞůůƐ ŝŶƚĞƌŶĂƚŝŽŶĂů͘
ϮϬϭϭ͖ϮϬϭϭ͗Ϯϳϲϭϵϯ͘
΀ϳϭ΁ >ĂƵŐŚůŝŶ D:͕ ĂƌŬĞƌ :͕ ĂŵďĂĐŚ ͕ <ŽĐ KE͕ ZŝǌǌŝĞƌŝ ͕ tĂŐŶĞƌ :͕ Ğƚ Ăů͘ ,ĞŵĂƚŽƉŽŝĞƚŝĐ
ĞŶŐƌĂĨƚŵĞŶƚĂŶĚƐƵƌǀŝǀĂůŝŶĂĚƵůƚƌĞĐŝƉŝĞŶƚƐŽĨƵŵďŝůŝĐĂůͲĐŽƌĚďůŽŽĚĨƌŽŵƵŶƌĞůĂƚĞĚĚŽŶŽƌƐ͘dŚĞEĞǁ
ŶŐůĂŶĚũŽƵƌŶĂůŽĨŵĞĚŝĐŝŶĞ͘ϮϬϬϭ͖ϯϰϰ͗ϭϴϭϱͲϮϮ͘
΀ϳϮ΁ĞǆƚĞƌdD͕dĞƐƚĂE'͘ŝĨĨĞƌĞŶƚŝĂƚŝŽŶĂŶĚƉƌŽůŝĨĞƌĂƚŝŽŶŽĨŚĞŵŽƉŽŝĞƚŝĐĐĞůůƐŝŶĐƵůƚƵƌĞ͘DĞƚŚŽĚƐ
ŝŶĐĞůůďŝŽůŽŐǇ͘ϭϵϳϲ͖ϭϰ͗ϯϴϳͲϰϬϱ͘
΀ϳϯ΁ dŚĂůŵĞŝĞƌ <͕ DĞŝƐƐŶĞƌ W͕ ZĞŝƐďĂĐŚ '͕ &ĂůŬ D͕ ƌĞĐŚƚĞů ͕ ŽƌŵĞƌ W͘ ƐƚĂďůŝƐŚŵĞŶƚ ŽĨ ƚǁŽ
ƉĞƌŵĂŶĞŶƚŚƵŵĂŶďŽŶĞŵĂƌƌŽǁƐƚƌŽŵĂůĐĞůů ůŝŶĞƐǁŝƚŚ ůŽŶŐͲƚĞƌŵƉŽƐƚ ŝƌƌĂĚŝĂƚŝŽŶĨĞĞĚĞƌĐĂƉĂĐŝƚǇ͘
ůŽŽĚ͘ϭϵϵϰ͖ϴϯ͗ϭϳϵϵͲϴϬϳ͘
΀ϳϰ΁DĂŐŶƵƐƐŽŶD͕^ŝĞƌƌĂD/͕^ĂƐŝĚŚĂƌĂŶZ͕WƌĂƐŚĂĚ^>͕ZŽŵĞƌŽD͕^ĂĂƌŝŬŽƐŬŝW͕ĞƚĂů͘ǆƉĂŶƐŝŽŶŽŶ
ƐƚƌŽŵĂů ĐĞůůƐ ƉƌĞƐĞƌǀĞƐ ƚŚĞ ƵŶĚŝĨĨĞƌĞŶƚŝĂƚĞĚ ƐƚĂƚĞ ŽĨ ŚƵŵĂŶ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůůƐ ĚĞƐƉŝƚĞ
ĐŽŵƉƌŽŵŝƐĞĚƌĞĐŽŶƐƚŝƚƵƚŝŽŶĂďŝůŝƚǇ͘WůŽ^ŽŶĞ͘ϮϬϭϯ͖ϴ͗ĞϱϯϵϭϮ͘
΀ϳϱ΁ /ƐĞƌŶ :͕DĂƌƚŝŶͲŶƚŽŶŝŽ͕'ŚĂǌĂŶĨĂƌŝZ͕DĂƌƚŝŶD͕>ŽƉĞǌ :͕ĚĞůdŽƌŽZ͕ĞƚĂů͘^ĞůĨͲƌĞŶĞǁŝŶŐ
ŚƵŵĂŶ ďŽŶĞ ŵĂƌƌŽǁ ŵĞƐĞŶƐƉŚĞƌĞƐ ƉƌŽŵŽƚĞ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůů ĞǆƉĂŶƐŝŽŶ͘ Ğůů ƌĞƉŽƌƚƐ͘
ϮϬϭϯ͖ϯ͗ϭϳϭϰͲϮϰ͘
΀ϳϲ΁ƵĐŬůĞǇ^D͕hůůŽĂͲDŽŶƚŽǇĂ&͕ďƚƐ͕KŽƐƚĞŶĚŽƌƉZ͕ǌŝĞƌǌĂŬ͕ŬŬĞƌ^͕ĞƚĂů͘DĂŝŶƚĞŶĂŶĐĞ
ŽĨ,^ďǇtŶƚϱĂƐĞĐƌĞƚŝŶŐ'DͲĚĞƌŝǀĞĚƐƚƌŽŵĂůĐĞůůůŝŶĞ͘ǆƉĞƌŝŵĞŶƚĂůŚĞŵĂƚŽůŽŐǇ͘ϮϬϭϭ͖ϯϵ͗ϭϭϰͲϮϯ
ĞϭͲϱ͘
΀ϳϳ΁ĞŶŐĞůŝ^͕ĂŝŐƵĞƌĂ^͕ĞůWƵƉ>͕WĂǀĂŶ͕'ĂũŽ'͕ŝ>ŝĚĚŽZ͕ĞƚĂů͘DŝĚĚůĞͲƚĞƌŵĞǆƉĂŶƐŝŽŶŽĨ
ŚĞŵĂƚŽƉŽŝĞƚŝĐ ĐŽƌĚ ďůŽŽĚ ĐĞůůƐ ǁŝƚŚ ŶĞǁ ŚƵŵĂŶ ƐƚƌŽŵĂů ĐĞůů ůŝŶĞ ĨĞĞĚĞƌͲůĂǇĞƌƐ ĂŶĚ ĚŝĨĨĞƌĞŶƚ
ĐǇƚŽŬŝŶĞĐŽĐŬƚĂŝůƐ͘/ŶƚĞƌŶĂƚŝŽŶĂůũŽƵƌŶĂůŽĨŵŽůĞĐƵůĂƌŵĞĚŝĐŝŶĞ͘ϮϬϬϵ͖Ϯϰ͗ϴϯϳͲϰϱ͘
΀ϳϴ΁DŽŽƌĞ<͕WǇƚŽǁƐŬŝ͕tŝƚƚĞ>͕,ŝĐŬůŝŶ͕>ĞŵŝƐĐŚŬĂ/Z͘,ĞŵĂƚŽƉŽŝĞƚŝĐĂĐƚŝǀŝƚǇŽĨĂƐƚƌŽŵĂůĐĞůů
ƚƌĂŶƐŵĞŵďƌĂŶĞƉƌŽƚĞŝŶĐŽŶƚĂŝŶŝŶŐĞƉŝĚĞƌŵĂůŐƌŽǁƚŚ ĨĂĐƚŽƌͲůŝŬĞ ƌĞƉĞĂƚŵŽƚŝĨƐ͘WƌŽĐĞĞĚŝŶŐƐŽĨ ƚŚĞ
EĂƚŝŽŶĂůĐĂĚĞŵǇŽĨ^ĐŝĞŶĐĞƐŽĨƚŚĞhŶŝƚĞĚ^ƚĂƚĞƐŽĨŵĞƌŝĐĂ͘ϭϵϵϳ͖ϵϰ͗ϰϬϭϭͲϲ͘
΀ϳϵ΁ZŽǇs͕sĞƌĨĂŝůůŝĞD͘^ŽůƵďůĞ ĨĂĐƚŽƌ;ƐͿƉƌŽĚƵĐĞĚďǇĂĚƵůƚďŽŶĞŵĂƌƌŽǁƐƚƌŽŵĂ ŝŶŚŝďŝƚ ŝŶǀŝƚƌŽ
ƉƌŽůŝĨĞƌĂƚŝŽŶ ĂŶĚ ĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶ ŽĨ ĨĞƚĂů ůŝǀĞƌ &hͲ ďǇ ŝŶĚƵĐŝŶŐ ĂƉŽƉƚŽƐŝƐ͘ dŚĞ :ŽƵƌŶĂů ŽĨ ĐůŝŶŝĐĂů
ŝŶǀĞƐƚŝŐĂƚŝŽŶ͘ϭϵϵϳ͖ϭϬϬ͗ϵϭϮͲϮϬ͘
΀ϴϬ΁ dŝǁĂƌŝ͕dƵƌƐŬǇD>͕DƵƐŚĂŚĂƌǇ͕tĂƐŶŝŬ ^͕ ŽůůŝĞƌ &D͕ ^ƵŵĂ<͕Ğƚ Ăů͘ ǆ ǀŝǀŽĞǆƉĂŶƐŝŽŶŽĨ
ŚĂĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵͬƉƌŽŐĞŶŝƚŽƌ ĐĞůůƐ ĨƌŽŵ ŚƵŵĂŶ ƵŵďŝůŝĐĂů ĐŽƌĚ ďůŽŽĚ ŽŶ ĂĐĞůůƵůĂƌ ƐĐĂĨĨŽůĚƐ
ƉƌĞƉĂƌĞĚ ĨƌŽŵ D^Ͳϱ ƐƚƌŽŵĂů ĐĞůů ůŝŶĞ͘ :ŽƵƌŶĂů ŽĨ ƚŝƐƐƵĞ ĞŶŐŝŶĞĞƌŝŶŐ ĂŶĚ ƌĞŐĞŶĞƌĂƚŝǀĞ ŵĞĚŝĐŝŶĞ͘
ϮϬϭϯ͖ϳ͗ϴϳϭͲϴϯ͘
΀ϴϭ΁,ŽůǇŽĂŬĞd>͕&ƌĞƐŚŶĞǇD'͕DĐEĂŝƌ>͕WĂƌŬĞƌE͕DĐ<ĂǇW:͕^ƚĞǁĂƌĚtW͕ĞƚĂů͘ǆǀŝǀŽĞǆƉĂŶƐŝŽŶ
ǁŝƚŚƐƚĞŵĐĞůůĨĂĐƚŽƌĂŶĚŝŶƚĞƌůĞƵŬŝŶͲϭϭĂƵŐŵĞŶƚƐďŽƚŚƐŚŽƌƚͲƚĞƌŵƌĞĐŽǀĞƌǇƉŽƐƚƚƌĂŶƐƉůĂŶƚĂŶĚƚŚĞ
ĂďŝůŝƚǇƚŽƐĞƌŝĂůůǇƚƌĂŶƐƉůĂŶƚŵĂƌƌŽǁ͘ůŽŽĚ͘ϭϵϵϲ͖ϴϳ͗ϰϱϴϵͲϵϱ͘
΀ϴϮ΁WĞƚŝƚͲŽĐĂƵůƚ>͕sŽůůĞͲŚĂůůŝĞƌ͕&ůĞƵƌǇD͕WĞĂƵůƚ͕^ŽƵǇƌŝD͘ƵĂůƌŽůĞŽĨDƉůƌĞĐĞƉƚŽƌĚƵƌŝŶŐ
ƚŚĞĞƐƚĂďůŝƐŚŵĞŶƚŽĨĚĞĨŝŶŝƚŝǀĞŚĞŵĂƚŽƉŽŝĞƐŝƐ͘ĞǀĞůŽƉŵĞŶƚ͘ϮϬϬϳ͖ϭϯϰ͗ϯϬϯϭͲϰϬ͘
ZĞĨĞƌĞŶĐĞƐ
Ϯϯϱ

΀ϴϯ΁ ZĞŶŶŝĐŬ ͕ :ĂĐŬƐŽŶ :͕ zĂŶŐ '͕ tŝĚĞŵĂŶ :͕ >ĞĞ &͕ ,ƵĚĂŬ ^͘ /ŶƚĞƌůĞƵŬŝŶͲϲ ŝŶƚĞƌĂĐƚƐ ǁŝƚŚ
ŝŶƚĞƌůĞƵŬŝŶͲϰ ĂŶĚ ŽƚŚĞƌ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ŐƌŽǁƚŚ ĨĂĐƚŽƌƐ ƚŽ ƐĞůĞĐƚŝǀĞůǇ ĞŶŚĂŶĐĞ ƚŚĞ ŐƌŽǁƚŚ ŽĨ
ŵĞŐĂŬĂƌǇŽĐǇƚŝĐ͕ĞƌǇƚŚƌŽŝĚ͕ŵǇĞůŽŝĚ͕ĂŶĚŵƵůƚŝƉŽƚĞŶƚŝĂůƉƌŽŐĞŶŝƚŽƌĐĞůůƐ͘ůŽŽĚ͘ϭϵϴϵ͖ϳϯ͗ϭϴϮϴͲϯϱ͘
΀ϴϰ΁>ǇŵĂŶ^͘ŝŽůŽŐǇŽĨĨůƚϯůŝŐĂŶĚĂŶĚƌĞĐĞƉƚŽƌ͘/ŶƚĞƌŶĂƚŝŽŶĂůũŽƵƌŶĂůŽĨŚĞŵĂƚŽůŽŐǇ͘ϭϵϵϱ͖ϲϮ͗ϲϯͲ
ϳϯ͘
΀ϴϱ΁ ^ĐŚǁĂƌƚǌ ZD͕ ŵĞƌƐŽŶ ^'͕ ůĂƌŬĞD&͕ WĂůƐƐŽŶK͘ /Ŷ ǀŝƚƌŽŵǇĞůŽƉŽŝĞƐŝƐ ƐƚŝŵƵůĂƚĞĚ ďǇ ƌĂƉŝĚ
ŵĞĚŝƵŵĞǆĐŚĂŶŐĞĂŶĚƐƵƉƉůĞŵĞŶƚĂƚŝŽŶǁŝƚŚŚĞŵĂƚŽƉŽŝĞƚŝĐŐƌŽǁƚŚ ĨĂĐƚŽƌƐ͘ůŽŽĚ͘ϭϵϵϭ͖ϳϴ͗ϯϭϱϱͲ
ϲϭ͘
΀ϴϲ΁^ƵǌƵŬŝd͕zŽŬŽǇĂŵĂz͕<ƵŵĂŶŽ<͕dĂŬĂŶĂƐŚŝD͕<ŽǌƵŵĂ^͕dĂŬĂƚŽd͕ĞƚĂů͘,ŝŐŚůǇĞĨĨŝĐŝĞŶƚĞǆǀŝǀŽ
ĞǆƉĂŶƐŝŽŶ ŽĨ ŚƵŵĂŶ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůůƐ ƵƐŝŶŐ ĞůƚĂϭͲ&Đ ĐŚŝŵĞƌŝĐ ƉƌŽƚĞŝŶ͘ ^ƚĞŵ ĐĞůůƐ͘
ϮϬϬϲ͖Ϯϰ͗ϮϰϱϲͲϲϱ͘
΀ϴϳ΁ ŚĂƌĚǁĂũ '͕ DƵƌĚŽĐŚ ͕ tƵ ͕ ĂŬĞƌ W͕ tŝůůŝĂŵƐ <W͕ ŚĂĚǁŝĐŬ <͕ Ğƚ Ăů͘ ^ŽŶŝĐ ŚĞĚŐĞŚŽŐ
ŝŶĚƵĐĞƐ ƚŚĞ ƉƌŽůŝĨĞƌĂƚŝŽŶ ŽĨ ƉƌŝŵŝƚŝǀĞ ŚƵŵĂŶ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ĐĞůůƐ ǀŝĂ DW ƌĞŐƵůĂƚŝŽŶ͘ EĂƚƵƌĞ
ŝŵŵƵŶŽůŽŐǇ͘ϮϬϬϭ͖Ϯ͗ϭϳϮͲϴϬ͘
΀ϴϴ΁ĚĞ,ĂĂŶ'͕tĞĞƌƐŝŶŐ͕ŽŶƚũĞ͕ǀĂŶKƐZ͕ǇƐƚƌǇŬŚ>s͕sĞůůĞŶŐĂ͕ĞƚĂů͘/ŶǀŝƚƌŽŐĞŶĞƌĂƚŝŽŶŽĨ
ůŽŶŐͲƚĞƌŵƌĞƉŽƉƵůĂƚŝŶŐŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐďǇĨŝďƌŽďůĂƐƚŐƌŽǁƚŚĨĂĐƚŽƌͲϭ͘ĞǀĞůŽƉŵĞŶƚĂůĐĞůů͘
ϮϬϬϯ͖ϰ͗ϮϰϭͲϱϭ͘
΀ϴϵ΁ŚĂŶŐ͕>ŽĚŝƐŚ,&͘/ŶƐƵůŝŶͲůŝŬĞŐƌŽǁƚŚĨĂĐƚŽƌϮĞǆƉƌĞƐƐĞĚŝŶĂŶŽǀĞůĨĞƚĂůůŝǀĞƌĐĞůůƉŽƉƵůĂƚŝŽŶ
ŝƐĂŐƌŽǁƚŚĨĂĐƚŽƌĨŽƌŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͘ůŽŽĚ͘ϮϬϬϰ͖ϭϬϯ͗ϮϱϭϯͲϮϭ͘
΀ϵϬ΁ŚĂŶŐ͕<ĂďĂD͕'Ğ'͕yŝĞ<͕dŽŶŐt͕,ƵŐ͕ĞƚĂů͘ŶŐŝŽƉŽŝĞƚŝŶͲůŝŬĞƉƌŽƚĞŝŶƐƐƚŝŵƵůĂƚĞĞǆǀŝǀŽ
ĞǆƉĂŶƐŝŽŶŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͘EĂƚƵƌĞŵĞĚŝĐŝŶĞ͘ϮϬϬϲ͖ϭϮ͗ϮϰϬͲϱ͘
΀ϵϭ΁ĞůůĂƚŽƌĞ^D͕'ĂƌĐŝĂ^͕DŝůůĞƌtD͘DŝŵŝĐŬŝŶŐƐƚĞŵĐĞůůŶŝĐŚĞƐƚŽŝŶĐƌĞĂƐĞƐƚĞŵĐĞůůĞǆƉĂŶƐŝŽŶ͘
ƵƌƌĞŶƚŽƉŝŶŝŽŶŝŶďŝŽƚĞĐŚŶŽůŽŐǇ͘ϮϬϬϴ͖ϭϵ͗ϱϯϰͲϰϬ͘
΀ϵϮ΁<ƌĂƵƐĞ^͘ZĞŐƵůĂƚŝŽŶŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůĨĂƚĞ͘KŶĐŽŐĞŶĞ͘ϮϬϬϮ͖Ϯϭ͗ϯϮϲϮͲϵ͘
΀ϵϯ΁ WŚŝůƉ ͕ ŚĞŶ ^^͕ &ŝƚǌŐĞƌĂůĚt͕ KƌĞŶƐƚĞŝŶ :͕DĂƌŐŽůŝƐ >͕ <ůĞŝŶŵĂŶ ,<͘ ŽŵƉůĞǆ ĞǆƚƌĂĐĞůůƵůĂƌ
ŵĂƚƌŝĐĞƐƉƌŽŵŽƚĞƚŝƐƐƵĞͲƐƉĞĐŝĨŝĐƐƚĞŵĐĞůůĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶ͘^ƚĞŵĐĞůůƐ͘ϮϬϬϱ͖Ϯϯ͗ϮϴϴͲϵϲ͘
΀ϵϰ΁ ŚĞŶ ^^͕ &ŝƚǌŐĞƌĂůĚt͕ ŝŵŵĞƌďĞƌŐ :͕ <ůĞŝŶŵĂŶ,<͕DĂƌŐŽůŝƐ >͘ ĞůůͲĐĞůů ĂŶĚ ĐĞůůͲĞǆƚƌĂĐĞůůƵůĂƌ
ŵĂƚƌŝǆŝŶƚĞƌĂĐƚŝŽŶƐƌĞŐƵůĂƚĞĞŵďƌǇŽŶŝĐƐƚĞŵĐĞůůĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶ͘^ƚĞŵĐĞůůƐ͘ϮϬϬϳ͖Ϯϱ͗ϱϱϯͲϲϭ͘
΀ϵϱ΁ <ůĞŝŶ '͘ dŚĞ ĞǆƚƌĂĐĞůůƵůĂƌ ŵĂƚƌŝǆ ŽĨ ƚŚĞ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ŵŝĐƌŽĞŶǀŝƌŽŶŵĞŶƚ͘ ǆƉĞƌŝĞŶƚŝĂ͘
ϭϵϵϱ͖ϱϭ͗ϵϭϰͲϮϲ͘
΀ϵϲ΁ tŚĞƚƚŽŶ ͕ ^ƉŽŽŶĐĞƌ ͘ ZŽůĞ ŽĨ ĐǇƚŽŬŝŶĞƐ ĂŶĚ ĞǆƚƌĂĐĞůůƵůĂƌ ŵĂƚƌŝǆ ŝŶ ƚŚĞ ƌĞŐƵůĂƚŝŽŶ ŽĨ
ŚĂĞŵŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͘ƵƌƌĞŶƚŽƉŝŶŝŽŶŝŶĐĞůůďŝŽůŽŐǇ͘ϭϵϵϴ͖ϭϬ͗ϳϮϭͲϲ͘
΀ϵϳ΁ ^ŝůĞƌ h͕ ^ĞŝĨĨĞƌƚD͕ WƵĐŚ ^͕ ZŝĐŚĂƌĚƐ ͕ dŽƌŽŬͲ^ƚŽƌď ͕DƵůůĞƌ ͕ Ğƚ Ăů͘ ŚĂƌĂĐƚĞƌŝǌĂƚŝŽŶ ĂŶĚ
ĨƵŶĐƚŝŽŶĂůĂŶĂůǇƐŝƐŽĨůĂŵŝŶŝŶŝƐŽĨŽƌŵƐŝŶŚƵŵĂŶďŽŶĞŵĂƌƌŽǁ͘ůŽŽĚ͘ϮϬϬϬ͖ϵϲ͗ϰϭϵϰͲϮϬϯ͘
΀ϵϴ΁^ĂŐĂƌD͕ZĞŶƚĂůĂ^͕'ŽƉĂůWE͕^ŚĂƌŵĂ^͕DƵŬŚŽƉĂĚŚǇĂǇ͘&ŝďƌŽŶĞĐƚŝŶĂŶĚůĂŵŝŶŝŶĞŶŚĂŶĐĞ
ĞŶŐƌĂĨƚŝďŝůŝƚǇ ŽĨ ĐƵůƚƵƌĞĚ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůůƐ͘ ŝŽĐŚĞŵŝĐĂů ĂŶĚ ďŝŽƉŚǇƐŝĐĂů ƌĞƐĞĂƌĐŚ
ĐŽŵŵƵŶŝĐĂƚŝŽŶƐ͘ϮϬϬϲ͖ϯϱϬ͗ϭϬϬϬͲϱ͘
΀ϵϵ΁ zŽŬŽƚĂ d͕ KƌŝƚĂŶŝ <͕ DŝƚƐƵŝ ,͕ ŽǇĂŵĂ <͕ /ƐŚŝŬĂǁĂ :͕ ^ƵŐĂŚĂƌĂ ,͕ Ğƚ Ăů͘ 'ƌŽǁƚŚͲƐƵƉƉŽƌƚŝŶŐ
ĂĐƚŝǀŝƚŝĞƐ ŽĨ ĨŝďƌŽŶĞĐƚŝŶ ŽŶ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵͬƉƌŽŐĞŶŝƚŽƌ ĐĞůůƐ ŝŶ ǀŝƚƌŽ ĂŶĚ ŝŶ ǀŝǀŽ͗ ƐƚƌƵĐƚƵƌĂů
ƌĞƋƵŝƌĞŵĞŶƚĨŽƌĨŝďƌŽŶĞĐƚŝŶĂĐƚŝǀŝƚŝĞƐŽĨ^ϭĂŶĚĐĞůůͲďŝŶĚŝŶŐĚŽŵĂŝŶƐ͘ůŽŽĚ͘ϭϵϵϴ͖ϵϭ͗ϯϮϲϯͲϳϮ͘
΀ϭϬϬ΁tĞŝŶƐƚĞŝŶZ͕ZŝŽƌĚĂŶD͕tĞŶĐ<͕<ƌĞĐǌŬŽ^͕ŚŽƵD͕ĂŝŶŝĂŬE͘ƵĂů ƌŽůĞŽĨ ĨŝďƌŽŶĞĐƚŝŶ ŝŶ
ŚĞŵĂƚŽƉŽŝĞƚŝĐĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶ͘ůŽŽĚ͘ϭϵϴϵ͖ϳϯ͗ϭϭϭͲϲ͘
΀ϭϬϭ΁>ĞŝƐƚĞŶ/͕<ƌĂŵĂŶŶZ͕sĞŶƚƵƌĂ&ĞƌƌĞŝƌĂD^͕ŽǀŝD͕EĞƵƐƐ^͕ŝĞŐůĞƌW͕ĞƚĂů͘ϯĐŽͲĐƵůƚƵƌĞŽĨ
ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĂŶĚ ƉƌŽŐĞŶŝƚŽƌ ĐĞůůƐ ĂŶĚ ŵĞƐĞŶĐŚǇŵĂů ƐƚĞŵ ĐĞůůƐ ŝŶ ĐŽůůĂŐĞŶ ƐĐĂĨĨŽůĚƐ ĂƐ Ă
ŵŽĚĞůŽĨƚŚĞŚĞŵĂƚŽƉŽŝĞƚŝĐŶŝĐŚĞ͘ŝŽŵĂƚĞƌŝĂůƐ͘ϮϬϭϮ͖ϯϯ͗ϭϳϯϲͲϰϳ͘
΀ϭϬϮ΁ƵĐŬĞƌŵĂŶ<^͕ZŚŽĚĞƐZ<͕'ŽŽĚƌƵŵ͕WĂƚĞůsZ͕^ƉĂƌŬƐ͕tĞůůƐ:͕ĞƚĂů͘/ŶŚŝďŝƚŝŽŶŽĨĐŽůůĂŐĞŶ
ĚĞƉŽƐŝƚŝŽŶ ŝŶ ƚŚĞ ĞǆƚƌĂĐĞůůƵůĂƌ ŵĂƚƌŝǆ ƉƌĞǀĞŶƚƐ ƚŚĞ ĞƐƚĂďůŝƐŚŵĞŶƚ ŽĨ Ă ƐƚƌŽŵĂ ƐƵƉƉŽƌƚŝǀĞ ŽĨ
ŚĞŵĂƚŽƉŽŝĞƐŝƐ ŝŶ ůŽŶŐͲƚĞƌŵ ŵƵƌŝŶĞ ďŽŶĞ ŵĂƌƌŽǁ ĐƵůƚƵƌĞƐ͘ dŚĞ :ŽƵƌŶĂů ŽĨ ĐůŝŶŝĐĂů ŝŶǀĞƐƚŝŐĂƚŝŽŶ͘
ϭϵϴϱ͖ϳϱ͗ϵϳϬͲϱ͘
ZĞĨĞƌĞŶĐĞƐ
Ϯϯϲ

΀ϭϬϯ΁ <ƵŵĂƌĂƐƵƌŝǇĂƌ ͕DƵƌĂůŝ ^͕ EƵƌĐŽŵďĞ s͕ ŽŽů ^D͘'ůǇĐŽƐĂŵŝŶŽŐůǇĐĂŶ ĐŽŵƉŽƐŝƚŝŽŶ ĐŚĂŶŐĞƐ
ǁŝƚŚ D'Ͳϲϯ ŽƐƚĞŽƐĂƌĐŽŵĂ ŽƐƚĞŽŐĞŶĞƐŝƐ ŝŶ ǀŝƚƌŽ ĂŶĚ ŝŶĚƵĐĞƐ ŚƵŵĂŶ ŵĞƐĞŶĐŚǇŵĂů ƐƚĞŵ ĐĞůů
ĂŐŐƌĞŐĂƚŝŽŶ͘:ŽƵƌŶĂůŽĨĐĞůůƵůĂƌƉŚǇƐŝŽůŽŐǇ͘ϮϬϬϵ͖Ϯϭϴ͗ϱϬϭͲϭϭ͘
΀ϭϬϰ΁DĂǌǌŽŶ͕ŶƐĞůŵŽ͕ŝďĞůůĂ:͕^ŽůĚĂŶŝ͕ĞƐƚƌŽ͕<ŝŵE͕ĞƚĂů͘dŚĞĐƌŝƚŝĐĂůƌŽůĞŽĨĂŐƌŝŶŝŶƚŚĞ
ŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůŶŝĐŚĞ͘ůŽŽĚ͘ϮϬϭϭ͖ϭϭϴ͗ϮϳϯϯͲϰϮ͘
΀ϭϬϱ΁^ůĂƚĞ>͕ƌƵŶŽE͕ĂƐĞǇ^D͕ƵƚƐŚŝE͕'ĂƌǀŝŶ>:͕tƵ,͕ĞƚĂů͘Z^ͲϯϯϮϵϱͲϭϵϴ͗ĂŶŽǀĞů͕ƉŽƚĞŶƚ
ŵŽĚƵůĂƚŽƌŽĨWͲŐůǇĐŽƉƌŽƚĞŝŶͲŵĞĚŝĂƚĞĚŵƵůƚŝĚƌƵŐƌĞƐŝƐƚĂŶĐĞ͘ŶƚŝĐĂŶĐĞƌƌĞƐĞĂƌĐŚ͘ϭϵϵϱ͖ϭϱ͗ϴϭϭͲϰ͘
΀ϭϬϲ΁zƵy&͕,ĂŶ͘DĂƚƌŝǆŵĞƚĂůůŽƉƌŽƚĞŝŶĂƐĞƐŝŶďŽŶĞŵĂƌƌŽǁ͗ƌŽůĞƐŽĨŐĞůĂƚŝŶĂƐĞƐŝŶƉŚǇƐŝŽůŽŐŝĐĂů
ŚĞŵĂƚŽƉŽŝĞƐŝƐĂŶĚŚĞŵĂƚŽƉŽŝĞƚŝĐŵĂůŝŐŶĂŶĐŝĞƐ͘,ŝƐƚŽůŽŐǇĂŶĚŚŝƐƚŽƉĂƚŚŽůŽŐǇ͘ϮϬϬϲ͖Ϯϭ͗ϱϭϵͲϯϭ͘
΀ϭϬϳ΁ ^ŚĞŶ z͕ tŝŶŬůĞƌ /'͕ ĂƌďŝĞƌ s͕ ^ŝŵƐ E͕ ,ĞŶĚǇ :͕ >ĞǀĞƐƋƵĞ :W͘ dŝƐƐƵĞ ŝŶŚŝďŝƚŽƌ ŽĨ
ŵĞƚĂůůŽƉƌŽƚĞŝŶĂƐĞͲϯ;d/DWͲϯͿƌĞŐƵůĂƚĞƐŚĞŵĂƚŽƉŽŝĞƐŝƐĂŶĚďŽŶĞĨŽƌŵĂƚŝŽŶŝŶǀŝǀŽ͘WůŽ^ŽŶĞ͘ϮϬϭϬ͖ϱ͘
΀ϭϬϴ΁ĂŐůĞǇ:͕ZŽƐĞŶǌǁĞŝŐD͕DĂƌŬƐ&͕WǇŬĞƚƚD:͘ǆƚĞŶĚĞĚĐƵůƚƵƌĞŽĨŵƵůƚŝƉŽƚĞŶƚŚĞŵĂƚŽƉŽŝĞƚŝĐ
ƉƌŽŐĞŶŝƚŽƌƐ ǁŝƚŚŽƵƚ ĐǇƚŽŬŝŶĞ ĂƵŐŵĞŶƚĂƚŝŽŶ ŝŶ Ă ŶŽǀĞů ƚŚƌĞĞͲĚŝŵĞŶƐŝŽŶĂů ĚĞǀŝĐĞ͘ ǆƉĞƌŝŵĞŶƚĂů
ŚĞŵĂƚŽůŽŐǇ͘ϭϵϵϵ͖Ϯϳ͗ϰϵϲͲϱϬϰ͘
΀ϭϬϵ΁ŚƌŝŶŐ͕ŝďĞƌ<͕hƉƚŽŶdD͕WůŽƐŬǇ͕WǇŬĞƚƚD͕ZŽƐĞŶǌǁĞŝŐD͘ǆƉĂŶƐŝŽŶŽĨ,WƐĨƌŽŵĐŽƌĚ
ďůŽŽĚŝŶĂŶŽǀĞůϯŵĂƚƌŝǆ͘ǇƚŽƚŚĞƌĂƉǇ͘ϮϬϬϯ͖ϱ͗ϰϵϬͲϵ͘
΀ϭϭϬ΁Ăƌŝ^͕ŚƵWW͕>ŝŵ͕&ĂŶy͕'ĂǇ&W͕ƵŶƚĞZD͕ĞƚĂů͘WƌŽƚĞĐƚŝǀĞƌŽůĞŽĨĨƵŶĐƚŝŽŶĂůŝǌĞĚƐŝŶŐůĞ
ǁĂůůĞĚĐĂƌďŽŶŶĂŶŽƚƵďĞƐĞŶŚĂŶĐĞĞǆǀŝǀŽĞǆƉĂŶƐŝŽŶŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĂŶĚƉƌŽŐĞŶŝƚŽƌĐĞůůƐŝŶ
ŚƵŵĂŶƵŵďŝůŝĐĂůĐŽƌĚďůŽŽĚ͘EĂŶŽŵĞĚŝĐŝŶĞ͗ŶĂŶŽƚĞĐŚŶŽůŽŐǇ͕ďŝŽůŽŐǇ͕ĂŶĚŵĞĚŝĐŝŶĞ͘ϮϬϭϯ͘
΀ϭϭϭ΁,ŝƌĂďĂǇĂƐŚŝz͕,ĂƚƚĂz͕dĂŬĞƵĐŚŝ :͕dƐƵďŽŝ /͕,ĂƌĂĚĂd͕KŶŽ<͕ĞƚĂů͘EŽǀĞů ƚŚƌĞĞͲĚŝŵĞŶƐŝŽŶĂů
ůŽŶŐͲƚĞƌŵďŽŶĞŵĂƌƌŽǁĐƵůƚƵƌĞƐǇƐƚĞŵƵƐŝŶŐƉŽůǇŵĞƌƉĂƌƚŝĐůĞƐǁŝƚŚŐƌĂĨƚĞĚĞƉŽǆǇͲƉŽůǇŵĞƌͲĐŚĂŝŶƐ
ƐƵƉƉŽƌƚƐƚŚĞƉƌŽůŝĨĞƌĂƚŝŽŶĂŶĚĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͘ǆƉĞƌŝŵĞŶƚĂůďŝŽůŽŐǇĂŶĚ
ŵĞĚŝĐŝŶĞ͘ϮϬϭϭ͖Ϯϯϲ͗ϭϯϰϮͲϱϬ͘
΀ϭϭϮ΁ ^ŚĂƌŵĂD͕ >ŝŵĂǇĞ >^͕ <ĂůĞ sW͘DŝŵŝĐŬŝŶŐ ƚŚĞ ĨƵŶĐƚŝŽŶĂů ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůů ŶŝĐŚĞ ŝŶ
ǀŝƚƌŽ͗ ƌĞĐĂƉŝƚƵůĂƚŝŽŶ ŽĨ ŵĂƌƌŽǁ ƉŚǇƐŝŽůŽŐǇ ďǇ ŚǇĚƌŽŐĞůͲďĂƐĞĚ ƚŚƌĞĞͲĚŝŵĞŶƐŝŽŶĂů ĐƵůƚƵƌĞƐ ŽĨ
ŵĞƐĞŶĐŚǇŵĂůƐƚƌŽŵĂůĐĞůůƐ͘,ĂĞŵĂƚŽůŽŐŝĐĂ͘ϮϬϭϮ͖ϵϳ͗ϲϱϭͲϲϬ͘
΀ϭϭϯ΁&ĞƌƌĞŝƌĂD^͕:ĂŚŶĞŶͲĞĐŚĞŶƚt͕>ĂďƵĚĞE͕ŽǀŝD͕,ŝĞƌŽŶǇŵƵƐd͕ĞŶŬĞD͕ĞƚĂů͘ŽƌĚďůŽŽĚͲ
ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůů ĞǆƉĂŶƐŝŽŶ ŝŶ ϯ ĨŝďƌŝŶ ƐĐĂĨĨŽůĚƐ ǁŝƚŚ ƐƚƌŽŵĂů ƐƵƉƉŽƌƚ͘ ŝŽŵĂƚĞƌŝĂůƐ͘
ϮϬϭϮ͖ϯϯ͗ϲϵϴϳͲϵϳ͘
΀ϭϭϰ΁&ĞŶŐY͕ŚĂŝ͕:ŝĂŶŐy^͕>ĞŽŶŐ<t͕DĂŽ,Y͘ǆƉĂŶƐŝŽŶŽĨĞŶŐƌĂĨƚŝŶŐŚƵŵĂŶŚĞŵĂƚŽƉŽŝĞƚŝĐ
ƐƚĞŵͬƉƌŽŐĞŶŝƚŽƌĐĞůůƐŝŶƚŚƌĞĞͲĚŝŵĞŶƐŝŽŶĂůƐĐĂĨĨŽůĚƐǁŝƚŚƐƵƌĨĂĐĞͲŝŵŵŽďŝůŝǌĞĚĨŝďƌŽŶĞĐƚŝŶ͘:ŽƵƌŶĂůŽĨ
ďŝŽŵĞĚŝĐĂůŵĂƚĞƌŝĂůƐƌĞƐĞĂƌĐŚWĂƌƚ͘ϮϬϬϲ͖ϳϴ͗ϳϴϭͲϵϭ͘
΀ϭϭϱ΁ ŝĚǁĂŶŝĂ D͕ ŝĚǁĂŶŝĂ ͕ DĞŚƚĂ '͕ ĂƐĂŬ 't͕ zĂƐƵŬĂǁĂ ^͕ dĂŬĂǇĂŵĂ ^͕ Ğƚ Ăů͘ ƌƚŝĨŝĐŝĂů
ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůů ŶŝĐŚĞ͗ ďŝŽƐĐĂĨĨŽůĚƐ ƚŽŵŝĐƌŽĨůƵŝĚŝĐƐ ƚŽŵĂƚŚĞŵĂƚŝĐĂů ƐŝŵƵůĂƚŝŽŶƐ͘ ƵƌƌĞŶƚ
ƚŽƉŝĐƐŝŶŵĞĚŝĐŝŶĂůĐŚĞŵŝƐƚƌǇ͘ϮϬϭϭ͖ϭϭ͗ϭϱϵϵͲϲϬϱ͘
΀ϭϭϲ΁ >Ă/ƵƉƉĂ :͕ DĐĚĂŵƐ d͕ WĂƉŽƵƚƐĂŬŝƐ d͕ DŝůůĞƌ tD͘ ƵůƚƵƌĞ ŵĂƚĞƌŝĂůƐ ĂĨĨĞĐƚ Ğǆ ǀŝǀŽ
ĞǆƉĂŶƐŝŽŶŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐƉƌŽŐĞŶŝƚŽƌĐĞůůƐ͘:ŽƵƌŶĂůŽĨďŝŽŵĞĚŝĐĂůŵĂƚĞƌŝĂůƐƌĞƐĞĂƌĐŚ͘ϭϵϵϳ͖ϯϲ͗ϯϰϳͲ
ϱϵ͘
΀ϭϭϳ΁<ŽƵƚƐŽƉŽƵůŽƐ^͕ŚĂŶŐ^͘>ŽŶŐͲƚĞƌŵƚŚƌĞĞͲĚŝŵĞŶƐŝŽŶĂůŶĞƵƌĂůƚŝƐƐƵĞĐƵůƚƵƌĞƐŝŶĨƵŶĐƚŝŽŶĂůŝǌĞĚ
ƐĞůĨͲĂƐƐĞŵďůŝŶŐƉĞƉƚŝĚĞŚǇĚƌŽŐĞůƐ͕ŵĂƚƌŝŐĞůĂŶĚĐŽůůĂŐĞŶ/͘ĐƚĂďŝŽŵĂƚĞƌŝĂůŝĂ͘ϮϬϭϯ͖ϵ͗ϱϭϲϮͲϵ͘
΀ϭϭϴ΁YŝĂŶ>͕^ĂůƚǌŵĂŶtD͘/ŵƉƌŽǀŝŶŐƚŚĞĞǆƉĂŶƐŝŽŶĂŶĚŶĞƵƌŽŶĂůĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶŽĨŵĞƐĞŶĐŚǇŵĂů
ƐƚĞŵĐĞůůƐƚŚƌŽƵŐŚĐƵůƚƵƌĞƐƵƌĨĂĐĞŵŽĚŝĨŝĐĂƚŝŽŶ͘ŝŽŵĂƚĞƌŝĂůƐ͘ϮϬϬϰ͖Ϯϱ͗ϭϯϯϭͲϳ͘
΀ϭϭϵ΁ ĚĂŵƐ '͘ ĞĐŽŶƐƚƌƵĐƚŝŶŐ ƚŚĞ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůů ŶŝĐŚĞ͗ ƌĞǀĞĂůŝŶŐ ƚŚĞ ƚŚĞƌĂƉĞƵƚŝĐ
ƉŽƚĞŶƚŝĂů͘ZĞŐĞŶĞƌĂƚŝǀĞŵĞĚŝĐŝŶĞ͘ϮϬϬϴ͖ϯ͗ϱϮϯͲϯϬ͘
΀ϭϮϬ΁ ĂŶƵ E͕ ZŽƐĞŶǌǁĞŝŐ D͕ <ŝŵ ,͕ ĂŐůĞǇ :͕ WǇŬĞƚƚ D͘ ǇƚŽŬŝŶĞͲĂƵŐŵĞŶƚĞĚ ĐƵůƚƵƌĞ ŽĨ
ŚĂĞŵĂƚŽƉŽŝĞƚŝĐ ƉƌŽŐĞŶŝƚŽƌ ĐĞůůƐ ŝŶ Ă ŶŽǀĞů ƚŚƌĞĞͲĚŝŵĞŶƐŝŽŶĂů ĐĞůů ŐƌŽǁƚŚ ŵĂƚƌŝǆ͘ ǇƚŽŬŝŶĞ͘
ϮϬϬϭ͖ϭϯ͗ϯϰϵͲϱϴ͘
΀ϭϮϭ΁ ĞůůĂƚŽƌĞ ^D͕ 'ĂƌĐŝĂ ^͕ DŝůůĞƌ tD͘ DŝŵŝĐŬŝŶŐ ƐƚĞŵ ĐĞůů ŶŝĐŚĞƐ ƚŽ ŝŶĐƌĞĂƐĞ ƐƚĞŵ ĐĞůů
ĞǆƉĂŶƐŝŽŶ͘ƵƌƌĞŶƚŽƉŝŶŝŽŶŝŶďŝŽƚĞĐŚŶŽůŽŐǇ͘ϮϬϬϴ͖ϭϵ͗ϱϯϰͲϰϬ͘
΀ϭϮϮ΁,ŽƐŚŝďĂ d͕ >Ƶ,͕ <ĂǁĂǌŽĞE͕ ŚĞŶ'͘ĞĐĞůůƵůĂƌŝǌĞĚŵĂƚƌŝĐĞƐ ĨŽƌ ƚŝƐƐƵĞ ĞŶŐŝŶĞĞƌŝŶŐ͘ ǆƉĞƌƚ
ŽƉŝŶŝŽŶŽŶďŝŽůŽŐŝĐĂůƚŚĞƌĂƉǇ͘ϮϬϭϬ͖ϭϬ͗ϭϳϭϳͲϮϴ͘
ZĞĨĞƌĞŶĐĞƐ
Ϯϯϳ

΀ϭϮϯ΁ ƌĂƉŽ WD͕'ŝůďĞƌƚ dt͕ ĂĚǇůĂŬ ^&͘ ŶŽǀĞƌǀŝĞǁŽĨ ƚŝƐƐƵĞ ĂŶĚǁŚŽůĞŽƌŐĂŶ ĚĞĐĞůůƵůĂƌŝǌĂƚŝŽŶ
ƉƌŽĐĞƐƐĞƐ͘ŝŽŵĂƚĞƌŝĂůƐ͘ϮϬϭϭ͖ϯϮ͗ϯϮϯϯͲϰϯ͘
΀ϭϮϰ΁ ŶŐůĞƌ :͕ ^ĞŶ ^͕ ^ǁĞĞŶĞǇ ,>͕ ŝƐĐŚĞƌ ͘ DĂƚƌŝǆ ĞůĂƐƚŝĐŝƚǇ ĚŝƌĞĐƚƐ ƐƚĞŵ ĐĞůů ůŝŶĞĂŐĞ
ƐƉĞĐŝĨŝĐĂƚŝŽŶ͘Ğůů͘ϮϬϬϲ͖ϭϮϲ͗ϲϳϳͲϴϵ͘
΀ϭϮϱ΁ >ŝ ͕ ŚŽƵ :͕ ŚŽǁĚŚƵƌǇ &͕ ŚĞŶŐ :͕ tĂŶŐ E͕ tĂŶŐ &͘ ZŽůĞ ŽĨ ŵĞĐŚĂŶŝĐĂů ĨĂĐƚŽƌƐ ŝŶ ĨĂƚĞ
ĚĞĐŝƐŝŽŶƐŽĨƐƚĞŵĐĞůůƐ͘ZĞŐĞŶĞƌĂƚŝǀĞŵĞĚŝĐŝŶĞ͘ϮϬϭϭ͖ϲ͗ϮϮϵͲϰϬ͘
΀ϭϮϲ΁ >ĞĞͲdŚĞĚŝĞĐŬ ͕ ZĂƵĐŚE͕ &ŝĂŵŵĞŶŐŽ Z͕ <ůĞŝŶ '͕ ^ƉĂƚǌ :W͘ /ŵƉĂĐƚ ŽĨ ƐƵďƐƚƌĂƚĞ ĞůĂƐƚŝĐŝƚǇ ŽŶ
ŚƵŵĂŶ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĂŶĚ ƉƌŽŐĞŶŝƚŽƌ ĐĞůů ĂĚŚĞƐŝŽŶ ĂŶĚ ŵŽƚŝůŝƚǇ͘ :ŽƵƌŶĂů ŽĨ ĐĞůů ƐĐŝĞŶĐĞ͘
ϮϬϭϮ͖ϭϮϱ͗ϯϳϲϱͲϳϱ͘
΀ϭϮϳ΁ ŝǌŵĂŶ /͕ dĂƚĞ ͕ DĐ'ƌŽŐĂŶ D͕ ĂƐĞ ͘ ǆƚƌĂĐĞůůƵůĂƌ ŵĂƚƌŝǆ ƉƌŽĚƵĐĞĚ ďǇ ďŽŶĞ ŵĂƌƌŽǁ
ƐƚƌŽŵĂů ĐĞůůƐ ĂŶĚ ďǇ ƚŚĞŝƌ ĚĞƌŝǀĂƚŝǀĞ͕ ^ϲϮϯ ĐĞůůƐ͕ ƐƵƉƉŽƌƚƐ ŶĞƵƌĂů ĐĞůů ŐƌŽǁƚŚ͘ :ŽƵƌŶĂů ŽĨ
ŶĞƵƌŽƐĐŝĞŶĐĞƌĞƐĞĂƌĐŚ͘ϮϬϬϵ͖ϴϳ͗ϯϭϵϴͲϮϬϲ͘
΀ϭϮϴ΁ĞYƵĂĐŚ:͕zƵĂŶ^,͕'ŽůĚƐƚĞŝŶ>^͕ŚƌŝƐƚŵĂŶ<>͘ĞĐĞůůƵůĂƌŝǌĞĚƉŽƌĐŝŶĞďƌĂŝŶŵĂƚƌŝǆĨŽƌĐĞůů
ĐƵůƚƵƌĞĂŶĚƚŝƐƐƵĞĞŶŐŝŶĞĞƌŝŶŐƐĐĂĨĨŽůĚƐ͘dŝƐƐƵĞĞŶŐŝŶĞĞƌŝŶŐWĂƌƚ͘ϮϬϭϭ͖ϭϳ͗ϮϱϴϯͲϵϮ͘
΀ϭϮϵ΁ ŚĞŶ y͕ ƵƐĞǀŝĐŚ s͕ &ĞŶŐ :Y͕ DĂŶŽůĂŐĂƐ ^͕ :ŝůŬĂ Z>͘ ǆƚƌĂĐĞůůƵůĂƌ ŵĂƚƌŝǆ ŵĂĚĞ ďǇ ďŽŶĞ
ŵĂƌƌŽǁ ĐĞůůƐ ĨĂĐŝůŝƚĂƚĞƐ ĞǆƉĂŶƐŝŽŶ ŽĨŵĂƌƌŽǁͲĚĞƌŝǀĞĚŵĞƐĞŶĐŚǇŵĂů ƉƌŽŐĞŶŝƚŽƌ ĐĞůůƐ ĂŶĚ ƉƌĞǀĞŶƚƐ
ƚŚĞŝƌĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶ ŝŶƚŽŽƐƚĞŽďůĂƐƚƐ͘ :ŽƵƌŶĂůŽĨďŽŶĞĂŶĚŵŝŶĞƌĂů ƌĞƐĞĂƌĐŚ ͗ ƚŚĞŽĨĨŝĐŝĂů ũŽƵƌŶĂůŽĨ
ƚŚĞŵĞƌŝĐĂŶ^ŽĐŝĞƚǇĨŽƌŽŶĞĂŶĚDŝŶĞƌĂůZĞƐĞĂƌĐŚ͘ϮϬϬϳ͖ϮϮ͗ϭϵϰϯͲϱϲ͘
΀ϭϯϬ΁tŝůƐŚĂǁ ^W͕ <ĞĂƌŶĞǇ :E͕ &ŝƐŚĞƌ :͕ /ŶŐŚĂŵ͘ WƌŽĚƵĐƚŝŽŶ ŽĨ ĂŶ ĂĐĞůůƵůĂƌ ĂŵŶŝŽƚŝĐŵĞŵďƌĂŶĞ
ŵĂƚƌŝǆĨŽƌƵƐĞŝŶƚŝƐƐƵĞĞŶŐŝŶĞĞƌŝŶŐ͘dŝƐƐƵĞĞŶŐŝŶĞĞƌŝŶŐ͘ϮϬϬϲ͖ϭϮ͗ϮϭϭϳͲϮϵ͘
΀ϭϯϭ΁,ĞĚŵĂŶ<͕<ƵƌŬŝŶĞŶD͕ůŝƚĂůŽ<͕sĂŚĞƌŝ͕:ŽŚĂŶƐƐŽŶ^͕,ŽŽŬD͘/ƐŽůĂƚŝŽŶŽĨƚŚĞƉĞƌŝĐĞůůƵůĂƌ
ŵĂƚƌŝǆŽĨŚƵŵĂŶĨŝďƌŽďůĂƐƚĐƵůƚƵƌĞƐ͘dŚĞ:ŽƵƌŶĂůŽĨĐĞůůďŝŽůŽŐǇ͘ϭϵϳϵ͖ϴϭ͗ϴϯͲϵϭ͘
΀ϭϯϮ΁,ŽƐŽŬĂǁĂd͕ĞƚƐƵǇĂŬƵd͕EŝƐŚŝŵƵƌĂD͕&ƵƌƵǇĂŵĂ͕<ĂƚĂŐŝƌŝ<͕DŽĐŚŝƚĂƚĞ<͘ŝĨĨĞƌĞŶƚŝĂƚŝŽŶŽĨ
ƚƌĂĐŚĞĂů ďĂƐĂů ĐĞůůƐ ƚŽ ĐŝůŝĂƚĞĚ ĐĞůůƐ ĂŶĚ ƚŝƐƐƵĞ ƌĞĐŽŶƐƚƌƵĐƚŝŽŶ ŽŶ ƚŚĞ ƐǇŶƚŚĞƐŝǌĞĚ ďĂƐĞŵĞŶƚ
ŵĞŵďƌĂŶĞƐƵďƐƚƌĂƚƵŵŝŶǀŝƚƌŽ͘ŽŶŶĞĐƚŝǀĞƚŝƐƐƵĞƌĞƐĞĂƌĐŚ͘ϮϬϬϳ͖ϰϴ͗ϵͲϭϴ͘
΀ϭϯϯ΁ ,ŝŐƵĐŚŝ z͕ ^ŚŝƌĂŬŝ E͕ zĂŵĂŶĞ <͕ YŝŶ ͕ DŽĐŚŝƚĂƚĞ <͕ ƌĂŬŝ <͕ Ğƚ Ăů͘ ^ǇŶƚŚĞƐŝǌĞĚ ďĂƐĞŵĞŶƚ
ŵĞŵďƌĂŶĞƐ ĚŝƌĞĐƚ ƚŚĞ ĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶ ŽĨ ŵŽƵƐĞ ĞŵďƌǇŽŶŝĐ ƐƚĞŵ ĐĞůůƐ ŝŶƚŽ ƉĂŶĐƌĞĂƚŝĐ ůŝŶĞĂŐĞƐ͘
:ŽƵƌŶĂůŽĨĐĞůůƐĐŝĞŶĐĞ͘ϮϬϭϬ͖ϭϮϯ͗ϮϳϯϯͲϰϮ͘
΀ϭϯϰ΁WŚĂŵDd͕ZĞƵƚŚĞƌ,͕DĂŝƚǌD&͘EĂƚŝǀĞĞǆƚƌĂĐĞůůƵůĂƌŵĂƚƌŝǆĐŽĂƚŝŶŐŽŶdŝƐƵƌĨĂĐĞƐ͘:ŽƵƌŶĂůŽĨ
ďŝŽŵĞĚŝĐĂůŵĂƚĞƌŝĂůƐƌĞƐĞĂƌĐŚWĂƌƚ͘ϮϬϬϯ͖ϲϲ͗ϯϭϬͲϲ͘
΀ϭϯϱ΁ >Ăŝ z͕ ^ƵŶ z͕ ^ŬŝŶŶĞƌ D͕ ^ŽŶ >͕ >Ƶ ͕ dƵĂŶ Z^͕ Ğƚ Ăů͘ ZĞĐŽŶƐƚŝƚƵƚŝŽŶ ŽĨ ŵĂƌƌŽǁͲĚĞƌŝǀĞĚ
ĞǆƚƌĂĐĞůůƵůĂƌ ŵĂƚƌŝǆ Ğǆ ǀŝǀŽ͗ Ă ƌŽďƵƐƚ ĐƵůƚƵƌĞ ƐǇƐƚĞŵ ĨŽƌ ĞǆƉĂŶĚŝŶŐ ůĂƌŐĞͲƐĐĂůĞ ŚŝŐŚůǇ ĨƵŶĐƚŝŽŶĂů
ŚƵŵĂŶŵĞƐĞŶĐŚǇŵĂůƐƚĞŵĐĞůůƐ͘^ƚĞŵĐĞůůƐĂŶĚĚĞǀĞůŽƉŵĞŶƚ͘ϮϬϭϬ͖ϭϵ͗ϭϬϵϱͲϭϬϳ͘
΀ϭϯϲ΁ŚŽŝ<,͕ŚŽŝ,͕WĂƌŬ^Z͕<ŝŵ:͕DŝŶ,͘dŚĞĐŚŽŶĚƌŽŐĞŶŝĐĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶŽĨŵĞƐĞŶĐŚǇŵĂů
ƐƚĞŵ ĐĞůůƐ ŽŶ ĂŶ ĞǆƚƌĂĐĞůůƵůĂƌ ŵĂƚƌŝǆ ƐĐĂĨĨŽůĚ ĚĞƌŝǀĞĚ ĨƌŽŵ ƉŽƌĐŝŶĞ ĐŚŽŶĚƌŽĐǇƚĞƐ͘ ŝŽŵĂƚĞƌŝĂůƐ͘
ϮϬϭϬ͖ϯϭ͗ϱϯϱϱͲϲϱ͘
΀ϭϯϳ΁ ƌŽĚŬŝŶ <Z͕ 'ĂƌĐŝĂ :͕ >ĞǀĞŶƐƚŽŶ D͘ ŚŽŶĚƌŽĐǇƚĞ ƉŚĞŶŽƚǇƉĞƐ ŽŶ ĚŝĨĨĞƌĞŶƚ ĞǆƚƌĂĐĞůůƵůĂƌ
ŵĂƚƌŝǆŵŽŶŽůĂǇĞƌƐ͘ŝŽŵĂƚĞƌŝĂůƐ͘ϮϬϬϰ͖Ϯϱ͗ϱϵϮϵͲϯϴ͘
΀ϭϯϴ΁,ŽƐŚŝďĂd͕<ĂǁĂǌŽĞE͕dĂƚĞŝƐŚŝd͕ŚĞŶ'͘ĞǀĞůŽƉŵĞŶƚŽĨĞǆƚƌĂĐĞůůƵůĂƌŵĂƚƌŝĐĞƐŵŝŵŝĐŬŝŶŐ
ƐƚĞƉǁŝƐĞĂĚŝƉŽŐĞŶĞƐŝƐŽĨŵĞƐĞŶĐŚǇŵĂůƐƚĞŵĐĞůůƐ͘ĚǀĂŶĐĞĚŵĂƚĞƌŝĂůƐ͘ϮϬϭϬ͖ϮϮ͗ϯϬϰϮͲϳ͘
΀ϭϯϵ΁ &ƌĂŶŬĞ <͕ WŽŵƉĞ d͕ ŽƌŶŚĂƵƐĞƌD͕tĞƌŶĞƌ ͘ ŶŐŝŶĞĞƌĞĚŵĂƚƌŝǆ ĐŽĂƚŝŶŐƐ ƚŽŵŽĚƵůĂƚĞ ƚŚĞ
ĂĚŚĞƐŝŽŶŽĨϭϯϯнŚƵŵĂŶŚĞŵĂƚŽƉŽŝĞƚŝĐƉƌŽŐĞŶŝƚŽƌĐĞůůƐ͘ŝŽŵĂƚĞƌŝĂůƐ͘ϮϬϬϳ͖Ϯϴ͗ϴϯϲͲϰϯ͘
΀ϭϰϬ΁ ŚĂƚŝĂ D͕ tĂůƚĞƌƐ D͘ ,ĞŵĂƚŽƉŽŝĞƚŝĐ ĐĞůů ƚƌĂŶƐƉůĂŶƚĂƚŝŽŶ ĨŽƌ ƚŚĂůĂƐƐĞŵŝĂ ĂŶĚ ƐŝĐŬůĞ ĐĞůů
ĚŝƐĞĂƐĞ͗ƉĂƐƚ͕ƉƌĞƐĞŶƚĂŶĚĨƵƚƵƌĞ͘ŽŶĞŵĂƌƌŽǁƚƌĂŶƐƉůĂŶƚĂƚŝŽŶ͘ϮϬϬϴ͖ϰϭ͗ϭϬϵͲϭϳ͘
΀ϭϰϭ΁ĂŶŬ͕ŽƌĂǌŝŽZ͕>ĞďŽƵůĐŚW͘ƉŚĂƐĞ/ͬ//ĐůŝŶŝĐĂůƚƌŝĂůŽĨďĞƚĂͲŐůŽďŝŶŐĞŶĞƚŚĞƌĂƉǇĨŽƌďĞƚĂͲ
ƚŚĂůĂƐƐĞŵŝĂ͘ŶŶĂůƐŽĨƚŚĞEĞǁzŽƌŬĐĂĚĞŵǇŽĨ^ĐŝĞŶĐĞƐ͘ϮϬϬϱ͖ϭϬϱϰ͗ϯϬϴͲϭϲ͘
΀ϭϰϮ΁WĂŝD͕ĂĐŚĂƌŽƵůŝƐ͕DŝůŝĐĞǀŝĐDE͕,ĞůŵǇ^͕:ŝĂŽ>Z͕>ĞǀŝĐĂƌE͕ĞƚĂů͘ƵƚŽůŽŐŽƵƐ ŝŶĨƵƐŝŽŶŽĨ
ĞǆƉĂŶĚĞĚ ŵŽďŝůŝǌĞĚ ĂĚƵůƚ ďŽŶĞ ŵĂƌƌŽǁͲĚĞƌŝǀĞĚ ϯϰн ĐĞůůƐ ŝŶƚŽ ƉĂƚŝĞŶƚƐ ǁŝƚŚ ĂůĐŽŚŽůŝĐ ůŝǀĞƌ
ĐŝƌƌŚŽƐŝƐ͘dŚĞŵĞƌŝĐĂŶũŽƵƌŶĂůŽĨŐĂƐƚƌŽĞŶƚĞƌŽůŽŐǇ͘ϮϬϬϴ͖ϭϬϯ͗ϭϵϱϮͲϴ͘
΀ϭϰϯ΁^ĂŬĂŐƵĐŚŝ^͕zĂŵĂŐƵĐŚŝd͕EŽŵƵƌĂd͕KŶŽD͘ZĞŐƵůĂƚŽƌǇdĐĞůůƐĂŶĚ ŝŵŵƵŶĞƚŽůĞƌĂŶĐĞ͘Ğůů͘
ϮϬϬϴ͖ϭϯϯ͗ϳϳϱͲϴϳ͘
ZĞĨĞƌĞŶĐĞƐ
Ϯϯϴ

΀ϭϰϰ΁ŚĂŽz͕:ŝĂŶŐ͕ŚĂŽd͕zĞD͕,Ƶ͕zŝŶ͕ĞƚĂů͘ZĞǀĞƌƐĂůŽĨƚǇƉĞϭĚŝĂďĞƚĞƐǀŝĂŝƐůĞƚďĞƚĂĐĞůů
ƌĞŐĞŶĞƌĂƚŝŽŶ ĨŽůůŽǁŝŶŐ ŝŵŵƵŶĞ ŵŽĚƵůĂƚŝŽŶ ďǇ ĐŽƌĚ ďůŽŽĚͲĚĞƌŝǀĞĚ ŵƵůƚŝƉŽƚĞŶƚ ƐƚĞŵ ĐĞůůƐ͘ D
ŵĞĚŝĐŝŶĞ͘ϮϬϭϮ͖ϭϬ͗ϯ͘
΀ϭϰϱ΁^ŚƉĂůů:͕YƵŝŶŽŶĞƐZ͕'ŝůůĞƌZ͕ĞŶŐ͕ĂƌŽŶ͕ :ŽŶĞƐZ͕ĞƚĂů͘dƌĂŶƐƉůĂŶƚĂƚŝŽŶŽĨĞǆǀŝǀŽ
ĞǆƉĂŶĚĞĚĐŽƌĚďůŽŽĚ͘ŝŽůŽŐǇŽĨďůŽŽĚĂŶĚŵĂƌƌŽǁƚƌĂŶƐƉůĂŶƚĂƚŝŽŶ͗ũŽƵƌŶĂůŽĨƚŚĞŵĞƌŝĐĂŶ^ŽĐŝĞƚǇ
ĨŽƌůŽŽĚĂŶĚDĂƌƌŽǁdƌĂŶƐƉůĂŶƚĂƚŝŽŶ͘ϮϬϬϮ͖ϴ͗ϯϲϴͲϳϲ͘
΀ϭϰϲ΁DĐEŝĞĐĞ/͕<ƵďĞŐŽǀ͕<ĞƌǌŝĐW͕^ŚƉĂůů:͕'ƌŽƐƐ^͘/ŶĐƌĞĂƐĞĚĞǆƉĂŶƐŝŽŶĂŶĚĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶŽĨ
ĐŽƌĚďůŽŽĚƉƌŽĚƵĐƚƐƵƐŝŶŐĂƚǁŽͲƐƚĞƉĞǆƉĂŶƐŝŽŶĐƵůƚƵƌĞ͘ǆƉĞƌŝŵĞŶƚĂůŚĞŵĂƚŽůŽŐǇ͘ϮϬϬϬ͖Ϯϴ͗ϭϭϴϭͲϲ͘
΀ϭϰϳ΁ĞůĂŶĞǇ͕,ĞŝŵĨĞůĚ^͕ƌĂƐŚĞŵͲ^ƚĞŝŶ͕sŽŽƌŚŝĞƐ,͕DĂŶŐĞƌZ>͕ĞƌŶƐƚĞŝŶ/͘EŽƚĐŚͲŵĞĚŝĂƚĞĚ
ĞǆƉĂŶƐŝŽŶ ŽĨ ŚƵŵĂŶ ĐŽƌĚ ďůŽŽĚ ƉƌŽŐĞŶŝƚŽƌ ĐĞůůƐ ĐĂƉĂďůĞ ŽĨ ƌĂƉŝĚŵǇĞůŽŝĚ ƌĞĐŽŶƐƚŝƚƵƚŝŽŶ͘ EĂƚƵƌĞ
ŵĞĚŝĐŝŶĞ͘ϮϬϭϬ͖ϭϲ͗ϮϯϮͲϲ͘
΀ϭϰϴ΁'ĞƌƚŽǁ:͕ĞƌŐůƵŶĚ^͕KŬĂƐD͕<ĂƌƌĞ<͕ZĞŵďĞƌŐĞƌD͕DĂƚƚƐƐŽŶ:͕ĞƚĂů͘ǆƉĂŶƐŝŽŶŽĨdͲĐĞůůƐ
ĨƌŽŵ ƚŚĞ ĐŽƌĚ ďůŽŽĚ ŐƌĂĨƚ ĂƐ Ă ƉƌĞĚŝĐƚŝǀĞ ƚŽŽů ĨŽƌ ĐŽŵƉůŝĐĂƚŝŽŶƐ ĂŶĚ ŽƵƚĐŽŵĞ ŽĨ ĐŽƌĚ ďůŽŽĚ
ƚƌĂŶƐƉůĂŶƚĂƚŝŽŶ͘ůŝŶŝĐĂůŝŵŵƵŶŽůŽŐǇ͘ϮϬϭϮ͖ϭϰϯ͗ϭϯϰͲϰϰ͘
΀ϭϰϵ΁ DĐEŝĞĐĞ /͕ ,ĂƌƌŝŶŐƚŽŶ :͕ dƵƌŶĞǇ :͕ <ĞůůŶĞƌ :͕ ^ŚƉĂůů :͘ ǆ ǀŝǀŽ ĞǆƉĂŶƐŝŽŶ ŽĨ ĐŽƌĚ ďůŽŽĚ
ŵŽŶŽŶƵĐůĞĂƌĐĞůůƐŽŶŵĞƐĞŶĐŚǇŵĂůƐƚĞŵĐĞůůƐ͘ǇƚŽƚŚĞƌĂƉǇ͘ϮϬϬϰ͖ϲ͗ϯϭϭͲϳ͘
΀ϭϱϬ΁ tĂůĂƐĞŬ D͕ ǀĂŶ KƐ Z͕ ĚĞ ,ĂĂŶ '͘ ,ĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůů ĞǆƉĂŶƐŝŽŶ͗ ĐŚĂůůĞŶŐĞƐ ĂŶĚ
ŽƉƉŽƌƚƵŶŝƚŝĞƐ͘ŶŶĂůƐŽĨƚŚĞEĞǁzŽƌŬĐĂĚĞŵǇŽĨ^ĐŝĞŶĐĞƐ͘ϮϬϭϮ͖ϭϮϲϲ͗ϭϯϴͲϱϬ͘
΀ϭϱϭ΁ 'ƵĞŶĞĐŚĞĂ '͕ ^ĞŐŽǀŝĂ :͕ ůďĞůůĂ ͕ >ĂŵĂŶĂ D͕ ZĂŵŝƌĞǌ D͕ ZĞŐŝĚŽƌ ͕ Ğƚ Ăů͘ ĞůĂǇĞĚ
ĞŶŐƌĂĨƚŵĞŶƚ ŽĨ ŶŽŶŽďĞƐĞ ĚŝĂďĞƚŝĐͬƐĞǀĞƌĞ ĐŽŵďŝŶĞĚ ŝŵŵƵŶŽĚĞĨŝĐŝĞŶƚ ŵŝĐĞ ƚƌĂŶƐƉůĂŶƚĞĚ ǁŝƚŚ Ğǆ
ǀŝǀŽͲĞǆƉĂŶĚĞĚŚƵŵĂŶϯϰ;нͿĐŽƌĚďůŽŽĚĐĞůůƐ͘ůŽŽĚ͘ϭϵϵϵ͖ϵϯ͗ϭϬϵϳͲϭϬϱ͘
΀ϭϱϮ΁ŽŵĞŶ:͕ŚĞƐŚŝĞƌ^,͕tĞŝƐƐŵĂŶ/>͘dŚĞƌŽůĞŽĨĂƉŽƉƚŽƐŝƐŝŶƚŚĞƌĞŐƵůĂƚŝŽŶŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐ
ƐƚĞŵ ĐĞůůƐ͗ KǀĞƌĞǆƉƌĞƐƐŝŽŶ ŽĨ ĐůͲϮ ŝŶĐƌĞĂƐĞƐ ďŽƚŚ ƚŚĞŝƌ ŶƵŵďĞƌ ĂŶĚ ƌĞƉŽƉƵůĂƚŝŽŶ ƉŽƚĞŶƚŝĂů͘ dŚĞ
:ŽƵƌŶĂůŽĨĞǆƉĞƌŝŵĞŶƚĂůŵĞĚŝĐŝŶĞ͘ϮϬϬϬ͖ϭϵϭ͗ϮϱϯͲϲϰ͘
΀ϭϱϯ΁>ŝƵ͕ƵĐŬůĞǇ^D͕>ĞǁŝƐ/͕'ŽůĚŵĂŶ/͕tĂŐŶĞƌ:͕ǀĂŶĚĞƌ>ŽŽ:͘,ŽŵŝŶŐĚĞĨĞĐƚŽĨĐƵůƚƵƌĞĚ
ŚƵŵĂŶ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ĐĞůůƐ ŝŶ ƚŚĞ EKͬ^/ ŵŽƵƐĞ ŝƐ ŵĞĚŝĂƚĞĚ ďǇ &ĂƐͬϵϱ͘ ǆƉĞƌŝŵĞŶƚĂů
ŚĞŵĂƚŽůŽŐǇ͘ϮϬϬϯ͖ϯϭ͗ϴϮϰͲϯϮ͘
΀ϭϱϰ΁'ŝĞƚK͕,ƵǇŐĞŶ^͕ĞŐƵŝŶz͕'ŽƚŚŽƚ͘ĞůůĐǇĐůĞĂĐƚŝǀĂƚŝŽŶŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐƉƌŽŐĞŶŝƚŽƌĐĞůůƐ
ŝŶĐƌĞĂƐĞƐ ǀĞƌǇ ůĂƚĞ ĂŶƚŝŐĞŶͲϱͲŵĞĚŝĂƚĞĚ ĂĚŚĞƐŝŽŶ ƚŽ ĨŝďƌŽŶĞĐƚŝŶ͘ ǆƉĞƌŝŵĞŶƚĂů ŚĞŵĂƚŽůŽŐǇ͘
ϮϬϬϭ͖Ϯϵ͗ϱϭϱͲϮϰ͘
΀ϭϱϱ΁dƌĂŶŶŽǇ>>͕ǀĂŶ,ĞŶƐďĞƌŐĞŶz͕>ĂŐĞƌďĞƌŐ:t͕ƌĂŶĚ͘WŚŽƚŽĚǇŶĂŵŝĐƚƌĞĂƚŵĞŶƚǁŝƚŚŵŽŶŽͲ
ƉŚĞŶǇůͲƚƌŝͲ;EͲŵĞƚŚǇůͲϰͲƉǇƌŝĚǇůͿͲƉŽƌƉŚǇƌŝŶĨŽƌƉĂƚŚŽŐĞŶŝŶĂĐƚŝǀĂƚŝŽŶŝŶĐŽƌĚďůŽŽĚƐƚĞŵĐĞůůƉƌŽĚƵĐƚƐ͘
dƌĂŶƐĨƵƐŝŽŶ͘ϮϬϬϴ͖ϰϴ͗ϮϲϮϵͲϯϳ͘
΀ϭϱϲ΁ŚĂŶŐ͕<ĂďĂD͕/ŝǌƵŬĂ^͕,ƵǇŶŚ,͕>ŽĚŝƐŚ,&͘ŶŐŝŽƉŽŝĞƚŝŶͲůŝŬĞϱĂŶĚ/'&WϮƐƚŝŵƵůĂƚĞĞǆ
ǀŝǀŽ ĞǆƉĂŶƐŝŽŶ ŽĨ ŚƵŵĂŶ ĐŽƌĚ ďůŽŽĚ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůůƐ ĂƐ ĂƐƐĂǇĞĚ ďǇ EKͬ^/
ƚƌĂŶƐƉůĂŶƚĂƚŝŽŶ͘ůŽŽĚ͘ϮϬϬϴ͖ϭϭϭ͗ϯϰϭϱͲϮϯ͘
΀ϭϱϳ΁ ĞůĂŶĞǇ ͕ sĂƌŶƵŵͲ&ŝŶŶĞǇ ͕ ŽǇĂŵĂ <͕ ƌĂƐŚĞŵͲ^ƚĞŝŶ ͕ ĞƌŶƐƚĞŝŶ /͘ ŽƐĞͲĚĞƉĞŶĚĞŶƚ
ĞĨĨĞĐƚƐŽĨƚŚĞEŽƚĐŚůŝŐĂŶĚĞůƚĂϭŽŶĞǆǀŝǀŽĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶĂŶĚŝŶǀŝǀŽŵĂƌƌŽǁƌĞƉŽƉƵůĂƚŝŶŐĂďŝůŝƚǇ
ŽĨĐŽƌĚďůŽŽĚĐĞůůƐ͘ůŽŽĚ͘ϮϬϬϱ͖ϭϬϲ͗ϮϲϵϯͲϵ͘
΀ϭϱϴ΁tĂƚƚƐ<>͕ĞůĂŶĞǇ͕,ƵŵƉŚƌŝĞƐZ<͕ĞƌŶƐƚĞŝŶ/͕<ŝĞŵ,W͘ŽŵďŝŶĂƚŝŽŶŽĨ,KyϰĂŶĚĞůƚĂͲϭ
ůŝŐĂŶĚŝŵƉƌŽǀĞƐĞǆƉĂŶƐŝŽŶŽĨĐŽƌĚďůŽŽĚĐĞůůƐ͘ůŽŽĚ͘ϮϬϭϬ͖ϭϭϲ͗ϱϴϱϵͲϲϲ͘
΀ϭϱϵ΁ ŽŝƚĂŶŽ ͕ tĂŶŐ :͕ ZŽŵĞŽ Z͕ ŽƵĐŚĞǌ >͕ WĂƌŬĞƌ ͕ ^ƵƚƚŽŶ ^͕ Ğƚ Ăů͘ ƌǇů ŚǇĚƌŽĐĂƌďŽŶ
ƌĞĐĞƉƚŽƌ ĂŶƚĂŐŽŶŝƐƚƐ ƉƌŽŵŽƚĞ ƚŚĞ ĞǆƉĂŶƐŝŽŶ ŽĨ ŚƵŵĂŶ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůůƐ͘ ^ĐŝĞŶĐĞ͘
ϮϬϭϬ͖ϯϮϵ͗ϭϯϰϱͲϴ͘
΀ϭϲϬ΁'ƵŝůĂŬ&͕ŽŚĞŶD͕ƐƚĞƐd͕'ŝŵďůĞ :D͕>ŝĞĚƚŬĞt͕ŚĞŶ^͘ŽŶƚƌŽůŽĨ^ƚĞŵĞůů&ĂƚĞďǇ
WŚǇƐŝĐĂů/ŶƚĞƌĂĐƚŝŽŶƐǁŝƚŚƚŚĞǆƚƌĂĐĞůůƵůĂƌDĂƚƌŝǆ͘Ğůů^ƚĞŵĞůů͘ϮϬϬϵ͖ϱ͗ϭϳͲϮϲ͘
΀ϭϲϭ΁>ŽĞůƐŽ͕^ĐĂĚĚĞŶd͘dŚĞŚĂĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůŶŝĐŚĞĂƚĂŐůĂŶĐĞ͘:ŽƵƌŶĂůŽĨĐĞůůƐĐŝĞŶĐĞ͘
ϮϬϭϭ͖ϭϮϰ͗ϯϱϮϵͲϯϱ͘
΀ϭϲϮ΁ EǁĂũĞŝ &͕ <ŽŶŽƉůĞǀĂ D͘ dŚĞ ďŽŶĞ ŵĂƌƌŽǁ ŵŝĐƌŽĞŶǀŝƌŽŶŵĞŶƚ ĂƐ ŶŝĐŚĞ ƌĞƚƌĞĂƚƐ ĨŽƌ
ŚĞŵĂƚŽƉŽŝĞƚŝĐĂŶĚůĞƵŬĞŵŝĐƐƚĞŵĐĞůůƐ͘ĚǀĂŶĐĞƐŝŶŚĞŵĂƚŽůŽŐǇ͘ϮϬϭϯ͖ϮϬϭϯ͗ϵϱϯϵϴϮ͘
ZĞĨĞƌĞŶĐĞƐ
Ϯϯϵ

΀ϭϲϯ΁ EĂŬĂŵƵƌĂͲ/ƐŚŝǌƵ ͕ KŬƵŶŽ z͕ KŵĂƚƐƵ z͕ KŬĂďĞ <͕DŽƌŝŵŽƚŽ :͕ hĞĚĞ d͕ Ğƚ Ăů͘ ǆƚƌĂĐĞůůƵůĂƌ
ŵĂƚƌŝǆ ƉƌŽƚĞŝŶ ƚĞŶĂƐĐŝŶͲ ŝƐ ƌĞƋƵŝƌĞĚ ŝŶ ƚŚĞ ďŽŶĞ ŵĂƌƌŽǁ ŵŝĐƌŽĞŶǀŝƌŽŶŵĞŶƚ ƉƌŝŵĞĚ ĨŽƌ
ŚĞŵĂƚŽƉŽŝĞƚŝĐƌĞŐĞŶĞƌĂƚŝŽŶ͘ůŽŽĚ͘ϮϬϭϮ͖ϭϭϵ͗ϱϰϮϵͲϯϳ͘
΀ϭϲϰ΁<ůĞŝŶŵĂŶ,<͕WŚŝůƉ͕,ŽĨĨŵĂŶDW͘ZŽůĞŽĨƚŚĞĞǆƚƌĂĐĞůůƵůĂƌŵĂƚƌŝǆŝŶŵŽƌƉŚŽŐĞŶĞƐŝƐ͘ƵƌƌĞŶƚ
ŽƉŝŶŝŽŶŝŶďŝŽƚĞĐŚŶŽůŽŐǇ͘ϮϬϬϯ͖ϭϰ͗ϱϮϲͲϯϮ͘
΀ϭϲϱ΁ ZŽĞĐŬůĞŝŶ ͕ dŽƌŽŬͲ^ƚŽƌď ͘ &ƵŶĐƚŝŽŶĂůůǇ ĚŝƐƚŝŶĐƚ ŚƵŵĂŶ ŵĂƌƌŽǁ ƐƚƌŽŵĂů ĐĞůů ůŝŶĞƐ
ŝŵŵŽƌƚĂůŝǌĞĚ ďǇ ƚƌĂŶƐĚƵĐƚŝŽŶ ǁŝƚŚ ƚŚĞ ŚƵŵĂŶ ƉĂƉŝůůŽŵĂ ǀŝƌƵƐ ϲͬϳ ŐĞŶĞƐ͘ ůŽŽĚ͘ ϭϵϵϱ͖ϴϱ͗ϵϵϳͲ
ϭϬϬϱ͘
΀ϭϲϲ΁>ĂĞŵŵůŝh<͘ůĞĂǀĂŐĞŽĨƐƚƌƵĐƚƵƌĂůƉƌŽƚĞŝŶƐĚƵƌŝŶŐƚŚĞĂƐƐĞŵďůǇŽĨƚŚĞŚĞĂĚŽĨďĂĐƚĞƌŝŽƉŚĂŐĞ
dϰ͘EĂƚƵƌĞ͘ϭϵϳϬ͖ϮϮϳ͗ϲϴϬͲϱ͘
΀ϭϲϳ΁'ĂůĂŶ /͕Ğ>ĞŽŶ :͕ŝĂǌ >͕,ŽŶŐ :^͕<ŚĂůĞŬE͕DƵŶŽǌͲ&ĞƌŶĂŶĚĞǌD͕ĞƚĂů͘ĨĨĞĐƚŽĨĂďŽŶĞ
ŵĂƌƌŽǁŵŝĐƌŽĞŶǀŝƌŽŶŵĞŶƚŽŶƚŚĞĞǆͲǀŝǀŽĞǆƉĂŶƐŝŽŶŽĨƵŵďŝůŝĐĂů ĐŽƌĚďůŽŽĚƉƌŽŐĞŶŝƚŽƌ ĐĞůůƐ͘ /Ŷƚ :
>Ăď,ĞŵĂƚŽů͘ϮϬϬϳ͖Ϯϵ͗ϱϴͲϲϯ͘
΀ϭϲϴ΁ZŽĚŐĞƌƐ<͕^ĂŶŶƚŽŶŝŽ:͕:ĂĐĞŶŬŽK͘,ĞƉĂƌĂŶƐƵůĨĂƚĞƉƌŽƚĞŽŐůǇĐĂŶƐ͗Ă''ŐůĞŽĨƐŬĞůĞƚĂůͲ
ŚĞŵĂƚŽƉŽŝĞƚŝĐƌĞŐƵůĂƚŽƌƐ͘ĞǀǇŶ͘ϮϬϬϴ͖Ϯϯϳ͗ϮϲϮϮͲϰϮ͘
΀ϭϲϵ΁DĂŶƚĂůĂƌŝƐ͕<ĞŶŐW͕ŽƵƌŶĞW͕ŚĂŶŐz͕tƵ:,͘ŶŐŝŶĞĞƌŝŶŐĂŚƵŵĂŶďŽŶĞŵĂƌƌŽǁŵŽĚĞů͗Ă
ĐĂƐĞƐƚƵĚǇŽŶĞǆǀŝǀŽĞƌǇƚŚƌŽƉŽŝĞƐŝƐ͘ŝŽƚĞĐŚŶŽůŽŐǇƉƌŽŐƌĞƐƐ͘ϭϵϵϴ͖ϭϰ͗ϭϮϲͲϯϯ͘
΀ϭϳϬ΁WƌĞǁŝƚǌD͕ ^Ğŝď &W͕ ǀŽŶŽŶŝŶD͕ &ƌŝĞĚƌŝĐŚƐ :͕ ^ƚŝƐƐĞů͕EŝĞŚĂŐĞ͕Ğƚ Ăů͘ dŝŐŚƚůǇ ĂŶĐŚŽƌĞĚ
ƚŝƐƐƵĞͲŵŝŵĞƚŝĐŵĂƚƌŝĐĞƐĂƐŝŶƐƚƌƵĐƚŝǀĞƐƚĞŵĐĞůůŵŝĐƌŽĞŶǀŝƌŽŶŵĞŶƚƐ͘EĂƚƵƌĞŵĞƚŚŽĚƐ͘ϮϬϭϯ͖ϭϬ͗ϳϴϴͲ
ϵϰ͘
΀ϭϳϭ΁ ŝŶŐ >͕ ^ĂƵŶĚĞƌƐ d>͕ ŶŝŬŽůŽƉŽǀ '͕DŽƌƌŝƐŽŶ ^:͘ ŶĚŽƚŚĞůŝĂů ĂŶĚ ƉĞƌŝǀĂƐĐƵůĂƌ ĐĞůůƐŵĂŝŶƚĂŝŶ
ŚĂĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͘EĂƚƵƌĞ͘ϮϬϭϮ͖ϰϴϭ͗ϰϱϳͲϲϮ͘
΀ϭϳϮ΁ DĞŶĚĞǌͲ&ĞƌƌĞƌ ^͕ DŝĐŚƵƌŝŶĂ ds͕ &ĞƌƌĂƌŽ &͕ DĂǌůŽŽŵ Z͕ DĂĐĂƌƚŚƵƌ ͕ >ŝƌĂ ^͕ Ğƚ Ăů͘
DĞƐĞŶĐŚǇŵĂů ĂŶĚ ŚĂĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůůƐ ĨŽƌŵ Ă ƵŶŝƋƵĞ ďŽŶĞ ŵĂƌƌŽǁ ŶŝĐŚĞ͘ EĂƚƵƌĞ͘
ϮϬϭϬ͖ϰϲϲ͗ϴϮϵͲϯϰ͘
΀ϭϳϯ΁ůůŝƐ^>͕EŝůƐƐŽŶ^<͘dŚĞůŽĐĂƚŝŽŶĂŶĚĐĞůůƵůĂƌĐŽŵƉŽƐŝƚŝŽŶŽĨƚŚĞŚĞŵŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůŶŝĐŚĞ͘
ǇƚŽƚŚĞƌĂƉǇ͘ϮϬϭϮ͖ϭϰ͗ϭϯϱͲϰϯ͘
΀ϭϳϰ΁ZĂŵĂůŚŽͲ^ĂŶƚŽƐD͕zŽŽŶ^͕DĂƚƐƵǌĂŬŝz͕DƵůůŝŐĂŶZ͕DĞůƚŽŶ͘Ζ^ƚĞŵŶĞƐƐΖ͗ƚƌĂŶƐĐƌŝƉƚŝŽŶĂů
ƉƌŽĨŝůŝŶŐŽĨĞŵďƌǇŽŶŝĐĂŶĚĂĚƵůƚƐƚĞŵĐĞůůƐ͘^ĐŝĞŶĐĞ͘ϮϬϬϮ͖Ϯϵϴ͗ϱϵϳͲϲϬϬ͘
΀ϭϳϱ΁/ǀĂŶŽǀĂE͘ƐƚĞŵĐĞůůŵŽůĞĐƵůĂƌƐŝŐŶĂƚƵƌĞ͘^ĐŝĞŶĐĞ͘ϮϬϬϮ͖Ϯϵϴ͗ϲϬϭͲϰ͘
΀ϭϳϲ΁WŚŝůůŝƉƐZ>͕ƌŶƐƚZ͕ƌƵŶŬ͕/ǀĂŶŽǀĂE͕DĂŚĂŶD͕ĞĂŶĞŚĂŶ:<͕ĞƚĂů͘dŚĞŐĞŶĞƚŝĐƉƌŽŐƌĂŵ
ŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͘^ĐŝĞŶĐĞ͘ϮϬϬϬ͖Ϯϴϴ͗ϭϲϯϱͲϰϬ͘
΀ϭϳϳ΁zĂƐŚŝƌŽz͕ĂŶŶĂŝ,͕DŝŶŽǁĂd͕zĂďŝŬƵd͕DŝǇĂŶŽ^͕KƐĂǁĂD͕ĞƚĂů͘dƌĂŶƐĐƌŝƉƚŝŽŶĂůƉƌŽĨŝůŝŶŐŽĨ
ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůůƐ ďǇ ŚŝŐŚͲƚŚƌŽƵŐŚƉƵƚ ƐĞƋƵĞŶĐŝŶŐ͘ /ŶƚĞƌŶĂƚŝŽŶĂů :ŽƵƌŶĂů ŽĨ ,ĞŵĂƚŽůŽŐǇ͘
ϮϬϬϵ͖ϴϵ͗ϮϰͲϯϯ͘
΀ϭϳϴ΁ŚĂƚĞĂƵǀŝĞƵǆ^͕/ĐŚĂŶƚĞ:>͕ĞůŽƌŵĞ͕&ƌŽƵŝŶs͕WŝĞƚƵ'͕>ĂŶŐŽŶŶĞ͕ĞƚĂů͘DŽůĞĐƵůĂƌƉƌŽĨŝůĞ
ŽĨŵŽƵƐĞƐƚƌŽŵĂůŵĞƐĞŶĐŚǇŵĂůƐƚĞŵĐĞůůƐ͘WŚǇƐŝŽů'ĞŶŽŵŝĐƐ͘ϮϬϬϳ͖Ϯϵ͗ϭϮϴͲϯϴ͘
΀ϭϳϵ΁DĂƌƚŝŶD͕ŚĂƚŝĂD͘ŶĂůǇƐŝƐŽĨƚŚĞŚƵŵĂŶĨĞƚĂůůŝǀĞƌŚĞŵĂƚŽƉŽŝĞƚŝĐŵŝĐƌŽĞŶǀŝƌŽŶŵĞŶƚ͘^ƚĞŵ
ĞůůƐĞǀ͘ϮϬϬϱ͖ϭϰ͗ϰϵϯͲϱϬϰ͘
΀ϭϴϬ΁>ŽƌĞŶǌů^͕ůďĞƌƐ^͕EĂƌƌ^͕ŚŝƌŝĐŚŝŐŶŽ:͕ĞĂůD&͘ǆƉƌĞƐƐŝŽŶŽĨDDWͲϮ͕DDWͲϵ͕ĂŶĚDDWͲϭ
ĂŶĚ ƚŚĞŝƌ ĞŶĚŽŐĞŶŽƵƐ ĐŽƵŶƚĞƌƌĞŐƵůĂƚŽƌƐ d/DWͲϭ ĂŶĚ d/DWͲϮ ŝŶ ƉŽƐƚŵŽƌƚĞŵ ďƌĂŝŶ ƚŝƐƐƵĞ ŽĨ
WĂƌŬŝŶƐŽŶΖƐĚŝƐĞĂƐĞ͘ǆƉĞƌŝŵĞŶƚĂůŶĞƵƌŽůŽŐǇ͘ϮϬϬϮ͖ϭϳϴ͗ϭϯͲϮϬ͘
΀ϭϴϭ΁ ^ĂƵůŶŝĞƌ E͕ 'ƵŝŚĂƌĚ ^͕ ,ŽůǇ y͕ ĞĐĞŵďƌĞ ͕ :ƵƌĚŝĐ W͕ ůĂǇ ͕ Ğƚ Ăů͘ Z<ϭ ƌĞŐƵůĂƚĞƐ ƚŚĞ
ŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůŶŝĐŚĞƐ͘WůŽ^ŽŶĞ͘ϮϬϭϮ͖ϳ͗ĞϯϬϳϴϴ͘
΀ϭϴϮ΁dĞŝǆŝĚŽ:͕,ĞŵůĞƌD͕'ƌĞĞŶďĞƌŐĞƌ:^͕ŶŬůĞƐĂƌŝĂW͘ZŽůĞŽĨďĞƚĂϭĂŶĚďĞƚĂϮŝŶƚĞŐƌŝŶƐŝŶƚŚĞ
ĂĚŚĞƐŝŽŶŽĨŚƵŵĂŶϯϰŚŝƐƚĞŵĐĞůůƐƚŽďŽŶĞŵĂƌƌŽǁƐƚƌŽŵĂ͘dŚĞ:ŽƵƌŶĂůŽĨĐůŝŶŝĐĂůŝŶǀĞƐƚŝŐĂƚŝŽŶ͘
ϭϵϵϮ͖ϵϬ͗ϯϱϴͲϲϳ͘
΀ϭϴϯ΁ŚĂŶŐ:y͕DĂŽW͘΀ǆƉĂŶƐŝŽŶŽĨĞƌǇƚŚƌŽŝĚƉƌŽŐĞŶŝƚŽƌƐĂŶĚϯϰнĐĞůůƐďǇƵŵďŝůŝĐĂůĐŽƌĚďůŽŽĚ
ŵŽŶŽŶƵĐůĞĂƌĐĞůůƐ΁͘ŚŽŶŐŐƵŽƐŚŝǇĂŶǆƵĞǇĞǆƵĞǌĂǌŚŝͬŚŽŶŐŐƵŽďŝŶŐůŝƐŚĞŶŐůŝǆƵĞŚƵŝс:ŽƵƌŶĂů
ŽĨĞǆƉĞƌŝŵĞŶƚĂůŚĞŵĂƚŽůŽŐǇͬŚŝŶĞƐĞƐƐŽĐŝĂƚŝŽŶŽĨWĂƚŚŽƉŚǇƐŝŽůŽŐǇ͘ϮϬϬϱ͖ϭϯ͗ϰϮϵͲϯϯ͘
ZĞĨĞƌĞŶĐĞƐ
ϮϰϬ

΀ϭϴϰ΁hĐŚŝĚĂD͕ <ŝƌŝƚŽ <͕ ^ŚŝŵŝǌƵZ͕DŝƵƌĂz͕KǌĂǁĂ<͕ <ŽŵĂƚƐƵE͘  ĨƵŶĐƚŝŽŶĂů ƌŽůĞŽĨŵŝƚŽŐĞŶͲ
ĂĐƚŝǀĂƚĞĚƉƌŽƚĞŝŶ ŬŝŶĂƐĞƐ͕ĞƌŬϭĂŶĚĞƌŬϮ͕ ŝŶ ƚŚĞĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶŽĨ ĂŚƵŵĂŶ ůĞƵŬĞŵŝĂ ĐĞůů ůŝŶĞ͕hdͲ
ϳͬ'D͗ Ă ƉŽƐƐŝďůĞ ŬĞǇ ĨĂĐƚŽƌ ĨŽƌ ĐĞůů ĨĂƚĞ ĚĞƚĞƌŵŝŶĂƚŝŽŶ ƚŽǁĂƌĚ ĞƌǇƚŚƌŽŝĚ ĂŶĚ ŵĞŐĂŬĂƌǇŽĐǇƚŝĐ
ůŝŶĞĂŐĞƐ͘/ŶƚĞƌŶĂƚŝŽŶĂůũŽƵƌŶĂůŽĨŚĞŵĂƚŽůŽŐǇ͘ϮϬϬϭ͖ϳϯ͗ϳϴͲϴϯ͘
΀ϭϴϱ΁ŚĂŶŐ:͕^ŽĐŽůŽǀƐŬǇD͕'ƌŽƐƐt͕>ŽĚŝƐŚ,&͘ZŽůĞŽĨZĂƐƐŝŐŶĂůŝŶŐŝŶĞƌǇƚŚƌŽŝĚĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶ
ŽĨŵŽƵƐĞĨĞƚĂůůŝǀĞƌĐĞůůƐ͗ĨƵŶĐƚŝŽŶĂůĂŶĂůǇƐŝƐďǇĂĨůŽǁĐǇƚŽŵĞƚƌǇͲďĂƐĞĚŶŽǀĞůĐƵůƚƵƌĞƐǇƐƚĞŵ͘ůŽŽĚ͘
ϮϬϬϯ͖ϭϬϮ͗ϯϵϯϴͲϰϲ͘
΀ϭϴϲ΁ŽŬŝĐsW͕ŚĂƚƚĂĐŚĂƌǇĂ͕ĞůĞƐůŝŶͲŽŬŝĐ͕EŽŐƵĐŚŝd͕WƵƌŝZ<͕^ĐŚĞĐŚƚĞƌE͘:<Ͳ^ddĂŶĚ
<dƉĂƚŚǁĂǇͲĐŽƵƉůĞĚŐĞŶĞƐŝŶĞƌǇƚŚƌŽŝĚƉƌŽŐĞŶŝƚŽƌĐĞůůƐƚŚƌŽƵŐŚŽŶƚŽŐĞŶǇ͘:ŽƵƌŶĂůŽĨƚƌĂŶƐůĂƚŝŽŶĂů
ŵĞĚŝĐŝŶĞ͘ϮϬϭϮ͖ϭϬ͗ϭϭϲ͘
΀ϭϴϳ΁ WĂŝďŽŽŶƐƵŬǁŽŶŐ <͕ ŚŽŝ /͕ DĂƚƐƵƐŚŝŵĂ d͕ ďĞ z͕ EŝƐŚŝŵƵƌĂ :͕ tŝŶŝĐŚĂŐŽŽŶ W͕ Ğƚ Ăů͘ dŚĞ
ƐŝŐŶĂůŝŶŐ ƉĂƚŚǁĂǇƐ ŽĨ ĞƌǇƚŚƌŽƉŽŝĞƚŝŶ ĂŶĚ ŝŶƚĞƌĨĞƌŽŶͲŐĂŵŵĂ ĚŝĨĨĞƌ ŝŶ ƉƌĞǀĞŶƚŝŶŐ ƚŚĞ ĂƉŽƉƚŽƐŝƐ ŽĨ
ŵĂƚƵƌĞĞƌǇƚŚƌŽŝĚƉƌŽŐĞŶŝƚŽƌĐĞůůƐ͘/ŶƚĞƌŶĂƚŝŽŶĂůũŽƵƌŶĂůŽĨŚĞŵĂƚŽůŽŐǇ͘ϮϬϬϯ͖ϳϴ͗ϰϮϭͲϴ͘
΀ϭϴϴ΁WĂƌŬ͕^ǇŬĞƐ͕^ĐĂĚĚĞŶd͘dŚĞŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůŶŝĐŚĞ͘&ƌŽŶƚŝŽƐĐŝ͘ϮϬϭϮ͖ϭϳ͗ϯϬͲϵ͘
΀ϭϴϵ΁KƌĞůŝŽ͕WĞĞƚĞƌƐD͕,ĂĂŬ͕ǀĂŶĚĞƌ,ŽƌŶ<͕ǌŝĞƌǌĂŬ͘/ŶƚĞƌůĞƵŬŝŶͲϭƌĞŐƵůĂƚĞƐŚĞŵĂƚŽƉŽŝĞƚŝĐ
ƉƌŽŐĞŶŝƚŽƌĂŶĚƐƚĞŵĐĞůůƐŝŶƚŚĞŵŝĚŐĞƐƚĂƚŝŽŶŵŽƵƐĞĨĞƚĂůůŝǀĞƌ͘,ĂĞŵĂƚŽůŽŐŝĐĂ͘ϮϬϬϵ͖ϵϰ͗ϰϲϮͲϵ͘
΀ϭϵϬ΁ :ĂĐŬƐŽŶ :͕ zĂŶ z͕ ƌƵŶĚĂ D:͕ <ĞůƐĞǇ >^͕ dĂůŵĂĚŐĞ :͘ /ŶƚĞƌůĞƵŬŝŶͲϭϮ ĞŶŚĂŶĐĞƐ ƉĞƌŝƉŚĞƌĂů
ŚĞŵĂƚŽƉŽŝĞƐŝƐŝŶǀŝǀŽ͘ůŽŽĚ͘ϭϵϵϱ͖ϴϱ͗ϮϯϳϭͲϲ͘
΀ϭϵϭ΁'ŚĂĨĨĂƌŝ^͕tƵ,͕'ĞƌůĂĐŚD͕,ĂŶz͕>ŽĚŝƐŚ,&͕ĂůĞǇ'Y͘ZͲ>ĂŶĚǀͲ^ZƚǇƌŽƐŝŶĞŬŝŶĂƐĞ
ŽŶĐŽƉƌŽƚĞŝŶƐƐƵƉƉŽƌƚŶŽƌŵĂůĞƌǇƚŚƌŽŝĚĚĞǀĞůŽƉŵĞŶƚŝŶĞƌǇƚŚƌŽƉŽŝĞƚŝŶƌĞĐĞƉƚŽƌͲĚĞĨŝĐŝĞŶƚƉƌŽŐĞŶŝƚŽƌ
ĐĞůůƐ͘ WƌŽĐĞĞĚŝŶŐƐ ŽĨ ƚŚĞ EĂƚŝŽŶĂů ĐĂĚĞŵǇ ŽĨ ^ĐŝĞŶĐĞƐ ŽĨ ƚŚĞ hŶŝƚĞĚ ^ƚĂƚĞƐ ŽĨ ŵĞƌŝĐĂ͘
ϭϵϵϵ͖ϵϲ͗ϭϯϭϴϲͲϵϬ͘
΀ϭϵϮ΁ ,ŽŶĐǌĂƌĞŶŬŽ D͕ >Ğ z͕ ^ǁŝĞƌŬŽǁƐŬŝ D͕ 'ŚŝƌĂŶ /͕ 'ůŽĚĞŬ D͕ ^ŝůďĞƌƐƚĞŝŶ >͘ ,ƵŵĂŶ ďŽŶĞ
ŵĂƌƌŽǁ ƐƚƌŽŵĂů ĐĞůůƐ ĞǆƉƌĞƐƐ Ă ĚŝƐƚŝŶĐƚ ƐĞƚ ŽĨ ďŝŽůŽŐŝĐĂůůǇ ĨƵŶĐƚŝŽŶĂů ĐŚĞŵŽŬŝŶĞ ƌĞĐĞƉƚŽƌƐ͘ ^ƚĞŵ
ĐĞůůƐ͘ϮϬϬϲ͖Ϯϰ͗ϭϬϯϬͲϰϭ͘
΀ϭϵϯ΁EĞůŝƐƐĞŶ:D͕dŽƌĞŶƐŵĂZ͕WůƵǇƚĞƌD͕ĚĞŵĂ':͕ZĂǇŵĂŬĞƌƐZ͕ǀĂŶ<ŽŽǇŬz͕ĞƚĂů͘DŽůĞĐƵůĂƌ
ĂŶĂůǇƐŝƐŽĨƚŚĞŚĞŵĂƚŽƉŽŝĞƐŝƐƐƵƉƉŽƌƚŝŶŐŽƐƚĞŽďůĂƐƚŝĐĐĞůůůŝŶĞhϮͲK^͘ǆƉ,ĞŵĂƚŽů͘ϮϬϬϬ͖Ϯϴ͗ϰϮϮͲϯϮ͘
΀ϭϵϰ΁DĂƌƚŝŶŽǀŝĐ^͕DĂǌŝĐ^͕<ŝƐŝĐs͕ĂƐŝĐE͕:ĂŬŝĐͲZĂǌƵŵŽǀŝĐ:͕ŽƌŽǀĞĐŬŝ&͕ĞƚĂů͘ǆƉƌĞƐƐŝŽŶŽĨďŽŶĞ
ŵŽƌƉŚŽŐĞŶĞƚŝĐƉƌŽƚĞŝŶƐŝŶƐƚƌŽŵĂůĐĞůůƐĨƌŽŵŚƵŵĂŶďŽŶĞŵĂƌƌŽǁůŽŶŐͲƚĞƌŵĐƵůƚƵƌĞ͘dŚĞũŽƵƌŶĂůŽĨ
ŚŝƐƚŽĐŚĞŵŝƐƚƌǇĂŶĚĐǇƚŽĐŚĞŵŝƐƚƌǇ͗ŽĨĨŝĐŝĂůũŽƵƌŶĂůŽĨƚŚĞ,ŝƐƚŽĐŚĞŵŝƐƚƌǇ^ŽĐŝĞƚǇ͘ϮϬϬϰ͖ϱϮ͗ϭϭϱϵͲϲϳ͘
΀ϭϵϱ΁ ŝ z͕ ^ƚƵĞůƚĞŶ ,͕ <ŝůƚƐ d͕ tĂĚŚǁĂ ^͕ /ŽǌǌŽ Zs͕ ZŽďĞǇ W'͕ Ğƚ Ăů͘ ǆƚƌĂĐĞůůƵůĂƌ ŵĂƚƌŝǆ
ƉƌŽƚĞŽŐůǇĐĂŶƐ ĐŽŶƚƌŽů ƚŚĞ ĨĂƚĞ ŽĨ ďŽŶĞŵĂƌƌŽǁ ƐƚƌŽŵĂů ĐĞůůƐ͘ dŚĞ :ŽƵƌŶĂů ŽĨ ďŝŽůŽŐŝĐĂů ĐŚĞŵŝƐƚƌǇ͘
ϮϬϬϱ͖ϮϴϬ͗ϯϬϰϴϭͲϵ͘
΀ϭϵϲ΁ >ŽŶŐ Dt͕ ŝǆŝƚ sD͘ dŚƌŽŵďŽƐƉŽŶĚŝŶ ĨƵŶĐƚŝŽŶƐ ĂƐ Ă ĐǇƚŽĂĚŚĞƐŝŽŶ ŵŽůĞĐƵůĞ ĨŽƌ ŚƵŵĂŶ
ŚĞŵĂƚŽƉŽŝĞƚŝĐƉƌŽŐĞŶŝƚŽƌĐĞůůƐ͘ůŽŽĚ͘ϭϵϵϬ͖ϳϱ͗ϮϯϭϭͲϴ͘
΀ϭϵϳ΁>ƵŽ͕>ƵŽW͕zƵz͕ŚĂŽY͕ŚĂŽy͕ŚĞŶŐ>͘^WZƉƌŽŵŽƚĞƐƚŚĞĚĞǀĞůŽƉŵĞŶƚŽĨĞƌǇƚŚƌŽŝĚ
ƉƌŽŐĞŶŝƚŽƌƐ͘ǆƉĞƌŝŵĞŶƚĂůŚĞŵĂƚŽůŽŐǇ͘ϮϬϭϮ͖ϰϬ͗ϴϮϴͲϯϲ͘
΀ϭϵϴ΁ KŚŵŽƌŝ d͕ <ĂƐŚŝǁĂŬƵƌĂ z͕ /ƐŚŝǁĂƚĂ ͕DĂĚŽŝǁĂ ^͕DŝŵƵƌŽ :͕ &ƵƌƵŬĂǁĂ z͕ Ğƚ Ăů͘ sŝŶĐƵůŝŶ ŝƐ
ŝŶĚŝƐƉĞŶƐĂďůĞ ĨŽƌ ƌĞƉŽƉƵůĂƚŝŽŶďǇŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵĐĞůůƐ͕ ŝŶĚĞƉĞŶĚĞŶƚŽĨ ŝŶƚĞŐƌŝŶ ĨƵŶĐƚŝŽŶ͘dŚĞ
:ŽƵƌŶĂůŽĨďŝŽůŽŐŝĐĂůĐŚĞŵŝƐƚƌǇ͘ϮϬϭϬ͖Ϯϴϱ͗ϯϭϳϲϯͲϳϯ͘
΀ϭϵϵ΁ĂƌƚůŝŶŐ͕<ŽĐŚ͕^ŝŵŵ͕^ĐŚĞƵďĞůZ͕^ŝůďĞƌZ͕^ĂŶƚŽƐE͘/ŶƐƵůŝŶͲůŝŬĞŐƌŽǁƚŚĨĂĐƚŽƌďŝŶĚŝŶŐ
ƉƌŽƚĞŝŶƐͲϮ ĂŶĚ Ͳϰ ĞŶŚĂŶĐĞ ƚŚĞ ŵŝŐƌĂƚŝŽŶ ŽĨ ŚƵŵĂŶ ϯϰͲͬϭϯϯн ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĂŶĚ
ƉƌŽŐĞŶŝƚŽƌĐĞůůƐ͘/ŶƚĞƌŶĂƚŝŽŶĂůũŽƵƌŶĂůŽĨŵŽůĞĐƵůĂƌŵĞĚŝĐŝŶĞ͘ϮϬϭϬ͖Ϯϱ͗ϴϵͲϵϲ͘
΀ϮϬϬ΁WĂǌ,͕>ǇŶĐŚDZ͕ŽŐƵĞt͕'ĂƐƐŽŶ:͘dŚĞŚŽŵĞŽďŽǆŐĞŶĞ,ŚĞǆƌĞŐƵůĂƚĞƐƚŚĞĞĂƌůŝĞƐƚƐƚĂŐĞƐ
ŽĨĚĞĨŝŶŝƚŝǀĞŚĞŵĂƚŽƉŽŝĞƐŝƐ͘ůŽŽĚ͘ϮϬϭϬ͖ϭϭϲ͗ϭϮϱϰͲϲϮ͘
΀ϮϬϭ΁ ƐƐĞƌƐ D͕ KĨĨŶĞƌ ^͕ ůĂŶĐŽͲŽƐĞ t͕tĂŝďůĞƌ ͕ <ĂůŝŶŬĞ h͕ ƵĐŚŽƐĂů D͕ Ğƚ Ăů͘ /&EĂůƉŚĂ
ĂĐƚŝǀĂƚĞƐĚŽƌŵĂŶƚŚĂĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐŝŶǀŝǀŽ͘EĂƚƵƌĞ͘ϮϬϬϵ͖ϰϱϴ͗ϵϬϰͲϴ͘
΀ϮϬϮ΁^ĂƚŽd͕KŶĂŝE͕zŽƐŚŝŚĂƌĂ,͕ƌĂŝ&͕^ƵĚĂd͕KŚƚĞŬŝd͘ /ŶƚĞƌĨĞƌŽŶƌĞŐƵůĂƚŽƌǇ ĨĂĐƚŽƌͲϮƉƌŽƚĞĐƚƐ
ƋƵŝĞƐĐĞŶƚŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐĨƌŽŵƚǇƉĞ/ŝŶƚĞƌĨĞƌŽŶͲĚĞƉĞŶĚĞŶƚĞǆŚĂƵƐƚŝŽŶ͘EĂƚƵƌĞŵĞĚŝĐŝŶĞ͘
ϮϬϬϵ͖ϭϱ͗ϲϵϲͲϳϬϬ͘
ZĞĨĞƌĞŶĐĞƐ
Ϯϰϭ

΀ϮϬϯ΁ŚĂŶŐ>͕WƌĂŬ>͕ZĂǇŽŶͲƐƚƌĂĚĂs͕dŚŝƌƵW͕&ůǇŐĂƌĞ:͕>ŝŵ͕ĞƚĂů͘&Wϯϲ>ϮŝƐƌĞƋƵŝƌĞĚĨŽƌƐĞůĨͲ
ƌĞŶĞǁĂůŽĨĞĂƌůǇďƵƌƐƚͲĨŽƌŵŝŶŐƵŶŝƚĞƌǇƚŚƌŽŝĚƉƌŽŐĞŶŝƚŽƌƐ͘EĂƚƵƌĞ͘ϮϬϭϯ͖ϰϵϵ͗ϵϮͲϲ͘
΀ϮϬϰ΁ŽƵ͕ŶŝƐZ͕Ƶŝ,͕<ŚĂŶĚƌŽƐ͕<ƵŵĂƌs͕:ĂŬƵƐ͕ĞƚĂů͘dŚĞƐĞĐƌĞƚĞĚůǇŵƉŚĂŶŐŝŽŐĞŶŝĐĨĂĐƚŽƌ
ϭŝƐĞƐƐĞŶƚŝĂůĨŽƌĨĞƚĂůůŝǀĞƌĞƌǇƚŚƌŽƉŽŝĞƐŝƐ͘ůŽŽĚ͘ϮϬϭϯ͖ϭϮϭ͗ϯϮϮϴͲϯϲ͘
΀ϮϬϱ΁'ĞƵƚƐŬĞŶƐ^͕ŶĚƌĞǁƐt͕ǀĂŶ^ƚĂůďŽƌĐŚD͕ƌƵƐƐĞŶ<͕,ŽůƚƌŽƉͲĚĞ,ĂĂŶ^͕WĂƌŶĂǀĞůĂƐ:'͕
Ğƚ Ăů͘ ŽŶƚƌŽů ŽĨ ŚƵŵĂŶ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵͬƉƌŽŐĞŶŝƚŽƌ ĐĞůůŵŝŐƌĂƚŝŽŶ ďǇ ƚŚĞ ĞǆƚƌĂĐĞůůƵůĂƌŵĂƚƌŝǆ
ƉƌŽƚĞŝŶ^ůŝƚϯ͘>ĂďŽƌĂƚŽƌǇŝŶǀĞƐƚŝŐĂƚŝŽŶ͖ĂũŽƵƌŶĂůŽĨƚĞĐŚŶŝĐĂůŵĞƚŚŽĚƐĂŶĚƉĂƚŚŽůŽŐǇ͘ϮϬϭϮ͖ϵϮ͗ϭϭϮϵͲ
ϯϵ͘
΀ϮϬϲ΁ WĂŶŐ :͕ >ĞŵƐĂĚĚĞŬt͕ ůŚĂƐŚĞŵ zE͕ ŽŶĚǌŝ ͕ ZĞĚŵŽŶĚ >͕ ŚͲ^ŽŶE͕ Ğƚ Ăů͘ <ƌƵƉƉĞůͲůŝŬĞ
ĨĂĐƚŽƌϭ;<>&ϭͿ͕<>&Ϯ͕ĂŶĚDǇĐĐŽŶƚƌŽůĂƌĞŐƵůĂƚŽƌǇŶĞƚǁŽƌŬĞƐƐĞŶƚŝĂůĨŽƌĞŵďƌǇŽŶŝĐĞƌǇƚŚƌŽƉŽŝĞƐŝƐ͘
DŽůĞĐƵůĂƌĂŶĚĐĞůůƵůĂƌďŝŽůŽŐǇ͘ϮϬϭϮ͖ϯϮ͗ϮϲϮϴͲϰϰ͘
΀ϮϬϳ΁ ZŽďĞƌƚƐ ͕ DĐƵŶĞ <͕ ^ƉŽƌŶ D͘ d'&ͲďĞƚĂ͗ ƌĞŐƵůĂƚŝŽŶ ŽĨ ĞǆƚƌĂĐĞůůƵůĂƌ ŵĂƚƌŝǆ͘ <ŝĚŶĞǇ
ŝŶƚĞƌŶĂƚŝŽŶĂů͘ϭϵϵϮ͖ϰϭ͗ϱϱϳͲϵ͘
΀ϮϬϴ΁ŚƌŝƐƚD͕DĐĂƌƚŶĞǇͲ&ƌĂŶĐŝƐE>͕<ƵůŬĂƌŶŝ͕tĂƌĚ :D͕DŝǌĞů͕DĂĐŬĂůů>͕ĞƚĂů͘ /ŵŵƵŶĞ
ĚǇƐƌĞŐƵůĂƚŝŽŶŝŶd'&ͲďĞƚĂϭͲĚĞĨŝĐŝĞŶƚŵŝĐĞ͘:ŽƵƌŶĂůŽĨŝŵŵƵŶŽůŽŐǇ͘ϭϵϵϰ͖ϭϱϯ͗ϭϵϯϲͲϰϲ͘
΀ϮϬϵ΁ ĞŶͲzŽƐĞĨ z͕ >ĂŚĂƚ E͕ ^ŚĂƉŝƌŽ ^͕ ŝƚƚĞƌŵĂŶ ,͕ DŝůůĞƌ ͘ ZĞŐƵůĂƚŝŽŶ ŽĨ ĞŶĚŽƚŚĞůŝĂů ŵĂƚƌŝǆ
ŵĞƚĂůůŽƉƌŽƚĞŝŶĂƐĞͲϮďǇŚǇƉŽǆŝĂͬƌĞŽǆǇŐĞŶĂƚŝŽŶ͘ŝƌĐƵůĂƚŝŽŶƌĞƐĞĂƌĐŚ͘ϮϬϬϮ͖ϵϬ͗ϳϴϰͲϵϭ͘
΀ϮϭϬ΁,ŽůůďŽƌŶD͕^ƚĂƚŚŽƉŽƵůŽƐ͕^ƚĞĨĨĞŶ͕tŝĞĚĞŵĂŶŶW͕<ŽŚĞŶ>͕ƌŝŶŐŵĂŶŶ͘WŽƐŝƚŝǀĞĨĞĞĚďĂĐŬ
ƌĞŐƵůĂƚŝŽŶ ďĞƚǁĞĞŶ DDWͲϵ ĂŶĚ s'& ŝŶ ŚƵŵĂŶ ZW ĐĞůůƐ͘ /ŶǀĞƐƚŝŐĂƚŝǀĞ ŽƉŚƚŚĂůŵŽůŽŐǇ Θ ǀŝƐƵĂů
ƐĐŝĞŶĐĞ͘ϮϬϬϳ͖ϰϴ͗ϰϯϲϬͲϳ͘
΀Ϯϭϭ΁ŚŽŝ:z͕:ĂŶŐz^͕DŝŶ^z͕^ŽŶŐ:z͘KǀĞƌĞǆƉƌĞƐƐŝŽŶŽĨDDWͲϵĂŶĚ,/&ͲϭĂůƉŚĂŝŶƌĞĂƐƚĂŶĐĞƌ
ĞůůƐƵŶĚĞƌ,ǇƉŽǆŝĐŽŶĚŝƚŝŽŶƐ͘:ŽƵƌŶĂůŽĨďƌĞĂƐƚĐĂŶĐĞƌ͘ϮϬϭϭ͖ϭϰ͗ϴϴͲϵϱ͘
΀ϮϭϮ΁ Žǆ dZ͕ ƌůĞƌ :d͘ ZĞŵŽĚĞůŝŶŐ ĂŶĚ ŚŽŵĞŽƐƚĂƐŝƐ ŽĨ ƚŚĞ ĞǆƚƌĂĐĞůůƵůĂƌ ŵĂƚƌŝǆ͗ ŝŵƉůŝĐĂƚŝŽŶƐ ĨŽƌ
ĨŝďƌŽƚŝĐĚŝƐĞĂƐĞƐĂŶĚĐĂŶĐĞƌ͘ŝƐĞĂƐĞŵŽĚĞůƐΘŵĞĐŚĂŶŝƐŵƐ͘ϮϬϭϭ͖ϰ͗ϭϲϱͲϳϴ͘
΀Ϯϭϯ΁,ĞŝƐƐŝŐ͕,ĂƚƚŽƌŝ<͕ŝĂƐ^͕&ƌŝĞĚƌŝĐŚD͕&ĞƌƌŝƐ͕,ĂĐŬĞƚƚEZ͕ĞƚĂů͘ZĞĐƌƵŝƚŵĞŶƚŽĨƐƚĞŵĂŶĚ
ƉƌŽŐĞŶŝƚŽƌĐĞůůƐ ĨƌŽŵƚŚĞďŽŶĞŵĂƌƌŽǁŶŝĐŚĞƌĞƋƵŝƌĞƐDDWͲϵŵĞĚŝĂƚĞĚƌĞůĞĂƐĞŽĨŬŝƚͲůŝŐĂŶĚ͘Ğůů͘
ϮϬϬϮ͖ϭϬϵ͗ϲϮϱͲϯϳ͘
΀Ϯϭϰ΁ĞƌŐĞƌƐ'͕ƌĞŬŬĞŶZ͕DĐDĂŚŽŶ'͕sƵd,͕/ƚŽŚd͕dĂŵĂŬŝ<͕ĞƚĂů͘DĂƚƌŝǆŵĞƚĂůůŽƉƌŽƚĞŝŶĂƐĞͲϵ
ƚƌŝŐŐĞƌƐƚŚĞĂŶŐŝŽŐĞŶŝĐƐǁŝƚĐŚĚƵƌŝŶŐĐĂƌĐŝŶŽŐĞŶĞƐŝƐ͘EĂƚƵƌĞĐĞůůďŝŽůŽŐǇ͘ϮϬϬϬ͖Ϯ͗ϳϯϳͲϰϰ͘
΀Ϯϭϱ΁ ŝŐƌŝŶŽ W͕ ƌĞƐĐŚĞƌ ͕ DĂƵĐŚ ͘ ŽůůĂŐĞŶͲŝŶĚƵĐĞĚ ƉƌŽDDWͲϮ ĂĐƚŝǀĂƚŝŽŶ ďǇ DdϭͲDDW ŝŶ
ŚƵŵĂŶĚĞƌŵĂů ĨŝďƌŽďůĂƐƚƐĂŶĚ ƚŚĞƉŽƐƐŝďůĞ ƌŽůĞŽĨ ĂůƉŚĂϮďĞƚĂϭ ŝŶƚĞŐƌŝŶƐ͘ ƵƌŽƉĞĂŶ ũŽƵƌŶĂůŽĨ ĐĞůů
ďŝŽůŽŐǇ͘ϮϬϬϭ͖ϴϬ͗ϲϴͲϳϳ͘
΀Ϯϭϲ΁^ƚĞƌŶůŝĐŚƚD͕tĞƌď͘,ŽǁŵĂƚƌŝǆŵĞƚĂůůŽƉƌŽƚĞŝŶĂƐĞƐƌĞŐƵůĂƚĞĐĞůůďĞŚĂǀŝŽƌ͘ŶŶƵĂůƌĞǀŝĞǁ
ŽĨĐĞůůĂŶĚĚĞǀĞůŽƉŵĞŶƚĂůďŝŽůŽŐǇ͘ϮϬϬϭ͖ϭϳ͗ϰϲϯͲϱϭϲ͘
΀Ϯϭϳ΁ZŝĞƐ͕WĞƚƌŝĚĞƐW͘ǇƚŽŬŝŶĞƌĞŐƵůĂƚŝŽŶŽĨŵĂƚƌŝǆŵĞƚĂůůŽƉƌŽƚĞŝŶĂƐĞĂĐƚŝǀŝƚǇĂŶĚŝƚƐƌĞŐƵůĂƚŽƌǇ
ĚǇƐĨƵŶĐƚŝŽŶŝŶĚŝƐĞĂƐĞ͘ŝŽůŽŐŝĐĂůĐŚĞŵŝƐƚƌǇ,ŽƉƉĞͲ^ĞǇůĞƌ͘ϭϵϵϱ͖ϯϳϲ͗ϯϰϱͲϱϱ͘
΀Ϯϭϴ΁ ĂŬĞƌ ,͕ ĚǁĂƌĚƐ Z͕ DƵƌƉŚǇ '͘ DĞƚĂůůŽƉƌŽƚĞŝŶĂƐĞ ŝŶŚŝďŝƚŽƌƐ͗ ďŝŽůŽŐŝĐĂů ĂĐƚŝŽŶƐ ĂŶĚ
ƚŚĞƌĂƉĞƵƚŝĐŽƉƉŽƌƚƵŶŝƚŝĞƐ͘:ŽƵƌŶĂůŽĨĐĞůůƐĐŝĞŶĐĞ͘ϮϬϬϮ͖ϭϭϱ͗ϯϳϭϵͲϮϳ͘
΀Ϯϭϵ΁EĂŐĂƐĞ,͕sŝƐƐĞZ͕DƵƌƉŚǇ'͘^ƚƌƵĐƚƵƌĞĂŶĚĨƵŶĐƚŝŽŶŽĨŵĂƚƌŝǆŵĞƚĂůůŽƉƌŽƚĞŝŶĂƐĞƐĂŶĚd/DWƐ͘
ĂƌĚŝŽǀĂƐĐƵůĂƌƌĞƐĞĂƌĐŚ͘ϮϬϬϲ͖ϲϵ͗ϱϲϮͲϳϯ͘
΀ϮϮϬ΁ tŝůůŝĂŵƐ ,͕ :ŽŚŶƐŽŶ :>͕ :ĂĐŬƐŽŶ >͕ tŚŝƚĞ ^:͕ 'ĞŽƌŐĞ ^:͘ DDWͲϳ ŵĞĚŝĂƚĞƐ ĐůĞĂǀĂŐĞ ŽĨ EͲ
ĐĂĚŚĞƌŝŶĂŶĚƉƌŽŵŽƚĞƐƐŵŽŽƚŚŵƵƐĐůĞĐĞůůĂƉŽƉƚŽƐŝƐ͘ĂƌĚŝŽǀĂƐĐƵůĂƌƌĞƐĞĂƌĐŚ͘ϮϬϭϬ͖ϴϳ͗ϭϯϳͲϰϲ͘
΀ϮϮϭ΁WĂƵůƵƐt͕ĂƵƌ/͕,ƵĞƚƚŶĞƌ͕^ĐŚŵĂƵƐƐĞƌ͕ZŽŐŐĞŶĚŽƌĨt͕^ĐŚůŝŶŐĞŶƐŝĞƉĞŶ<,͕ĞƚĂů͘ĨĨĞĐƚƐ
ŽĨ ƚƌĂŶƐĨŽƌŵŝŶŐ ŐƌŽǁƚŚ ĨĂĐƚŽƌͲďĞƚĂ ϭ ŽŶ ĐŽůůĂŐĞŶ ƐǇŶƚŚĞƐŝƐ͕ ŝŶƚĞŐƌŝŶ ĞǆƉƌĞƐƐŝŽŶ͕ ĂĚŚĞƐŝŽŶ ĂŶĚ
ŝŶǀĂƐŝŽŶŽĨŐůŝŽŵĂĐĞůůƐ͘:ŽƵƌŶĂůŽĨŶĞƵƌŽƉĂƚŚŽůŽŐǇĂŶĚĞǆƉĞƌŝŵĞŶƚĂůŶĞƵƌŽůŽŐǇ͘ϭϵϵϱ͖ϱϰ͗ϮϯϲͲϰϰ͘
΀ϮϮϮ΁dŝǁĂƌŝ͕dƵƌƐŬǇD>͕DƵƐŚĂŚĂƌǇ͕tĂƐŶŝŬ^͕ŽůůŝĞƌ&D͕^ƵŵĂ<͕ĞƚĂů͘ǆǀŝǀŽĞǆƉĂŶƐŝŽŶŽĨ
ŚĂĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵͬƉƌŽŐĞŶŝƚŽƌ ĐĞůůƐ ĨƌŽŵ ŚƵŵĂŶ ƵŵďŝůŝĐĂů ĐŽƌĚ ďůŽŽĚ ŽŶ ĂĐĞůůƵůĂƌ ƐĐĂĨĨŽůĚƐ
ƉƌĞƉĂƌĞĚĨƌŽŵD^ͲϱƐƚƌŽŵĂůĐĞůůůŝŶĞ͘:ŽƵƌŶĂůŽĨƚŝƐƐƵĞĞŶŐŝŶĞĞƌŝŶŐĂŶĚƌĞŐĞŶĞƌĂƚŝǀĞŵĞĚŝĐŝŶĞ͘ϮϬϭϮ͘
΀ϮϮϯ΁ dĂŶ :͕ >ŝƵ d͕ ,ŽƵ >͕ DĞŶŐ t͕ tĂŶŐ z͕ Śŝ t͕ Ğƚ Ăů͘ DĂŝŶƚĞŶĂŶĐĞ ĂŶĚ ĞǆƉĂŶƐŝŽŶ ŽĨ
ŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵͬƉƌŽŐĞŶŝƚŽƌĐĞůůƐ ŝŶďŝŽŵŝŵĞƚŝĐŽƐƚĞŽďůĂƐƚŶŝĐŚĞ͘ǇƚŽƚĞĐŚŶŽůŽŐǇ͘ϮϬϭϬ͖ϲϮ͗ϰϯϵͲ
ϰϴ͘
ZĞĨĞƌĞŶĐĞƐ
ϮϰϮ

΀ϮϮϰ΁>ŝz͕DĂd͕<ŶŝƐƐ͕zĂŶŐ^d͕>ĂƐŬǇ>͘,ƵŵĂŶĐŽƌĚĐĞůůŚĞŵĂƚŽƉŽŝĞƐŝƐ ŝŶƚŚƌĞĞͲĚŝŵĞŶƐŝŽŶĂů
ŶŽŶǁŽǀĞŶ ĨŝďƌŽƵƐ ŵĂƚƌŝĐĞƐ͗ ŝŶ ǀŝƚƌŽ ƐŝŵƵůĂƚŝŽŶ ŽĨ ƚŚĞ ŵĂƌƌŽǁ ŵŝĐƌŽĞŶǀŝƌŽŶŵĞŶƚ͘ : ,ĞŵĂƚŽƚŚĞƌ
^ƚĞŵĞůůZĞƐ͘ϮϬϬϭ͖ϭϬ͗ϯϱϱͲϲϴ͘
΀ϮϮϱ΁ >ƵŶĚ t͕ zĞŶĞƌ ͕ ^ƚĞŐĞŵĂŶŶ :W͕ WůŽƉƉĞƌ '͘ dŚĞ ŶĂƚƵƌĂů ĂŶĚ ĞŶŐŝŶĞĞƌĞĚ ϯ
ŵŝĐƌŽĞŶǀŝƌŽŶŵĞŶƚĂƐĂ ƌĞŐƵůĂƚŽƌǇĐƵĞĚƵƌŝŶŐ ƐƚĞŵĐĞůů ĨĂƚĞĚĞƚĞƌŵŝŶĂƚŝŽŶ͘dŝƐƐƵĞŶŐWĂƌƚZĞǀ͘
ϮϬϬϵ͖ϭϱ͗ϯϳϭͲϴϬ͘
΀ϮϮϲ΁DŝǇŽƐŚŝ,͕DƵƌĂŽD͕KŚƐŚŝŵĂE͕ dƵŶd͘ dŚƌĞĞͲĚŝŵĞŶƐŝŽŶĂů ĐƵůƚƵƌĞŽĨŵŽƵƐĞďŽŶĞŵĂƌƌŽǁ
ĐĞůůƐ ǁŝƚŚŝŶ Ă ƉŽƌŽƵƐ ƉŽůǇŵĞƌ ƐĐĂĨĨŽůĚ͗ ĞĨĨĞĐƚƐ ŽĨ ŽǆǇŐĞŶ ĐŽŶĐĞŶƚƌĂƚŝŽŶ ĂŶĚ ƐƚƌŽŵĂů ůĂǇĞƌ ŽŶ
ĞǆƉĂŶƐŝŽŶŽĨŚĂĞŵĂƚŽƉŽŝĞƚŝĐƉƌŽŐĞŶŝƚŽƌĐĞůůƐ͘:dŝƐƐƵĞŶŐZĞŐĞŶDĞĚ͘ϮϬϭϭ͖ϱ͗ϭϭϮͲϴ͘
΀ϮϮϳ΁ ,ƵǇŶŚ ,͕ ŚĞŶŐ :͕ hŵŝŬĂǁĂ D͕ ŚĂŶŐ ͕ ^ŝůǀĂŶǇ Z͕ /ŝǌƵŬĂ ^͕ Ğƚ Ăů͘ /'& ďŝŶĚŝŶŐ ƉƌŽƚĞŝŶ Ϯ
ƐƵƉƉŽƌƚƐƚŚĞƐƵƌǀŝǀĂůĂŶĚĐǇĐůŝŶŐŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͘ůŽŽĚ͘ϮϬϭϭ͖ϭϭϴ͗ϯϮϯϲͲϰϯ͘
΀ϮϮϴ΁ŶŶĂďŝ͕>ĞĞzd͕dƵƌĐŽƚƚĞ^͕EĂƵĚ͕ĞƐƌŽƐŝĞƌƐZZ͕ŚĂŵƉĂŐŶĞD͕ĞƚĂů͘,ǇƉŽǆŝĂƉƌŽŵŽƚĞƐ
ŵƵƌŝŶĞďŽŶĞͲŵĂƌƌŽǁͲĚĞƌŝǀĞĚƐƚƌŽŵĂů ĐĞůůŵŝŐƌĂƚŝŽŶĂŶĚ ƚƵďĞ ĨŽƌŵĂƚŝŽŶ͘^ƚĞŵĐĞůůƐ͘ϮϬϬϯ͖Ϯϭ͗ϯϯϳͲ
ϰϳ͘
΀ϮϮϵ΁ DĐYƵŝďďĂŶ '͕ ƵƚůĞƌ '^͕ 'ŽŶŐ :,͕ ĞŶĚĂůů >͕ WŽǁĞƌ ͕ ůĂƌŬͲ>ĞǁŝƐ /͕ Ğƚ Ăů͘ DĂƚƌŝǆ
ŵĞƚĂůůŽƉƌŽƚĞŝŶĂƐĞĂĐƚŝǀŝƚǇŝŶĂĐƚŝǀĂƚĞƐƚŚĞyĐŚĞŵŽŬŝŶĞƐƚƌŽŵĂůĐĞůůͲĚĞƌŝǀĞĚĨĂĐƚŽƌͲϭ͘dŚĞ:ŽƵƌŶĂů
ŽĨďŝŽůŽŐŝĐĂůĐŚĞŵŝƐƚƌǇ͘ϮϬϬϭ͖Ϯϳϲ͗ϰϯϱϬϯͲϴ͘
΀ϮϯϬ΁ŽŶĞǁĂůĚ>&͕DƵŶĚǇ'Z͘ZŽůĞŽĨƚƌĂŶƐĨŽƌŵŝŶŐŐƌŽǁƚŚĨĂĐƚŽƌͲďĞƚĂŝŶďŽŶĞƌĞŵŽĚĞůŝŶŐ͘ůŝŶŝĐĂů
ŽƌƚŚŽƉĂĞĚŝĐƐĂŶĚƌĞůĂƚĞĚƌĞƐĞĂƌĐŚ͘ϭϵϵϬ͗ϮϲϭͲϳϲ͘
΀Ϯϯϭ΁ sĞƌƌĞĐĐŚŝĂ &͕DĂƵǀŝĞů ͘ d'&ͲďĞƚĂ ĂŶĚ dE&ͲĂůƉŚĂ͗ ĂŶƚĂŐŽŶŝƐƚŝĐ ĐǇƚŽŬŝŶĞƐ ĐŽŶƚƌŽůůŝŶŐ ƚǇƉĞ /
ĐŽůůĂŐĞŶŐĞŶĞĞǆƉƌĞƐƐŝŽŶ͘ĞůůƵůĂƌƐŝŐŶĂůůŝŶŐ͘ϮϬϬϰ͖ϭϲ͗ϴϳϯͲϴϬ͘
΀ϮϯϮ΁DĂƌƚŝŶĞǌͲŐŽƐƚŽ:͕DŝŬŬŽůĂ,<͕,ĂƌƚĞŶƐƚĞŝŶs͕ĂŶĞƌũĞĞh͘dŚĞŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůĂŶĚ
ŝƚƐŶŝĐŚĞ͗ĂĐŽŵƉĂƌĂƚŝǀĞǀŝĞǁ͘'ĞŶĞƐΘĚĞǀĞůŽƉŵĞŶƚ͘ϮϬϬϳ͖Ϯϭ͗ϯϬϰϰͲϲϬ͘
΀Ϯϯϯ΁^ĐĂĚĚĞŶd͘dŚĞƐƚĞŵͲĐĞůůŶŝĐŚĞĂƐĂŶĞŶƚŝƚǇŽĨĂĐƚŝŽŶ͘EĂƚƵƌĞ͘ϮϬϬϲ͖ϰϰϭ͗ϭϬϳϱͲϵ͘
΀Ϯϯϰ΁zŝŶd͕>ŝ>͘dŚĞƐƚĞŵĐĞůůŶŝĐŚĞƐ ŝŶďŽŶĞ͘dŚĞ:ŽƵƌŶĂůŽĨĐůŝŶŝĐĂů ŝŶǀĞƐƚŝŐĂƚŝŽŶ͘ϮϬϬϲ͖ϭϭϲ͗ϭϭϵϱͲ
ϮϬϭ͘
΀Ϯϯϱ΁ dƌĂƉŚĂŐĞŶ ^͕ zĞůŝĐŬ W͘ ZĞĐůĂŝŵŝŶŐ Ă ŶĂƚƵƌĂů ďĞĂƵƚǇ͗ǁŚŽůĞͲŽƌŐĂŶ ĞŶŐŝŶĞĞƌŝŶŐǁŝƚŚ ŶĂƚƵƌĂů
ĞǆƚƌĂĐĞůůƵůĂƌŵĂƚĞƌŝĂůƐ͘ZĞŐĞŶĞƌĂƚŝǀĞŵĞĚŝĐŝŶĞ͘ϮϬϬϵ͖ϰ͗ϳϰϳͲϱϴ͘
΀Ϯϯϲ΁hŶǁŝŶZ͕^ŵŝƚŚ>͕ůŝŶĐŽ͕tŝůƐŽŶ>͕DŝůůĞƌ:͕ǀĂŶƐ͕ĞƚĂů͘YƵĂŶƚŝƚĂƚŝǀĞƉƌŽƚĞŽŵŝĐƐ
ƌĞǀĞĂůƐƉŽƐƚƚƌĂŶƐůĂƚŝŽŶĂůĐŽŶƚƌŽůĂƐĂƌĞŐƵůĂƚŽƌǇĨĂĐƚŽƌ ŝŶƉƌŝŵĂƌǇŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͘ůŽŽĚ͘
ϮϬϬϲ͖ϭϬϳ͗ϰϲϴϳͲϵϰ͘
΀Ϯϯϳ΁ ŝƉŽůůĞƐĐŚŝ D'͕ ĞůůŽ ^ďĂƌďĂ W͕ KůŝǀŽƚƚŽ D͘ dŚĞ ƌŽůĞ ŽĨ ŚǇƉŽǆŝĂ ŝŶ ƚŚĞ ŵĂŝŶƚĞŶĂŶĐĞ ŽĨ
ŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĐĞůůƐ͘ůŽŽĚ͘ϭϵϵϯ͖ϴϮ͗ϮϬϯϭͲϳ͘
΀Ϯϯϴ΁ DŽƐƚĂĨĂ ^^͕ DŝůůĞƌ tD͕ WĂƉŽƵƚƐĂŬŝƐ d͘ KǆǇŐĞŶ ƚĞŶƐŝŽŶ ŝŶĨůƵĞŶĐĞƐ ƚŚĞ ĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶ͕
ŵĂƚƵƌĂƚŝŽŶĂŶĚĂƉŽƉƚŽƐŝƐŽĨŚƵŵĂŶŵĞŐĂŬĂƌǇŽĐǇƚĞƐ͘ƌŝƚŝƐŚũŽƵƌŶĂůŽĨŚĂĞŵĂƚŽůŽŐǇ͘ϮϬϬϬ͖ϭϭϭ͗ϴϳϵͲ
ϴϵ͘
΀Ϯϯϵ΁ ŶĚƌĂĞ :͕ 'ĂůůŝŶŝ Z͕ ĞƚƐŚŽůƚǌ ͘ ZŽůĞ ŽĨ ƉůĂƚĞůĞƚͲĚĞƌŝǀĞĚ ŐƌŽǁƚŚ ĨĂĐƚŽƌƐ ŝŶ ƉŚǇƐŝŽůŽŐǇ ĂŶĚ
ŵĞĚŝĐŝŶĞ͘'ĞŶĞƐΘĚĞǀĞůŽƉŵĞŶƚ͘ϮϬϬϴ͖ϮϮ͗ϭϮϳϲͲϯϭϮ͘
΀ϮϰϬ΁^ĐŚǁĂƌƚǌD͕>ĞĐŚĞŶĞ͘ĚŚĞƐŝŽŶŝƐƌĞƋƵŝƌĞĚĨŽƌƉƌŽƚĞŝŶŬŝŶĂƐĞͲĚĞƉĞŶĚĞŶƚĂĐƚŝǀĂƚŝŽŶŽĨƚŚĞ
EĂнͬ,н ĂŶƚŝƉŽƌƚĞƌ ďǇ ƉůĂƚĞůĞƚͲĚĞƌŝǀĞĚ ŐƌŽǁƚŚ ĨĂĐƚŽƌ͘ WƌŽĐĞĞĚŝŶŐƐ ŽĨ ƚŚĞ EĂƚŝŽŶĂů ĐĂĚĞŵǇ ŽĨ
^ĐŝĞŶĐĞƐŽĨƚŚĞhŶŝƚĞĚ^ƚĂƚĞƐŽĨŵĞƌŝĐĂ͘ϭϵϵϮ͖ϴϵ͗ϲϭϯϴͲϰϭ͘
΀Ϯϰϭ΁ tŚĞƚƚŽŶ ͕ 'ƌĂŚĂŵ ':͘ ,ŽŵŝŶŐ ĂŶĚ ŵŽďŝůŝǌĂƚŝŽŶ ŝŶ ƚŚĞ ƐƚĞŵ ĐĞůů ŶŝĐŚĞ͘ dƌĞŶĚƐ ŝŶ ĐĞůů
ďŝŽůŽŐǇ͘ϭϵϵϵ͖ϵ͗ϮϯϯͲϴ͘
΀ϮϰϮ΁,ĞƌŐĞƚŚ^W͕ŝĐŚĞƌt<͕ƐƐůD͕^ĐŚƌĞŝďĞƌd͕^ĂƐĂŬŝd͕<ůĞŝŶ'͘ŚĂƌĂĐƚĞƌŝǌĂƚŝŽŶĂŶĚĨƵŶĐƚŝŽŶĂů
ĂŶĂůǇƐŝƐ ŽĨ ŽƐƚĞŽďůĂƐƚͲĚĞƌŝǀĞĚ ĨŝďƵůŝŶƐ ŝŶ ƚŚĞ ŚƵŵĂŶ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ƐƚĞŵ ĐĞůů ŶŝĐŚĞ͘ ǆƉĞƌŝŵĞŶƚĂů
ŚĞŵĂƚŽůŽŐǇ͘ϮϬϬϴ͖ϯϲ͗ϭϬϮϮͲϯϰ͘
΀Ϯϰϯ΁ ZĞŶƐƚƌŽŵ :͕ /ƐƚǀĂŶĨĨǇ Z͕ 'ĂƵƚŚŝĞƌ <͕ ^ŚŝŵŽŶŽ ͕DĂŐĞƐ :͕ :ĂƌĚŽŶͲůǀĂƌĞǌ ͕ Ğƚ Ăů͘ ^ĞĐƌĞƚĞĚ
ĨƌŝǌǌůĞĚͲƌĞůĂƚĞĚƉƌŽƚĞŝŶϭĞǆƚƌŝŶƐŝĐĂůůǇ ƌĞŐƵůĂƚĞƐ ĐǇĐůŝŶŐ ĂĐƚŝǀŝƚǇ ĂŶĚŵĂŝŶƚĞŶĂŶĐĞŽĨŚĞŵĂƚŽƉŽŝĞƚŝĐ
ƐƚĞŵĐĞůůƐ͘ĞůůƐƚĞŵĐĞůů͘ϮϬϬϵ͖ϱ͗ϭϱϳͲϲϳ͘
ZĞĨĞƌĞŶĐĞƐ
Ϯϰϯ

΀Ϯϰϰ΁ ŽƌŶƐƚĞŝŶ W͕ ƌŵƐƚƌŽŶŐ >͕ ,ĂŶŬĞŶƐŽŶ <͕ <ǇƌŝĂŬŝĚĞƐ dZ͕ zĂŶŐ ͘ dŚƌŽŵďŽƐƉŽŶĚŝŶ Ϯ͕ Ă
ŵĂƚƌŝĐĞůůƵůĂƌƉƌŽƚĞŝŶǁŝƚŚĚŝǀĞƌƐĞĨƵŶĐƚŝŽŶƐ͘DĂƚƌŝǆďŝŽůŽŐǇ͗ũŽƵƌŶĂůŽĨƚŚĞ/ŶƚĞƌŶĂƚŝŽŶĂů^ŽĐŝĞƚǇĨŽƌ
DĂƚƌŝǆŝŽůŽŐǇ͘ϮϬϬϬ͖ϭϵ͗ϱϱϳͲϲϴ͘
΀Ϯϰϱ΁ dŽƌĚũŵĂŶ Z͕ KƌƚĞŐĂ E͕ ŽƵůŽŵďĞů >͕ WůŽƵĞƚ :͕ ZŽŵĞŽ W,͕ >ĞŵĂƌĐŚĂŶĚĞů s͘ EĞƵƌŽƉŝůŝŶͲϭ ŝƐ
ĞǆƉƌĞƐƐĞĚ ŽŶ ďŽŶĞ ŵĂƌƌŽǁ ƐƚƌŽŵĂů ĐĞůůƐ͗ Ă ŶŽǀĞů ŝŶƚĞƌĂĐƚŝŽŶ ǁŝƚŚ ŚĞŵĂƚŽƉŽŝĞƚŝĐ ĐĞůůƐ͍ ůŽŽĚ͘
ϭϵϵϵ͖ϵϰ͗ϮϯϬϭͲϵ͘
΀Ϯϰϲ΁^ŚŝƌǀĂŝŬĂƌE͕DĂƌƋƵĞǌͲƵƌƚŝƐ>͕:ĂŶŽǁƐŬĂͲtŝĞĐǌŽƌĞŬ͘,ĞŵĂƚŽƉŽŝĞƚŝĐ^ƚĞŵĞůůDŽďŝůŝǌĂƚŝŽŶ
ĂŶĚ ,ŽŵŝŶŐ ĂĨƚĞƌ dƌĂŶƐƉůĂŶƚĂƚŝŽŶ͗ dŚĞ ZŽůĞ ŽĨ DDWͲϮ͕ DDWͲϵ͕ ĂŶĚ DdϭͲDDW͘ ŝŽĐŚĞŵŝƐƚƌǇ
ƌĞƐĞĂƌĐŚŝŶƚĞƌŶĂƚŝŽŶĂů͘ϮϬϭϮ͖ϮϬϭϮ͗ϲϴϱϮϲϳ͘
΀Ϯϰϳ΁ ǀĂŶƐE͕DŝŶĞůůŝ ͕ 'ĞŶƚůĞŵĂŶ ͕ >ĂWŽŝŶƚĞ s͕ WĂƚĂŶŬĂƌ ^E͕ <ĂůůŝǀƌĞƚĂŬŝD͕ Ğƚ Ăů͘ ^ƵďƐƚƌĂƚĞ
ƐƚŝĨĨŶĞƐƐ ĂĨĨĞĐƚƐ ĞĂƌůǇ ĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶ ĞǀĞŶƚƐ ŝŶ ĞŵďƌǇŽŶŝĐ ƐƚĞŵ ĐĞůůƐ͘ ƵƌŽƉĞĂŶ ĐĞůůƐ ΘŵĂƚĞƌŝĂůƐ͘
ϮϬϬϵ͖ϭϴ͗ϭͲϭϯ͖ĚŝƐĐƵƐƐŝŽŶͲϰ͘
΀Ϯϰϴ΁DĐDƵƌƌĂǇZ:͕tĂŶŶ<͕dŚŽŵƉƐŽŶ>͕ŽŶŶĞůůǇ:d͕<ŶŝŐŚƚDD͘^ƵƌĨĂĐĞƚŽƉŽŐƌĂƉŚǇƌĞŐƵůĂƚĞƐ
ǁŶƚƐŝŐŶĂůŝŶŐƚŚƌŽƵŐŚĐŽŶƚƌŽůŽĨƉƌŝŵĂƌǇĐŝůŝĂƐƚƌƵĐƚƵƌĞŝŶŵĞƐĞŶĐŚǇŵĂůƐƚĞŵĐĞůůƐ͘^ĐŝĞŶƚŝĨŝĐƌĞƉŽƌƚƐ͘
ϮϬϭϯ͖ϯ͗ϯϱϰϱ͘
΀Ϯϰϵ΁ EĂǀĂDD͕ ZĂŝŵŽŶĚŝDd͕ WŝĞƚƌĂďŝƐƐĂ Z͘ ŽŶƚƌŽůůŝŶŐ ƐĞůĨͲƌĞŶĞǁĂů ĂŶĚ ĚŝĨĨĞƌĞŶƚŝĂƚŝŽŶ ŽĨ ƐƚĞŵ
ĐĞůůƐǀŝĂŵĞĐŚĂŶŝĐĂůĐƵĞƐ͘:ŽƵƌŶĂůŽĨďŝŽŵĞĚŝĐŝŶĞΘďŝŽƚĞĐŚŶŽůŽŐǇ͘ϮϬϭϮ͖ϮϬϭϮ͗ϳϵϳϰϭϬ͘
΀ϮϱϬ΁^ŝƐƚĂ^͕tĞŶ͕,ŽĚŐƐŽŶW͕WĂŶĚĞ'͘dŚĞ ŝŶĨůƵĞŶĐĞŽĨƐƵƌĨĂĐĞĞŶĞƌŐǇŽĨƚŝƚĂŶŝƵŵͲǌŝƌĐŽŶŝƵŵ
ĂůůŽǇŽŶŽƐƚĞŽďůĂƐƚĐĞůůĨƵŶĐƚŝŽŶƐŝŶǀŝƚƌŽ͘:ŽƵƌŶĂůŽĨďŝŽŵĞĚŝĐĂůŵĂƚĞƌŝĂůƐƌĞƐĞĂƌĐŚWĂƌƚ͘ϮϬϭϭ͘
΀Ϯϱϭ΁sĞŝƐ͕dƌŝƐŝW͕WĂƉĂĚŝŵŝƚƌŝŽƵ^͕dƐŝƌůŝƐd͕WĂƌŝƐƐŝƐE͕ĞƐŝƌŝƐ<͕ĞƚĂů͘KƐƐĞŽŝŶƚĞŐƌĂƚŝŽŶŽĨ
KƐƐĞŽƚŝƚĞ ĂŶĚ ŵĂĐŚŝŶĞĚ ƚŝƚĂŶŝƵŵ ŝŵƉůĂŶƚƐ ŝŶ ĂƵƚŽŐĞŶŽƵƐ ďŽŶĞ ŐƌĂĨƚ͘  ŚŝƐƚŽůŽŐŝĐ ĂŶĚ
ŚŝƐƚŽŵŽƌƉŚŽŵĞƚƌŝĐƐƚƵĚǇŝŶĚŽŐƐ͘ůŝŶŝĐĂůŽƌĂůŝŵƉůĂŶƚƐƌĞƐĞĂƌĐŚ͘ϮϬϬϰ͖ϭϱ͗ϱϰͲϲϭ͘
΀ϮϱϮ΁ĂŽD͕,ĂƐŚŝŶŽ<͕<ĂƚŽ/͕EŽůƚĂ:͘ĚŚĞƐŝŽŶƚŽĨŝďƌŽŶĞĐƚŝŶŵĂŝŶƚĂŝŶƐƌĞŐĞŶĞƌĂƚŝǀĞĐĂƉĂĐŝƚǇ
ĚƵƌŝŶŐĞǆǀŝǀŽĐƵůƚƵƌĞĂŶĚƚƌĂŶƐĚƵĐƚŝŽŶŽĨŚƵŵĂŶŚĞŵĂƚŽƉŽŝĞƚŝĐƐƚĞŵĂŶĚƉƌŽŐĞŶŝƚŽƌĐĞůůƐ͘ůŽŽĚ͘
ϭϵϵϴ͖ϵϮ͗ϰϲϭϮͲϮϭ͘
΀Ϯϱϯ΁ƌǌĞŶŝĞŬ͕^ŝĞďĞƌƚǌ͕^ƚŽĐŬĞƌ'͕:ƵƐƚh͕KƐƚĞƌƚĂŐt͕'ƌĞŝůŝŶŐ,͕ĞƚĂů͘WƌŽƚĞŽŐůǇĐĂŶƐǇŶƚŚĞƐŝƐ
ŝŶŚĂĞŵĂƚŽƉŽŝĞƚŝĐĐĞůůƐ͗ŝƐŽůĂƚŝŽŶĂŶĚĐŚĂƌĂĐƚĞƌŝǌĂƚŝŽŶŽĨŚĞƉĂƌĂŶƐƵůƉŚĂƚĞƉƌŽƚĞŽŐůǇĐĂŶƐĞǆƉƌĞƐƐĞĚ
ďǇƚŚĞďŽŶĞͲŵĂƌƌŽǁƐƚƌŽŵĂůĐĞůůůŝŶĞD^Ͳϱ͘dŚĞŝŽĐŚĞŵŝĐĂůũŽƵƌŶĂů͘ϭϵϵϳ͖ϯϮϳ;WƚϮͿ͗ϰϳϯͲϴϬ͘
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